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Abstract        
 Chlamydia abortus is the most common known infectious cause of ovine abortion 
worldwide but is rarely linked with bovine abortion. The reasons for this differential 
pathogenesis are unknown but may involve differences in innate immune recognition 
and immune responsiveness. This is supported by the observation that chlamydial 
abortion in sheep is associated with an inflammatory cytokine/chemokine cascade 
that is not commonly observed in cattle. Studies with other Chlamydia species have 
demonstrated that innate inflammatory pathways including inflammasome activation 
contribute to both pathogen clearance and pathology. Pattern recognition receptors 
(PRRs) activate these innate immune signalling pathways but are relatively poorly 
characterized in ruminants. We hypothesize that the ruminant hosts differ in their 
ability to innately sense C. abortus infection and activate the inflammasome. The 
main aims of this project were to: analyse PRR expression in innate immune cells; 
assess cytokine production from innate immune cells in response to C. abortus; 
investigate the role of PRRs in the induction of innate immune responses to C. 
abortus; and, conduct RNA-seq analysis on macrophages following infection with C. 
abortus to identify important immune signalling pathways. 
Ruminant oro-nasal turbinate cells, monocyte derived dendritic cells (MDDCs) and 
monocyte derived macrophages (MDMs) express the cell-surface PRRs TLR2 and 
TLR4 and also the intracellular PRRs NOD 1 and NLRP3. Oro-nasal turbinate cells 
produce CXCL8 late into the chlamydial developmental cycle independent of IL-1β. 
In contrast, ruminant MDMs and MDDCs secrete early IL-1β in response to C. 
abortus infection. In MDMs and MDDCs, live and UV-inactivated C. abortus 
induced TNF-α and CXCL8 but live infection was required for IL-1β secretion. 
Therefore, intracellular C. abortus multiplication is necessary to stimulate the IL-1β 
processing pathway within these cells. In order to determine PRR function, NOD1 
and NLRP3 were knocked down in ruminant MDMs using siRNA. In both ovine and 
bovine MDMs, NOD1 was identified as a factor in C. abortus mediated IL-1β 
production. NLRP3 knockdown in bovine but not ovine MDMs also reduced IL-1β 
production, indicating species-specific differences in C. abortus recognition. The 
 
  x 
RNA-seq analysis of ruminant MDMs identified novel pathways of immune 
activation by C. abortus and potentially important species-specific differences. An 
improved understanding of the innate immune pathways activated in susceptible and 
resistant hosts following C. abortus infection will inform on disease pathogenesis 
and could contribute to novel chlamydial vaccine design.
 
  xi 
Lay summary 
Chlamydia abortus is the most common known infectious cause of ovine abortion 
and therefore is of considerable importance to the farming industry. C. abortus rarely 
causes abortion in cattle which is interesting considering that sheep and cattle are 
often farmed together. In sheep, the bacterium activates the immune system and 
induces inflammation at the placenta which results in abortion. The bacteria multiply 
inside the host cell and the way that the host immune system recognises and responds 
to C. abortus is not well understood. Receptors found on the surface and inside the 
host immune cells are responsible for recognising foreign molecules and activating 
response pathways. Response pathways often result in the production of signalling 
molecules which aid communication between host immune cells. Important 
signalling molecules include CXCL8, IL-1β, IL-6 and TNF-α. We hypothesize that 
cattle and sheep differ in the way that they recognise and respond to the bacteria, 
which results in the different outcomes of infection. The main aims of this project 
were to: assess receptor expression on immune cells; assess the production of 
signalling molecules by immune cells in response to C. abortus; assess the role of 
receptors in the activation of response pathways to C. abortus; and, assess the 
expression of genes activated in macrophages (immune cell) in response to C. 
abortus. 
Receptors which were expressed inside (NOD1 and NLRP3) and on the surface of 
the cell (TLR2 and TLR4) were identified on various immune cells including: cells 
which line the oro-nasal cavity, macrophages and dendritic cells. Oro-nasal cells 
produced CXCL8 but not IL-1β unlike macrophages and DCs which were capable of 
both CXCL8 and IL-1β production. Using technology to reduce the expression of 
receptors we identified an important role for NOD1 in the production of IL-1β in 
both sheep and cattle macrophages.  NLRP3 was involved in IL-1β production in 
cattle but not sheep macrophages indicating differences in the recognition of C. 
abortus between species. The analysis of gene expression following C. abortus 
infection in macrophages has identified the type of response pathways activated and 
differences in the pathways activated between sheep and cattle. Identifying 
 
  xii 
differences in the way that sheep and cattle recognise and respond to C. abortus will 
improve our understanding of how abortion is mediated by the immune system and 
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Chapter 1: General Introduction 
1.1 Chlamydial diversity and host tropism 
1.1.1 Classification 
The phylum Chlamydiae encompasses the Chlamydiaceae and Chlamydia-like 
organisms. The discovery of Chlamydia-like organisms (environmental Chlamydiae) 
in 1990 challenged the perception of chlamydial diversity, which was previously 
based on just the Chlamydiaceae family but now includes 8 families (Horn, 2008). 
Research into the Chlamydia-like organisms is expanding; however, the 
Chlamydiaceae family is the focus of this review. 
Previously the Chlamydiaceae were classified into two genera: Chlamydia 
(Chlamydia trachomatis, C. suis and C. muridarum) and Chlamydophila 
(Chlamydophila abortus, C. psittaci, C. caviae, C. felis, C. pecorum and C. 
pneumoniae). This division was based on genetic differences in the 16S and 23S 
ribosomal RNA in a variety of isolates from multiple hosts (Everett et al., 1999). 
This division was not widely accepted at the time, and although it was used 
extensively by veterinary chlamydiologists, it was perhaps most notably not adopted 
by groups working on the human pathogen C. pneumoniae (Stephens et al., 2009). 
The criterion for species to fall within a particular genus was set at 95% identity. 
However, species from different genera were over 94% identical suggesting that the 
separation was based on sequence differences that may not be biologically 
meaningful (Schachter et al., 2001). Growing evidence of genetic similarity between 
the two genera has meant that the single Chlamydia genus classification has been re-
adopted (section 1.1.3) until the genomic data have been completely reviewed 
(Entrican et al., 2012; Greub, 2010; Sachse et al., 2015; Stephens et al., 2009). 
Genome sequences for most chlamydial species have recently become available, 
which has allowed for more thorough investigation into the genetics behind species 
diversity (see section 1.1.4) (Clarke, 2011).  
1.1.2 Chlamydial developmental cycle 
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All Chlamydiae share a characteristic biphasic intracellular developmental cycle. The 
bacterium exists extracellularly as an infectious but metabolically inactive 
elementary body (EB) (Abdelrahman and Belland, 2005).  The bacteria attach to the 
host cell before becoming internalized after complex host cell-pathogen interactions 
(Dautry-Varsat et al., 2005). The EBs transform into metabolically active reticulate 
bodies (RBs) within a protective intracellular niche termed an inclusion. Within the 
inclusion the RBs multiply by binary fission and then transform back into EBs 
(Abdelrahman and Belland, 2005), before being released via host cell lysis or by 
extrusion to infect other cells and begin the cycle once again (Hybiske and Stephens, 












Figure 1.1: The chlamydial developmental cycle. The infectious but metabolically inactive 
elementary body (EB) attaches to the host cell. Once internalised, the EB transforms into a 
metabolically active reticulate body (RB) and begins to multiply within the cell. RB 
multiplication and the transformation back to EBs is asynchronous, before the EBs are 
released to infect further host cells (adapted from Abdelrahman and Belland, 2005). 
1.1.3 Host and tissue tropism 
The Chlamydia genus is currently composed of 12 species, namely C. trachomatis, 
C. muridarum, C. suis, C. pneumoniae, C. felis, C. pecorum, C. caviae, C. abortus, 
EB 
RB 
Host cell Inclusion 
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C. psittaci, C. avium, C. gallinacea and C. ibidis (Sachse et al., 2015). These bacteria 
can cause a spectrum of diseases in a range of hosts (Table 1.1). The primary sites of 
chlamydial infection are mucosal surfaces and in some cases pathology is limited to 
these sites. However, some species, and biovars within species, can invade further to 
cause pathology at distal sites (Meeusen et al., 2004) .  
Table 1.1: The host tropism and disease spectrum of the Chlamydia genus.  
Chlamydial 
species 
Typical host (s) Serovars Example associated 
diseases 
References 
C. trachomatis  Humans D, E, F, 
G, H, I, J 
and K 












C. pneumoniae  Humans, horses 
and amphibians 
 Respiratory disease Nunes and 
Gomes, 
2014 








C. felis  Cats  Conjuctivitis Nunes and 
Gomes, 2014 

















C. abortus  Ruminants and 
swine 
 Abortion Schoborg, 
2011 
C. psittaci  Poultry and 
psittacine birds 
 Avian chlamydiosis  Knittler et al., 
2014 
C. avium  Pigeons and 
psittacine birds 
 Unknown Sachse et al., 
2014 
C. gallinacea  Poultry  Unknown Sachse et al., 
2014 
C. ibidis  Feral sacred 
ibis 
 Unknown Vorimore et 
al., 2013 
A number of the Chlamydia species are pathogens of clinical importance in humans. 
C. trachomatis is the most common bacterial cause of sexually transmitted disease in 
humans. Infection is often asymptomatic but can cause pathology including pelvic 
infertility disease (PID) and infertility. The serovars within the lymphogranuloma 
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venereum (LGV) biovar of C. trachomatis are capable of disseminating from the 
genital mucosa to the draining lymph nodes and may cause chronic granulomatous 
disease (Fehlner-Gardiner et al., 2002). Trachoma caused by serovars within the 
trachoma biovar of C. trachomatis is the leading cause of preventable blindness 
worldwide (Fehlner-Gardiner et al., 2002). Intravaginal inoculation of mice with C. 
muridarum results in a genital infection that has similar characteristics to C. 
trachomatis infection in women. C. muridarum is not a known pathogen of humans 
but provides a suitable model of disease for studies. C. pneumoniae is also an 
important human pathogen that can cause respiratory disease. Other chlamydial 
species which have known zoonotic potential include C. psittaci, C. abortus and C. 
felis (Nunes and Gomes, 2014). C. abortus is particularly important because of the 
severe consequences of infection, including abortion and septicaemia, in pregnant 
women (Essig and Longbottom, 2015). 
1.1.4 Comparative Chlamydiaceae genomics 
Genome sequencing has dramatically improved our understanding of the host 
adaptation and basic biology of Chlamydiaceae.  Comparative analyses of the 
Chlamydia genomes have demonstrated high levels of conservation across species 
and a common reduced genome size (Knittler et al, 2014). The reduced genome size 
is likely due to the increased reliance on host-derived molecules that accompanies an 
obligate intracellular life cycle. Evidence of this in the Chlamydiaceae is 
demonstrated by the loss of a number of genes involved in metabolic pathways, as 
these molecules could be scavenged from the host (Thomson et al., 2005).   
A number of common genes with important functions have been identified within all 
the Chlamydiceae genomes.  Polymorphic membrane proteins (Pmps) and inclusion 
membrane proteins (incs) (Gupta and Griffiths, 2006) are thought to function in 
interactions with the host, including in adhesion and antigen driven immune evasion 
(Nunes and Gomes, 2014).  Chlamydiaceae also possess a Type 3 Secretion System 
(T3SS), which is thought to be important for virulence as it allows the bacterium to 
insert effectors into the host cell. Translocated actin recruiting protein (TARP) is an 
example of a T3SS effector found in all sequenced Chlamydiaceae genomes, which 
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is thought to be responsible for the remodelling of host cell actin to facilitate 
infection (Nunes and Gomes, 2014). The plasticity zone (PZ) has been identified as a 
hypervariable region present in all Chlamydiceae genomes. A number of genes have 
been identified within the PZ regions that are thought to contribute to chlamydial 
pathogenicity and niche tropism (Rockey, 2011; Thomson et al., 2005) 
Comparative genomics has been used to compare Chlamydiaceae genomes and has 
revealed interspecies and intraspecies differences which may explain host and tissue 
tropism (Bachmann et al., 2014b).  
1.1.4.1 Interspecies variation 
There is a high degree of conservation in both gene order and content despite the 
varied host range and tissue tropism of the various Chlamydiaceae species 
(Bachmann et al., 2014a). Variability has been identified within the PZ region and 
pmp genes between different species, which may be important for determining host 
adaptation (Bachmann et al., 2014b).  
The PZ region of different species encode a number of genes including a tryptophan 
(Trp) operon, toxin genes and biotin synthesis genes, all of which have been 
implicated in interspecies variation. The Trp operon encodes tryptophan synthase, 
which is responsible for the synthesis of tryptophan essential for bacterial survival. 
The genital serovars of C. trachomatis encode a functional Trp operon which allow 
the bacteria to synthesise tryptophan from indole found in the genital microflora 
(Coers et al., 2009). The absence of the Trp operon means that the organisms are 
dependent on host cell tryptophan and are potentially more susceptible to IFN-γ 
mediated indolamine 2, 3-dioxygenase (IDO) activation, which mediates tryptophan 
depletion. C. pneumoniae, C. muridarum and C. abortus all lack a functional Trp 
operon, which may explain why these bacteria colonize certain anatomical niches 
with greater access to host tryptophan or where they have protection from IFN-γ 
mediated degradation (Thomson et al., 2005). IFN- γ avoidance genes may also have 
a role in determining host-tropism. C. muridarum has developed mechanisms to 
avoid IFN-γ inducible GTPases that are more important for immune defence against 
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Chlamydia in mice than tryptophan depletion (Nelson et al., 2005). IFN-γ is an 
important cytokine in immune defence to chlamydial infections and this will be 
discussed in section 1.4.3. 
Genes encoding a cytotoxin, similar to the Enterohemorrhagic E-coli (EHEC) 
adherence factor, are present in the PZ region of C. psittaci, C. felis, C. caviae, C. 
muridarum, C. pecorum and C. pneumoniae but absent in other chlamydial species 
(Voigt et al., 2012). C. psittaci, C. trachomatis, C. pecorum, C. felis and koala C. 
pneumoniae isolates express membrane attack complex/perforin genes (MACPF) 
(Sait et al., 2014; Voigt et al., 2012). The function of the cytotoxin and MACPF 
genes in chlamydial species is not yet known (Voigt et al., 2012). The guaAB-add 
gene cluster encodes accessory virulence genes thought to be involved in purine 
biosynthesis and is present in C. pneumoniae, C. muridarum, C. felis and C. psittaci 
genomes but not in C. trachomatis or C. abortus (Read et al., 2013). Biotin synthesis 
genes have been found in C. pneumoniae, C. abortus, C. psittaci, C. felis and C. 
pecorum genomes but were absent in C. muridarum, C. caviae and C. trachomatis 
(Sait et al., 2014). The presence of biotin synthesis genes within the C. abortus 
genome may be important for the ability of the bacteria to survive in the placenta 
(Thomson et al., 2005), as pregnancy has been shown to result in a biotin-deficiency 
in humans (Mock et al., 2002). 
The pmp genes were first identified on the outer membrane of C. abortus 
(Longbottom et al., 1998) and have since been identified in all other Chlamydia 
species.  The different species have varying numbers of pmp genes, from nine in C. 
trachomatis and C. muridarum to 21 in C. pneumoniae and C. psittaci (Knittler et al., 
2014). Pmp genes have been shown to be immunogenic and are thought to be 
involved in the attachment of EBs to the host cell surface. The pmp genes also 
contribute to antigenic variation facilitating evasion of the host immune system 
(Longbottom et al., 1998). They are characterized by a high rate of mutation between 
and within species, possibly indicative of adaptation to different hosts. The increased 
number of pmp genes in some species may be reflective of the ability to infect 
multiple hosts (Knittler et al., 2014).  
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Therefore, it is likely that the combination of a number of genetic differences, and 
not a single gene, are responsible for determining host and niche tropism between 
species of Chlamydia.  
1.1.4.2 Intraspecies variation 
 Chlamydial strains are isolates of the same species that are usually differentiated 
based on genetic variation, particularly in ompA that encodes the major outer 
membrane protein (MOMP). However, more recent typing studies have moved to a 
whole genome approach (Nunes and Gomes, 2014). C. trachomatis is the only 
chlamydial species which contains serovars (Table 1.1), which are groups of strains 
separated based on MOMP differences (Byrne et al, 2010). Different chlamydial 
serovars/strains can have varied host and tissue tropism (Bachmann et al., 2014b). 
Studying the genetics of these strains will help identify the specific genes involved in 
host-pathogen interactions.  
Mutations have been identified in the Trp operon of the ocular strains of C. 
trachomatis, which indicate they do not encode functional tryptophan synthase. 
Unlike in the genital tract, indole is not thought to be present (Fehlner-Gardiner et 
al., 2002) in the relatively limited cultivable microbiota of the conjunctiva (compared 
to other mucosal surfaces) (Willcox, 2013) and, therefore, the loss of the functional 
Trp operon may contribute to niche tropism of ocular strains (Fehlner-Gardiner et al., 
2002). Cytotoxin genes have been identified in ocular and genital strains of C. 
trachomatis but have been lost by the LGV strains. Chlamydial cytotoxin may 
inactivate GTP-binding proteins, which inhibits the trafficking of vesicles within the 
cell and may restrict infection to the mucosal site. Therefore, loss of the cytotoxin 
gene may facilitate dissemination of the LGV strains beyond the genital mucosa 
(Belland et al., 2001; Thomson et al., 2008). The N-terminal of the cytotoxin gene is 
complete in genital but not ocular strains of C. trachomatis. The N-terminal of the 
cytotoxin gene encodes a glycosyltranferase domain, which may promote the 
colonization of the genital tract (Bachmann et al., 2014b). Single nucleotide 
polymorphisms (SNPs) identified within the pmp gene family, particularly in pmpH, 
can distinguish ocular, genital and LGV C. trachomatis strains (Stothard et al., 
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2003). In addition, SNP distribution in two pmp genes can distinguish rectal from 
cervical C. trachomatis strains (Jeffrey et al., 2010). Therefore, the pmp genes may 
also contribute to the tissue tropism of different chlamydial strains. 
A study comparing C. pecorum strains from koala, sheep and cattle found that the 
region with the largest number of SNPs was the pmp gene region. A different region 
that includes genes encoding T3SS components and effector proteins also contained 
a large number of SNPs. A number of pseudogenes, including a toxin gene, were 
identified in the koala strains that were found to be intact in the ruminant strains. The 
loss of gene function suggests that these genes were not necessary for infection of the 
koala host but potentially important for infection of the ruminant hosts (Bachmann et 
al., 2014b). Three ruminant C. pecorum strains that caused different pathological 
conditions (asymptomatic enteric infection, polyarthritis and metritis) were found to 
have highly conserved genomes. A higher level of cluster tandem repeat sequences 
(CTRs) in ORF663 in the asymptomatic strain was identified compared to the 
pathogenic strains, which may account for the observed differences in pathology. 
The product of ORF663 is thought to be surface expressed and a reduction in CTRs 
may decrease surface area for antibody binding and increase pathogenicity (Sait et 
al., 2014). Comparison of the koala C. pneumoniae (LPCoLN) strain to 4 human 
strains of C. pneumoniae identified over 2000 SNPs in the pmp genes consistent with 
adaptation to different hosts. There were also polymorphisms detected in the 
MACPF region and the koala strain was missing the guAB-add cluster but contained 
a plasmid unlike the human strains (Mitchell et al., 2010). Similarly, a study 
comparing 20 C. psittaci strains identified differences in the PZ region, particularly 
in the gua-AB-add and toxin gene, which may reflect adaptation to particular niches 
(Read et al., 2013). 
Genes encoding recombination elements including chlamydiaphages and a conserved 
plasmid can be found in many of the Chlamydiaceae genomes and there is evidence 
that gene exchange usually occurs between different strains of the same species 
(Nunes et al., 2013; Nunes and Gomes, 2014). The analysis of multiple C. 
trachomatis strains has identified that recombination alters the sequence of important 
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genes (Joseph et al., 2012) and therefore is likely to be critical in promoting strain 
diversity. Isolates of C. trachomatis that do not possess the plasmid are rare, 
suggesting that it is important for C. trachomatis biology. The plasmid has been 
shown to encode a gene that facilitates the accumulation of glycogen and normal 
inclusion morphology (Song et al., 2013). C. trachomatis strains that have been 
cured of the plasmid protect mice against pathology following subsequent challenge 
with the wild-type strain (O'Connell et al., 2007). Ocular infection of macaques with 
a plasmid deficient strain was also shown to be non-pathogenic and protective 
against future challenge with the plasmid-positive strain (Kari et al., 2011). 
Therefore, in vivo the chlamydial plasmid has been identified as an important 
virulence factor that stimulates the pathological immune response and may 
potentially activate a TLR2 dependant pathway ( Kari et al., 2011; O'Connell et al., 
2011). 
Cattle and sheep are often grazed together and are therefore likely to be exposed to 
similar pathogens, including C. abortus. C. abortus rarely causes abortion in cattle, 
which is interesting considering it is an important cause of abortion in sheep (see 
section1.2.1). Whole genome sequencing of C. abortus strains isolated from cattle, 
sheep and goats revealed that the strains were highly conserved. Little variation was 
identified in the PZ region suggesting there was minimal intraspecies variation 
between C. abortus strains. Therefore, it is unlikely that genetic differences in the 
strains that infect cattle and sheep are responsible for the observed differential 
disease pathogenesis (Longbottom et al, unpublished). However, minimal genetic 
variation has previously been identified to induce differences in C. psittaci pathology 
(Miyairi et al., 2011), which suggests that the role of genetic variation between C. 
abortus strains in host tropism cannot be completely discounted. 
Intraspecies genetic variation has been identified within the PZ region or within pmp 
genes of the Chlamydiaceae family. The functional relevance of most of this genetic 
variation has yet to be fully elucidated.  Further analysis with novel genetic 
transformation systems should help to further identify the role for specific genes in 
both host and tissue tropism. 
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1.1.5 Genetic transformation 
The development of genetic transformation techniques for Chlamydiaceae has been 
hindered due to its obligate intracellular developmental cycle. The necessity for host 
cells to facilitate chlamydial growth makes the transformation process complicated, 
as complex technical steps are required to purify the bacteria and transformants take 
longer to generate (Beare et al., 2011). Early studies inserted DNA into C. 
trachomatis using electroporation but this method had limitations (Tam et al., 1994). 
Recently, however, three genetic transformation techniques have been successfully 
developed to identify gene function in C. trachomatis.  
A reverse-genetic method involving chemical mutagenesis was used to generate C. 
trachomatis trpB null mutants. The trpB mutants could not be rescued from IFN-γ 
induced tryptophan starvation with the addition of indole unlike the non-mutant 
strain identifying the known role for trpB in the expression of tryptophan synthase 
(Kari et al., 2011). The endogenous Chlamydia plasmid and an E. coli plasmid were 
combined to construct a shuttle vector in another study. The vector was capable of 
introducing penicillin resistance and GFP into a plasmid-cured strain of C. 
trachomatis. This technology was also used to demonstrate the role for the plasmid 
in driving glycogen synthesis and accumulation in the chlamydial inclusion (Wang et 
al., 2011). A different study developed dendrimers (synthetic nanomolecules), which 
deliver plasmid DNA into C. pneumoniae and C. trachomatis. Similarly to the 
previous study, GFP was expressed by Chlamydia following dendrimer delivery of 
the GFP containing plasmid (Gerard et al., 2013; Kannan et al., 2013; Mishra et al., 
2012). Dendrimers have also been used for targeted chlamydial gene knock-down 
(Mishra et al., 2012). Genetic transformation techniques have great potential for 
further elucidation of the genetic basis of pathogen virulence. 
1.1.6 Host species diversity in response to Chlamydia 
infection 
Successful pathogens evolve to survive within their host niche; however, genetic 
differences in the host can determine susceptibility to infection as well as the way the 
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immune system recognises and responds to infection. Mouse models are often used 
in studies of the immune response to chlamydial infection but these models have 
limitations. Chlamydial infection in mice does not induce a chronic infection, instead 
viable Chlamydia is only detected within 4 weeks post-infection contrasting to the 
months (may last over a year) before clearance with chlamydial infection in humans 
(Miyairi et al., 2010). Similarly, C. abortus establishes a persistent infection within 
the ruminant host but not within mice (Caro et al., 2009). This suggests that there are 
differences in the way that the host first recognizes the bacteria, which mediates 
clearance or the induction of persistence.  
Not all women infected with C. trachomatis will go on to develop upper genital tract 
hydrosalpinx, which is indicative of differences in disease severity. A study 
investigating 11 strains of mice from different genetic backgrounds identified 
differences in host susceptibility to hydrosalpinx development following C. 
muridarum infection (Chen et al., 2014). Diversity in immune response genes may 
determine differences in how the host recognises and responds to a pathogen (Sironi 
et al., 2015). SNPs in a number of inflammatory immune genes have been associated 
with the development of severe trachoma pathology in humans (Atik et al., 2008; 
Mozatto-Chamay et al., 2001; Natividad et al., 2007). Similarly, the presence of 
multiple SNPs in specific PRR genes has also been associated with increased risk of 
chlamydial tubal pathology, although this was not found to be significant (den 
Hartog et al., 2006).  
Host species diversity may play an important role in determining the disease 
pathogenesis of C. abortus. Cattle and sheep diverged around 30 million years ago 
(Hedges et al., 2006), which suggests that they are evolutionarily relatively closely 
related species. However, differences have been identified in cattle and sheep 
immune genes that may have functional consequences, including in TLR9 which 
responds in a species-specific manner to specific ligands (Werling et al., 2009). 
Therefore, genetic differences between cattle and sheep may impact on innate 
immune recognition and response, which may influence the differential outcome to 
C. abortus exposure. Although this project focuses on C. abortus, there is evidence 
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for differential disease pathogenesis between cattle and sheep for other intracellular 
pathogens, most notably the apicomplexan protozoan parasites Toxoplasma gondii 
and Neospora caninum. Both can infect cattle and sheep, and whereas T. gondii is a 
major cause of abortion in sheep but not cattle, the converse is true for N. caninum 
(Innes and Mattsson, 2007). This suggests some fundamental differences between 
these hosts that merit further investigation.   
Pathogens and hosts are continually under selective pressure from each other to 
evolve in order to survive (Sironi et al., 2015). Complex host-pathogen interactions 
are therefore likely to determine the outcome of pathogen exposure between different 
hosts. Comparing the innate immune response of two closely related hosts to the 
same pathogen may reveal species-specific differences that contribute to disease 
pathogenesis. 
1.2 Epidemiology, transmission and pathogenesis of 
C. abortus 
1.2.1 Epidemiology 
C. abortus is a major cause of lamb loss worldwide, with the exception of Australia 
and New Zealand (Entrican et al., 2010). Within the UK, C. abortus is the single 
most common diagnosed cause of infectious abortion in sheep (Figure 1.2) and is 
therefore of great economic and welfare importance. The UK Veterinary 
Investigation Surveillance Reports 2007-2014 statistics identified C. abortus as the 
cause of over 40% of diagnosed infectious ovine fetopathies but less than 1% of 
bovine fetopathies (Figure 1.2) (Animal and Plant Health Agency (APHA), 2014). 
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Figure 1.2: Diagnosed infectious causes of ovine and bovine fetopathies 2007-2014. 
The UK Veterinary Investigation Surveillance reports from 2007-2014 were used to produce 
pie charts of the diagnosed infectious causes of ruminant fetopathies (Animal and Plant 
Health Agency (APHA), 2014) 
Cattle are susceptible to infection even if they do not, in general, exhibit disease. In 
cattle C. abortus can cause chronic sub-clinical reproductive problems and has been 
linked with infertility and mastitis (Appino et al., 2007; Kaltenboeck et al., 2005; 
Reinhold et al., 2011). Much can be learned from the study of hosts that can be 
infected by the same pathogen but present with different pathologies. 
C. abortus is also a zoonotic pathogen, which can cause abortion in pregnant women 
(Longbottom and Coulter, 2003). The first diagnosed cases of human abortion caused 
by C. abortus were highlighted in a letter to the Veterinary Record in 1986, when 5 
pregnant women became seriously ill and lost their children (Eddy and Martin, 
1986). In humans, the bacteria can induce septicaemia that results in disseminated 
intravascular coagulation, which can lead to spontaneous abortion (Forsbach-Birk et 
al., 2013; Johnson et al., 1985). The extent of human infection, particularly within 
the high-risk agricultural population, is somewhat unknown due to the lack of 
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against close contact with birthing ruminants and adverse human responses due to C. 
abortus infection are currently rare (Essig and Longbottom, 2015).  
There have been few studies on the identification of C. abortus in wildlife, but those 
that have been done have identified C. abortus infection in wild boar and deer 
(Hotzel et al., 2004; Salinas et al., 2009). C. abortus was found in animals from 
fenced estates with no contact with livestock which suggests that wildlife may be an 
important self-propagating reservoir for disease (Salinas et al., 2009).  
1.2.2 Transmission 
A major route of transmission of C. abortus into a naïve sheep flock is through the 
introduction of infected replacement ewes (Milne et al., 2009). Infected ewes can 
shed large numbers of the bacteria in vaginal discharge and aborted material, such as 
placenta and coats of lambs (Essig and Longbottom, 2015). The bacteria can then 
remain viable within the environment for several days, which may be prolonged with 
colder weather facilitating further transmission (Longbottom and Coulter, 2003).  
Following oral-nasal ingestion, the bacteria can then persist, at a site as yet unknown, 
asymptomatically within the non-pregnant ewe. In the subsequent pregnancy, C. 
abortus infects the placenta and initiates pathology at around day 90 of gestation 
(Kerr et al., 2005), which causes abortion usually within the last 2-3 weeks of 
gestation (Rocchi et al., 2009). Often the first sign of the disease is the discovery of 
an infected dead lamb, which makes disease control difficult (Essig and Longbottom, 
2015). If a ewe is infected after around 110-120 days of gestation, they will generally 
deliver normally but may still abort during their next pregnancy. Interestingly, not all 
ewes which are infected with C. abortus will go on to abort (Figure 1.3) 
(Longbottom and Coulter, 2003). Once a ewe has aborted due to C. abortus it does 
not abort again with re-infection. However, the immunity that develops within these 
ewes is not necessarily sterile, as they have been shown to shed at oestrus and with 
subsequent lambing facilitating further transmission (Livingstone et al., 2009).  
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Figure 1.3: The transmission cycle of C. abortus. The introduction of an infected 
replacement ewe into a previously clean flock is a major route of transmission for C. abortus. 
Infected ewes can shed the bacteria in vaginal discharge and aborted material allowing the 
bacteria to infect naïve sheep via the oro-nasal route. Within the newly infected ewe, C. 
abortus establishes a persistent infection until pregnancy when it can induce abortion. 
Although not all sheep will go on to abort they may still shed the bacteria also contributing to 
the transmission cycle (Essig and Longbottom, 2015; Milne et al., 2009).  
The C. abortus transmission cycle means that after the introduction of a small 
number of infected ewes into a flock there are usually few abortions within the first 
year but an abortion storm, which can affect around 30% of the flock, in the second 
year as more ewes are exposed to infected material (Milne et al., 2009).  
1.2.3 Pathogenesis 
In order to understand the pathogenesis of C. abortus it is important to understand 
three key stages: persistence and recrudescence, inflammation mediated abortion and 
the development of protective immunity. 
1.2.3.1 Persistence and recrudescence 
A characteristic feature of all chlamydial species, including C. abortus, is the ability 
to establish chronic sub-clinical infections. In vitro and with certain stressors RBs 
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may develop into aberrant bodies (ABs), which allow the bacteria to persist within 
the host cell until the absence of stressors means they can continue multiplying 
(Schoborg, 2011). A number of stressors have been identified, including antibiotics 
and IFN-γ. Some researchers think that AB formation allows the development of 
these characteristic sub-clinical infections. However, the clinical relevance of AB 
formation is not known as its existence is yet to be proven in vivo (Bavoil, 2014). 
C. abortus is usually sub-clinical until pregnancy, when the bacteria can recrudesce 
from its persistent state and cause abortion. It is not yet known where the bacterium 
persists, although some studies suggest it may reside in the tonsil when the animals 
are first infected (Jones and Anderson, 1988; Longbottom et al., 2013b). Therefore, it 
remains unclear how C. abortus can persist sub-clinically in vivo or what triggers its 
recrudescence at pregnancy (Rocchi et al., 2009). 
1.2.3.2 Inflammation mediated abortion 
Recrudescence from the persistent state allows C. abortus to invade the placenta and 
multiply within trophoblast cells.  This results in the initiation of an inflammatory 
cascade, which is characterized by the production of the pro-inflammatory TNF-α 
and CXCL8.  Increased pro-inflammatory cytokine/chemokine production leads to 
recruitment of an inflammatory infiltrate, consisting of neutrophils, 
monocytes/macrophages, T cells and few B cells (Gutierrez et al., 2011; Rocchi et 
al., 2009). This infiltrate induces cell death and the formation of foetal membrane 
lesions, which disrupts the chorionic epithelium and also causes vascular thrombosis 
contributing to abortion (Rocchi et al., 2009). The development of placental lesions 
usually occurs after 90 days gestation, which coincides with abortion in the later 
stages of pregnancy (section 1.2.2) (Buxton et al., 1990; Longbottom et al., 2013b).  
Inflammation is important in the mediation of clearance of bacterial infections; 
however, the abundant expression of inflammatory cytokines such as TNF-α at the 
materno-fetal interface is associated with abortion (Buxton et al., 2002). Therefore, 
the immune response in the placenta may be inappropriately activated in response to 
C. abortus resulting in abortion.  
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1.2.3.3 Immunity that protects against chlamydial abortion 
Protective immunity does develop to C. abortus as once a ewe has aborted due to 
infection it does not abort again with re-infection (Littlejohn, 1950). However, 
protective immunity does not completely clear the bacteria as the animal can still 
shed C. abortus post-abortion, as described in section 1.2.2 (Livingstone et al., 
2005).  The development of protective immunity is complex. A recent paper 
identified that a low dose of C. abortus induced a persistent infection that resulted in 
abortion, whereas a high dose resulted in lower rates of abortion. This is indicative of 
the development of protective immunity with the larger dose. In the one ewe that did 
abort with the larger dose, a reduced number of C. abortus were detected in vaginal 
swabs post abortion compared to the mean number from ewes that aborted following 
challenge with the lower dose. This indicates that a strong immune response that 
promotes bacterial clearance is induced with the larger dose (Longbottom et al., 
2013b). 
Ewes produce low levels of antibodies in response to C. abortus infection which are 
rapidly increased at the time of abortion. There was no significant difference in 
antibody level in sheep following infection that went on to abort compared to those 
that didn’t abort (Livingstone et al., 2005). Sheep which were vaccinated against C. 
abortus and gave birth to healthy lambs also had comparable antibody titres pre-
infection challenge to those which went on to abort (Chalmers et al., 1997). These 
studies suggest that antibodies are not involved in protection against abortion during 
primary infection of the placenta, but may function in the development of protective 
immunity following abortion.  
Cell-mediated immunity is likely to play a more important role than antibodies in 
protection to primary C. abortus infection due to the bacteria’s obligate intracellular 
nature (Entrican et al., 2004). In vitro, IFN-γ has been shown to restrict C. abortus 
growth through tryptophan depletion (Entrican et al., 1998), described in section 
1.1.4.1. Increased IFN-γ in vivo has been identified in the lymph of immune sheep 
(sheep which have previously aborted due to C. abortus) in response to challenge 
with C. abortus, suggesting a protective role for the cytokine (Graham et al., 1995). 
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Peripheral blood mononuclear cells (PBMC) were collected from pregnant ewes 
experimentally infected with C. abortus at 2-week intervals and stimulated in vitro 
with Concanavalin A (ConA). A higher level of IFN-γ was detected in ewes that 
were infected but did not go on to abort compared to those which did abort. 
Similarly, PBMC from vaccinated animals produced higher IFN-γ in vitro in 
response to C. abortus EBs compared to non-vaccinated control sheep. Collectively, 
this suggests that early IFN-γ production may be protective against C. abortus 
induced abortion (Rocchi et al., 2009). 
Pregnancy complicates the potentially protective role of IFN-γ with C. abortus as 
IFN-γ has been shown to be incompatible with successful pregnancy. Pregnancy is 
thought to induce a switch in maternal immunity to a Th2 response (Rocchi et al., 
2009), and a predominance of IL-4 production has been identified with human 
pregnancy. However, a study of ovine PBMC found that IL-4, IFN-γ and IL-10 
responses to antigen were unaltered with pregnancy, suggesting potentially important 
differences between sheep and human pregnancy (Wattegedera et al., 2008).  
There have been limited studies on the type of host innate immune interactions that 
induce protective immunity to C. abortus, and the primary cellular producer of IFN-γ 
has not yet been identified in vivo. In order to understand more about chlamydial 
immunity the next two sections will review the better-characterized immune 
responses of hosts to C. trachomatis, C. muridarum and C. pneumoniae.  
1.3 Chlamydia and the innate immune system 
The immune system is composed of innate and adaptive arms. The innate immune 
system is the first line of defence and once activated can inform and shape the 
adaptive immune system. 
1.3.1 Cells of the innate immune system 
The skin, mucosal linings and bodily fluid act as the first barriers that Chlamydia 
encounters. These barriers are made up of innate immune cells including epithelial 
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cells, monocyte/macrophages and DCs. Chlamydia are primarily epitheliotropic 
where the bacteria can stimulate an inflammatory response through the production of 
pro-inflammatory cytokines, which induce the recruitment of innate immune cells 
such as neutrophils, natural killer (NK) cells, macrophages and dendritic cells (DCs) 
(Roan and Starnbach, 2008). Often, the site of chlamydial infection is not the site of 
pathology and innate immune cells may also play an important role in chlamydial 
dissemination. The diverse roles of the innate immune cells in relation to chlamydial 
infection including inflammation, polarization of the adaptive immune system and 
dissemination will be discussed.  
Neutrophils are one of the first cells to arrive at the site of chlamydial infection 
(Register et al., 1986). They are usually short-lived as undergo spontaneous 
apoptosis (Zandbergen et al., 2004) and are thought to respond to chlamydial 
infection through the release of inflammatory mediators (Frazer et al., 2011). Early in 
vitro studies demonstrated that neutrophils can internalize Chlamydia and are 
generally chlamydiacidal, however some viable bacteria were able to persist within 
these cells (Register et al., 1986). More recent studies have shown that chlamydial 
infection can prolong the life of neutrophils through the delay of apoptosis, allowing 
multiplication of the bacteria within the cell (Frazer et al., 2011; Zandbergen et al., 
2004). The neutrophils may also function in the dissemination of the bacteria from 
the site of infection and can be taken up by macrophages for long-term survival 
(Rupp et al., 2009). Neutrophils were also found to enhance chlamydial replication in 
epithelial cells (Rodriguez et al., 2005). Studies in vivo suggest that increased 
neutrophil recruitment is associated with the development of chlamydial pathology 
and increased bacterial load (Frazer et al., 2011; Rodriguez et al., 2005).  
NK cells have been shown to be recruited to the site of chlamydial infection, where 
they are thought to act as an early source of IFN-γ (Tseng and Rank, 1998). A role 
for NK cells has also been identified in the induction of lysis of Chlamydia-infected 
epithelial cells. Chlamydia have been shown to down-regulate MHC I expression on 
epithelial cells, which allows the bacteria to avoid presentation to cells of the 
adaptive immune system. However, this down-regulation also makes them targets for 
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NK cells as MHC I is required for NK inhibitory receptors (Hook et al., 2004). NK 
cell depletion in mice infected with C. muridarum lead to exacerbated disease with 
higher bacterial load. In this study, the role identified for NK cells was in the 
modulation of DC function for the production of a protective Th1 response (Jiao et 
al., 2011). Transcriptomic profiles of the conjunctiva indicated an up-regulation of 
genes involved in NK cell activation in individuals with active trachoma compared to 
non-infected controls (Natividad et al., 2010). 
Phagocytes such as macrophages and DCs are thought to be important for bridging 
the innate and adaptive immune systems as they process chlamydial antigens and 
present them on MHC I/II complexes to T cells. Early studies revealed that 
chlamydial EBs are rapidly taken up by macrophages and can survive and replicate 
within them, although replication is thought to be limited (Rey-Ladino et al., 2007). 
Survival within macrophages only occurs at low infectious doses as higher doses 
resulted in ‘immediate cytotoxicity’ (Manor and Sarov, 1986; Wyrick and 
Brownridge, 1978; Wyrick et al., 1978). In order to survive in macrophages, bacteria 
must be able to avoid lysosmal enzymes and it has been shown that the fusion of 
vacuoles containing Chlamydia with lysosomes is inhibited (Eissenberg and Wyrick, 
1981). Survival within macrophages facilitates their potential role in the 
dissemination of the bacteria from the site of infection (Gieffers et al., 2004; Moazed 
et al., 1998). Macrophages infected with Chlamydia have also been shown to induce 
T cell death through apoptosis, indicative of a role in the induction of persistent 
infections (Jendro et al., 2000). C. pneumoniae has been shown to induce the 
formation of macrophage foam cells, which accumulate in the formation of 
atherosclerotic plaques contributing to pathology (Kalayoglu and Byrne, 1998).  
Dendritic cells are antigen-presenting cells that have an important role in the 
activation and polarization of T cell immunity. Studies have shown that DCs are 
recruited to the site of chlamydial infection (Brunham and Rey-Ladino, 2005) and 
that bacteria can survive and persist within them. This suggests that DCs may also be 
involved in the maintenance of persistent infections and dissemination (Rey-Ladino 
et al., 2007). Co-culture of C. pneumoniae infected human MDDCs with T cells 
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induced type 1/type 17 polarization (Flego et al., 2013). In vitro, DCs pulsed with 
heat-inactivated C. muridarum induced the proliferation of type 1 polarized T cells, 
which produced IFN-γ. The adoptive transfer of these pulsed DCs protected mice 
from pathology following subsequent genital challenge with C. muridarum (Su et al., 
1998).  
Innate immune cells are critical for the early recognition of chlamydial infection.  
However, a number of studies have demonstrated the ability of Chlamydia to alter 
the function of innate immune cells to promote self-survival. Increased knowledge 
on how these innate immune cells recognise and respond to infection could be 
critical for understanding the balance between the mediation of persistence and the 
induction of inflammatory responses for chlamydial clearance.  
1.3.2  Pathogen recognition receptors 
Pathogen recognition receptors (PRRs) are sentinels of the innate immune system. 
PRRs are found on the surface or within innate immune cells and recognise unique 
molecular patterns, including pathogen associated microbial patterns (PAMPs) 
(Janeway, Jr., 1989) and damage-associated molecular patterns (DAMPs)(Seong and 
Matzinger, 2004). Cells express different complements of PRRs, which once 
activated induce signaling pathways within the cell. These signaling pathways can 
result in the production of cytokines and chemokines, activation of the adaptive 
immune response and induction of cell death (Bortoluci and Medzhitov, 2010). 
Although PRRs are a critical host defence mechanism, a number of microbes have 
evolved mechanisms to use receptors to promote self-survival (Matzinger, 2002).   
There are four main groups of PRRs, namely Toll-like receptors (TLRs), nucleotide 
binding and oligomerization domain (NOD) - like receptors (NLRs), RIG-I-like 
receptors (RLRs) and C-type lectin receptors (CLRs). TLRs and NLRs respond to 
pathogenic bacteria independently and collaboratively (Oviedo-Boyso et al., 2014). 
The specific TLRs and NLRs that have been implicated in the detection of 
chlamydial infection will be discussed further.  
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1.3.2.1 Toll-like receptors 
TLRs are found on immune cells such as monocytes/macrophages and DCs 
(Rodriguez et al., 2006), but are less ubiquitous on epithelial cells (McClure and 
Massari, 2014).They are often found on the host cell surface but also within 
endosomes. Generally, once activated, TLRs signal through the myeloid 
differentiation primary response gene 88 (MyD88) adaptor protein that activates the 
nuclear factor-kappa B (NF-κB) transcription factor switching on pro-inflammatory 
gene expression. In humans, ten members of the TLR family (twelve in mice) have 
been identified which recognise PAMPs derived from a range of different types of 
microbes (Kumar et al., 2011). Some microbes are thought to be recognised by a 
single TLR, however others have been shown to be recognised by multiple TLRs 
(Beutler, 2009).  
 A number of studies have implicated a role for both TLR2 and TLR4 in the host 
detection of chlamydial infection. TLR2 has been shown to recognise a number of 
different PAMPs, including lipoproteins found on Gram-negative bacteria (Philpott 
and Girardin, 2004). TLR4 recognises lipopolysaccharide (LPS) which is the major 
cell wall component of Gram-negative bacteria (Kumar et al., 2011). Chlamydial 
heat shock protein 60 (Chsp60) is a major protein that is produced within the 
intracellular chlamydial inclusion (Bulut et al., 2009). Both TLR2 and TLR4 have 
been implicated in binding Chsp60 (Da Costa et al., 2004), however the contribution 
of each receptor to chlamydial-induced inflammation is controversial. Chsp60 
derived from C. pneumoniae has been shown to activate pro-inflammatory cytokines 
predominantly through TLR4 but not TLR2 in knockout (KO) mice (Bulut et al., 
2009). However, a different C. pneumoniae study identified that double TLR2/TLR4 
KO mice failed to recruit polymorphonuclear neutrophils or produce keratinocyte 
chemokine in response to Chsp60, unlike the single knockouts (Da Costa et al., 
2004). Differences identified in studies investigating the same chlamydial species are 
likely due to experimental design and the fact that receptors play different roles 
throughout the course of infection. 
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Most studies with the whole organism, rather than Chsp60 alone, support a more 
important role for TLR2 compared to TLR4 in innate immune activation. A number 
of in vitro studies with different cell types have shown that TLR2 is critical for the 
activation of intracellular signalling pathways and pro-inflammatory cytokine 
production in response to chlamydial infection (Netea et al., 2002; Prebeck et al., 
2001; Rodriguez et al., 2006). TLR3 has also been implicated in the production of 
innate immune cytokines in oviduct epithelial cells in response to C. muridarum 
infection (Derbigny et al., 2012). The activation of TLR2 signalling pathways may 
contribute to the development of pathology in vivo. TLR2 KO mice had reduced 
oviduct pathology following challenge with C. muridarum compared to the TLR4 
KO or wild-type mice (Darville et al., 2003). A plasmid deficient strain of C. 
muridarum, which failed to activate TLR2 dependant cytokine production, did not 
induce oviduct pathology unlike the virulent C. muridarum strain (O'Connell et al., 
2007).  
The innate immune activation mediated by both TLR2 and TLR4 in vivo, has been 
shown to be beneficial. Combined TLR2/TLR4 KO mice had the highest C. 
pneumoniae burden, cellular infiltrate and biggest weight loss contributing to an 
increased mortality rate compared to single KO and wild type mice (Rodriguez et al., 
2006). Similarly, a different study found that single TLR2 and TLR4 KO mice had 
no effect on bacterial burden following C. pneumoniae infection (Mueller et al., 
2004).  This suggests that the combined function of TLR2/4 is important in host 
defence to C. pneumoniae infection. 
MyD88 is the downstream signalling adaptor protein for all the TLRs, with the 
exception of TLR3 and TLR4 that can signal through MyD88 independent pathways 
(Akira and Takeda, 2004). MyD88 KO mice failed to up-regulate early pro-
inflammatory cytokine production and exhibited delayed clearance of C. 
pneumoniae, ultimately resulting in increased mortality (Naiki et al., 2005). Similar 
results of reduced early pro-inflammatory cytokines and delayed bacterial clearance 
were also identified in MyD88 KO mice challenged with C. muridarum (Chen et al., 
2010). Therefore, studies support the involvement of the MyD88 signalling pathway 
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in the innate immune response to chlamydial infection. However, the specific role for 
single TLRs in disease pathogenesis and whether they are activating a protective or 
pathogenic response may be dependent on a number of factors. 
1.3.2.2 NOD-like receptors 
NLRs can be grouped broadly into two groups: receptors which function through 
NODosomes and receptors which activate inflammasome signalling complexes.  
NODosome receptors include NLRP10, NOD1, NOD2, NLRC3, NLRC5, NLRX1 
and CIITA. Inflammasome receptors include NLRP1, NLRP3, NLRP6, NLRP7, 
NLRP12, NLRC4 and NAIP (Barbe et al., 2014). The NODosome receptors contain 
a caspase activation and recruitment domain (CARD) and the inflammasome 
receptors contain an Apoptosis-associated Speck-like protein containing a CARD 
(ASC), which contains a pyrin domain and CARD. Assembly of the NODosome 
mediates the activation of NF-κB through RIP 2, whereas inflammasome assembly 
induces the activation of caspase-1 (Figure 1.4) (Le and Harton, 2013).   
 
Figure 1.4:  NOD-like receptor sub-types can form NODosome (A) and inflammasome 
(B) signalling complexes. Upon ligation of the NLR, the leucine-rich repeats (LRRs) 
undergo conformational change which allows CARD dependant recruitment of adaptor 
proteins, such as receptor interacting protein 2 (RIP2) in the case of the NODosome and 
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Generally, studies have focussed on the roles of NOD1 and NLR pyrin domain 
containing-3 (NLRP3) in chlamydial recognition and activation of the innate immune 
response.  
1.3.2.2.1 NOD 1 
NOD1 recognises peptidoglycan, which is a component of most bacterial cell walls 
that contributes to cell division and provides an anchor for transmembrane proteins. 
Chlamydiaceae are sensitive to antibiotics that inhibit cell wall synthesis and encode 
genes involved in peptidoglycan biosynthesis. However, conventional methods of 
peptidoglycan detection had not been able to prove its existence within the bacteria 
(Liechti et al., 2014). This disparity became known as the ‘chlamydial 
anomaly’(Jacquier et al., 2014). However, recent advances in peptidoglycan 
detection techniques have allowed the identification of low quantities within C. 
trachomatis (Liechti et al., 2014). Therefore, NOD1 may function in the recognition 
of chlamydial peptidoglycan. 
Previous in vitro studies have identified a role for NOD1 in the activation of NF-κB 
signalling pathways and production of pro-inflammatory cytokines and chemokines, 
including CXCL8, in response to chlamydial infection (Buchholz and Stephens, 
2008; Kavathas et al., 2013; Opitz et al., 2005; Welter-Stahl et al., 2006). CXCL8 
was not produced in response to heat-inactivated C. pneumoniae, implicating NOD1 
as a key receptor involved in the detection of the intracellular stage of chlamydial 
infection (Opitz et al., 2005). Mice deficient of receptor interacting protein 2 (RIP2), 
the downstream adapter protein of NOD1, exhibited delayed C. pneumoniae 
clearance and greater inflammation resulting in higher levels of mortality than wild-
type mice (Shimada et al., 2009). 
1.3.2.2.2 NLRP3 Inflammasome 
The best-characterized inflammasome is NLRP3, which has a diverse range of 
activators including bacterial PAMPs, DAMPS and inorganic compounds such as 
nanoparticles (Abderrazak et al., 2015). Activation of the NLRP3 inflammasome 
requires two signals. The first signal is a priming signal, which involves TLR 
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stimulation leading to the up-regulation of NLRP3 gene expression and the 
production of the inactive pro-IL-1β/IL-18. Signal 2 involves NLRP3 receptor 
ligation inducing assembly of the inflammasome complex and activation of caspase-
1, which mediates the cleavage of the IL-1β/IL-18 into its active form (Figure 1.5) 
(Franchi et al., 2012).  
 
Figure 1.5:  Activation of the NLRP3 inflammasome is a two-step process. The first step 
of NLRP3 activation involves ligation of a PRR, which activates NF-κB and MAPK pathways 
priming NLRP3 through up-regulating its expression. The second step involves activation of 
the intracellular NLRP3 receptor, which induces assembly of the inflammasome complex 
(adapted from Franchi et al,. 2012). 
The role of the NLRP3 inflammasome in response to Chlamydia infection has been 
highlighted by a number of studies. Knockdown of NLRP3 in cervical epithelial cells 
was shown to partially inhibit caspase-1 activation in response to C. trachomatis 
(Abdul-Sater et al., 2009). Bone marrow derived macrophages (BMDMs) from 
NLRP3 KO or ASC KO mice produced significantly reduced IL-1β/IL-18 in 
response to C. pneumoniae compared to macrophages from wild-type mice (He et al., 
2010; Itoh et al., 2014).  A different study identified that C. pneumoniae induced IL-
1β production was partially dependant on NLRP3 in human PBMC and murine 
BMDM (Eitel et al., 2012).  
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NLRP3 recognises lysosomal acidification, potassium efflux and reactive oxygen 
species (ROS), which are induced by a range of stimuli (Abdul-Sater et al., 2010; He 
et al., 2010). The addition of an antioxidant to deplete ROS and the blockage of the 
potassium channels in monocytes, resulted in a decrease in caspase-1 production and 
IL-1β secretion in response to C. trachomatis or C. muridarum infection (Abdul-
Sater et al., 2009; Abdul-Sater et al., 2010). Chlamydial T3SS may cause lysosomal 
disruption, potassium efflux and ROS production contributing to NLRP3 activation 
(Abdul-Sater et al., 2009; He et al., 2010). A T3SS inhibitor has been shown to 
abrogate caspase-1 activation with chlamydial infection, which supports the potential 
role of NLRP3 in T3SS detection (Abdul-Sater et al., 2009). Spleen tyrosine kinase 
(Syk) transmits signals from cell surface receptors and has also been implicated in 
NLRP3 activation with chlamydial infection (Abdul-Sater et al., 2010).  
Studies have also identified redundancy in components of the NLRP3 inflammasome 
for defence against chlamydial infection. ASC KO mice exhibited significantly 
increased C. muridarum colonization and delayed bacterial clearance, unlike NLRP3 
or NLRC4 KO mice. This implicates a role for a different inflammasome receptor in 
ASC activation in response to C. muridarum. IL-1β levels in genital secretions was 
found to be independent of NLRP3 or ASC after day 2 post infection, suggesting 
production of IL-1β may be through inflammasome independent pathways 
(Nagarajan et al., 2012).  
The role of caspase-1 activation in response to chlamydial infection extends beyond 
the cleavage of pro-IL-1β/IL-18. Caspase-1 can also drive pyroptosis, which is a type 
of cell death considered to be pro-inflammatory due to the rapid breakdown of the 
cell membrane and release of cell contents. Pyroptosis is thought to be an important 
innate immune mechanism against intracellular bacteria as it promotes clearance 
from the host cell niche (Miao et al., 2011). Caspase-1 KO mice infected with C. 
pneumoniae exhibited delayed bacterial clearance, which resulted in increased lung 
pathology and mortality rate (Shimada et al., 2011). However, in caspase-1 KO mice 
infected with C. muridarum there was an observed decrease in urogenital tract 
pathology with reduced inflammatory infiltrate after initial infection. This suggests 
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that caspase-1 may be involved in the development of pathology rather than 
resolution of infection (Cheng et al., 2008). Recently, a role for caspase-1 in 
facilitating chlamydial growth in macrophages and epithelial cells has also been 
demonstrated. The authors suggested that caspase-1functions in lipid utilization for 
membrane biogenesis, which is hijacked by Chlamydia to facilitate inclusion 
development (Abdul-Sater et al., 2009; Itoh et al., 2014).  
Therefore, studies have identified a role for the NLRP3 inflammasome in IL-1β 
production in response to chlamydial infection. However, a number of different 
pathways are also likely to contribute. The different components of the 
inflammasome may also have a number of roles beyond IL-1β production that are 
involved in determining chlamydial infection outcome.  
1.3.3 Cytokines and chemokines 
Cytokines and chemokines, which are produced with innate immune recognition, 
play a number of important roles in host immune defense to pathogens.  Critically, 
they are involved in the recruitment and activation of further innate immune cells and 
the stimulation of the adaptive immune response. Depending on both the timing and 
location of production, innate immune cytokines have been shown to have protective 
and/or pathogenic roles with chlamydial infection. The innate immune cytokines are 
often differentially expressed following heat-killing or UV-inactivation of the 
Chlamydia.  This may indicate that a live intracellular infection is necessary for the 
activation of cytokine-producing signaling pathways. Studies have identified the up-
regulation of a number of innate immune cytokines and chemokines, including 
CXCL8, TNF-α, IL-6 and IL-1β from a broad range of innate immune cells in 
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Table 1.2:  Production of innate cytokines/chemokines by different cell types in 
response to chlamydial infection (adapted from Rusconi and Greub, 2011). 
Cytokine/Chemokine Cellular producers 
CXCL8 Epithelial cells and monocytes 
TNF-α PBMC, monocytes, macrophages and oviduct epithelial cells 
IL-6 Epithelial cells, monocytes and macrophages 
IL-1β PBMC, monocytes and macrophages 
These innate immune cytokines and chemokines are pleiotropic and their specific 
roles in chlamydial infection have been identified by a number of studies. CXCL8 
binds to CXCR1 and CXCR2 that are expressed by various cell types, including 
neutrophils, inducing chemotaxis (Russo et al., 2014). The chemokine also functions 
in the activation of neutrophils, basophils and T cells (Buchholz and Stephens, 2006). 
CXCL8 has been shown to be involved in the recruitment of neutrophils to the site of 
C. pneumoniae infection (Molestina et al., 1999) and also inhibits spontaneous 
neutrophil apoptosis (Zandbergen et al., 2004). IL-6 functions in the differentiation 
of B cells into antibody producing plasma cells and also as an activator of T cells. IL-
6 KO mice displayed a decreased Th1 response with reduced IFN-γ production 
following chlamydial lung challenge compared to the wild type control (Williams et 
al., 1998).  
TNF-α is a powerful cytokine that induces vasodilation, recruits leukocytes to the 
site of infection (Bradley, 2008) and kills intracellular microbes (Kamalakaran et al., 
2013). Antibody mediated inhibition of early local TNF-α production decreased the 
level of apoptosis in inflammatory cells, but had no effect on chlamydial clearance in 
the genital tract (Darville et al., 2000). A recent study demonstrated that TNF-α KO 
mice had reduced upper genital tract pathology, but no reduction in bacterial 
clearance following primary and secondary chlamydial infection implicating a 
pathogenic role for the cytokine (Kamalakaran et al., 2013; Murthy et al., 2011). 
Similarly, TNF-α was detected in the tears of scarring trachoma patients more often 
than in non-infected control patients. An increased percentage of scarring trachoma 
patients possessed certain polymorphisms in the TNF-α gene promoter, supporting a 
pathogenic role for the cytokine (Conway et al., 1997). However, studies of 
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chlamydial infection in the lung have identified a role for TNF-α in chlamydial 
clearance and host survival (Williams et al., 1990). 
IL-1β is a potent pro-inflammatory cytokine that has been identified as an important 
mediator of bacterial infection associated pre-term birth (Romero et al., 1992). IL-1β 
KO mice challenged intra-vaginally with C. muridarum presented with reduced 
oviduct pathology and bacterial clearance compared to the challenged wild type mice 
(Prantner et al., 2009). IL-1R deficient mice presented with increased lung fibrosis 
compared to wild-type mice challenged intra-nasally with C. pneumoniae, suggesting 
a potential role for IL-1β and IL-1α in the mediation of protective immunity (He et 
al., 2010). The critical role for IL-1β in C. pneumoniae lung infection was 
demonstrated using caspase-1 KO mice. The addition of recombinant IL-1β early 
post-infection rescued caspase-1 KO mice from a higher mortality rate and impaired 
bacterial clearance (Shimada et al., 2011). 
 Innate immune cytokines can contribute to the inflammatory cascade by stimulating 
the production of other pro-inflammatory cytokines, for example, IL-1β can bind to 
the IL-1 receptor and stimulate the release of TNF-α and IL-6 (Netea et al., 2010). 
Considering this and KO experiment results, it is unlikely that a single cytokine will 
be responsible for determining chlamydial pathogenesis. Instead, the host niche as 
well as timing and quantity of each cytokine that contributes to the inflammatory 
milieu is likely to be critical.  
1.4 Chlamydia and the adaptive immune system 
1.4.1 Evidence for the development of protective chlamydial 
immunity 
The development of protective immunity to chlamydial infection has been mostly 
characterized in mice and guinea pigs (Batteiger et al., 2010). Rodents are able to 
resolve a primary infection naturally within a few weeks (Brunham and Rey-Ladino, 
2005) and are resistant to infection in a short period after the resolution of a primary 
infection (1-3 months), however after around 75 days they become susceptible to re-
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infection (Rank and Whittum-Hudson, 2010). Partial immunity is thought to remain 
for an extended period of time as mice have reduced bacterial load and shortened 
duration of infection following subsequent challenge (Rank and Whittum-Hudson, 
2010). Due to ethical issues, there have been limited studies into the duration of 
untreated chlamydial infection in humans. Studies have shown that the infection 
usually lasts for many months to years before being spontaneously cleared in the 
absence of antibiotics (Batteiger et al., 2010; Geisler et al., 2013). The prevalence of 
ocular and genital chlamydial infection decreases with age (Bailey et al., 1999), 
which suggests that protective immunity does develop over time. Studies in STD 
clinic patients suggest that those that have had repeated infections had lower 
bacterial load, which is indicative of the development of partial immunity (Batteiger 
et al., 2010). The different components of the adaptive immune system involved in 
clearance of a chlamydial infection and their role in protection from re-infection will 
be discussed. 
1.4.2 Cell mediated immunity 
Early experiments found that cell mediated immunity was critical for the resolution 
of chlamydial infection. Most of these early experiments used nude mice, which lack 
a thymus resulting in greatly reduced numbers of functional T cells. Wild-type mice 
were found to clear C. muridarum infection 20 days post intra-vaginal infection; 
however, nude mice were unable to clear the pathogen, which resulted in the 
development of a chronic infection. Nude mice also had reduced antibody levels and 
therefore further experiments were required to identify the specific role of cell 
mediated and humoral immunity (Rank et al., 1985). A follow-on study adoptively 
transferred T cells from wild type mice immunized with C. muridarum into nude 
mice, which were infected with C. muridarum pre-transfer. Mice which received the 
adoptive transfer were capable of resolving the infection, unlike the control nude 
mice (Ramsey and Rank, 1991). 
CD4
+
 T cells are recruited to the genital tract following chlamydial infection 
(Gondek et al., 2012; Johansson et al., 1997b).  CD4
+
 KO mice have demonstrated 
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 T cells are important for the control of bacterial shedding following a 
primary C. trachomatis infection and in protection from re-infection (Johansson et 
al., 1997b). A recent study, using a more relevant transcervical chlamydial 
inoculation model in mice, demonstrated that depletion of CD4
+
 T cells was 
sufficient to abrogate the protective immune response to secondary C. muridarum or 
C. trachomatis challenge (Gondek et al., 2012).  The CD4
+ 
T cells involved in 
protective immunity to C. trachomatis were identified to be mainly Th1-type as they 
produced IFN-γ rather than the characteristic Th2-type cytokine IL-4 (Cain and 
Rank, 1995; Van Voorhis et al., 1996). IL-4 KO mice were able to clear a primary C. 
trachomatis infection, unlike IFN-γ KO mice, which provides further evidence that 
protective immunity is mediated by a Th1 rather than a Th2 response (Johansson et 
al., 1997b). The level of IFN-γ produced by CD4
+
 T cells alone has been shown to be 
sufficient for the clearance of C. muridarum from the genital tract of mice (Li et al., 
2008).  Th2 responses have instead been associated with chlamydial persistence and 
more severe disease (Mascellino et al., 2011).  
The role for CD8
+
 T cells in immunity to Chlamydia is less clear but some studies 
suggest they may contribute to the protective immune response. CD8
+
 T cells have 
been shown to have a cytolytic effect on C. trachomatis infected cell lines (Beatty 
and Stephens, 1994).  Studies have also identified CD8
+
 T cell involvement in mice 
in bacterial clearance following secondary challenge with C. abortus and C. 
pneumoniae (Buzoni-Gatel et al., 1992; Penttila et al., 1999). A recent study, 





 T cells to protect mice against transcervical challenge with C. trachomatis 
(Nogueira et al., 2015). A role for CD8
+
 T cells in IFN-γ production in response to C. 
muridarum infection has also been identified in vivo. However, in the same study 
CD8
+
 T cell depletion did not lead to significant increases in mortality, unlike CD4
+ 
T cell depletion (Magee et al., 1995). Similarly, CD8
+ 
T cell KO mice did not display 
any significant defects in controlling bacterial shedding, compared to the wild-type, 
in response to primary or secondary challenge with C. trachomatis (Johansson et al., 
1997b). In macaques, the in vivo depletion of CD8
+ 
T-cells identified that the cells 
were critical for the protection mediated by a plasmid-deficient live attenuated 
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trachoma vaccine (described in section 1.1.4.2) (Olivares-Zavaleta et al., 2014). The 
detection of MOMP specific CD8
+
 T cells was associated with the detectable 
presence of ocular C. trachomatis infection but not clinical signs of disease in 
humans. This suggests that the CD8
+
 T cells may play a role during sub-clinical C. 
trachomatis infection (Holland et al., 2006). The normal functioning of CD8
+
 T cells 
requires CD4
+
 T cells, which means the role of CD8
+
 T cells in chlamydial infection 
may be underappreciated and not yet fully understood (Wizel et al., 2008). 
Recently, Th17 cells have also been identified as potentially important immune 
mediators in relation to chlamydial infection. Th17 cells are characterized by the 
production of IL-17A (Andrew et al., 2013), and have been identified along with Th1 
cells in the draining iliac lymph nodes of mice following genital infection with C. 
muridarum (Scurlock et al., 2011). The neutralization of IL-17A in mice following 
intranasal C. muridarum challenge resulted in impaired bacterial clearance and 
increased pathology (Bai et al., 2009).  IL-17 receptor knockout mice displayed no 
difference in rate of bacterial clearance or pathology following genital C. muridarum 
infection (Scurlock et al., 2011). However, a more recent study using IL-17A KO 
mice, infected with genital C. muridarum, identified increased bacterial clearance 
and reduced oviduct pathology (Andrew et al., 2013). The contrasting results 
observed between the genital tract studies were thought to be due to the different KO 
models used (IL-17 receptor and IL-17A) (Andrew et al., 2013). Studies that 
interfered with IL-17A signaling consistently identified decreased Th1 responses 
(Andrew et al., 2013; Bai et al., 2009; Scurlock et al., 2011), which was attributed to 
an altered DC phenotype in IL-17A neutralized mice (Bai et al., 2009). 
Antigen-specific CD4
+
 Th1-type T cells appear to be critical in the mediation of 
protective immunity to both primary and secondary chlamydial challenge. However, 
the contribution of other T cell subsets may depend on the model of chlamydial 
infection used.  
1.4.3 Cytokines 
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A number of inflammatory cytokines, including IFN-γ, IL-12 and IL-17 are produced 
in response to chlamydial infection. In vitro studies have demonstrated a role for 
IFN-γ in the restriction of intracellular chlamydial growth, which is important for 
host defense but may also induce a persistent infection important for disease 
pathogenesis (Mascellino et al., 2011). The mechanism of action of IFN-γ is through 
tryptophan depletion, which is described in section 1.1.4.1. Early studies assessed the 
effect of IFN-γ on mouse fibroblast cells and found that IFN-γ treatment before and 
after (up to four hours) C. trachomatis infection significantly reduced the number of 
cells with detectable inclusions (Rothermel et al., 1983).  This type of in vitro study 
has been repeated with the same results in a number of different cell types with 
different chlamydial strains. 
IFN-γ receptor KO mice suffered a more severe prolonged primary infection with C. 
trachomatis, supporting a role for IFN-γ in protective immunity (Johansson et al., 
1997a). Similarly, IFN-γ KO mice presented with delayed resolution and increased 
dissemination of C. muridarum primary infection compared to the wild-type mice. 
The response of IFN-γ KO mice to secondary infection was similar to the wild-type 
mice, suggesting that IFN-γ may not be essential for resistance to re-infection (Cotter 
et al., 1997). Mice treated with anti-IFN-γ and then infected with C. muridarum 
developed a chronic infection. The addition of recombinant IFN-γ into nude mice 
infected with C. muridarum was able to induce resolution in some animals, 
suggesting that IFN-γ does play an important role in determining the outcome of 
infection (Rank et al., 1992). These studies indicate an important role for IFN-γ in 
the development of protective host immunity for the resolution of a primary 
chlamydial infection. 
However, IFN-γ has also been shown to mediate persistent chlamydial infections and 
therefore may be involved in the promotion of chronic chlamydial disease. A study 
has associated elevated levels of IFN-γ to women with Chlamydia-associated fertility 
disorders compared to those infected but with no complications (Agrawal et al., 
2007). Therefore, the balance of IFN-γ including the timing and quantity of 
production may be critical in determining the outcome of chlamydial infection. 
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IL-12 is an important cytokine that functions in the promotion of Th1-type responses. 
The neutralization of IL-12 in vivo led to delayed clearance of C. muridarum from 
the genital tract compared to the wild type controls (Perry et al., 1997). IL-12 
consists of a p35 and a p40 subunit of which p40 is shared with IL-23, an 
inflammatory cytokine that promotes Th17 responses. Mice deficient in p35 or p40 
displayed delayed clearance of primary C. muridarum infection, although were able 
to clear re-infection at a similar rate to the wild-type mice. IL-12p40 KO mice did 
display increased dissemination to the kidneys compared to the IL-12p35 KO mice 
or wild type mice, which suggests a role for IL-23 in controlling spread of 
chlamydial organisms (Chen et al., 2013a).   
There are six IL-17 family members: IL-17A (also known as IL-17), IL-17B, IL-
17C, IL-17D, IL-17E and IL-17F. The best characterized members of the family are 
IL-17A and IL-17F, which are produced by Th17 cells but also γδ T cells and 
macrophages. The main mode of action of IL-17A and IL-17F is in the induction of 
pro-inflammatory cytokine production from cell types which express the IL-17 
receptor, including epithelial cells, macrophages and neutrophils (Jin and Dong, 
2013). A role for IL-17A has recently been identified in response to chlamydial 
infections. The cytokine has been shown to enhance the TH1 response and neutrophil 
recruitment in C. muridarum genital tract infection (Scurlock et al., 2011). The 
neutralization of IL-17A resulted in impaired bacterial clearance (Bai et al., 2009), 
increased dissemination (Zhang et al., 2009b) and more severe pathology following 
intranasal challenge with C. muridarum (Bai et al., 2009; Zhang et al., 2009b).  
Therefore, the balance of adaptive immune cytokine production is likely to be 
important in determining whether the inflammatory response will be protective or 
pathogenic.  
1.4.4 Humoral immunity 
Generally, the role for antibodies/B cells in protective immunity to primary infection 
is thought to be limited. It is well documented that the host produces antibodies in 
response to primary chlamydial infection. However, mice which were deficient in B 
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cells have been shown to resolve a primary infection with C. muridarum as 
effectively as the wild-type mice (Su et al., 1997).  
A role for antibodies in protection from re-infection has been demonstrated by a 




T cells in immune mice 
had no effect on their ability to resolve a secondary challenge with C. muridarum 
compared to the wild-type (Morrison and Morrison, 2001). However, mice that lack 
mature B cells are more susceptible to colonization with a secondary infection with 
C. muridarum and shed higher levels of the bacteria (Morrison et al., 2000; Su et al., 
1997). B-cell deficient mice do develop a degree of protective immunity, as present a 
shorter duration of secondary infection (Morrison et al., 2000). Similar experiments 
depleting B cell deficient immune mice of CD4
+
 T cells made mice susceptible to 
reinfection with C. muridarum; however, susceptibility to reinfection could be 
negated by the addition of immune serum. Interestingly, the addition of immune 
serum had no effect on primary infection of CD4
+
 T cell depleted mice (Morrison 
and Morrison, 2005).   
Therefore, studies have identified a redundancy for humoral immunity in the 
protective immune response to primary chlamydial infection. However, a 
contributory role along with CD4
+
 T cells has been identified in protection from 
secondary challenge.   
1.5 Diagnosis and Treatment of C. abortus infection 
1.5.1 Clinical signs 
Following infection, C. abortus usually establishes an asymptomatic infection within 
ewes. Occasionally, behavioural changes and vulval discharge can be detected for up 
to 48 hours before abortion, however often the first sign of infection is abortion in 
the last few weeks of gestation. Lambs may be weak or stillborn despite a normal 
appearance or present with a ‘pot-bellied’ appearance (Essig and Longbottom, 2015). 
Some infected ewes can give birth to healthy lambs or in the case of multiple births, 
one healthy and one dead lamb. Thickened placental membranes that are inflamed 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 1: General Introduction  37 
 
and often have yellow exudate on their surface are characteristic of C. abortus 
infection (Longbottom and Coulter, 2003). Ewes that have aborted due to C. abortus 
usually go on to make a full recovery. 
1.5.2 Diagnostic tests 
Flock history of disease and characteristic placental pathology are usually indicative 
of C. abortus infection, however confirmation requires laboratory tests. The gold 
standard test is isolation and propagation of the bacteria, which allows further 
characterization using molecular and biochemical techniques. However, this is time 
consuming and lab-intensive so more rapid tests have been developed (Essig and 
Longbottom, 2015).  
Smears and tissue sections can be taken from potentially infected placental 
membranes and stained to reveal chlamydial infection. Chlamydia can be detected in 
placental smears using various stains, including Giemsa or Ziehl-Neelsen stains 
(Essig and Longbottom, 2015). Immunohistochemistry can be used to detect 
chlamydial antigens (such as MOMP or LPS) within tissue sections. Serological 
diagnosis in the form of the complement fixation test (CFT) is the most commonly 
used method for C. abortus detection. However, the CFT is cross-reactive as the 
antibodies bind to LPS commonly expressed by all Chlamydiaceae. Other more 
specific methods of C. abortus antibody detection include ELISAs, which detect 
antibodies to specific antigens (MOMP and Pmps). There are a number of 
commercialized serological tests available; however, a weakness of the current 
serological tests is that they cannot differentiate between naturally infected and 
vaccinated animals (Sachse et al., 2009).  
The detection of chlamydial DNA by conventional PCR is rapid; however, the 
technology does not allow quantification of the target. Real-time PCR and DNA 
microarrays using the ArrayTube platform is an area of expanding development, 
which is favoured because of the rapidity and sensitivity of results. A real-time PCR 
that detects the ompA gene has been shown to be a specific method for C. abortus 
detection (Sachse et al., 2009). The recent advent of a PCR coupled with restriction 
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fragment length polymorphism (PCR-RFLP), which identifies specific SNPs unique 
to the vaccine strain, has allowed the differentiation of vaccinated and naturally 
infected animals (Laroucau et al., 2010; Wheelhouse et al., 2010).  
1.5.3 Control measures 
Antibiotics such as oxytetracycline can be used effectively to limit disease severity 
(Entrican et al., 2001) and reduce further losses during abortion storms. However, 
antibiotics are not guaranteed to prevent abortion or shedding of the bacteria and due 
to the absence of clinical signs with C. abortus they are not an effective control 
strategy. The development of antibiotic resistance is also a potential risk and 
resistance has been detected in C. suis strains isolated from pigs (Entrican et al., 
2012).  
Following chlamydial abortion, the bacteria are shed into the environment and 
therefore measures should be taken to limit contamination by isolating the ewe. The 
area should then be decontaminated and contaminated material safely destroyed 
(Essig and Longbottom, 2015). The importance of good biosecurity was emphasized 
in a recent survey, which identified that the majority of C. abortus was detected in 
flocks where other abortifacients (i.e. Toxoplasma and Campylobacter) were present 
(Longbottom et al., 2013a).  
The introduction of infected replacement animals is the major route of transmission 
between farms, as described in section 1.2.2. Maintaining closed flocks or only 
buying replacements from enzootic abortion of ewes (EAE) accredited flocks is the 
best way of preventing the introduction of disease (Longbottom et al., 2013a). The 
EAE accreditation scheme involves the submission of annual blood tests, which 
following testing of two consecutive negative samples allows the EAE accredited 
status to be awarded (Premium sheep and goat health scheme, 2008). Often, keeping 
closed flocks is not plausible and in these cases animals should be vaccinated 
(section 1.6). 
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1.6 Vaccination 
The ideal vaccine against any disease would induce sterile immunity and prevent 
infection. However, the more realistic aims for a chlamydial vaccine are to reduce 
pathology and limit shedding of infectious organisms (Beagley et al., 2009b). 
Inactivated and live attenuated chlamydial vaccines have been used with some 
success for animal chlamydioses. Commercially-available chlamydial vaccines 
include C. abortus vaccines and an inactivated C. felis vaccine (Longbottom, 2003). 
There are currently no commercially available vaccines to prevent chlamydial 
infections in humans. Live attenuated vaccines were tested against C. trachomatis, 
but they had major limitations. The vaccines exhibited only a short duration of 
immunity and increased immunopathology was observed in vaccinated non-human 
primates following subsequent exposure to a different chlamydial strain. Therefore, 
the focus for improved chlamydial vaccines has shifted to safer rational based design, 
particularly recombinant subunit vaccines involving MOMP (Brunham and 
Rappuoli, 2013).  
1.6.1 Current C. abortus vaccines 









 and CEVAC 
Chlamydia
®
 are based on the live-attenuated 1B strain of C. abortus, which is a 
temperature sensitive mutant that can grow at 35°C but not 39.5°C (the body 
temperature of sheep) (Entrican et al., 2012; Longbottom and Livingstone, 2006). 
Mydiavac
®
 is composed of inactivated whole organism with a mineral oil adjuvant 
and has only recently been reintroduced by Benchmark Animal Health (Essig and 
Longbottom, 2015). Enzovax
®
 and CEVAC Chlamydia
®
 should not be administered 
to pregnant sheep or handled by pregnant women (Entrican and Lunney, 2012), 
whereas an advantage of Mydiavac
®
 is that it can be used in pregnant ewes 
(Longbottom and Livingstone, 2006).   Both the live attenuated and inactivated 
vaccines have been successfully used to prevent OEA (Essig and Longbottom, 2015; 
Longbottom and Coulter, 2003), but they have a number of limitations with use. 
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The vaccines are expensive to produce due to the need for bulk Chlamydia growth 
and isolation (Longbottom and Coulter, 2003). They also do not induce sterile 
immunity as vaccinated ewes can still shed the bacteria at lambing, facilitating 
transmission to naïve ewes (Essig and Longbottom, 2015). Recently, the novel PCR-
RFLP that can differentiate vaccinated from naturally infected ewes, as described in 
section 1.5.2, has been used to implicate the 1B vaccine strain as a causal factor of C. 
abortus induced abortion (Laroucau et al., 2010; Wheelhouse et al., 2010). This 
causal link has since been reinforced by more recent studies and raises safety 
concerns (Livingstone et al., 2014; Sargison et al., 2015). Although the molecular 
detection technique has been recently developed, archived samples from the 1990s 
also tested positive for the vaccine strain.  This suggests that the apparent link to the 
1B vaccine strain is unlikely to be down to a recent breakdown in the vaccine 
(Wheelhouse et al., 2010). Nonetheless, vaccination is still the most effective method 
of controlling C. abortus and the current benefits outweigh the risks of use (Essig 
and Longbottom, 2015).  
1.6.2 Towards an improved C. abortus vaccine 
A number of factors need to be considered for the design of a new improved vaccine, 
including safety, cost and efficacy. Critically, a new C. abortus vaccine must not be 
able to revert to virulence and preferably would induce sterile protective immunity 
(Entrican et al., 2012). Therefore, studies have focused on developing new 
recombinant subunit or DNA vaccines, but also on novel routes of administration and 
selection of improved immune-stimulatory adjuvants. 
Recombinant subunit vaccines offer the opportunity to select protective antigens 
whilst omitting antigens that are pathogenic. Many early studies focused on 
recombinant protein vaccines using MOMP, which had little success in efficacy 
trials. This has led researchers to identify new antigens, such as Pmps and T3SS 
effector proteins, for the design of a multi-component subunit vaccine (Longbottom 
and Livingstone, 2006). Subunit vaccines often don’t induce sufficient levels of cell-
mediated immunity, and therefore they are used in conjunction with delivery systems 
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and adjuvants. One recent study compared the immune-stimulatory potential of the 
Vibrio cholerae ghost (VCG) platform with the CpG + Fms-like tyrosine kinase 3 
ligand adjuvant. The adjuvants were used in conjunction with C. abortus 
polymorphic membrane protein 18D (Pmp18D).VCG was found to be superior for 
activating DCs and reducing shedding in the mouse model after C. abortus 
challenge, but has not been evaluated in sheep (Pan et al., 2015). 
DNA vaccines involve using a plasmid that encodes a gene of interest from the 
pathogen. The plasmid is taken up by host cells and the gene of interest expressed 
and recognized within the host, inducing a protective immune response. This 
technology is attractive due to its inexpensive generation and stability, which omits 
the need for cold chain storage (Schautteet et al., 2011). DNA vaccination was 
shown to be effective at reducing incidence of avian chlamydiosis in turkeys 
(Longbottom and Coulter, 2003). Similarly, they were shown to effectively induce 
protective immunity to C. abortus in smaller mammals such as mice; however, they 
have not had the same success in larger mammals such as sheep (Ou et al., 2013). A 
recent study identified that the addition of a lambda bacteriophage delivery system to 
ompA DNA vaccines, increased the early level of MOMP specific IgG and 
lymphocyte proliferative responses compared to the commercial 1B vaccine in 
piglets (Ou et al., 2013). Improved plasmid delivery and expression of the antigen is 
hoped to increase the efficacy of DNA vaccination for future C. abortus vaccine 
design (Longbottom and Livingstone, 2006). 
As C. abortus is transmitted oral-nasally, mucosal immunity may be important in 
determining disease outcome (Entrican et al., 2012). The route of administration has 
previously been shown to determine the efficacy of recombinant chlamydial 
vaccines. Combining systemic and mucosal vaccination was shown to be more 
effective at preventing infection with C. muridarum than individual administration 
(Schautteet et al., 2011). Inducing protective mucosal immunity could be critical for 
an effective C. abortus vaccine as it may limit entry and dissemination from the site 
of infection, which may prevent the establishment of a latent infection. 
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Further studies are required to assess how the innate immune system educates the 
adaptive immune system in order to stimulate a protective immune response or 
induce a latent infection (Longbottom et al., 2013b). This knowledge could be used 
in combination with novel vaccine technology to design improved targeted vaccines. 
Identifying immune correlates of protection in ruminants has been hindered by a lack 
of veterinary immunology reagents (Entrican et al., 2012). However, the recent 
advent of veterinary immunology toolkit projects, which develop and commercialize 
novel veterinary reagents, means that more studies can now be conducted (Entrican 
and Lunney, 2012). 
1.7 General hypothesis and aims 
The sequencing of Chlamydia genomes has revealed a number of genes that may be 
associated with disease pathogenesis and tissue tropism within and between species. 
However, the C. abortus genome has revealed little that could explain the differences 
in pathology between cattle and sheep. Analyzing the early host immune response to 
the pathogen will help to expose differences that may explain disease pathogenesis. 
Studies with human and mouse Chlamydia strains have demonstrated that innate 
inflammatory pathways and particularly inflammasome activation contribute to both 
pathogen clearance and pathology. A better understanding of how C. abortus is 
recognized and activates the innate immune response will contribute to the design of 
improved novel vaccines for sheep.  
The underlying hypothesis of this thesis is that ruminant hosts differ in their 
ability to innately sense C. abortus infection and activate the inflammasome. In 
order to address this hypothesis, I had a number of overarching aims: 
 Analyse the expression of pattern recognition receptors (PRRs) known to be 
important for sensing chlamydial infections (TLR2, TLR4, NOD1 and 
NLRP3) in innate immune cells of cattle and sheep.  
 
 Compare the inflammatory response of these cells following infection with C. 
abortus by analyzing expression of IL-1β, IL-6, CXCL8, and TNF-α.  
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 1: General Introduction  43 
 
 
 Investigate the roles PRRs play in the induction of innate immunity to C. 
abortus through interference of signaling using siRNA.   
 
 Conduct RNA-seq analyses on cattle and sheep macrophages infected with C. 
abortus to identify differential pathways of immune activation in cattle and 
sheep.   
The research I conducted towards these aims is described and discussed in the 
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Chapter 2: Material and Methods 
These are the general protocols used throughout the study. Chapter-specific protocols 
are supplied within each chapter. 
2.1 Tissue culture with adherent cell lines 
2.1.1 Resuscitation of cryopreserved cell lines 
Cells were removed from liquid nitrogen and defrosted rapidly in a 37°C water bath 
before the addition of cold Iscove’s Modified Dulbecco’s Medium (IMDM; Life 
Technologies, Paisley, UK) supplemented with 10% heat-inactivated fetal bovine 
serum (FBS; PAA, Hanniger, Austria). Cells were centrifuged at 300g for 10 minutes 
at 4°C and resuspended in culture medium (IMDM supplemented with 10% heat-
inactivated FBS). A viability count was performed by diluting 20µl cells in 20µl of 
1% nigrosin before adding to a haemocytometer. The total cells were calculated to 
determine the appropriate flask size for cell line propagation.  
2.1.2 Propagation of cell lines 
Cells were routinely cultured in vented tissue culture flasks (Corning Costar, High 
Wycombe, UK) in culture medium until confluence. The adherent cells were washed 
twice with warm 1x phosphate buffered saline (PBS). The cells were then passaged 
using trypsin-versene (0.25%w/v trypsin and 20% v/v versene) and re-seeded into 
new flasks with fresh culture medium.  
2.1.3 Cryopreservation of cell lines 
Cells were centrifuged at 300g for 10 minutes at 4°C and a viability count conducted 
as described in section 2.1.1. Cells were washed and centrifuged before re-
suspension in freezing mix (40% culture medium, 50% heat-inactivated FBS and 
10% dimethyl sulfoxide (DMSO; Sigma-Aldrich, Dorset, UK)). Cells were adjusted 




and 5 x 10
6
/ml in ice-cold freezing mix. 
Cells were then added to cryovials (Nunc, Roskilde, Denmark) in 1ml volumes. The 
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cryovials were put in proprietary freezing tubs (Nalgene Mr. Frosty freezing 
container; Thermofisher Scientific, Rochester, NY, USA) containing isopropanol, 
placed in a -80°C freezer and allowed to freeze slowly overnight before being 
transferred to liquid nitrogen for long-term storage.  
2.2 Preparation of cells from whole blood 
2.2.1 Animals 
All animal experimental procedures were approved by Ethics Committees at the 
Roslin Institute (RI) and Moredun Research Institute (MRI) and performed to Home 
Office Guidelines under Project Licences (PPL 60/4394 and PPL 60/3854 
respectively). 
2.2.1.1 Sheep 
Eight healthy, Texel-Greyface cross female sheep were housed indoors at Moredun 
Research Institute with access to food and water ad libitum. The sheep were between 
2-4 years old for the duration of study.  
2.2.1.2 Cattle 
Eight healthy, Holstein-Friesian female cattle were housed indoors at the Roslin 
Institute with access to food and water ad libitum. The cattle were between 2-4 years 
old for the duration of study. 
2.2.2 Generation of peripheral blood mononuclear cells 
Blood was collected aseptically from the jugular vein into blood collection bags 
containing the anticoagulant Citrate Phosphate Dextrose Adenosine -1. Bag sizes 
were 350ml (Henry Schein, Melville, UK) for sheep blood and 500ml (Starstedt, 
Leicester, UK) for cattle blood. Buffy coat layers composed of white blood cells and 
platelets were collected by centrifugation of whole blood, in 50 ml volumes, at 1200g 
for 15 minutes. Buffy coats that were aspirated from two blood tubes were pooled 
into 50ml 1xPBS, before splitting and layering onto two tubes with 25ml lymphoprep 
(Axis Shield, Dundee, UK) for density gradient centrifugation at 1200g for 25 
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minutes. The interface containing mononuclear cells was collected and resuspended 
in1xPBS for centrifugation at 350g for 10 minutes. Contaminating red cells were 
removed using Ammonium-Chloride-Potassium (ACK) lysis buffer (Life 
Technologies) and washed three times in 1xPBS with centrifugation at 300g for 10 
minutes.  
2.2.3 Generation of CD14+ monocytes and monocyte-derived 
dendritic cells                                         
PBMCs were generated as described in section 2.2.2.  The cells were centrifuged at 
300g for 10 minutes before resuspension in 50mls MACs buffer (1xPBS, 0.5% 
bovine serum albumin (BSA) and 2 mM EDTA) at 4ºC followed by the addition of 
20µl of CD14 MicroBeads (Miltenyi Biotech, Surrey, UK) per 1 x 10
7 
cells. The 
cells were incubated at 4ºC for 15 minutes before washing in MACs buffer with 
centrifugation at 300g for 10 minutes. The cell pellet was resuspended in MACs 
buffer before magnetic separation through an LS column (Miltenyi Biotech) on a 
QuadroMACS
TM
 separator (Miltenyi Biotech) following the manufacturer’s 
instructions. Briefly, the cells were resuspended in 500µl MACs buffer for every 
1x10
8
 cells before adding to the column. The column was washed three times with 
3mls of MACs buffer before adding 5mls and detaching the cells with the plunger. 
CD14 expression was measured by flow cytometry (section 2.11) in PBMCs before 
separation, non-magnetically labeled cells and magnetically labeled cells. The CD14
+
 
cells were centrifuged at 300g for 10 minutes and resuspended to a concentration of 
1 x 10
6
 cells/ml, in ovine or bovine DC kit (Bio-Rad AbD Serotec, Kidlington, UK) 
diluted in IMDM supplemented with 10% heat inactivated FBS, 50 µg/ml 
gentamycin (Roussel Laboratories Ltd, West Malling, UK) and 50µM β-
mercaptoethanol (Sigma-Aldrich). These kits contain recombinant ovine or bovine 
IL-4 and GM-CSF respectively. The CD14
+
 cells were then cultured at 3 x 10
6
 cells 
per well in six well plates (Nunc) at 37ºC for either 3 days (cattle) or 6 days (sheep).  
2.2.4 Generation of monocyte-derived macrophages 
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PBMCs were isolated as described in section 2.2.2. The bovine monocyte-derived 
macrophages (MDMs) were generated using a previously published protocol (Jensen 
et al., 2014) as follows. Briefly, bovine PBMC were adjusted to 5 x 10
6 
cells/ml in 
Roswell Park Memorial Institute (RPMI)-1640 (Life Technologies) without serum 
and 20mls of the PBMC were incubated for 2 hours at 37ºC in 75cm
2
 tissue culture 
flasks. The RPMI containing non-adherent cells was then aspirated and replaced with 
bovine macrophage culture medium (RPM1-1640 supplemented with 20% FBS (Life 
Technologies), 4mM L-glutamine, 50µM β-mercaptoethanol and 50 µg/ml 
gentamycin) and the adherent cells cultured at 37ºC for 14 days with the medium 
changed on day 4 and day 10.  
The ovine MDMs were generated by adjusting the PBMC to 1 x 10
7
 cells per ml in 
ovine macrophage culture medium (IMDM supplemented with 20% autologous 
serum, 50µM β-mercaptoethanol and 50 µg/ml gentamycin) before adding 20mls of 
the cell suspension to 75cm
2
 tissue culture flasks. The cells were cultured for 7 days 
at 37ºC which included washing vigorously 3 times with 1xPBS at day 3, to remove 
non-adherent cells, and replacing with fresh medium.  
The differentiated bovine and ovine MDMs displayed the expected morphological 
macrophage characteristics, which included increased cytoplasm with a vacuolar 
appearance. The MDMs were washed 3 times with 1xPBS before dissociating the 
cells with the recombinant enzyme TrypLE™ Express (Life Technologies). Cell 
purity was assessed using flow cytometry (section 2.11) that consistently showed that 
over 90% of adherent cells expressed the molecule SIRP-α, consistent with them 
being of the monocyte/macrophage lineage. The MDMs were then plated out at 6 x 
10
5
 cells per well in six well plates and rested for 24 hours before further 
experimentation. 
2.2.5 Generation of ovine autologous serum 
Blood was collected aseptically from the jugular vein into red top vacutainers 
(Becton Dickinson, Cambridge, UK) and incubated at 37ºC for 3-4 hours. The 
vacutainers were then incubated at 4°C for 30 minutes and the serum transferred to 
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universals before centrifugation at 1300g for 10 minutes. The clear serum was 
collected avoiding the small contaminating red blood cell pellet.  
2.3 Preparation of C. abortus stocks 
2.3.1 Strain 
The S26/3 C. abortus strain was previously isolated at the Moredun Research 
Institute (MRI) from a ewe vaccinated with the 1956 single isolate (A22) vaccine but 
which subsequently aborted (Anderson, 1986). The isolate was then grown in the 
yolk sac of fertile chicken eggs that were homogenized and the bacterial suspensions 
diluted in sucrose-phosphate-glutamate (SPG) (sucrose based medium containing 
FBS, antibiotics and fungicides) and stored at -80°C (Graham et al., 1995).  
2.3.2 Propagation of C. abortus 
Sub-confluent 225cm
2
 flasks of HeLa cells (ATCC, Middlesex, UK) were washed 
with wash buffer (500ml Hank’s balanced salt solution (HBSS) supplemented with 
2.5 mls 8% sodium hydrogen carbonate) before adding infection buffer (wash buffer 
supplemented with 30µg/ml diethylaminoethyl (DEAE)-dextran) for 20 minutes. The 
infection buffer was removed and replaced with 1 vial of S26/3 seed stock in 5mls 
propagation buffer (IMDM supplemented with 5% heat-inactivated FBS, 1µg/ml 
cyclohexamide and 50µg/ml gentamycin) and incubated for 3-4 hours at 37ºC. The 
inoculum was replaced with 18mls fresh propagation buffer and flasks incubated at 
37º C for 72 hours or until lysis was observed.  
2.3.3 Harvesting of C. abortus and preparation of seed stocks 
 After 72 hours of culture, the HeLa cell monolayer was disrupted using glass beads 
and collected together with the supernatant and centrifuged at 900g for 10 minutes. 
The cell pellet was resuspended in supernatant and sonicated to release intracellular 
C. abortus. The suspension was spun again at 900g for 10 minutes. The supernatant 
was pooled and sub-aliquoted into eppendorfs in 1ml volumes for final centrifugation 
in a microfuge (1-15K, Sigma-Aldrich) at 10000g for 10 minutes at 4ºC.  The pellets 
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were then resuspended in SPG and stored at -80ºC. These seed stocks were titrated 
(section 2.3.4) and used throughout the project in the various infection protocols.  
2.3.4 Titration of the C. abortus stock 
HeLa cells were grown to sub-confluence in 8 well chamber slides (Nunc) before 
being infected with seven log10 sequential dilutions of a C.abortus seed stock along 
with an uninfected medium control. Chamber slides were incubated for 72 hours at 
37º C before the supernatant was removed, the cells fixed in cold 90% acetone/10% 
methanol and slides stored at -20°C. Slides were rehydrated in 1xPBS before 50µl 
Image-iT® FX signal enhancer (Life Technologies) was added to each well for 30 
minutes in a humidity chamber protected from light. The slides were washed and 
labelled with 100µl per well of 1:10000 dilution of ascites mouse IgG1 monoclonal 
anti-C. abortus LPS antibody (clone 13/4), which was produced at the MRI (Graham 
et al., 1995), in 1xPBS and incubated for 30 minutes. Following three washes with 
1xPBS, 100µl per well of 1:10000 dilution of Alexafluor 488 goat anti-mouse IgG1 
secondary polyclonal antibody (pAb) (Life Technologies) in 1xPBS was added for 
30 minutes. The slides were washed before they were mounted with ProLong Gold 
anti-fade reagent containing DAPI (Life Technologies), which stained the nuclei. 
2.4 Infection protocols 
Infection protocols varied between the different experiments so exact protocols will 
be specified in each experimental chapter. Generally, the cells were challenged with 
live and in some cases UV-inactivated C. abortus S26/3. C. abortus was inactivated 
by exposure to 2000 Joules of UV in a UVIlink cross-linker (Uvitec, Cambridge) and 
a challenge dose equivalent to multiplicity of infection (MOI) 10 used. Following 
challenge, supernatants and cell lysates (following addition of RLT lysis buffer 
discussed in section 2.7) were collected and stored at -80°C for further analyses. 
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2.5 Immunofluorescence 
Cells were grown to sub-confluence and fixed as described in 2.3.4. The slides were 
washed and 100µl per well of 1:1000 anti-C.abortus major outer membrane protein 
(MOMP) mouse IgG2b monoclonal antibody (mAb) (4/11) (Insight Biotechnology 
Ltd, Wembley, UK) diluted in 1xPBS was added to the slides for 30 minutes. After 
washing, labelling was visualized by adding 100µl per well of 1:2000 Alexafluor 488 
goat anti-mouse IgG (H+L) secondary polyclonal antibody (pAb) (Life 
Technologies) diluted in 1xPBS. Slides were mounted using ProLong Gold anti-fade 
reagent containing DAPI.  
2.6 Cytokine sandwich ELISAs 
Details of the coating buffers, antibodies and standards used in the cytokine 
sandwich ELISAs are supplied in Table 2.1. Briefly, high binding 96 well 
microplates (Greiner bio-one, Stonehouse, UK) were coated with 50µl (100µL for 
TNF-α) primary antibody diluted in carbonate buffer and incubated overnight at 4°C. 
The plates were washed six times with wash buffer (1xPBS with 0.05% Tween20; 
Sigma-Aldrich) before adding 100µl of the blocking buffer and incubating at room 
temperature (RT) for 1 hour. The plates were washed twice with wash buffer before 
adding the standards and samples in 50µl volumes for 1hour incubation at RT. The 
plates were washed six times before adding the 50µl (100µl for anti-TNF-α) 
secondary antibody and incubating at RT for 1 hour. The plates were washed six 
times and 50µl goat anti-rabbit HRP (Dako, Cambridgeshire, UK) or 100µl 
Streptavidin HRP (Dako), both at 2µg/ml, added for 1 hour before repeating the 6 
wash step. Peroxidase activity was detected by the addition of 3, 3’, 5, 5’- 
Tetramethylbendizine (TMB) (KPL, Maryland, USA) substrate and the reaction 
stopped by adding 0.2 M sulphuric acid. Optical density (OD) readings were taken at 
450nm by a microplate reader (M-RX II, Dynex Technologies, Worthing, UK). 
Standard curves were obtained using commercial or recombinant cytokines (Table 
2.1) generated in house by expression in Chinese hamster ovary (CHO) cells using a 
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standard protocol (Wattegedera et al., 2004). Cytokine concentrations in the samples 
were calculated from the standard curves and expressed as pg/ml.  
Table 2.1: Components of the cytokine sandwich ELISAs used for the detection of 
ruminant innate immune cytokines. 
 * Concentration of ovine IL-6 could not be calculated (discussed in Chapter 3). 
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2.7 Generation of RNA and cDNA production 
Total RNA was extracted using the RNAeasy® Mini kit (Qiagen, West Sussex, UK) 
according to the manufacturer’s instructions. The protocol included the QIAshredder 
(Qiagen) homogenisation pre-step and DNAse (Qiagen) for the removal of genomic 
DNA. All centrifugation steps were completed at RT in a microfuge.  Briefly, cell 
supernatant was removed and cells were lysed within culture wells, of up to 5 x10
6
 
cells, using 350   RLT lysis buffer containing β-mercaptoethanol. The samples were 
then homogenised in the QIAshredder column with centrifugation at maximum speed 
for 2 minutes. The next step was the addition of 350µl of 70% ethanol to the lysate, 
which was mixed before transferral to the RNeasy spin column for centrifugation at 
9000g for 15 seconds. The column was washed with 350µl of buffer RW1 and 
centrifugation at 9000g for 15 seconds. The removal of genomic DNA involved the 
addition of 80µl DNAse (10µl of DNAse I stock solution mixed with 70µl of buffer 
RDD) for incubation on the membrane for 15 minutes. The column was washed with 
350µl buffer RW1 and centrifuged at 9000g for 15 seconds. This was followed by a 
further two wash steps with 500µl of buffer RPE and centrifugation at 9000g for 15 
seconds and 2 minutes respectively. The column membrane was dried by 
centrifugation at maximum speed for 1 minute. RNA was eluted with addition of 
30µl of RNAse-free water and centrifugation for 1 minute at 9000g. The RNA 
concentration was increased by re-eluting the RNA onto the membrane for further 
centrifugation for 1 minute at 9000g. The concentration of RNA was assessed using 
a nanodrop spectrophotometer (Thermofisher Scientific) and only RNA samples with 
a 260/280 ratio > 1.8 were used for reverse transcription.  
RNA was reverse transcribed into cDNA using Taqman
®
 reverse transcription 
reagents (Invitrogen). Briefly, a mastermix was prepared comprising 10x reverse 
transcription buffer, 25mM MgCl2, 10mM dNTP mix, 50µM Random hexamers, 
Mutiscribe™ Reverse Transcriptase (20U/µL), RNase inhibitor (20U/µL) and 
molecular grade dH2O for a final volume of 30µl. 20µl (1µg) of RNA was added and 
the reaction incubated at 25°C for 10 minutes, 48°C for 60 minutes before 
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inactivation at 95°C for 5 minutes. The RNA and cDNA produced was stored at -
80°C. 
2.8 Standard PCR 
Standard PCR (S-PCR) was used to detect the expression of NOD1, NLRP3, TLR2 
and TLR4 in cDNA. Primers were designed using primer 3 
(http://primer3.sourceforge.net/) which considers a number of factors in design 
including primer length, melting temperature and GC content (Rozen and Skaletsky, 
2000). The specificity was assessed using Blast Local Alignment Sequencing Tool 
(www.ncbi.nlm.nih.gov/blast)(Altschul et al., 1990). The sequences are shown in 
Table 2.2. All PCR primers were synthesised by MWG (Eurofins MWG Operon, 
Wolverhampton, UK). PCR reactions contained 12.5ul Biomix™ (Bioline, London, 
UK), 1µM of each primer, 2.5µl cDNA and made up to 25µl with 5µl of molecular 
grade dH2O. Cycling conditions were 95° C for 5 minutes followed by 40 cycles of 
95°C for 30 seconds, the appropriate annealing temperature (Table 2.2) for 30 
seconds, 72°C for 1 minute and a final extension of 72° C for 5 minutes. PCR 
products were run along with a 100bp ladder (New England Biolabs, Hitchin, UK), 
to assess if products were of the correct size, on a 1% agarose gel containing Gel 
Red
TM
 (Biotum, Hayward, CA, USA) and visualized using a UV illuminator. 
Positive controls were generated by stimulating PBMC with Concanavalin A (Con 
A; ICN Biochemical, Cleveland, OH, USA) at 10µg/ml for 24 hours and negative 
controls generated by excluding reverse transcriptase in cDNA preparation. PBMC 
stimulated with ConA were used as a positive control because conA activates T cells, 
which in turn can activate the other cells in culture up-regulating PRR expression. 
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Table 2.2: Standard PCR primer sequences for the detection of PRRs 





Ovine NOD1 XM_004007930.1 
 
CCATCTTTGAAGTCGGGATG CGGGCTTTATCAAGTTTCCA 378 
 
50°C 
Ovine NLRP3 XM_004008740.1 
 
AATCCCTTTCCCTGAGGTTG GGGAATGGTTGGTGCTTAGA 531 
 
52°C 
Ovine TLR2 NM_001048231.1 GCTCCTGTGACTTCCTGTCC AGTGGGAGAAGTCCAGCTCA 555 
 
52°C 
Ovine TLR4 NM_001135930.1 
 
GGACAACCAACCTGAAGCAT TGAGGTTCCTTGGCAAATTC 525 50°C 
Bovine NOD1 NM_001256563.1 
 
GCCTTCTTTGCTGCCCTTTTTC CCCCACCTTTTCACTCTGTGTC 395 52°C 
Bovine NLRP3 NM_001102219.1 
 
TCAAGCTGTCCACCAGAATG CAGAATTCACCAACCCCAGT 711 52°C 
Bovine TLR2 NM_174197.2 
 
GGGGATGACAGAGGATGAGA GGCAGAAAGCTGATGGAAAG 404 52°C 
Bovine TLR4 NM_174198.6 
 
GACCCTTGCGTACAGGTTGT GGTTGAGTAGGGGCATTTGA 538 52°C 
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2.9 Taqman real-time PCR 
Primers and probes were either designed by primer express (PE, Life Technologies) 
to meet Taqman requirements or had been previously published as detailed in Table 
2.3 and Table 2.4. All primers and probes were synthesised by MWG. The specificity 
was assessed using BLAST and primers were designed to span exon-exon junctions 
to avoid amplifying genomic DNA. The 25µl reactions contained 12.5µl of Taqman 
Universal PCR Mastermix (Life Technologies), 3.75µl of molecular grade dH2O, 
2.5µl of primers/probes and 1.25µl cDNA. Reactions were analysed on an ABI Prism 
7000 thermocycler (Applied Biosystems, Foster City, CA, USA) using the following 
cycling conditions; 50°C for 2 minutes, 95°C for 10 minutes, 40 cycles at 95°C for 
15 seconds followed by 60°C for 1 minute. Samples were run in triplicate and a non 
template control included in each assay.  
The newly designed primers/probes were assessed using a 10-fold dilution series of 
cDNA from PBMC stimulated with ConA or plasmids containing the genes of 
interest (generated as described in section 2.10). The efficiencies of the assays were 
calculated by plotting the average cycle threshold (Ct) against log cDNA 
concentration. The slope values were consistently between -3.32 and -3.22 which, 
using E = 10
(-1/slope)
-1, is between 100 and 104% efficiency and the correlation 
coefficient R2> 0.99. Gene expression was normalized to eukaryotic 18s rRNA 
endogenous control (VIC/TAMRA
TM
, Life Technologies) to correct for inherent 
variability between samples. The stability of 18s rRNA was evaluated in turbinate 
cells (Chapter 3) and was found to be stable in MDMs (Chapter 4). The fold change 
was calculated using the 2
-ΔΔCT
 method relative to the medium only control at each 
time point. Samples that were undetectable due to extremely low expression levels 
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Table 2.3: Taqman RT-PCR primers and probes used to detect ovine targets. 




CXCL8 F  CACTGCGAAAATTCAGAAATCATTGTTA 
R  CTTCAAAAATGCCTGCACAACCTTC 
Pr CCAACGGAAAAGAGGTGTGCTTAGACCCC 
NM_001009401 
Il-1β F CGAACATGTCTTCCGTGATG 
R TCTCTGTCCTGGAGTTTGCAT 
Pr TGTGATGCAGCCGTGCAGTCA 
(Budhia et al., 
2006) 
TNF-α F GAACCAGAGGCCTGTTGA 
R GGTGCCTCAGCCTCTTCT 
Pr TGGTTGCAGGAGCCACCACG 
(Budhia et al., 
2006) 





TLR2 F CTGCTGGAGCCCATTGACA 
R TATTGCAGCTCTCAAATTCAACCA 
Pr AGGCCGTTCCCCAGCGCTTCT 
(Thonur et al., 
2012) 
TLR4 F ACTCTTGTCATTGGATACATTTCTTTATG 
R GTAAGATTTAGCCAAGTGAGGTTCCTT 
Pr TGCAGTTTCAACCGTATCACGGCCT 
(Thonur et al., 
2012) 













Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 2: Materials and Methods  58 
 
Table 2.4: Taqman RT-PCR primers and probes used to detect bovine targets. 









Il-1β F AGCATCCTTTCATTCATCTTTGAAG 
R GGGTGCGTCACACAGAAACTC 
Pr CCTGTCATCTTCGAAACGTCCTCCGA 
(Galvao et al., 
2012) 










TLR2 F ACGACGCCTTCGTGTCCTAC 
R GCTCCTGGACCATGAGGTTTC 
Pr CGAGCGGGATTCCTACTGGGTGG 
(Werling et al., 
2004) 
TLR4 F TGGAGGACATGCCAGTGCT 
R CACCGACACACTGATGATCGT 
Pr AGTTTCAGGAACGCCACTTGTCAGCTG 
(Werling et al., 
2004) 










F-forward primer; R-reverse primer, Pr-probe dual labelled with 5’-FAM and 3’-TAMRA 
2.10 Generation of plasmid clones 
Plasmid clones were generated for the validation and optimisation of ovine NOD1, 
NLRP3 and bovine NOD1 RT-PCR. S-PCR was conducted using PBMC stimulated 
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with ConA and the products fractionated using electrophoresis (section 2.8) using 
primers (Table 2.5), which covered the sequence amplified by RT-PCR 
primers/probe. 
Table 2.5: Standard PCR primer sequences used for the generation of plasmid clones. 
 Forward Primer (5´-3´) Reverse Primer (5´-3´) 
Ovine NOD 1 CCATCTTTGAAGTCGGGATG CGGGCTTTATCAAGTTTCCA 
Ovine NLRP3 CATGGGCCATTTCCCCAAAA GGGAATGGTTGGTGCTTAGA 
Bovine NOD1 TGGACCTGGTACAGAGCAAG TCTTGAAGCAGCTGAGGGTG 
 
2.10.1 Purification of PCR products 
The DNA band of interest was excised and purified using the Qiaquick gel extraction 
kit (Qiagen) according to the manufacturer’s instructions. Briefly, the band was 
excised from the gel and placed into sterile eppendorfs for weighing. Three volumes 
of buffer QG was added to one volume of gel for incubation at 50° C, vortexing 
every 2-3 minutes until the gel had melted. One volume of isopropanol was added 
and the sample mixed before adding to the Qiaquick spin column for centrifugation 
at 10000g for 1 minute. The column was washed with 750µl of buffer PE and 
centrifuged at 10000g for 1 minute. Following a repeated centrifugation step the 
column was placed in a sterile eppendorf before the addition of 30 µl buffer EB. A 
final centrifugation step produced purified DNA, which was quantified using the 
nanodrop.  
2.10.2 Gene cloning 
The DNA was ligated into a pGEM®-T easy vector (Promega, Southampton, UK) 
following the manufacturer’s instructions. The DNA (1µl) was added to a sterile 
eppendorf with 1µl pGEM®-T easy vector, 5µl 2x rapid ligation buffer, 1µl T4 DNA 
ligase and 2µl nuclease-free water. A positive control with control insert DNA and a 
background control with no DNA were also included. Following overnight ligation at 
4°C, 2 µl of the ligation reaction was added to 50µl of JM109 competent E. coli cells 
(Promega). The transformation reaction was incubated on ice for 20 minutes before 
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the cells were heat-shocked at 42°C for 50 seconds. The tube were returned to ice for 
2 minutes before the addition of 950µl of SOC medium for 1.5 hour incubation with 
shaking at 150rpm at 37°C. The cells were pelleted at 900g for 10 minutes before 
resuspension in 200µl SOC medium. 100µl of transformation reaction was plated 
onto ampicillin/IPTG/X-Gal lysogeny broth (LB) agar plates (100µg/ml ampicillin 
(Sigma-Aldrich) with LB agar spread with 20µl of 50mg/ml X-Gal (Promega) and 
100µl of 100mM IPTG (Promega)) for the detection of transformed colonies based 
on colour (non-transformed colonies are blue, transformed colonies are white). The 
plates were incubated overnight at 37°C before the selection of colonies for 
screening by standard PCR (section 2.8).  
2.10.3 Plasmid purification 
The culture was expanded by inoculating 10mls of LB (containing 100µg/ml 
ampicillin) with the S-PCR positive colonies. The cultures were incubated at 37°C 
with 200rpm shaking overnight. The plasmids were purified using the Qiaprep spin 
miniprep kit (Qiagen) according to the manufacturer’s instructions. Briefly, 5 mls of 
bacterial culture was centrifuged at 4000g for 3 minutes before the pellet was 
resuspended in 250µl buffer P1. The alkaline lysis of the bacterial cells involved the 
addition of 250µl of buffer R2 followed by inversion to mix. The reaction was 
neutralized through the addition of 350µl buffer N3 with further inversions. The 
solution was centrifuged at 10000g for 10 minutes and the supernatant applied to 
Qiaprep spin column and centrifuged at 10000g for 30 seconds. Sequential wash 
steps with buffer PB and buffer PE followed. The DNA was eluted off the column 
with 50µl buffer EB and centrifugation at 10000g for 1 minute. The DNA was 
quantified using the nanodrop.  
2.10.4 Sequencing 
Plasmid DNA was sent to MWG for sequencing with the vector specific M13 
forward and reverse primers using the ABI 3730xl sequencer (Applied Biosystems). 
The sequences were trimmed from the pGEM®-T easy vector and the sequences 
were analysed for known similarity with other sequences using BLAST(Altschul et 
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al., 1990). The sequences were aligned to the predicted sequences using CLUSTAL 
W v 1.83 multiple sequence alignment programme (Thompson et al., 1994).  
2.11 Flow cytometry 
Cells were suspended in 1xPBS before the addition of LIVE/DEAD® Fixable violet 
stain (Life Technologies) (1µl per 1x10
6
 cells) and incubated for 30 minutes 
protected from light. The cells were washed with 1xPBS and centrifuged at 300g for 
10 minutes. Cells were resuspended in 20% normal goat serum (Merck Millipore, 
Watford, UK) in 1xPBS and blocked for 30 minutes in round bottom 96well plates. 
The plates were washed with 100µl FACs buffer (5% FBS, 0.05% sodium azide in 
1xPBS) and spun at 900g for 2 minutes before the addition of 50µl of the primary 
antibodies or the equivalent isotype control mAb (Table 2.6). Following incubation 
for 30 minutes at 4°C the cells were centrifuged at 900g and washed twice with 
FACs buffer. The secondary antibodies were added in 50µl volumes and the plates 
incubated for a further 30 minutes. The plates were washed with FACs buffer and the 
final wash step preformed with 1xPBS. The cells were then fixed in 1% 
paraformaldehyde in x1PBS and analysed using the MACSQuant Analyser (Miltenyi 
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Table 2.6: Antibodies and isotypes used in flow cytometry. 
* Ammonium sulphate concentrated supernatant  **Ascites  ***Supernatant                      
mAb- monoclonal antibody, pAb- polyclonal antibody 
 
Antibody Clone Isotype Dilution Supplier Catologue 
number 
Isotype controls      
IgG1 isotype* VPM21 IgG1 1:500 In house  
IgG2b isotype* VPM22 IgG2b 1:500 In house  
Primary mAb      
Mouse anti-sheep CD14 
antibody** 
VPM65 IgG1 1:1000 In house  
Mouse anti-bovine signal 
regulatory protein α (SIRPα) 
antibody** 
IL-A24 IgG1 1:2000 In house  
Rat anti-sheep MHC class II 
antibody (DR, DQ, DP)*** 
SW73.2 IgG2b 1:500 In house  
Mouse anti-bovine CD11b 
antibody 
CC126 IgG2b 1:500 Bio-Rad 
AbD serotec 
MCA1425GA 
Mouse anti-bovine CD1w2 
antibody 




Mouse anti-bovine CD80 
antibody 




Mouse anti-bovine CD205 
antibody 
CC98 IgG2b 1:500 Bio-Rad 
AbD serotec 
MCA1651GA 
Secondary pAb      
Goat anti-mouse IgG2b:RPE 
antibody 
  1:500 Bio-Rad 
AbD serotec 
STAR134PE 
AlexaFluor® 488 goat anti-
mouse IgG1 antibody 
  1:2000 Life 
technologies 
A21121 
AlexaFluor® 488 goat anti-rat 
IgG (H+L) antibody 
  1:2000 Life 
technologies 
A1106 
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Chapter 3: Characterizing the innate immune 
response of ruminant oro-nasal turbinate cells 




There are several routes by which C. abortus can be delivered to sheep under 
experimental conditions to induce abortion and mimic disease. Early studies 
identified that oral as well as subcutaneous, intravenous and intradermal inoculation 
of C. abortus could induce abortion in pregnant ewes (McEwen et al., 1951). These 
in vivo infection models have been very valuable for vaccine and pathogenesis 
studies, but of these, the oral route is the most likely to represent a natural route of 
infection. The inoculation of C. abortus over the tonsillar crypts in pregnant ewes 
resulted in similar abortion rates to subcutaneous inoculation, although intra-ruminal 
inoculation failed to induce abortion (Jones and Anderson, 1988).  More recent 
studies identified that oral and intranasal inoculation prior to pregnancy also induced 
abortion (Gutierrez et al., 2011; Longbottom et al., 2013b). Therefore, the natural 
route of infection for C. abortus is likely to be oro-nasal, which means that cells of 
the oro-nasal mucosa may be the primary targets for infection. 
An early serial kill study utilising oro-nasal inoculation with C. abortus in the non-
pregnant ewe attempted to identify the initial stages of C. abortus infection. 
Chlamydial LPS was detected in blood and tissues using the commercial IDEIA 
chlamydial ELISA kit and immunofluorescence, and Chsp60 detected by 
immunohistochemistry. Chlamydia was detected in the tonsil, suprapharyngeal 
lymph node, abomasum and jejunum at 27 hours post infection; followed by the 
                                                 
1
 The work described in this chapter has provided the basis of a peer-reviewed publication (see 
appendix 9.3). 
Doull L, Wattegedera SR, Longbottom D, Mwangi D, Nath M, Glass EJ, Entrican G., 2015. Late 
production of CXCL8 in ruminant oro-nasal turbinate cells in response to Chlamydia abortus 
infection. Vet Immunol Immunopathol.  In press, corrected proof. 
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lung, spleen and mandibular lymph node at 48 hours. There was no chlamydial 
antigen detected at 25 days post-inoculation or in the non-pregnant uterus at any 
time-point (Amin and Wilsmore, 1995). It therefore appears that following oro-nasal 
transmission the bacterium initially infects cells of the oral-pharyngeal tonsil area 
before wider dissemination into the lymph nodes. The bacterium then resides in an 
unknown location until late stage pregnancy when an optimal environment allows 
recrudescence and invasion of the placenta to induce pathology.  
The oro-nasal mucosa is a first line of defence against inhaled pathogens. The 
mucosa consists of epithelial cells, which act as a barrier to pathogens (Kweon, 
2014). Epithelial cells are capable of recognising pathogens through PRRs and 
express immune molecules, including cytokines and chemokines in response to 
challenge with bacteria, viruses and fungi (Kato and Schleimer, 2007). Chlamydiae 
are epitheliotropic (Igietseme et al., 2001) and are thought to primarily infect their 
hosts via the epithelial cells of the mucous membranes (Lu et al., 2000). The cellular 
paradigm of chlamydial pathogenesis identifies that Chlamydiae infected epithelial 
cells produce pro-inflammatory cytokines and chemokines that recruit neutrophils, T 
cells, B cells and macrophages. These immune cells can become activated within the 
pro-inflammatory environment to produce further inflammatory mediators inducing 
an inflammatory cascade. The inflammatory environment could lead to chlamydial 
clearance and healing or contribute to pathology and scarring (Stephens, 2003).  
The oro-nasal transmission of C. abortus suggests that turbinate cells, which line the 
oral-nasal mucosa, are likely to be among the first cells that the bacterium 
encounters. Cells which line mucosal surfaces have been shown to play critical roles 
in the pathogenesis of other chlamydial species (Rasmussen et al., 1997; Stephens, 
2003). Therefore, the role for ruminant turbinate cells in response to C. abortus was 
investigated. The expression of important chlamydial PRRs and pro-inflammatory 
cytokines (as described in Chapter 1) were assessed. One of the difficulties with 
working in ruminant immunology is the lack of commercially available reagents 
(Entrican et al., 2012). While there are antibodies (monoclonal and polyclonal) that 
can be used in pairs to detect ruminant cytokines and chemokines there are very few 
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commercially available kits that are sold with a recombinant ovine/bovine standard. 
In the case of ruminant CXCL8, IL-1β, TNF-α or IL-6 the antibody pairs have been 
produced against one species (Table 2.1) but are not optimised or marketed for 
comparative studies between sheep and cattle. It was therefore necessary to evaluate 
these pairs using recombinant target cytokine for both cattle and sheep. The aims of 
chapter were to:  
 Optimise and validate cytokine ELISAs for the detection of both ovine 
and bovine CXCL8, IL-1β, TNF-α and IL-6. 
 
 Determine the expression of TLR2, TLR4, NOD1 and NLRP3 by 
ruminant turbinate cells.  
 
 Assess the susceptibility of ruminant turbinate cells to C. abortus 
infection. 
 
 Assess the production of CXCL8, TNF-α, IL-1β and IL-6 by ruminant 









Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 3: Characterizing the innate response of ruminant oro-nasal turbinate cells to 
Chlamydia abortus infection  66 
3.2 Materials and methods 
3.2.1 Oro-nasal turbinate cell lines 
Ruminant turbinate cells were generated at post-mortem by harvesting foetal 
turbinate tissues, which were then trypsinised to make a single cell suspension and 
cultured as previously reported (McClurkin et al., 1974). The primary cell lines used 
in all experiments represent different passages derived from the same foetal material. 
After resuscitation, cells were adjusted to 1 x 10
5
 cells/ml and grown to sub-
confluence by adding 1 ml/well in 24 well plates (Corning Costar, High Wycombe, 
UK) or 500µl/well in 8 well chamber slides.   
3.2.2 Cross-species ELISA assessment 
Serial dilutions of both the ovine and bovine recombinant cytokines and chemokines 
(Table 3.1) were run on commercial antibody ELISA pairs (Table 2.1). The ovine 
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Table 3.1: Ovine and bovine recombinant cytokines/chemokine used for the 
generation of ELISA standard curves.  













(Bio-Rad AbD Serotec)                                                                                                                                                                                                                                                                   






TNF-α Ovine TNF-α 




(Bio-Rad AbD Serotec) 
IL-6 Ovine IL-6 
 (Unknown 
concentration)*** 
( In house) 
Bovine IL-6 
 (5µg/ml) 
(Kingfisher Biotech, Saint Paul, 
USA) 
* Estimated concentrations based on standard curve of affinity purified ovine recombinant 
standard (CSIRO, Australia) measured using the ELISA as described in Section 2.6. 
** Unknown concentration but contains 56 biological units/ml as evaluated by the L929 
mouse fibroblast killing assay (Preston et al., 1993). 
***Concentration not quantified but known to be detected by the ELISA (discussed in section 
3.3.1). 
 
3.2.3 Detection of PRR expression  
The expression of NOD1, NLPR3, TLR2 and TLR4 by ruminant turbinate cells was 
assessed using standard PCR (as described in section 2.8) on cDNA (generated as 
described in section 2.7). 
3.2.4 Infection of ruminant turbinate cells 
Ovine and bovine turbinate cells were challenged with an MOI of 0.1, 1 and 10 live 
C. abortus, UV-inactivated C. abortus (equivalent to MOI 10) and medium only 
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controls. The cell supernatant and lysate was harvested at 24, 48 and 72 hours and 
stored as described in section 2.4. The experiments were repeated on three separate 
occasions. 
3.2.5 Immunofluorescent detection of C. abortus  
The chamber slides were fixed and stained for the detection of C. abortus as 
described in section 2.5.  
3.2.6 Detection of innate immune cytokine/chemokine protein 
production 
The production of CXCL8, IL6, TNF-α and IL-1β protein by ruminant turbinate cells 
was assessed using cytokine sandwich ELISAs, as described in section 2.6, on the 
harvested supernatant. 
3.2.7 Comparison of normalizing genes for RT-PCR 
RNA was extracted from ruminant turbinate cells and cDNA produced according to 
the protocols detailed in section 2.7. The expression stability of the commonly used 
reference genes GAPDH, β-actin (Table 3.2) and 18s rRNA (VIC/TAMRATM, Life 
Technologies) was assessed in bovine turbinate cell samples across different time 
and treatment groups. The two most stable reference genes, GAPDH and 18s rRNA, 
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Table 3.2: Taqman RT-PCR primers and probes used to detect ovine and bovine 
reference genes.                 

















F-forward primer; R-reverse primer, Pr-probe dual labelled with 5’-FAM and 3’-TAMRA 
18s rRNA was determined to be the most stably expressed reference gene within the 
turbinate cells as had the smallest standard deviation (SD) from the mean across 
samples (Table 3.3). 
Table 3.3: Comparison of 18s rRNA, β-actin and GAPDH stability across ovine and 
bovine turbinate cell treatment groups.  
Species Normalizing gene Mean (Ct) Standard deviation 
Bovine 18s rRNA 13.38 0.76 
Bovine β-actin 20.65 1.25 
Bovine GAPDH 22.93 0.80 
Ovine 18s rRNA 12.81 1.03 
Ovine GAPDH 23.05 1.26 
3.2.8 Detection of innate immune cytokine/chemokine mRNA 
The production of CXCL8, IL6, TNF-α and IL-1β mRNA by ruminant turbinate 
cells was assessed using RT-PCR, as described in section 2.9, on cDNA generated 
from lysates as described in section 2.7. 
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3.2.9 Statistical analysis 
The fold change mRNA was calculated using the comparative 2
-ΔΔCT 
method, which 
included calibrating the expression from the treatment groups to the medium control 
for each time point. Both mRNA and protein data showed increased variability with 
increased mean, therefore the data was transformed. The mRNA data were 
transformed by the logarithmic (after adding a constant value of 1) and the protein 
data by square root transformation. Univariate analysis of variance (ANOVA) was 
used to assess the main effects of the independent variables (species, treatment group 
and time) as well as possible two and three-way interaction effects for the dependant 
variable (CXCL8 mRNA or protein). The blocking structure included the cell line, 
cell line interaction with treatment group and cell line interaction with time. The 
overall statistical significance of the interaction effects were assessed using the F-
statistic. If a significant effect was identified (p<0.05) post-hoc analysis was 
conducted, which involved calculating the two-sided probabilities of comparisons of 
means of treatment groups at each time point. Probabilities were adjusted using a 
False Discovery Rate (FDR) approach (Benjamini and Hochberg, 1995) to take into 
account the multiple comparisons of means. Statistical analyses were performed 
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3.3 Results 
3.3.1 Comparison of ruminant ELISA standard curves 
As described in Table 3.1, the concentrations of CHO-expressed recombinant ovine 
CXCL8 and recombinant ovine IL-1β had previously been calculated by titration 
against affinity purified ovine recombinant standards expressed in bacteria (Seow et 
al., 1994a; Seow et al., 1994b). In both cases, the ELISAs for these mediators are 
based on a mAb capture and pAb detector (Table 2.1) raised to the bacterially-
expressed recombinants (Caswell et al., 1998; Rothel et al., 1997). These ELISAs 
both detect the CHO-expressed recombinant products and the commercially-
available recombinant respective bovine orthologue (Figure 3.1A, B). The 
commercially-available recombinant bovine CXCL8 and IL-1β are sold as defined 
concentrations. In the case of CXCL8, the ovine and bovine standards match well. In 
the case of IL-1β the ELISA appears to be more sensitive for the bovine standard, but 
this may be due to the way the standards have been calculated.  
The anti-ovine IL-6 ELISA was developed in a similar manner to the CXCL8 and 
IL-1β ELISAs, comprising a mAb capture and pAb detector (Table 2.1) both raised 
against bacterially-expressed recombinant ovine IL-6 (McWaters et al., 2000). This 
ELISA also detects the in-house CHO-expressed recombinant ovine IL-6, but unlike 
the CXCL8 and IL-1β, there was no existing purified recombinant ovine standard for 
comparison. Hence, the values are expressed as dilutions of the CHO recombinant 
ovine standard. In this case, the ovine ELISA appears to be relatively poor at 
detecting the commercially-available recombinant bovine orthologue as shown by 
the low optical densities (ODs) given that the starting concentration of this material 
was 1000ng/ml (Figure 3.1C).  
The TNF-α ELISA consisted of a pAb in both capture and detection phases raised 
against recombinant bovine TNF-α (Table 2.1). In this case it was necessary to test 
the ELISA for the ability to detect the ovine orthologue. Again, this was done using 
CHO-expressed recombinant cytokine. As for the IL-6, there was no purified 
recombinant ovine TNF-α available to use as a comparator for determination of 
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concentration so values are again expressed as dilutions of the CHO-expressed TNF-
α. This ELISA does detect the ovine orthologue, but appears to have low sensitivity 
as the curve is relatively flat. Additionally, the starting concentration of the bovine 
standard was 1640 ng/ml, again indicative of low sensitivity even for the bovine 
cytokine as concentrations in excess of 1ng/ml give very low ODs (Figure 3.1D). In 
conclusion, from these profiles it is clear that the four ELISAs detect the respective 
bovine and ovine orthologues, but not with equal sensitivity.                        
  
  
Figure 3.1: Comparison of CXCL8, IL-1β, TNF-α and IL-6 ELISA standard curves 
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3.3.2 Expression of TLR2, TLR4, NOD1 and NLRP3 by 
ruminant turbinate cells 
Standard PCR was used to identify that bovine (Figure 3.2A) and ovine (Figure 
3.2B) turbinate cells expressed NLRP3, NOD1, TLR2 and TLR4. There were no 
bands detected in the negative control and bands of the correct size identified in the 
positive control (ConA stimulated PBMC) and turbinate cell samples. 
 
Figure 3.2: Expression of NLRP3, NOD1, TLR2 and TLR4 by bovine (A) and ovine (B) 
turbinate cells. Total RNA was extracted from ruminant turbinate cells and Con A 
stimulated PBMC, which was then reverse transcribed and PRRs amplified with specific 
primers using S-PCR. No reverse transcriptase controls were used as negative controls. 
Lanes 1, 4, 7 and 10: turbinate cells; Lanes 2, 5, 8 and 11: PBMC; Lanes 3, 6, 9 and 12: no 
reverse transcriptase control. Lanes 1-3: NLRP3; Lanes 4-6: NOD1; Lanes 7-9: TLR2; Lanes 
10-12: TLR4. L: 100bp ladder. Products obtained were of the expected molecular weight 
(Table 2.2). 
3.3.3 C. abortus inclusion formation in ruminant turbinate 
cells 
Ovine and bovine turbinate cells were challenged with an MOI of 10, 1 and 0.1 live 
C. abortus, UV-inactivated C. abortus (MOI10 equivalent) and medium alone. 
Challenge with live C. abortus resulted in the formation of large intracellular 
inclusions in ruminant turbinate cells (Figure 3.3A, Figure 3.4A) at 72 hours post-
infection. A decrease in the number of inclusions was observed with the lower MOI 
of 1 and 0.1 (Figure 3.3B, C; Figure 3.4B, C). Inclusions were not visible in cells 
exposed to UV-inactivated C. abortus.  However, visible fluorescent specks were 
present (Figure 3.3D, Figure 3.4D) that were not detected in the medium alone 
controls (Figure 3.3E, Figure 3.4E) and may represent inactivated bacteria adhering 
to the cells or in the cell cytosol.   
       (A) L    1     2      3     4    5    6    7    8    9   10   11 12          (B)  1    2    3     4    5     6    7    8      9    10   11   12    L     
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 Figure 3.3: Immunofluorescent images of bovine turbinate cells demonstrating 
susceptibility to C. abortus infection. C. abortus was labelled green with anti-C. abortus 
MOMP mouse monoclonal antibody 4/11 and visualized using Alexafluor 488 goat anti-
mouse IgG secondary antibody. Host cell nuclei are stained blue with DAPI. Bovine turbinate 
cells challenged with MOI 10 live C. abortus (A), MOI 1 live C.abortus (B), MOI 0.1 live C. 
abortus (C), UV-inactivated C. abortus (MOI 10 equivalent) (D) and medium alone (E) for 72 
hours. The scale bars correspond to 20µm.  
B 
 
A                                     
C D 
E 
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Figure 3.4: Immunofluorescent images of ovine turbinate cells demonstrating 
susceptibility to C. abortus infection. C. abortus was labelled green with anti-C. abortus 
MOMP mouse monoclonal antibody 4/11 and visualized using Alexafluor 488 goat anti-
mouse IgG secondary antibody. Host cell nuclei are stained blue with DAPI. Ovine turbinate 
cells were challenged with MOI 10 live C. abortus (A), MOI 1 live C.abortus (B), MOI 0.1 live 
C. abortus (C), UV-inactivated C. abortus (MOI 10 equivalent) (D) and medium alone (E) for 
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3.3.4 Innate immune cytokine/chemokine mRNA and protein 
production by ruminant turbinate cells in response to 
C. abortus infection 
There was no IL-1β or TNF-α mRNA or protein production detected in ovine or 
bovine turbinate cells at any time point or dose of C. abortus (data not shown). There 
was also no IL-6 protein detected but IL-6 mRNA analysis was not completed. 
Increased production of CXCL8 mRNA and protein was observed at 72 hours with 
an MOI 10 but not MO1 0.1 or MOI 1 live C. abortus infection in both ovine and 









UV-inactivated MOI 0.1 MOI 1 MOI 10 
Fold change 























Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 3: Characterizing the innate response of ruminant oro-nasal turbinate cells to 
Chlamydia abortus infection  77 
 
 
Figure 3.5: The pattern of expression of CXCL8 production from ovine and bovine 
turbinate cells in response to C. abortus. CXCL8 mRNA (A, C) and protein (B, D) was 
measured in ovine (A, B) and bovine (C, D) turbinate cells. CXCL8 mRNA production was 
measured in 4 treatment groups (UV-inactivated C. abortus, MOI 0.1, MOI 1, MOI 10 live C. 
abortus) calculated relative to the medium alone control at each time point.  CXCL8 protein 
production was measured in 5 treatment groups (medium alone, UV-inactivated C. abortus, 
MOI 0.1, MOI 1, MOI 10 live C. abortus).The graphs are representative of results from the 
three passages of a primary cell line.  
As there was no observable increase in CXCL8 production in response to an MOI 0.1 
or MOI 1 statistical analysis was only conducted on the CXCL8 expression in 
response to live C. abortus (MOI 10) infection compared to medium alone and UV-
inactivated C. abortus.  A significant time- and treatment-effect was detected in the 
CXCL8 mRNA (p<0.05) and protein (p<0.001) in the ovine and bovine turbinate 
cells. The production of CXCL8 mRNA was significantly higher (p<0.001) at 72 
hours post-infection with live C. abortus compared to the UV-inactivated treatment 
group in both ovine and bovine turbinate cells (Figure 3.6A). The production of 
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with the UV-inactivated C. abortus group at 72 hours post infection in both ovine 
(p<0.001) and bovine (p<0.05) turbinate cells. Significantly higher CXCL8 protein 
was produced in response to live C. abortus compared with the medium only group 
at 72 hours post infection in both ovine (p<0.001) and bovine (p<0.05) turbinate cells 
(Figure 3.6B). The mean CXCL8 protein production did not differ significantly 
(p>0.05) between the medium only group and the UV-inactivated C. abortus 
challenged group at any time point in either species. There was no significant 
interaction effect observed between species and treatment group, and between 
species and time for the expression of mRNA (p>0.12) and protein (p>0.77). 
Therefore, the production of CXCL8 followed a similar trend across treatment 
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Figure 3.6: CXCL8 mRNA (A) and protein (B) production by ruminant turbinate cells in 
response to C. abortus. The expression of CXCL8 mRNA (on the logarithmic scale after 
adding a constant of one), measured in two treatment groups (UV-inactivated C. abortus and 
live C. abortus) relative to medium alone at each time point and protein (on the square root 
scale) measured in three treatment groups (medium alone, UV-inactivated C. abortus and 
live C. abortus) at three different time points (24, 48 and 72 h) in bovine and ovine turbinate 
cells. The plots show mRNA or protein data for each treatment group in separate panels; 
with shapes (circle, triangle and diamond) representing each of the three treatment groups. 
The mean expression is represented by a solid square with corresponding 95% confidence 
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3.4 Discussion 
The limited availability of species-specific reagents is a major hurdle in the 
veterinary immunology field. An early objective was to find reagents that could be 
used to detect both sheep and cattle cytokines. The ELISAs for CXCL8, IL-1β, TNF-
α and IL-6 were found to be cross-reactive for both sheep and cattle, but with 
apparent differences in sensitivity. These differences in sensitivity may be due to the 
affinity of the mAbs/pAbs in the ELISAs for the two species or due to differences in 
the estimated concentration of the recombinant standards given that it is currently not 
possible to reliably measure the concentrations of CHO-expressed ovine 
cytokines/chemokines. This is because the culture supernatants contain other proteins 
(including low levels of FBS and cell-derived products) and the proteins are not 
tagged, making purification difficult. Validated commercially-available 
cytokine/chemokine ELISA kits that have standards for both cattle and sheep would 
be ideal and preferable for species-comparison studies, however the veterinary 
immunological toolkit still contains many gaps in capability (Entrican and Lunney, 
2012). Hence, reproducible standard curves were generated with known 
concentrations of either ovine or bovine recombinant products and used to quantify 
cytokine/chemokine production in all further experiments. 
As turbinate cells are a component of the oro-nasal mucosa, they are likely to be 
important sentinels of the immune system. The human nasal mucosa expresses 
TLR2, TLR4 (Vandermeer et al., 2004), NOD1 and NLRP3 (Bogefors et al., 2010), 
and this is the first study to demonstrate that turbinate cells of the ruminant oro-nasal 
mucosa also express these receptors. A varied complement of PRRs would be 
beneficial in the detection of a broad range of pathogens and induce the production 
of appropriate host-defence mediators. The expression of both intracellular and 
extracellular PRRs also suggests that ruminant turbinate cells have the capability to 
respond to all developmental stages of C. abortus infection.  
Live C. abortus formed large inclusions within the turbinate cells. Chlamydial entry 
into the host cell is induced by the EB, which interacts with the plasma membrane to 
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induce endocytosis (Moore and Ouellette, 2014). Inclusion size was originally 
thought to reflect bacterial replication; however, recent studies have identified that C. 
trachomatis inclusions expand in the absence of replication (Engstrom et al., 2015). 
UV-inactivated bacteria did not form inclusions within the turbinate cells. UV-
inactivation damages chlamydial DNA and renders them unable to multiply (Byrne 
and Moulder, 1978). However, UV-inactivation does not damage components on the 
bacterial surface, unlike heat-killing, and the uptake into a mouse fibroblast cell line 
was shown not to be affected (Byrne, 1976).  The fluorescent specks of bacteria that 
were visible following challenge with UV-inactivated C. abortus may be indicative 
of clumps of inactivated bacteria on the turbinate cell surface or within the host cell 
cytosol.  
Previous studies using epithelial cells from mucosal surfaces have identified that they 
are immunoreactive to chlamydial infection. C. pneumoniae induced NF-κB 
activation leading to CXCL8 production in human airway epithelial cells (Jahn et al, 
2000). Primary endocervical epithelial cells infected with C. trachomatis have been 
shown to produce increased pro-inflammatory cytokines, including CXCL8, IL-6 and 
IL-1α (Rasmussen et al., 1997). In contrast, a more recent study using polarized 
endocervical epithelial cells did not identify a significant up-regulation in CXCL8, 
IL-6 or TNF-α (Buckner et al., 2013). The ruminant turbinate cells produced CXCL8 
but not IL-6, TNF-α or IL-1β in response to C. abortus infection. CXCL8 is a pro-
inflammatory chemokine that can function in chemotaxis driving the recruitment of 
immune cells including neutrophils to the site of infection. Neutrophils have been 
identified as potential carriers of C. pneumoniae, which may perpetuate the survival 
and dissemination of the bacteria (Rupp et al., 2009; Zandbergen et al., 2004). 
Therefore, the production of CXCL8 by ruminant turbinate cells may aid in the 
dissemination of C. abortus from the site of infection. Further experiments using 
LPS are required to determine whether the lack of production of NF-κB dependant 
IL-6, TNF-α or IL-1β is specific to C. abortus or an indication that turbinate cells do 
not respond to traditional TLR stimulation.   
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Significant CXCL8 protein and mRNA production was only detected at 72 hours 
post C. abortus infection, which is late in the chlamydial developmental cycle 
(Longbottom and Coulter, 2003). The late production of CXCL8 has previously been 
identified as a feature of C. trachomatis infection of epithelial cells (Buchholz and 
Stephens, 2006; Rasmussen et al., 1997). Late CXCL8 production at 72 hours was 
also identified in trophoblast cells in response to live C. abortus (Wheelhouse et al., 
2009). There are a number of potential explanations for late CXCL8 production 
which include: inhibition of CXCL8 production by C. abortus during early 
developmental stages, the cell PAMP threshold is not reached until the bacteria has 
multiplied or cell lysis is necessary for CXCL8 production (Buchholz and Stephens, 
2008; O'Connell et al., 2006).  
An active C. abortus infection was necessary for the stimulation of CXCL8 
expression as no significant production was detected in response to UV-inactivated 
C. abortus compared to the medium alone control. This is consistent with findings 
from a previous study that demonstrated that CXCL8 production in ovine 
trophoblasts is dependent on challenge with live compared to UV-inactivated C. 
abortus (Wheelhouse et al., 2009).  Similarly, CXCL8 production in an epithelial cell 
line was identified to be dependent on a live C. trachomatis infection. In this study 
the production of CXCL8 was inhibited with UV-inactivation of the C. trachomatis 
or following treatment with chlamydiacidal antibiotics (O'Connell et al., 2006). 
Therefore, an active replicative developmental cycle is required for the activation of 
CXCL8 producing signalling pathways. Previous studies have identified that the 
MAPK and NF-κB signalling pathways regulated the induction of CXCL8 
production following chlamydial infection (Buchholz and Stephens, 2006; Buchholz 
and Stephens, 2008; Rasmussen et al., 1997; Welter-Stahl et al., 2006).  TLR2 and 
MyD88 co-localise intracellularly with the chlamydial inclusion and were identified 
to be necessary for CXCL8 production from an epithelial cell line challenged with C. 
trachomatis (O'Connell et al., 2006).  Intracellular NOD 1 mediated production of 
CXCL8 in a different epithelial cell line challenged with C. trachomatis (Buchholz 
and Stephens, 2008). The ruminant turbinate cells were found to express both TLR2 
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and NOD1, which indicates that C. abortus may activate similar signalling pathways 
for the production of CXCL8. 
The same trend in CXCL8 production was identified within both ovine and bovine 
turbinate cells. There were no species specific differences identified in the 
production of CXCL8, IL-1β, TNF-α or IL-6, which is interesting as it suggests that 
the initial course of in vivo infection may be similar. C. abortus infection has 
commonly been identified in cattle; however, the role for C. abortus in clinical 
disease is not fully understood. C. abortus infection in cattle is thought to be 
primarily sub-clinical, but has been associated with infertility and mastitis (Reinhold 
et al, 2011). Therefore, the early course of infection involving the establishment of a 
sub-clinical C. abortus infection may be similar between sheep and cattle. Following 
this, the turbinate cells are unlikely to play a critical role in determining the 
differential disease pathogenesis between sheep and cattle. 
Understanding how the pathogen is first recognised by the host is important for 
deciphering early disease pathogenesis. In this study, the first aim to optimise and 
validate innate cytokine ELISAs was completed. The ELISAs were shown to be 
cross-reactive to both cattle and sheep, but differences in sensitivity were 
demonstrated.  To address the second aim, the ruminant oro-nasal turbinate cells 
were shown to express both intracellular and extracellular PRRs, which may be 
important in chlamydial detection. Thirdly, C. abortus was shown to be capable of 
infecting both ovine and bovine turbinate cells to produce large intracellular 
inclusions. The final aim identified similar trends in cytokine and chemokine 
production in cattle and sheep turbinate cells in response to C. abortus infection: 
production of CXCL8 late in the chlamydial developmental cycle and undetectable 
levels of IL-1β, IL-6 and TNF-α. Therefore, the production of CXCL8, IL-6, TNF-α 
and IL-1β by turbinate cells in response to C. abortus is not a discriminating factor 
for disease pathogenesis between cattle and sheep. 
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Chapter 4: Characterizing the innate immune 
response of ruminant monocyte-derived cells 
to C. abortus infection 
4.1 Introduction 
Monocytes, DCs and macrophages are important innate immune cells that compose 
the mononuclear phagocyte system (MPS) (Guilliams et al., 2014). Monocytes 
circulate in blood and were originally thought to primarily function as precursors for 
mononuclear phagocytes that are resident in tissues (reviewed by Ginhoux and Jung, 
2014). However, recent studies suggest that DCs can be derived from distinct DC 
precursor cells and most tissue macrophages have embryonic origin and can 
proliferate to maintain tissue-resident populations (Guilliams et al., 2014). 
Monocytes are recruited to sites of inflammation where they can differentiate into 
monocyte-derived macrophages (MDMs) or monocyte-derived DCs (MDDCs) 
depending on environmental stimuli (Ginhoux and Jung, 2014). Cells with dendritic-
like and macrophage-like functions can be differentiated from blood monocytes in 
vitro (Guilliams et al., 2014). Monocytes differentiate into MDDCs following culture 
with IL-4 and GM-CSF (Peters et al., 1996) and into MDMs through adherence 
(Jensen et al., 2014). The ability to differentiate MDM and MDDC in vitro overcame 
the difficulties associated with ex vivo isolation of these cells from tissues. 
Consequently, these in vitro-differentiated cells are often used for functional 
experimental studies (Haniffa et al., 2015).  
Monocytes, macrophages and DCs are extremely heterogeneous and this can make 
discrimination between them difficult (Geissmann et al., 2010). Generally, cells of 
the MPS can be characterized based on their cellular origin, morphology, phenotype 
and specialized functions. DCs were first defined by Ralph Steinman in the 1970s as 
cells of the mouse spleen with dendrite processes, which give them a characteristic 
star shape (Steinman and Cohn, 1973).  The main functions of DCs are to sample the 
environment, sense damage and danger, and present antigens to prime naïve T cells.  
Macrophages are large cells with a vacuolated cytoplasm that phagocytose cell-
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derived debris and pathogens within their local environment and promote 
inflammation (Guilliams et al., 2014). Macrophages also have anti-inflammatory 
functions that may contribute to the restoration of tissue homeostasis (Murray and 
Wynn, 2011). 
The advent of flow cytometry has enabled the phenotyping of cells based on their 
cell surface markers, which has been invaluable for characterizing cell subsets 
(Guilliams et al., 2014). Combinations of different cell surface markers have been 
used to discriminate between the cells of the MPS in both humans and mice (Vu 
Manh et al., 2015a). However, the availability of antibodies for cell surface marker 
detection in ruminants is more limited. We can combine mouse and human 
phenotyping data with studies to date in cattle, to build a likely representative picture 
of the ruminant MPS.  
CD14 is part of the LPS receptor complex and is expressed on bovine monocytes and 
macrophages (Berthon and Hopkins, 1996), but is down-regulated on human 
MDDCs compared to monocyte precursors (Elkord et al., 2005). CD172-α is a 
member of the signal regulatory protein (SIRP) family and its expression is restricted 
to myeloid cells, including bovine monocytes, macrophages and populations of DCs 
(Ellis et al., 1988; Hall et al., 1993).  CD11b is a β2-integrin involved in cell adhesion 
and is expressed by bovine monocytes, DCs and macrophages (Ammon et al., 2000; 
Howard and Naessens, 1993). The co-stimulatory markers CD80 (and CD86) and the 
major histocompatibility complex Class II molecules (MHCII) are expressed on 
antigen presenting cells, which includes macrophages and dendritic cells (Elkord et 
al., 2005; Santin et al., 1999). CD1w2 is a homologue of the human CD1b surface 
marker and is expressed by bovine cortical thymocytes and DC subsets but not 
monocytes. CD205 is a c-type lectin that is part of the mannose receptor family 
(Butler et al., 2007) and is found on bovine cortical thymocytes and DC subsets 
(Gliddon et al., 2004; Howard and Naessens, 1993). CD205 is considered a “gold 
standard” DC marker in mice (Kato et al., 2006). To summarize, the predicted 
expression of cell surface markers in the ruminant MPS are presented in Table 4.1.   
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Table 4.1: Cell surface markers that can be used to differentiate monocytes, MDMs 
and MDDCs. Marker expression information was collated from studies in humans, mice and 
cattle.  
 CD14  CD172  CD11b  CD80  MHC II   CD1w2   CD205 
Monocytes + + + - - - - 
DCs - + + + + + + 
Macrophages + + + + + - - 
Monocytes are often recruited to the site of bacterial, viral, protozoan or fungal 
infection. Monocyte recruitment is an important immune defence mechanism 
contributing to pathogen clearance but may also contribute to the induction of 
immunopathology if not appropriately controlled. At the site of infection, monocyte-
derived cells can secrete pro-inflammatory cytokines, chemokines and antimicrobial 
products. They can also carry antigen to the draining lymph node for activation of the 
adaptive immune response (Shi and Pamer, 2011).  
Monocytes are among the first immune cells to be recruited to sites of chlamydial 
infection where they contribute to the in vivo inflammatory milieu (Darville and 
Hiltke, 2010). In vitro, Chlamydiae have been shown to be capable of infecting 
mononuclear phagocytes (Datta et al., 2014; Flego et al., 2013; Jendro et al., 2000), 
suggesting that these cells may play a role in disease pathogenesis and host 
immunity. Although Chlamydiae infect their hosts via mucosal surfaces, they have 
also been implicated in disease at non-mucosal sites, for example reactive arthritis in 
joints (C. trachomatis) and coronary artery disease (C. pneumoniae), indicative of 
systemic dissemination (Beagley et al., 2009a). In the case of C. abortus infection in 
sheep, the organism is thought to infect via the oronasal route, primarily infecting 
epithelial cells and then accessing lymphoid tissue via the tonsil. The bacteria may 
then systemically disseminate through blood to the lymphoid organs, where it may 
reside sub-clinically until pregnancy (Kerr et al., 2005).  The mechanism of 
dissemination of invasive species of Chlamydiae remains unclear (Beagley et al., 
2009a). Free organisms have not been detected in blood plasma and therefore cellular 
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vectors such as mononuclear phagocytes are thought to be necessary for facilitating 
dissemination from the site of infection. C. pneumoniae has been detected in vivo in 
blood monocytes following intratracheal C. pneumoniae infection of rabbits 
(Gieffers et al., 2004).  
A previous study has identified that ovine alveolar macrophages produce pro-
inflammatory cytokines in response to C. abortus (Entrican et al., 1999). However, 
the effects of C. abortus infection in different monocyte-derived cell subsets in 
ruminants have never been investigated. The innate immune response of these cells 
to C. abortus may be important for the differential pathogenesis of the infection in 
sheep and cattle. With this in mind, the objectives of this chapter were to: 
 Characterize ruminant monocytes, MDDCs and MDMs. 
 
 Determine the expression of TLR2, TLR4, NOD1and NLRP3 by 
ruminant MDDCs/MDMs.  
 
 Assess TLR2, TLR4, NOD1 and NLRP3 expression in response to C. 
abortus infection. 
 
 Assess innate immune cytokine/chemokine production in response to 
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4.2 Materials and methods 
4.2.1 CD14+ monocytes, MDMs and MDDCs 
Ruminant monocytes, MDMs and MDDCs were generated as described in section 
2.2.  
4.2.2 Kwik-Diff™ staining 
MDMs (1 x 10
5
) were deposited onto glass slides using the Shandon Cytospin 3 
(Thermoscientific) at 700rpm for 10 minutes. The Kwik-Diff
™
 kit (Thermoscientific) 
was used to fix and stain the cells with eosin and methylene blue following the 
manufacturer’s instructions. Slides were mounted with DPX mountant (Sigma-
Aldrich). 
4.2.3 Phagocytosis assay 
MDMs were seeded in 8 well chamberslides at 1 x 10
5
 cells per well and incubated 
for 24 hours at 37°C. The Zymosan A (S. cerevisiae) Bioparticles™ labeled with 
Fluorescein (Life Technologies) were then added at 100 beads per cell and incubated 
for 1 hour at 37°C. Ice-cold 1xPBS was added to stop phagocytosis and the cells 
were washed 4 times with the 1xPBS to remove extracellular beads. The cells were 
fixed in 4% PFA before they were mounted using ProLong Gold anti-fade reagent 
containing DAPI. 
4.2.4  Non-specific esterase staining 
Non-specific esterase (NSE) staining was detected in MDMs using the α-Naphthyl 
Acetate kit (Sigma-Aldrich) according to the manufacturer’s instructions. Briefly, 
cells were cytospun onto slides as described in section 4.2.2 and fixed in Citrate-
Acetone-Formaldehyde for 30 seconds before rinsing with deionized water. The 
slides were incubated for 30 minutes at 37°C in a solution containing Sodium Nitrite 
solution, Fast Blue BB Base solution, TRIZMAL
TM
 7.6 buffer concentrate and α-
Naphthyl Acetate solution. The slides were rinsed in deionized water and 
counterstained in Haematoxylin solution, Gill No. 3 for 2 minutes. The non-specific 
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esterase kit forms black deposits if the α-napthyl esterase is hydrolysed by non-
specific esterases, which are primarily found in monocytes, macrophages and 
histocytes. 
4.2.5 Phenotyping ruminant monocytes, MDDCs and MDMs 
The ruminant monocytes, MDDCs and MDMs were phenotyped using the flow 
cytometry protocol described in section 2.11 and the data analysed as described in 
section 4.2.6. 
4.2.6 Gating strategy for flow cytometry 
The cells were first gated on forward and side scatter to exclude debris to generate 
population 1 (P1) for further gating (Figure 4.1A). The cells within P1 were then 
gated on live cells by analysing the live/dead cell vioblue fluorescent stain to 
generate population 2 (P1/P2) (Figure 4.1B). The P1/P2 cells were then gated to 
exclude doublets using forward scatter area (FSC-A) and forward scatter height 
(FSC-H) to generation population 3 (P1/P2/P3) (Figure 4.1C). The level of FITC or 
PE fluorescence from the cells within the P1/P2/P3 gate was assessed. Quadrants 
were set on the isotype-matched controls so that cells were gated on FITC/PE 
expression to generate population 4 (P1/P2/P3/UL4) (Figure 4.1D) to assess the 
percentage positive cells. The isotype-matched control was overlaid onto the stained 
population and presented in histogram format (Figure 4.1E). Median fluorescent 
intensities (MFIs) were calculated by subtracting the median fluorescence of the 
P1/P2/P3 isotype control population from the P1/P2/P3 marker population.  
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Figure 4.1: The gating strategy used for the phenotyping of monocytes, MDDCs and 
MDMs. The cells were gated based on forward and side scatter (A), live cells (B), single cells 
(C) and FITC or PE fluorescence with quadrants based on the isotype matched control (D). 
The fluorescence of the marker population (blue histogram) was overlaid with the isotype 




   
4.2.7 Infection of ruminant MDMs and MDDCs 
Ruminant MDMs and MDDCs were infected with C. abortus S26/3 at an MOI 10, 1 
or 0.1 diluted in culture medium. Cells were also exposed to UV-inactivated C. 
abortus (equivalent to MOI10) and culture medium alone. Supernatants and cell 
lysates were collected at 6, 24, 48 and 72 hours post infection and stored at -80°C for 
further analyses (described in section 2.4). The experiments were repeated on four 
separate occasions. 
4.2.8 Immunofluorescent detection of C. abortus  
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The MDMs were seeded at 1 x 10
5
 and MDDCs at 5 x10
5
 in chamber slides and 
infected according to section 4.2.7 before fixing and staining using the protocol 
detailed in section 2.5. 
4.2.9 Detection of innate immune cytokine/chemokine protein  
The production of CXCL8, IL6, TNF-α and IL-1β protein by ruminant MDMs and 
MDDCs was assessed using cytokine sandwich ELISAs, as described in section 2.6, 
on the harvested supernatant. 
4.2.10 Detection of PRR expression using S-PCR  
The expression of NOD1, NLPR3, TLR2 and TLR4 by ruminant MDMs and 
MDDCs was assessed using standard PCR (as described in section 2.8) on cDNA 
(generated as described in section 2.7). 
4.2.11 Detection of PRRs and innate immune 
cytokine/chemokine mRNA using RT-PCR 
The expression of TLR2, TLR4, NOD1, NLRP3, CXCL8, IL-6, TNF-α and IL-1β 
was detected in ruminant MDM 6 hour post-infection samples using RT-PCR 
(described in section 2.9) on cDNA (generated as described in section 2.7). 18s 
rRNA was used as a reference gene as it was expressed at a stable level across 
treatment groups and animal replicates with the average SD of 0.18 in ovine MDMs 
and 0.27 in bovine MDMs.  
4.2.12 Statistical analyses 
The MFIs were assessed for normality using the Anderson-Darling test. Non-normal 
data were log-transformed. The difference between the cell types was assessed using 
a one way ANOVA. For the cattle, CD11b staining could not be transformed into 
normal distributions and therefore a non-parametric Kruskal-Wallis test was 
conducted followed by pairwise Mann-Whitney U tests. The difference between the 
species was assessed using two-sample T-tests following log-transformation. The 
CD205 monocytes and CD11b DCs cross-species comparison could not be 
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transformed into normal distributions and therefore comparisons were made with the 
Mann-Whitney U test. 
The fold change RT-PCR data were tested for normality using the Anderson-Darling 
test. As the data were non-normally distributed they were rank transformed (Beasley 
et al., 2009).  The different treatment groups were analysed using a one-way 
ANOVA and comparisons between treatments made using Tukey’s pairwise 
comparison test which resulted in adjusted (controlling for the family error rate for 
multiple comparisons) p-values. The cross-species comparison was completed using 
a general linear model with species, treatment and species*treatment fixed factors.  
The cytokine/chemokine protein data were tested for normality using the Anderson-
Darling test. As the data were not normally distributed they were rank transformed. 
Linear mixed models were used to assess the fixed effects: time, treatment and 
time*treatment with animal set as a random effect. Dr Javier Palarea used zero 
inflated general linear mixed models to assess two of the data sets (ovine MDDC IL-
1β and bovine MDDC IL-1β) which had inflated numbers of zeros. Zero-inflated 
modelling could not be applied to three of the data sets (bovine MDM TNF-α, ovine 
MDDC TNF-α and ovine macrophage IL-1β) due to the fact that all of the medium-
alone values were zero. Removing the medium-alone group allowed the data (bovine 
MDM TNF-α and ovine MDDC TNF-α) to be analysed using the LMM. If there was 
a significant F-statistic (p<0.05) from the linear mixed models, two-sided 
probabilities of comparisons of means were obtained. The probabilities were adjusted 
using a FDR approach (Benjamini and Hochberg, 1995). However, the one 
remaining data set (ovine MDM IL-1β) had a number of zeros in other treatment 
groups so could not be analysed using a mixed model approach and therefore 
summary measures (Matthews et al., 1990), which involves calculating area under 
the curve, was used. The Kruskal-Wallis test was used to assess the effect of 
treatment and the pairwise comparisons completed using the Mann-Whitney U test.  
The requirement for different statistical models for the cytokine/chemokine protein 
data sets meant that the cross-species comparison could not be incorporated into a 
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single model. Quantitative differences were assessed using the area under the curve 
of cytokine production from the MOI10 treatment group and compared between 
species using a two-sample T-test. The MOI10 treatment group was chosen because 
there was production of cytokine across all data sets and it is the treatment extreme 
likely to have the largest response.  
Statistical analysis for the RT-PCR and flow cytometry data was conducted using 
Minitab v. 17. The linear mixed models were conducted using GenStat (GenStat 
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4.3 Results 
4.3.1 Ruminant MDDC morphology 
The ruminant MDDCs developed dendrite like protrusions but appeared to develop 
differently between cattle and sheep. The bovine MDDCs developed in clusters and 
many became non-adherent (Figure 4.2 A, B), whereas the ovine MDDCs were 
largely adherent and confluent (Figure 4.2 C, D).  
 
 
Figure 4.2: Comparison of bovine (A, B) and ovine (C, D) MDDCs following 3 and 6 
days in culture respectively. The MDDCs were visualized using light microscopy at x10 (A, 
C) and x40 (B, D) magnification.      
4.3.2 Ovine MDM morphology and function  
The production of ovine MDMs required optimisation as the published protocol for 
the generation of bovine MDMs (Jensen et al., 2014) was not effective for sheep. The 
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generation of macrophage-like cells from ovine PBMC. The ovine cells were 
characteristically large and vacuolated with irregular nuclei (Figure 4.3A, B). The 
ovine cells also expressed non-specific esterases and were capable of phagocytosis 
(Figure 4.3C, D), characteristic of macrophages.  
 
 
Figure 4.3: Characterisation of ovine MDMs. The cells were analysed microscopically 
(x40 magnification) (A), using a Kwik-Diff stain (B), using non-specific esterase staining (C) 
and using fluorescein labelled phagocytic beads (D).  
4.3.3 Phenotypic analysis of ruminant MPS cells 
Flow cytometric analysis of bovine (Figure 4.4) and ovine (Figure 4.5) monocytes 
demonstrated that they expressed CD172-α, MHCII, CD11b, CD14 and CD80 but 
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Figure 4.4: Expression of cell surface markers by bovine monocytes. The red 
histograms represent the isotype-matched controls and the blue histograms represent cell 
surface markers (CD172-α, MHCII, CD11b, CD1w2, CD205, CD14 and CD80). The 
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Figure 4.5: Expression of cell surface markers by ovine monocytes. The red histograms 
represent the isotype-matched controls and the blue histograms represent cell surface 
markers (CD172-α, MHCII, CD11b, CD1w2, CD205, CD14 and CD80). The histograms are 
from one animal but are representative of the profiles observed in four animals.  
Bovine MDDCs expressed CD172-α, CD11b, CD80, MHCII and CD14 but not 
CD205 or CD1w2 (Figure 4.6). 
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Figure 4.6: Expression of cell surface markers by bovine MDDCs. The red histograms 
represent the isotype-matched controls and the blue histograms represent cell surface 
markers (CD172-α, MHCII, CD11b, CD1w2, CD205, CD14 and CD80). The histograms are 
from one animal but are representative of the profiles observed in four animals. 
Ovine MDDCs expressed CD11b, CD80 and CD172-α; however, two populations of 
cells with different levels of expression for some of the markers (MHCII, CD11b and 
CD14) were apparent (Figure 4.7).   
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Figure 4.7: Expression of cell surface markers by ovine MDDCs. The red histograms 
represent the isotype-matched controls and the blue histograms represent cell surface 
markers (CD172-α, MHCII, CD11b, CD1w2, CD205, CD14 and CD80). The histograms are 
from one animal but are representative of the profiles observed in four animals. 
Bovine (Figure 4.8) and ovine (Figure 4.9) MDMs expressed CD172-α, MHCII, 
CD11b, CD1w2, CD14 and CD80. The ovine MDMs also expressed CD205 unlike 
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Figure 4.8: Expression of cell surface markers by bovine MDMs. The red histograms 
represent the isotype-matched controls and the blue histograms represent cell surface 
markers (CD172-α, MHCII, CD11b, CD1w2, CD205, CD14 and CD80). The histograms are 
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Figure 4.9: Expression of cell surface markers by ovine MDMs. The red histograms 
represent the isotype-matched controls and the blue histograms represent cell surface 
markers (CD172-α, MHCII, CD11b, CD1w2, CD205, CD14 and CD80). The histograms are 
from one animal but are representative of the profiles observed in four animals. 
4.3.3.1 Comparison of the percentage positivities and median 
fluorescent intensities of monocytes, MDDCs and MDMs 
The percentage positivities of markers for the different cell types were calculated in 
sheep (Table 4.2) and cattle (Table 4.3). High percentages of all of the MPS cells 
expressed CD14, CD11b and CD172α. Most of the ovine and bovine monocytes and 
MDMs expressed MHC II and CD80. The percentage positivity of CD80 in ovine 
and bovine MDDCs was reduced relative to the monocytes. The percentage 
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compared to the monocytes. The percentage of cells expressing CD1w2 and CD205 
was low in monocytes but increased with differentiation into MDDCs and MDMs in 
both cattle and sheep.  
The median fluorescent intensities (MFIs) were calculated for the markers for the 
different cell types in sheep (Table 4.4) and cattle (Table 4.5). There was no 
significant difference detected in CD14 comparing monocytes to MDDCs or MDMs 
(p>0.05). The MFI of CD11b was significantly up-regulated in both the ovine and 
bovine MDMs and MDDCs compared to the monocytes (p<0.05). The expression of 
CD11b was significantly higher in MDMs than MDDCs (p<0.05).  There was a 
significant up-regulation of MHCII in ovine MDMs compared to MDDCs (p<0.05) 
but no significant differences between the other cell subsets or between bovine cells 
(p>0.05). The MFI of CD172-α was significantly up-regulated in MDMs compared 
to monocytes and MDDCs in both cattle and sheep (p<0.05). CD80 was significantly 
up-regulated in MDMs compared to monocytes in both cattle and sheep (p<0.01) and 
also in MDDCs compared to monocytes in cattle (p<0.01). CD205 expression was 
significantly up-regulated in ovine and bovine MDMs compared to monocytes and 
MDDCs (p<0.01). The expression of CD205 was up-regulated in ovine MDDCs 
compared to monocytes (p<0.01) but not in bovine MDDCs (p>0.05). CD1w2 
expression was significantly up-regulated in ovine and bovine MDMs and also ovine 
MDDCs compared to monocytes (p<0.05). There was a significant up-regulation in 
CD1w2 expression in MDMs compared to MDDCs in ovine (p<0.01) but not bovine 
cells. 
 The comparison of MFIs between cattle and sheep (Table 4.6) revealed significantly 
increased expression of MHC II in all bovine compared to ovine mononuclear cells 
(p<0.05). CD11b expression was significantly increased in ovine compared to bovine 
MDDCs (p<0.05) but increased in bovine compared to ovine MDMs (p<0.01). 
CD205 expression was significantly higher in ovine compared to bovine MDDCs 
(p<0.05) and MDMs (p<0.01). The expression of CD1w2 was significantly higher in 
ovine compared to bovine monocytes and MDDCs (p<0.05). There was no 
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significant difference between cattle and sheep in CD80, CD172-α or CD14 MFIs 
(p>0.05).
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Table 4.4: MFIs and p-values of surface markers on ovine MPS cells. The MFIs ± SE. Green values represent significant differences (p<0.05). 
 CD14 CD1w2 CD172-α CD80 CD11b CD205 MHC II 
MFIs        
Ovine monocytes 5.92 ± 0.77    0.16 ± 0.03  11.71 ± 0.86  1.06 ± 0.34 15.81± 2.05 0.01 ± 0.01   1.84 ±0.30   
Ovine MDDCs 9.75 ± 2.22  1.56 ± 0.26  10.87 ± 1.09   4.04 ± 0.99 31.36 ± 3.91 1.53 ±0.36  1.73 ± 0.62  
Ovine MDMs 16.45 ± 5.02 1.94 ± 0.48 20.78 ± 3.84 6.60 ± 0.99 136.39 ± 11.93  3.27 ± 0.24  3.41 ± 0.19 
P-values        
Monocytes - MDDCs 0.510 0.030 0.900 0.075 0.008 0.005 0.981 
Monocytes - MDMs 0.080 0.008 0.048 0.003 <0.001 <0.001 0.057 
MDDCs - MDDMs 0.411 0.675 0.024 0.130 <0.001 0.002 0.043 
 CD14 CD1w2 CD172-α CD80 CD11b CD205 MHC II 
Ovine monocytes 92.63 ± 2.23  13.69 ± 3.11 96.3 ± 0.84   70.11 ± 16.18 98.40 ± 0.34 4.30 ± 0.39  70.66 ± 3.33 
Ovine MDDCs 64.41 ± 8.36 16.07 ± 4.67 70.79 ± 7.04 37.05 ± 13.30 78.09 ± 5.96 19.54 ± 6.47 22.25 ± 4.06  
Ovine MDMs 85.36 ± 12.17  28.04 ± 8.92 93.86 ± 1.28 72.88 ± 9.48  99.25 ± 0.44 63.29 ± 24.24  55.36 ± 8.69 
 CD14 CD1w2 CD172-α CD80 CD11b CD205 MHC II 
Bovine monocytes 99.00 ± 0.15 1.68 ± 0.27 99.04 ± 0.15 64.28 ± 4.36 99.07 ± 0.16 1.49 ± 0.24 97.96 ± 1.05 
Bovine MDDCs 86.57 ± 2.35 9.18 ± 1.33 89.84 ± 3.26  45.77 ± 3.71 87.93 ± 1.02  3.03 ± 0.34 93.28 ± 2.33  
Bovine MDMs 84.37 ± 0.90  20.81 ± 3.32 95.19 ± 1.05 55.17 ± 5.98 95.05 ± 1.47 7.19 ± 3.3  57.37 ± 10.09  
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Table 4.5: MFIs and p-values of surface markers on bovine MPS cells. The MFIs ± SE. The values highlighted in green represent significant 
differences (p<0.05). 
 CD14 CD1w2 CD172-α CD80 CD11b CD205 MHC II 
MFIs        
Bovine monocytes 8.59 ±0.77   0.03 ± 0.01 17.95 ± 4.74   0.77 ±0.07   12.42 ± 0.85 0.02 ± 0.01  9.08 ± 1.91 
Bovine MDDCs 16.02 ±1.33   0.40 ± 0.08  16.79 ± 6.02  2.59 ±0.26   5.34 ± 0.15  0.08 ± 0.07   16.1 ±1.69   
Bovine MDMs 20.09 ± 5.54   2.87 ±0.70    45.49 ±9.19   6.61 ± 1.66  225.99 ± 15.38  0.59 ± 0.15   14.47 ± 2.82  
P-values        
Monocytes - MDDCs 0.301 0.106 0.992 0.004 0.0304 0.749 0.114 
Monocytes - MDMs 0.085 <0.001 0.024 <0.001 0.0304 0.002 0.245 
MDDCs - MDDMs 0.673 0.002 0.040 0.032 0.0304 0.005 0.861 
 
Table 4.6: The p-values of the comparison of ovine and bovine cell surface marker MFIs from MPS cells. The values highlighted in green 
represent significant differences (p<0.05). 
 CD14 CD1w2 CD172-α CD80 CD11b CD205 MHC II 
Monocytes 0.057 0.017 0.332 0.468 0.202 0.6198 0.033 
MDDCs 0.073 0.025 0.564 0.251 0.0304 0.028 0.004 
MDMs 0.648 0.325 0.068 0.997 0.006 0.001 0.030 
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4.3.4 Expression of TLR2, TLR4, NOD1 and NLRP3 by 
ruminant monocyte-derived cells 
The ruminant MDDCs (Figure 4.10) and MDMs (Figure 4.11) expressed TLR2, 
TLR4, NOD1 and NLRP3 as shown using S-PCR. 
  
Figure 4.10:  Expression of NLRP3, NOD1, TLR2 and TLR4 by bovine (A) and ovine (B) 
MDDCs. Total RNA was extracted from ruminant MDDCs and Con A stimulated PBMC, 
which was then reverse transcribed and PRRs amplified with specific primers using S-PCR. 
No reverse transcriptase controls were used as negative controls. Lanes 1, 4, 7 and 10: 
DCs; Lanes 2, 5, 8 and 11: PBMC; Lanes 3, 6, 9 and 12: no reverse transcriptase control. 
Products obtained were of the expected molecular weight (Table 2.2). 
 
    
Figure 4.11: Expression of NLRP3, NOD1, TLR2 and TLR4 by bovine (A) and ovine (B) 
MDMs. Total RNA was extracted from ruminant MDMs and Con A stimulated PBMC, which 
was then reverse transcribed and PRRs amplified with specific primers using S-PCR. No 
reverse transcriptase controls were used as negative controls. Lanes 1, 4, 7 and 10: MDMs; 
Lanes 2, 5, 8 and 11: PBMC; Lanes 3, 6, 9 and 12: no reverse transcriptase control. 
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4.3.5 Immunofluorescent images of C. abortus-infected 
monocyte-derived cells 
The bovine and ovine MDDCs were susceptible to C. abortus infection, shown by 
the multiple small inclusions of varying fluorescent intensity. Green fluorescent 
specks were also visible in the UV-inactivated control but not in the medium alone 
control (Figure 4.12 and Figure 4.13). 
 
 
Figure 4.12: Immunofluorescent images of bovine MDDCs demonstrating 
susceptibility to C. abortus infection. C. abortus was labelled green with anti-C. abortus 
MOMP mouse monoclonal antibody 4/11 and visualized using Alexafluor 488 goat anti-
mouse IgG secondary antibody. The host cell nuclei were stained blue with DAPI. Bovine 
MDDCs were exposed to MOI 10 live C. abortus (A), MOI 1 live C. abortus (B), UV-
inactivated C. abortus (MOI 10 equivalent) (C) and medium alone (D) for 48 hours. The scale 
bars correspond to 20µm.  
A B 
C D 
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Figure 4.13: Immunofluorescent images of ovine MDDCs demonstrating susceptibility 
to C. abortus infection. C. abortus was labelled green with anti-C. abortus MOMP mouse 
monoclonal antibody 4/11 and visualized using Alexafluor 488 goat anti-mouse IgG 
secondary antibody. The host cell nuclei were stained blue with DAPI. Ovine MDDCs were 
exposed to MOI 10 live C. abortus (A), MOI 1 live C. abortus (B), UV-inactivated C. abortus 
(MOI 10 equivalent) (C) and medium alone (D) for 48 hours. The scale bars correspond to 
20µm.  
The bovine and ovine MDMs were also susceptible to C. abortus infection with 
multiple small inclusions visible following infection with live C. abortus. Green 
fluorescent specks were visible in the UV-inactivated control but not in the medium 
alone control (Figure 4.14 and Figure 4.15). 
A B 
C D 
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Figure 4.14: Immunofluorescent images of bovine MDMs demonstrating susceptibility 
to C. abortus infection. C. abortus was labelled green with anti-C. abortus MOMP mouse 
monoclonal antibody 4/11 and visualized using Alexafluor 488 goat anti-mouse IgG 
secondary antibody. The host cell nuclei were stained blue with DAPI. Bovine MDMs were 
exposed to MOI 10 live C. abortus (A), MOI 1 live C. abortus (B), UV-inactivated C. abortus 
(MOI 10 equivalent) (C) and medium alone (D) for 48 hours. The scale bars correspond to 











Inflammasome activation in ruminant cells infected with Chlamydia abortus 
  
 
Chapter 4: Characterizing the innate immune response of ruminant monocyte-derived 





Figure 4.15: Immunofluorescent images of ovine MDMs demonstrating susceptibility 
to C. abortus infection. C. abortus was labelled green with anti-C. abortus MOMP mouse 
monoclonal antibody 4/11 and visualized using Alexafluor 488 goat anti-mouse IgG 
secondary antibody. The host cell nuclei were stained blue with DAPI. Ovine MDMs were 
exposed to MOI 10 live C. abortus (A), MOI 1 live C. abortus (B), UV-inactivated C. abortus 
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4.3.6 PRR and cytokine/chemokine mRNA expression by 
ruminant MDMs following C. abortus infection 
The mRNA expression of IL-1β, IL-6, CXCL8, TNF-α, NOD1, NLRP3, TLR2 and 
TLR4 was assessed in bovine MDMs in response to medium alone, MOI 0.1, 1, 10 
and UV-inactivated C. abortus at 6 hours post-infection by RT-PCR. The data are 
presented as fold change relative to the medium alone control. There was an up-
regulation of all of the mRNA targets in response to the different treatments except 
from NOD1, which appears to be down-regulated with MOI10 and UV-inactivated 
organisms. There was animal to animal variation in the quantity of production as 
shown by the large standard errors (Table 4.7).  
Table 4.7: Cytokine/chemokine and PRR mRNA fold changes from bovine MDMs 
treated with medium alone, MOI 0.1, MOI 1, MOI 10 and UV-inactivated C. abortus. The 
results are presented as mean fold change ± standard error compared to the medium alone 
control.  The experiment was repeated with MDMs from 4 different animals with the 
exception of a missing MOI 0.1 sample.   
 Medium 
alone 
MOI 0.1 MOI 1 MOI 10 UV-inactivated 






IL-6 1 1.07 ± 0.12 3.50 ± 1.36 29.21 ± 23.83 11.93 ± 5.96 
CXCL8 1 1.81 ± 0.66  9.46 ± 4.42 83.37 ± 62.78 63.32 ±  38.87 
TNF-α 1 4.11 ± 1.41 40.77 ± 30.87 77.33 ± 26.28 137.24 ± 84.98 
NOD1 1 1.09 ± 0.06 1.11 ± 0.07 0.68 ± 0.17 0.61 ± 0.14 
NLRP3 1 1.80 ± 0.08 4.05 ± 0.72 8.01 ± 1.32 13.51 ± 3.64 
TLR2 1 0.92 ± 0.10 1.58 ± 0.14 1.87 ± 0.25 1.85 ± 0.28 
TLR4 1 1.02 ± 0.21 1.41 ± 0.17 1.94 ± 0.52 1.55 ± 0.56 
The bovine MDM fold change values were not normally distributed and therefore the 
values were rank-transformed before they were graphed on interval plots (Figure 
4.16) and statistically analysed (Table 4.8).  
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Figure 4.16: The mRNA expression of IL-1β (A), IL-6 (B), CXCL8 (C), TNF-α (D), NOD1 
(E), NLRP3 (F), TLR2 (G) and TLR4 (H) following treatment of bovine MDMs with MOI 
0.1, 1 and 10 or UV-inactivated C. abortus at the equivalent of MOI 10 for 6 hours. The 
fold change was calculated by comparing expression to the medium alone control. The 
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results are presented as rank transformed fold change (black squares) ± 95% confidence 
intervals (blue error bars). The results are representative of repeat experiments using MDMs 
from 4 different animals with the exception of a missing MOI 0.1 sample.   
There was a significant fold increase in IL-1β, IL-6, CXCL8 and TNF-α mRNA 
expression in response to the MOI10 compared to the MOI 0.1 (Table 4.8, all with 
p<0.05). There was a significant increase in NLRP3 and TLR2 expression with MO1 
10 compared to MOI 0.1 (Table 4.8, both with p<0.05). The UV-inactivated 
organisms compared to the MOI 0.1 produced significantly higher IL-1β, IL-6, 
CXCL8, TNF-α and NLRP3 mRNA expression (Table 4.8, all with p<0.05). There 
was no significant difference between UV-inactivated organisms and the MOI 10 in 
any of the mRNA targets. There was no significant difference in TLR4 or NOD1 
mRNA expression between any of the treatment groups (Table 4.8, all with p>0.05). 
Table 4.8: The p-values from the statistical comparison of fold changes between the 
different treatments in bovine MDMs. Data were analysed using a one-way ANOVA and 
comparisons between treatments made using Tukey’s pairwise comparison. The values 
highlighted in green represent significant differences (p<0.05). 
Comparisons IL-1β IL-6 CXCL8 TNF-α NOD1 NLRP3 TLR2 TLR4 
MOI1 – MOI 0.1 0.294 0.179 0.310 0.286 1 0.342 0.101 0.625 
MOI 10 – MOI 
0.1  
0.027 0.010 0.018 0.030 0.331 0.001 0.028 0.403 
UV-inactivated 
– MOI 0.1 
0.013 0.007 0.013 0.022 0.126 0.003 0.069 0.732 
MOI 10 – MOI 1 0.405 0.281 0.269 0.454 0.249 0.027 0.831 0.971 
UV-inactivated 
– MOI1 
0.214 0.202 0.196 0.349 0.083 0.062 0.994 0.997 
UV-inactivated 
– MOI 10 
0.964 0.995 0.996 0.996 0.890 0.963 0.932 0.917 
The mRNA expression of IL-1β, IL-6, CXCL8, TNF-α, NOD1, NLRP3, TLR2 and 
TLR4 was also assessed in ovine MDMs at 6 hours in response to the same treatment 
groups. There is an up-regulation of the expression of all the mRNA targets in 
response to the different treatments (Table 4.9). 
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Table 4.9: Cytokine/chemokine and PRR mRNA fold change from ovine MDMs treated 
with medium alone, MOI 0.1, MOI 1, MOI 10 and UV inactivated C. abortus. The results 
are presented as mean fold change ± standard error compared to the medium alone control.  




MOI 0.1 MOI 1 MOI 10 UV-inactivated 




IL-6 1 1.24 ± 0.13 28.24 ±  21.88      128.33 ± 39.28 537.08 ± 240.03 
CXCL8 1 2.77 ± 0.71 7.47 ± 4.40 28.71 ± 17.19 29.06 ± 17.18 
TNF-α 1 2.22 ± 0.68 8.42 ± 4.50 33.08 ± 6.97 36.57 ± 11.97 
NOD1 1 1.32 ± 0.11 1.19 ± 0.15 1.41± 0.26 1.55 ± 0.30 
NLRP3 1 1.19 ± 0.21 1.82 ± 0.26 5.10 ± 0.71 4.87 ± 0.59 
TLR2 1 2.02 ± 0.50 3.57 ± 1.12 5.08 ± 0.93 6.28 ± 0.84 
TLR4 1 1.34 ± 0.12 1.32 ± 0.18 1.72 ± 0.21 1.83 ± 0.18 
The ovine MDM fold change values were not normally distributed and therefore the 
values were rank-transformed before they were graphed on interval plots (Figure 
4.17) and statistically analysed (Table 4.10).  
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Figure 4.17: The mRNA expression of IL-1β (A), IL-6 (B), CXCL8 (C), TNF-α (D), NOD1 
(E), NLRP3 (F), TLR2 (G) and TLR4 (H) following treatment of ovine MDMs with MOI 
0.1, 1 and 10 or UV-inactivated C. abortus at the equivalent of MOI 10 for 6 hours. The 
fold change was calculated by comparing expression to the medium alone control. The 
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results are presented as rank transformed fold change (black squares) ± 95% confidence 
intervals (blue error bars). The results are representative of repeat experiments using MDMs 
from four different animals.     
There was a significant increase in IL-1β, IL-6, CXCL8 and TNF-α mRNA 
expression in response to an MOI 10 compared to an MOI 0.1 C. abortus (Table 
4.10, all with p<0.05), indicating a dose dependant increase in cytokine production. 
There was a significant increase in NLRP3 and TLR2 expression in response to the 
MOI 10 compared to MOI 0.1 (Table 4.10, both with p<0.05). NLRP3 and TLR2 
expression was also significantly up-regulated in response to UV-inactivated C. 
abortus compared to the MOI 0.1 (Table 4.10, both with p<0.05). There was no 
significant difference between UV-inactivated organisms and the MOI 10 in any of 
the mRNA targets. There was no significant difference in NOD1 or TLR4 expression 
between any of the different treatment groups (Table 4.10, all with p>0.05). 
Table 4.10: The p-values from the statistical comparison of fold change between the 
different treatments in ovine MDMs. Data were analysed using a one-way ANOVA and 
comparisons between treatments made using Tukey’s pairwise comparison. The values 
highlighted in green represent significant differences (p<0.05). 
Comparisons IL-1β IL-6 CXCL8 TNF-α NOD1 NLRP3 TLR2 TLR4 
MOI1 – MOI 
0.1 
0.311 0.079 0.654 0.671 0.998  0.149 0.404 0.998 
MOI 10 – MOI 
0.1  
0.002 0.003 0.046 0.015 0.587 0.004 0.049 0.587 
UV – 0.1 0.002 0 0.051 0.010 0.240 0.001 0.010 0.240 
10 - 1 0.038 0.315 0.303 0.107 0.481 0.131 0.546 0.481 
UV-1 0.050 0.003 0.329 0.075 0.182 0.022 0.166 0.182 
UV – 10 0.998 0.079 1 0.996 0.890 0.709 0.811 0.890 
 
4.3.6.1 Cross-species mRNA comparison 
The level of mRNA expression was compared between sheep and cattle to assess 
whether there was a difference between species (Table 4.11). Bovine MDMs 
expressed significantly higher TNF-α (Table 4.11, p<0.05) and NLRP3 (Table 4.11, 
p<0.01), whereas ovine MDMs expressed significantly higher IL-6, TLR2 and 
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NOD1 (Table 4.11, p<0.01). There was no significant difference between species in 
expression of IL-1β or CXCL8. The only significant interaction effect of treatment 
and species was with NOD1 (Table 4.11, p<0.05), which appeared to be down-
regulated in bovine MDMs but up-regulated in ovine MDMs although the treatment 
effect was not significant.   
Table 4.11: The p-values from the statistical comparison of sheep and cattle mRNA 
fold changes. The values highlighted in green represent significant differences (p<0.05). 
 IL-1β IL-6 CXCL8 TNF-α NOD1 NLRP3 TLR2 TLR4 
Treatment 0 0 0 0 0.997 0 0 0.163 
Species 0.762 0 0.469 0.043 0 0 0 0.339 
Treatment * 
Species 
0.809 0.094 0.404 0.983 0.004 0.819 0.518 0.564 
4.3.7 Innate immune cytokine/chemokine protein production 
by ruminant monocyte-derived cells in response to C. 
abortus infection 
The production of CXCL8, IL-6, TNF-α and IL-1β protein in response to medium 
alone, MO1 0.1, 1, 10 and UV-inactivated C. abortus was assessed in ruminant 
MDM and MDDC supernatant by ELISA. There was no IL-6 production detected 
from any of the cell types. The production of CXCL8, TNF-α and IL-1β in response 
to medium alone, MOI 0.1, 1, 10 and UV-inactivated C. abortus data was rank 
transformed and graphed using interval plots. 
The bovine MDDCs produce IL-1β, TNF-α and CXCL8 in response to the different 
treatments (Figure 4.18). 
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Figure 4.18: Production of IL-1β (A), TNF-α (B) and CXCL8 (C) protein by bovine 
MDDCs in response to medium alone, MOI 0.1,1,10 and UV-inactivated C. abortus. The 
rank transformed fold changes from each animal were plotted (black squares) ± 95% 
confidence intervals (blue error bars). The results are representative of repeat experiments 
using MDDCs from four different animals. 
There was a significant treatment effect detected for IL-1β, CXCL8 and TNF-α 
(p<0.05) in bovine MDDCs. Following pairwise comparison of the treatment groups, 
MOI 10 C. abortus was found to produce significantly higher levels of IL-1β and 
TNF-α than the medium alone control (p<0.01). The production of IL-1β and TNF-α 
was dose dependant as MOI 10 produced significantly higher levels of 
cytokine/chemokine than the MOI 0.1 treatment group (p<0.05). There was no 
significant difference between the UV-inactivated and MOI 10 treatment group for 
TNF-α production, however there was a significant difference in IL-1β production 
(p<0.05). There is also no significant difference between the UV-inactivated and 
control group with IL-1β production (p>0.05). There was a significant time effect 
with TNF-α production (p<0.05) but not with IL-1β production. The production of 
TNF-α was significantly reduced at 48 and 72 hours indicating a peak in production 
at 6 and 24 hours, which then declines. There was no significant difference in 
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production of CXCL8 was significantly higher (p<0.05) in the UV-inactivated 
treatment group compared to MOI 10 or the unchallenged control.  
The ovine MDDCs produce IL-1β, TNF-α and CXCL8 in response to the different 
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Figure 4.19: Production of IL-1β (A), TNF-α (B) and CXCL8 (C) protein by ovine MDDCs 
in response to medium alone, MOI 0.1,1,10 and UV-inactivated C. abortus. The rank 
transformed fold changes from each animal were plotted (black squares) ± 95% confidence 
intervals (blue error bars). The results are representative of repeat experiments using 
MDDCs from four different animals. 
There was a significant treatment effect detected for IL-1β, TNF-α and CXCL8 in 
ovine MDDCs (p<0.01). CXCL8 and IL-1β were significantly increased with the 
MOI 10 compared to the medium alone control (p<0.05). TNF-α production was 
increased with MOI 10 compared to the medium alone, which produced no TNF-α. 
The production of CXCL8 and IL-1β was found to be dose-dependent with 
significantly higher production with MOI 10 relative to MOI 0.1(p<0.05).  There was 
no significant difference in CXCL8 or TNF-α production in the MOI 10 compared to 
the UV-inactivated treatment groups (p>0.05). There was a significant increase in IL-
1β production from the MOI 10 compared to the UV-inactivated treatment groups 
(p<0.05). CXCL8 is significantly elevated at 24 hours compared to 6 hours (p<0.05) 
and production remains elevated. There was significant interaction of time and 
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24 hours in the MOI 10 treatment group which then decreases whereas production in 
the MOI 1 and MOI 0.1 continue to increase more gradually. 
The bovine MDMs produce CXCL8, TNF-α and IL-1β protein in response to 
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Figure 4.20: Production of IL-1β (A), TNF-α (B) and CXCL8 (C) protein by bovine MDMs 
in response to medium alone, MOI 0.1,1,10 and UV-inactivated C. abortus. The rank 
transformed fold changes from each animal were plotted (black squares) ± 95% confidence 
intervals (blue error bars). The results are representative of repeat experiments using MDMs 
from four different animals with the exception of a missing MOI 0.1 sample across all time 
points from one animal. 
There was a significant treatment effect detected for IL-1β, CXCL8 and TNF-α 
(p<0.05). Following pairwise comparison of the treatment groups the MOI 10 was 
found to produce significantly higher levels of IL-1β and CXCL8 than the medium 
alone control (p<0.05). TNF-α production was increased with MOI 10 compared to 
the medium alone, in which no TNF-α was detected. Production of CXCL8, IL-1β 
and TNF-α was dose dependant as MOI 10 produced significantly higher levels of 
cytokine/chemokine than the MO1 0.1 treatment group (p<0.05). There was no 
significant difference between the UV-inactivated and MOI 10 treatment group for 
CXCL8 and TNF-α production (p>0.05), however there was significantly lower IL-
1β production in the UV-inactivated treatment group (p<0.05). There was no 
significant difference between the UV-inactivated and control group with IL-1β 
production (p>0.05). CXCL8 was significantly increased at 24 hours compared to 6 
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interaction of time and treatment with IL-1β production (p<0.05). An early peak of 
IL-1β production in the MOI 10 treatment group is evident which then decreases, 
whereas production in the MOI 1 treatment group shows a gradual increase with 
higher production than MOI 10 at 72 hours. 
The ovine MDMs produce CXCL8, TNF-α and IL-1β protein in response to the 
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Figure 4.21: Production of IL-1β (A), TNF-α (B) and CXCL8 (C) protein by ovine MDMs 
in response to medium alone, MOI 0.1,1,10 and UV-inactivated C. abortus. The rank 
transformed fold changes from each animal were plotted (black squares) ± 95% confidence 
intervals (blue error bars). The results are representative of repeat experiments using MDMs 
from four different animals with the exception of single missing MOI 1 and UV 72 hour 
samples from 2 different animals. 
There was a significant treatment effect detected for CXCL8, IL-1β and TNF-α 
(p<0.05). The MOI 10 treatment group produced significantly higher levels of 
CXCL8 and TNF-α than the medium alone control (p<0.01). The production of IL-
1β was increased with MOI 10 compared to the medium alone, in which no IL-1β 
was detected. Production of all cytokines/chemokines was dose dependant as MOI 
10 produced significantly higher levels than the MO1 0.1 treatment group (p<0.05). 
There was no significant difference between the UV-inactivated and MOI 10 
treatment group for CXCL8 and TNF-α production. There was a significant increase 
in IL-1β production in the MOI 10 treatment group compared to the UV-inactivated 
treatment group (p<0.05). There was a significant time effect with CXCL8 
production, with significantly increased CXCL8 production detected at 24 hours 
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4.3.7.1 Cross-species protein comparison 
Comparison between the different species revealed quantitative differences in the 
production of cytokine/chemokines in the MOI 10 treatment group. There was 
significantly increased production of TNF-α in bovine compared to ovine MDDCs 
(p<0.01), but no significant difference in CXCL8 or IL-1β production between 
species (p>0.05). There was significantly increased production of CXCL8 and TNF-
α by ovine compared to bovine MDMs (p<0.05), but no significant difference in the 
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4.4 Discussion 
Ruminant MDDCs and MDMs were generated using conventional protocols and 
their responses to C. abortus assessed. The addition of IL-4 and GM-CSF was used 
to generate MDDCs and an adherence protocol in the presence of high levels of 
serum used for the generation of MDMs. The generation of ovine MDMs required 
optimisation and the addition of autologous serum instead of commercial FBS, which 
suggests that important components of the FBS were not cross-reactive. 
Morphologically, the ruminant MDDCs and MDMs were found to be distinct. The 
MDDCs developed dendrite like-processes whereas the MDMs developed into large 
cells with a vacuolated cytoplasm. There was a difference between the ovine and 
bovine MDDCs in terms of morphology with the ovine MDDCs remaining largely 
adherent. The ovine MDMs were also confirmed to have macrophage-like functions, 
including phagocytosis and non-specific esterase activity.  
Flow cytometric analysis of cell surface markers was used to characterize the 
monocytes, MDDCs and MDMs. All ruminant mononuclear phagocytes expressed 
high levels of the myeloid markers CD11b and CD172-α. There was no significant 
difference in CD14 expression between monocytes and MDDCs or MDMs. This is 
consistent with some human MDM studies, although other studies have identified 
up-regulated/down-regulated expression (Ziegler-Heitbrock and Ulevitch, 1993). In 
contrast, human MDDCs have previously been identified to down-regulate CD14 
expression with the differentiation of monocytes into MDDCs (Elkord et al., 2005).  
The down-regulation of CD14 in human MDDCs compared to monocytes is thought 
to be a consequence of IL-4 down-regulating the expression of CD14 mRNA 
(Lauener et al., 1990). Immature human MDDCs have been shown to retain CD14 
expression, although at a lower level relative to the monocytes, with expression 
disappearing with DC maturation (Elkord et al., 2005). DC maturation occurs 
following the addition of LPS, viral products, cytokines (including TNF-α) and 
binding of receptors on the cell surface. However, CD14 expression has also been 
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identified on porcine MDDCs, which was increased with maturation (Carrasco et al., 
2001). 
There was no significant up-regulation in MHC II expression with differentiation 
from monocytes into MDDCs or MDMs. The lack of up-regulation may be explained 
by the immaturity of the cells as human MDDC maturation has been shown to lead to 
increased expression of MHC II (Elkord et al., 2005). The absence of CD1w2 and 
CD205 staining on ruminant monocytes has been previously identified in other 
studies (Gliddon et al., 2004; Howard and Naessens, 1993; McKeever et al., 1991). 
In contrast, CD205 expression has been identified on human monocytes, which 
potentially indicates species-specific differences in marker expression (Butler et al., 
2007; Kato et al., 2006). The absence of staining of CD205 and CD1w2 on MDDCs 
also contrasts with studies that have identified expression in human MDDCs (Butler 
et al., 2007; Giuliani et al., 1997). The cell-surface expression of CD205 is up-
regulated on mature human MDDC compared to immature MDDCs as it is thought 
to be primarily intracellular until maturation (Butler et al., 2007), which may explain 
the lack of expression on ruminant immature MDDCs. There was no CD1w2 
expression detected on ruminant MDDCs, which is consistent with a previous study 
which demonstrated no or weak expression in ovine MDDCs (Chan et al., 2002). 
Therefore, the phenotype of ruminant mononuclear phagocytes differs from the 
characteristic human phenotypes. Similarly, the phenotype of porcine and equine 
MDDCs have been shown to differ (Carrasco et al., 2001; Mauel et al., 2006), 
indicating potentially important species-specific differences.  Future work should 
compare the phenotype of these ruminant cells following maturation as a number of 
markers are affected by maturation state.  
The pattern of cell surface marker expression was similar between cattle and sheep, 
which indicates that the MPS cells are differentiating in the same way in both 
species. There was increased MHC II expression in bovine compared to ovine cells 
as well as increased CD205 and CD1w2 expression in ovine compared to bovine 
cells, but this may reflect differences in antibody sensitivity. The MHCII antibody 
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was raised against sheep and the CD205 and CD1w2 against cattle so if these results 
are down to sensitivity issues this is somewhat surprising. 
Gene expression profiling studies have helped to define human and mouse 
monocytes, DCs and macrophages (Haniffa et al., 2015). Specific genes have been 
shown to be differentially expressed in both human and mouse subsets, which can 
define subsets across the two species (McGovern et al., 2014), however species-
specific differences have also been identified (Haniffa et al., 2012). Cattle and sheep 
monocytes, MDDCs and MDMs have been analysed using RNA-sequencing and will 
be discussed in more detail in Chapter 6.  
Cattle and sheep MDDCs and MDMs expressed TLR2, TLR4, NOD1 and NLRP3. 
Similarly, human peripheral blood cells express a range of TLRs and CD14
+
 
monocytes expressed the highest levels of TLR2, TLR4 and TLR8 compared to B 
and T cell populations (Zarember and Godowski, 2002). NLRP3 expression has been 
identified in mouse myeloid (CD11b
+
) cells and was highly expressed in monocytes 
and cDCs from the spleen but not in lymphoid cells (Guarda et al., 2011). Human 
MDDCs have also previously been shown to express NOD1 (Tada et al., 2005). The 
expression of TLR2, TLR4, NOD1 and NLRP3 by MDMs and MDDCs is likely to 
be important for their role as innate immune sentinels within inflamed tissues and 
will aid in the detection of a broad range of microbes. PRR expression on immune 
cells contributes not only to the production of cytokines/chemokines but also to the 
induction of phagocytosis, activation, antigen presentation and apoptosis (Zhang et 
al., 2009a). 
Previous studies have identified that TLRs are differentially expressed between 
monocyte-derived cells. The expression of TLR4 is increased in human MDMs 
compared to monocytes unlike TLR2, which had similar levels of expression 
(O'Mahony et al., 2008). Bovine monocytes were found to express higher levels of 
TLR2 and TLR4 than MDDCs but lower levels than MDMs (Werling et al., 2004). 
The differential expression of PRRs may reflect the specialized roles of the 
monocyte-derived cells in innate immune recognition.  
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The ruminant MDDCs and MDMs were shown to be susceptible to C. abortus 
infection using immunofluorescent staining. C. abortus formed multiple small 
inclusions within the cells which were distinct from the large inclusions that were 
observed in the turbinate cells. Previous immunofluorescence studies have also 
identified that multiple C. pneumoniae inclusions are formed within mononuclear 
phagocytes, which range in size and staining intensity (Airenne et al., 1999). 
Similarly, the infection of human monocytes and MDDCs with C. trachomatis also 
resulted in the formation of small inclusions of varied staining intensity (Datta et al., 
2014). Fluorescent specks were visible in the UV-inactivated C. abortus treated 
ruminant MDDCs and MDMs but no inclusion structures were formed. Further 
studies using confocal microscopy are necessary to confirm that the UV-inactivated 
C. abortus are inside the cell. A previous study identified that heat-killed C. psittaci 
is internalized by bone marrow derived DCs at a similar rate to live C. psittaci 
(Ojcius et al., 1998). UV-inactivated C. muridarum has also been shown to be 
internalized by MDDCs (Prantner et al., 2009; Rey-Ladino et al., 2005) and within 
phagocytes is thought to reside in the phagocytic vacuoles (Prantner et al., 2009).  
Further work is necessary to assess whether C. abortus is capable of producing 
infectious EBs following infection of mononuclear phagocytes.  The outcome of C. 
trachomatis infection of human mononuclear phagocytes was shown to be dependent 
on strain. The L2 C. trachomatis serovar was able to survive and remained infectious 
following infection of monocytes and MDDCs. However, the C. trachomatis Ba and 
D serovars did not form inclusions in HeLa cells following infection of monocytes 
and MDDCs and instead became persistent (Datta et al., 2014).  Similarly, C. 
pneumoniae was unable to form inclusions in HeLa cells following infection of 
human monocytes, which indicates that the development of infectious EBs is not 
supported (Airenne et al., 1999). Following culture in human MDMs the ability of C. 
pneumoniae to form inclusions was reduced but not completely inhibited in Hep-2 
cells (Gaydos et al., 1996), which indicates cell-type specific differences.  
The critical role for PRRs in a diverse range of innate immune processes suggests 
that the up-regulation of PRR expression in MDMs increases the cells responsiveness 
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to infection. The expression of TLR2 and TLR4 in response to live and UV-
inactivated C. abortus was assessed. The up-regulation of TLR2 expression was 
dose-dependent with a significantly increased expression in response to MOI 10 C. 
abortus compared to MOI 0.1 C. abortus. There was no significant difference 
comparing the UV-inactivated to the MOI10 treatment group indicating that 
intracellular multiplication is not necessary for TLR2 up-regulation. There was no 
significant difference in TLR4 expression between the different treatment groups. 
Previous studies have shown that the expression level of TLR2 and TLR4 in human 
monocytes can be modulated with the addition of bacterial LPS and pro-
inflammatory cytokines including IL-1β, TNF-α, GM-CSF and IFN-γ (Muzio et al., 
2000; O'Mahony et al., 2008). Interestingly, the expression of TLR2 and TLR4 in 
bovine MDMs and MDDCs was not affected following the addition of recombinant 
bovine IFN-γ (Werling et al., 2004).  
There was no significant difference in NOD1 mRNA expression in response to live 
or UV-inactivated C. abortus in ruminant MDMs. A previous study identified that 
the stimulation of human MDMs with the NOD1 ligand L-Ala- γ-D-Glu-meso-
diaminopimelic acid (Tri-DAP) did not significantly increase NOD1 expression 
(Juarez et al., 2014), which suggests that the MDMs do not up-regulate NOD1 
expression in response to stimuli. However, there was a significant dose-dependent 
increase in NLRP3 expression in the ruminant MDMs. There was no significant 
difference comparing the UV-inactivated to the MOI10 treatment group, which 
indicates that the up-regulation of NLRP3 does not require a live infection. A 
different study identified that the stimulation of mouse macrophages with LPS dose-
dependently increased NLRP3 mRNA and protein expression, which was mediated 
through NF-κB activation. The up-regulation of NLRP3 expression is likely the first 
step necessary for NLRP3 inflammasome activation, although up-regulation alone is 
not sufficient for NLRP3 activation and a second signal is required (described in 
section 1.3.2.2.2) (Bauernfeind et al., 2009).  
Increased PRR expression by cells may enhance cellular responses to PAMPs and be 
an important host defence mechanism to pathogens. However the up-regulation of 
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PRRs has also been implicated in a number of inflammatory diseases, including in 
type 1 diabetes (Devaraj et al., 2008) and inflammatory bowel disease (Szebeni et al., 
2008). Therefore, the up-regulation of TLR2 and NLRP3 in response to C. abortus 
infection may be a protective host-defence mechanism or induce excessive 
inflammation. The pattern of PRR expression between species was similar; however, 
there were significant differences in the quantity of up-regulation of TLR2, NOD1 
and NLRP3 expression between species. The relevance of PRR expression levels in 
C. abortus disease pathogenesis requires further investigation.  
A dose-dependent increase in CXCL8, TNF-α, IL-6 and IL-1β mRNA was observed 
at 6 hours post C. abortus infection in ruminant MDMs. CXCL8, TNF-α and IL-1β 
protein was significantly increased in ovine and bovine MDMs and MDDCs infected 
with C. abortus, which in most cases was dose dependant. The only exception was 
the production of CXCL8 protein from bovine MDDCs that was not significantly 
higher in the treated groups relative to the medium alone control, which may be due 
to the high background CXCL8 levels in these cells. The production of 
cytokines/chemokine peaked at 24 hours, which is early post-infection compared to 
the turbinate cells. Therefore, mononuclear phagocytes rapidly respond to chlamydial 
infection through the up-regulation of pro-inflammatory cytokines/chemokines, 
which may be due to their specialised roles in the innate immune defence. Similarly, 
the infection of MDDCs with C. trachomatis resulted in the induction of CXCL8, IL-
1β and TNF-α protein at 24 hours post-infection (Datta et al., 2014; Gervassi et al., 
2004). Ovine alveolar macrophages challenged with C. abortus also produced early 
IL-1β and cumulative CXCL8 production over 72 hours post infection (Entrican et 
al., 1999).  
The production of CXCL8, IL-6, TNF-α and IL-1β mRNA was similar between the 
UV-inactivated and MOI10 C. abortus treatment groups in ruminant MDMs. The 
production of CXCL8 and TNF-α protein was similar with UV-inactivated and live 
C. abortus in ruminant MDDCs and MDMs. However, the production of IL-1β 
protein was dependent on a live infection as it was not induced in response to UV-
inactivated C. abortus. The production of IL-1β protein by ovine alveolar 
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macrophages was also shown to be dependent on a live C. abortus infection 
compared to heat-killed C. abortus (Entrican et al., 1999). Similar results were found 
in human MDDCs and MDMs where the production of CXCL8 and TNF-α was 
induced in response to both live and heat-killed C. trachomatis, but IL-1β was 
dependant on live C. trachomatis (Gervassi et al., 2004). Therefore, UV-
inactivated/heat-killed Chlamydia is sufficient to stimulate the production of CXCL8 
and TNF-α but not the production of IL-1β. The differences in the response of bone 
marrow derived DCs (BMDCs) to live compared to UV-inactivated C. muridarum 
was assessed by microarray, which identified that a number of genes were 
differentially up-regulated. These genes included pro-inflammatory cytokine genes 
(including IL-1β), chemokine genes involved in neutrophil recruitment and 
interferon response genes (Zaharik et al., 2007). The difference in response of cells 
to live and inactivated bacteria may have important implications for vaccine design. 
The inactivated C. abortus vaccine has been shown to be effective in controlling 
flock outbreaks and has recently been re-introduced onto the market (Essig and 
Longbottom, 2015). Therefore, this may indicate that IL-1β is not participating in the 
mediation of protection induced by the vaccine or that the adjuvant is functioning in 
the activation of an IL-1β response.  
The production of IL-1β mRNA in response to UV-inactivated C. abortus does not 
mirror the IL-1β protein profile and is up-regulated. This indicates that pro-IL-1β 
may be up-regulated in response to UV-inactivated C. abortus but not cleaved or 
extracellularly secreted. Therefore, a live infection may be necessary to provide the 
second signal for cleavage. Similar results have been found in peritoneal 
macrophages, which were challenged in vitro with live and UV-inactivated C. 
muridarum. The UV-inactivated C. muridarum did not induce IL-1β protein although 
increased IL-1β mRNA at 3 hours post infection (Prantner et al., 2009). Live and 
heat-killed C. trachomatis could also induce pro-IL-1β production in MDDCs, but 
mature IL-1β production was dependant on a live infection that activated caspase-1 
(Gervassi et al., 2004). The production of pro-IL-1β is controlled by NF-κB 
(Cogswell et al., 1994) and therefore UV-inactivated Chlamydia is likely to provide a 
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sufficient signal for NF-κB activation. However, pro-IL-1β cleavage requires a 
second signal thought to be mediated through intracellular stress signals, including 
potassium efflux and the generation of ROS (Tschopp and Schroder, 2010). 
Considering that UV-inactivated Chlamydia does not form inclusions and multiply 
within the host cell, it follows that it does not activate the same intracellular stress 
pathways as a live infection.  
Quantitative differences were identified in the up-regulation of cytokine/chemokine 
mRNA and protein produced by ovine and bovine MDDCs and MDMs in response 
to C. abortus infection. However, differences in protein are complicated by 
sensitivities of the ELISA antibodies. Further investigation into the particular roles of 
different cytokines in vivo following C. abortus pathogenesis will identify the 
importance of the quantitative differences between cattle and sheep.  
To conclude, the outcomes of the chapter have been summarized in relation to the 
four stated objectives. Ruminant monocytes, MDDCs and MDMs were characterized 
using flow cytometry for the first time, however defining the profile of different 
subsets is complicated by maturation states and species-specific differences. The 
MDDCs and MDMs were susceptible to C. abortus infection and expressed both 
intracellular and extracellular PRRs, which are likely to be important for chlamydial 
detection. The MDMs are capable of responding rapidly to C. abortus through the 
up-regulation of NLRP3 and TLR2 expression. Both MDMs and MDDCs respond to 
C. abortus through the production of CXCL8, TNF-α and IL-1β.  UV-inactivating C. 
abortus does not affect the production of CXCL8 or TNF-α; however, the production 
of IL-1β is inhibited highlighting the strict control mechanisms required for its 
production. In vivo, pro-inflammatory cytokine/chemokine production by 
mononuclear cells is likely to be involved in the recruitment of innate immune cells 
and in T cell polarization. A previous study identified that MDDCs infected with C. 
pneumoniae induced the polarization of a Type 1/ Type17 T cell response (Flego et 
al., 2013). Therefore, the response of ruminant MDDCs and MDMs to C. abortus 
may be critical in the induction of an adaptive immune response and have important 
implications for vaccine design. 
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Chapter 5: Identifying the role of NOD1 and 
NLRP3 in ruminant MDMs in response to C. 
abortus infection 
5.1 Introduction 
RNA interference (RNAi) is a conserved gene silencing process that was first 
identified in animal cells using C. elegans (Fire et al., 1998), and later in mammalian 
cells (Elbashir et al., 2001). The RNAi pathway involves cleavage of double-
stranded RNA (dsRNA) into small interfering RNAs (siRNAs) by the Dicer enzyme. 
The siRNA is taken up by a RNA-induced silencing complex (RISC) and unwinds to 
guide RISC to target mRNA for cleavage, by Argonaute-2, inducing degradation 
(reviewed by Dykxhoorn and Lieberman, 2005). The RNAi pathway is a natural 
cellular mechanism that is involved in controlling gene expression for a number of 
biological processes, including cell growth and proliferation. Dysregulation of the 
RNAi pathway is linked with diseases, including cancer, which emphasizes its 
importance in maintaining homeostasis (Wilson and Doudna, 2013).  
The RNAi pathway can be exploited to experimentally silence genes in mammalian 
cells. SiRNA and short hairpin RNA (shRNA) can be chemically synthesized and 
delivered into the cell to directly mediate mRNA degradation. Once inside the cell, 
shRNA can be cleaved by DICER for the generation of siRNA and facilitate longer-
term knockdown of the gene, whereas siRNA only mediates transient gene 
knockdown. SiRNA is often the preferred method for transient gene knockdown as 
reagents are affordable and easy to use (Miller et al., 2013). Gene knockdown 
enables functional analysis of defined gene products in vitro and in vivo and has also 
been evaluated for potential clinical applications, including in the treatment of viral 
and genetic diseases (Ambesajir et al., 2012). This technology is especially useful for 
non-traditional biomedical models, such as sheep and cattle, as there are limited 
reagents and resources to characterize molecular function compared to what is 
available for human and mouse studies (Jensen et al., 2014).  
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SiRNA can be designed to target any gene of interest for knockdown if the gene 
sequence is known (Dykxhoorn et al., 2006). The siRNA design process is complex 
as it involves the consideration of a number of factors, including molecule 
thermodynamics and potential off-target effects. Off-target effects include activating 
a type-1 interferon response, participating in the microRNA pathway and knocking 
down non-target genes due to high levels of sequence complementarity. Computer 
programmes, that incorporate multiple design rules and formulas, are available to 
help produce siRNA with high levels of gene knockdown but minimal off-target 
effects (Peek and Behlke, 2007). The design of siRNAs for most studies is now often 





 (Shan, 2010).  However, it is not fully 
understood what makes a perfect siRNA and therefore a number of controls are also 
required when setting up a siRNA experiment. In order to control for potential off-
target effects, ideally two or three siRNAs that target different areas of the gene 
should be evaluated and shown to deliver the same effect (Peek and Behlke, 2007). A 
number of other controls which are important include non-transfected cells, 
transfection reagent only cells, transfection efficiency controls and scrambled or non-
target siRNA (Ponthan et al., 2015; Shan, 2010).  
The use of siRNA technology in cells of the immune system has proven challenging 
(Mao et al., 2007). The delivery of siRNA into macrophages is particularly difficult. 
Macrophages are susceptible to toxicity mediated by transfection protocols and also 
possess enzymes that can degrade nucleic acids (Zhang et al., 2009a). Immune cells 
can also respond to siRNA through the production of an interferon response and 
activation of TLR mediated signaling pathways. However, siRNA technology has 
successfully been used to investigate gene function of both innate and adaptive 
immune cells. SiRNA studies have identified the role of specific genes in immune 
cell activation, differentiation and effector mechanisms (Mao et al., 2007). The 
specific role of immune cell genes in response to pathogens has also been elucidated 
using this technology, including the role of PRRs in response to bacterial infections. 
For example, the role of NOD1 in the recognition of Campylobacter jejuni was 
demonstrated in human epithelial cells (Zilbauer et al., 2007) and the role of NLRP3 
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inflammasome in the recognition of Propionibacterium acnes demonstrated in 
human monocytes (Qin et al., 2014).  
There are a number of different methods that have been used to deliver siRNA into 
mammalian cells including microinjection, chemical transfection reagents containing 
cationic lipids, viral vectors and electroporation (Ponthan et al., 2015). Different cell 
types show varying responses to transfection protocols and therefore it is often 
necessary to compare a number of different methods (Mocellin and Provenzano, 
2004). Recently, an optimised protocol for transfection of siRNA into bovine MDMs 
was published. Electroporation and various transfection reagents were compared in 
terms of gene knockdown, toxicity and up-regulation of type 1 interferon response 
genes. The study identified that an optimised Lipofectamine
®
 RNAiMAX protocol 
resulted in effective gene knockdown, reduced type 1 interferon response gene 
expression and reduced toxicity, compared to electroporation and other transfection 
reagents (Jensen et al., 2014). The protocol provides a method for the investigation 
of the role of specific PRRs in response to stimuli in non-model species such as cattle 
and sheep. 
The intracellular PRRs NLRP3 and NOD1 have important roles in the recognition of 
human and mouse chlamydial species, and activate the production of pro-
inflammatory cytokines, including IL-1β and CXCL8 (as discussed in detail in 
Chapter 1). Macrophages have been identified as a major source of IL-1β in vivo in 
the genital tract following intravaginal infection with C. muridarum (Prantner et al., 
2009). Ruminant MDMs express a range of PRRs, including NOD1 and NLRP3, and 
respond to C. abortus through the production of pro-inflammatory cytokines 
including IL-1β (see Chapter 4). The role of intracellular NOD1 and NLRP3 in 
ruminant MDMs in response to C. abortus infection was assessed using the 
previously described published siRNA protocol (Jensen et al., 2014). The aims of 
this chapter were to: 
 Establish the siRNA procedure in ovine MDMs. 
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 Assess siRNA knockdown of NOD1 and NLRP3 in ruminant MDMs. 
 
 Identify the role (if any) of NOD1 and NLRP3 in IL-1β production by 
C. abortus in ruminant MDMs. 
 
 Assess the effect of C. abortus infection and siRNA knockdown on the 
different components of the IL-β pathway, including caspase-1 and pro-
IL-1β. 
 
 Identify the role (if any) of NOD1 and NLRP3 in the production of 
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5.2 Materials and methods 
5.2.1 Ruminant MDMs 
Ruminant MDMs were generated as described in section 2.2.4. 
5.2.2 Transfection of ruminant MDMs with siRNA   
MDMs were plated out at a density of 6x10
5
 cells per well in six well plates and 
rested and allowed to adhere for 24 hours. The siRNA and RNAiMAX complex was 
generated by adding 6µl of the 20µM siRNA stock (50nM final transfection 
concentration) and 6µl of Lipofectamine RNAiMAX (Life Technologies) to 400µl 
Opti-Mem I serum free medium (Life Technologies) followed by a 20 minute 
incubation at RT. The cells were transfected with the siRNA by replacing the 
medium of the well with 2mls of fresh medium and adding the siRNA/RNAiMAX 
complex solution. The controls included non-transfected cells (NTC), transfection 
reagent only (TC) and Mission siRNA universal negative control (NC siRNA) 
(Sigma-Aldrich), which shares no known homology to any mammalian gene.  
5.2.3 SiRNA duplexes 
 The ovine and bovine NOD1/NLRP3/GAPDH protein sequences were aligned using 
BLAST and found to be 98% (NLRP3), 96% (NOD1) and 99% (GAPDH) identical. 
The accession numbers were sent to Sigma-Aldrich for the custom design of siRNA 
duplexes, which were cross-reactive to both cattle and sheep (Table 5.1). SiRNA 
stocks of 20µM were prepared and sub-aliquoted for storage at -20°C. 
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Table 5.1: Duplex siRNA targeting ovine and bovine NLRP3, NOD1 and GAPDH. 
 Accession numbers 
(bovine/ovine) 
SiRNA sequence (5’ – 3’) 
Sense Antisense 
Ruminant NLRP3 version 1  NM_001102219/ XM_004008740 GUGUAUAUCUUCUUCCUCUdTdT AGAGGAAGAAGAUAUACACdTdT 
Ruminant NLRP3 version 2 NM_001102219/ XM_004008740 CAUUCCUCCUUCAGCAUUAdTdT UAAUGCUGAAGGAGGAAUGdTdT 
Ruminant NLRP3 version 3 NM_001102219/ XM_004008740 GAAACUUUACCAGGAUAGAdTdT UCUAUCCUGGUAAAGUUUCdTdT 
Ruminant NOD1 version1 NM_001256563/ XM_004007930 GUGUGAACCAGAUCACUGAdTdT UCAGUGAUCUGGUUCACACdTdT 
Ruminant NOD1 version 2 NM_001256563/ XM_004007930 GUGAGAUCAUCUUCGUGUUdTdT AACACGAAGAUGAUCUCACdTdT 
Ruminant NOD1 version 3 NM_001256563/ XM_004007930 CAGAAUUCUGGACCUGGUAdTdT UACCAGGUCCAGAAUUCUGdTdT 
Ruminant GAPDH version 1 NM_001034034/NM_001190390  CAGGUUGUCUCCUGCGACUdTdT AGUCGCAGGAGACAACCUGdTdT 
Ruminant GAPDH version 2 NM_001034034/NM_001190390 GCAACAGGGUGGUGGACCUdTdT AGGUCCACCACCCUGUUGCdTdT 
Ruminant GAPDH version 3 NM_001034034/NM_001190390 CCAUCACUGCCACCCAGAAdTdT UUCUGGGUGGCAGUGAUGGdTdT 
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5.2.4 Measuring siRNA uptake  
The MDMs were incubated for 24 hours following the transfection with AllStars 
negative control siRNA labelled with Alexa Fluor 488 (Qiagen) and harvested using 
TrypLE Express.  The cells were washed in 1xPBS and then stained with 
LIVE/DEAD® Fixable violet stain for 30 minutes before analysis on the 
MACSQuant. The cells were gated on size, live cells and single cells as described in 
section 4.2.6. The expression of FITC was measured and the percentage positive 
cells calculated by comparing between the non-transfected cells and cells transfected 
with fluorescently labelled siRNA.  
5.2.5 Measuring siRNA knockdown 
RT-PCR was used to assess the knockdown of siRNA targets using the protocol and 
primer/probes described in section 2.9. 
5.2.6 Infection of siRNA transfected MDMs 
The MDMs were incubated for 24 hours at 37°C following transfection. The medium 
was then replaced with fresh medium and MDMs incubated for a further 24 hours at 
37°C. The MDMs were then infected with an MOI 4 C. abortus or medium alone for 
24 hours before the supernatants and lysates were harvested.  
5.2.7 Measuring innate immune cytokine/chemokine 
production 
The production of IL-1β, CXCL8 and TNF-α from siRNA transfected MDMs was 
measured using ELISAs detailed in section 2.6. IL-1β mRNA was measured by RT-
PCR as described in section 2.9. 
5.2.8 FAM-FLICA™ caspase-1 activation 
Caspase-1 activation was measured using the FAM FLICA
™
 caspase-1 kit (Bio-Rad 
AbD Serotec) according to the manufacturer’s instructions for adherent cells. Briefly, 
the MDMs were dissociated using TrypLE and centrifuged at 200g for 5 minutes. 
The cells were resuspended in MDM culture medium before the addition of 1:30 
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30xFLICA. The cells were incubated at 37°C for 1 hour, mixing every 10 minutes, 
before the addition of 1xapoptosis wash buffer for centrifugation at 200g for 5 
minutes. The pellet was resuspended in 1xapoptosis wash buffer and incubated for 10 
minutes at 37°C. The cells were centrifuged again at 200g for 5 minutes and 
resuspended in 1xapoptosis wash buffer with 1:10 fixative. The cells were analysed 
on the MACSQuant and gated on size, single cells and fluorescence.  
5.2.9 IL-1β SDS-PAGE and Western blot 
The IL-1β western blot was optimised using IL-1β CHO transfected cells and CHO 
untransfected cells, generated as described previously (Wattegedera et al., 2010). The 
MDMs were washed with 1xPBS before replacing the medium with Opti-MEM I 
reduced serum medium (Life Technologies). The MDMs were infected with C. 
abortus or cultured with medium alone for 24 hours. The cell pellets were collected 
and solubilised in 0.8% (w/v) 3-[(3-Cholamidopropyl)dimethylammonio]-1-
propanesulfonate (CHAPS) in PBS for 30 minutes at RT. The pellets were spun 
down at 10000g for 10 minutes. Serumless supernatant was concentrated using 
Amicon ultra 0.5ml 10K centrifugal filters (Merck Millipore, Watford, UK) at 
14000g for 10 minutes. The soluble portion of the cell pellet and the concentrated 
cell supernatant was denatured using reduced sample buffer (250mM Tris (pH 6.8), 
8% sodium dodecyl sulphate (SDS), 20% β-mercaptoethanol, 15% glycerol and 
0.1% bromophenol blue) and incubated at 100°C for 5 minutes. Samples were loaded 
onto NuPAGE 4-12% Bis-Tris gels (Life Technologies) with SeeBlue Plus 2 
Prestained standards (Life Technologies) and run in NuPAGE MES SDS Running 
buffer (Life Technologies) for protein separation using X-cell surelock mini-cell 
electrophoresis system (Life Technologies). The protein bands were transferred onto 
a Hybond ECL nitrocellulose membrane (Amersham Biosciences, Buckinghamshire, 
UK) in transfer buffer (48mM Tris base, 0.0375% SDS, 39mM Glycine, 20% 
methanol, dH2O) using a semi-dry blotter (Sigma-Aldrich). 
The blots were washed in wash buffer (1xPBS, 0.5M NaCL and 0.5%Tween 80) and 
blocked in 4% Marvel (diluted in 1xPBS with 0.05% Tween 20) for 1 hour with 
shaking at RT. The blots were washed in wash buffer before the proteins were 
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probed with 4 µg/ml rabbit anti-sheep IL-1β polyclonal antibody (Bio-Rad AbD 
Serotec) for 1 hour at RT with shaking. Following three wash steps the blots were 
incubated with 1:1000 goat anti-rabbit HRP (Dako) for 1 hour at RT with shaking. 
The blots were vigorously washed three times before incubating with SuperSignal 
West Pico Chemiluminescent Substrate (Thermoscientific) for 5 minutes. 
Chemiluminescence was visualized using the ImageQuant LAS4000 imaging system 
(GE Healthcare). 
5.2.10 Statistical analysis 
The siRNA target knockdown was assessed using 2-sample T-tests comparing the 
siRNA to the scrambled siRNA. The cytokine data was not normally distributed and 
therefore was logarithmically or SQRT+1 transformed. A linear mixed model was 
applied where treatment was fitted as a fixed effect and animal as a random effect. If 
there was a significant F-statistic (p<0.05) from the model, two-sided probabilities of 
comparisons of means were obtained. The probabilities were adjusted using an FDR 
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5.3 Results 
5.3.1 Efficacy of siRNA transfection in ruminant MDMs 
The uptake of fluorescently labeled siRNA was measured in ruminant MDMs 
(Figure 5.1). The uptake experiment was repeated three times with MDMs from three 
different cattle and sheep. The ovine MDMs consistently demonstrated over 80% 
uptake (95.71%, 97.44% and 86.65%) whereas the bovine MDMs demonstrated 
more variable uptake (87.39%, 63.36% and 66.17%). 
   
Figure 5.1: The uptake of fluorescently labelled siRNA by ovine (A) and bovine (B) 
MDMs. The red histogram represents the non-transfected control MDMs and the blue 
histogram represents the MDMs transfected with FITC labelled siRNA. The light blue bar and 
percentage indicates the FITC positive cells. The histograms are from one animal but are 
representative of the profiles observed in three animals. 
5.3.2 Knockdown of GAPDH, NOD1 and NLRP3 in ruminant 
MDMs 
Detection of fluorescently-labelled siRNA effectively demonstrates tranfection 
efficiency. However, it also essential to confirm that the transfection method can 
facilitate gene knockdown. Two siRNA were used in each experiment, due to limited 
numbers of cells, and were selected as NLRP3#3 was identified to be toxic to cells 
(through visual inspection) and lower levels of knockdown were observed with 
NOD1#3 and GAPDH#3. GAPDH is a ubiquitously expressed gene which is 
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study identified that GAPDH#1 and GAPDH#2 siRNA knocked down mRNA 
expression by over 70% in both ovine and bovine MDMs. The NLRP3 siRNAs did 
not induce GAPDH knock-down indicating the effect was specific to GAPDH 
siRNA and not just an off-target effect of siRNA tranfection (Figure 5.2).     
 
 
Figure 5.2: Knockdown of GAPDH mRNA in ovine (A) and bovine (B) MDMs. Ruminant 
MDMs were transfected with NLRP3 and GAPDH siRNA for 24 hours. The GAPDH mRNA 
fold changes relative to the transfection reagent only control (TC) are presented.  
A preliminary study investigating siRNA gene knockdown over time identified that 
NLRP3 knockdown was stable at 24, 48 and 72 hours following transfection in both 
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Figure 5.3: Knockdown of NLRP3 across 24, 48 and 72 hours in ovine (A) and bovine 
(B) MDMs. Ruminant MDMs were transfected with NLRP3#1 and NLRP3#2 and fold change 
was calculated by comparing the NLRP3 siRNA treated cells to the transfection reagent only 
control (TC).  
Ruminant MDMs were transfected with NOD1 and NLRP3 siRNA. Controls 
included NC siRNA, TC and NTC. The expression of NLRP3 and NOD1 was 
measured at 72 hours post transfection and fold change calculated relative to the 
NTC. NOD1 expression was significantly reduced with both NOD1#1 and NOD1#2 
compared to the NC siRNA control in both ovine and bovine MDMs (p<0.05). 
NOD1#1 reduced NOD1 expression by over 65% in bovine and 50% in ovine 
MDMs and NOD1#2 reduced expression by over 80% in bovine and 64% in ovine 
MDMs. NLRP3 expression was significantly reduced compared to the NC siRNA 
(p<0.05) by around 45% with NLRP3#2 in bovine MDMs. NLRP3#1 and NLRP3#2 
reduced  NLRP3 expression by over 40% in ovine MDMs, although this was not 
significant compared to the NC siRNA control (p>0.05). Similarly, NLRP3#1 
reduced NLRP3 expression in bovine MDMs, but this was not significant compared 
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Figure 5.4: Knockdown of NOD1 (A, C) and NLRP3 (B, D) in ovine (A, B) and bovine (C, 
D) MDMs. The fold change of NLRP3 and NOD1 was calculated by comparing expression to 
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least 3 different animals and the error bars represent standard error between the replicates. 
Significant reductions in NOD1 and NLRP3 relative to the negative control (NC) siRNA 
(p<0.05) are denoted with asterisks. 
5.3.3 Impact of NOD1 and NLRP3 knockdown on IL-1β 
production 
The impact of NOD1 and NLRP3 knockdown on the IL-1β produced by ruminant 
MDMs infected with C. abortus was assessed (Figure 5.5). The knockdown of 
NOD1 but not NLRP3 resulted in significantly reduced IL-1β production by over 
50% compared to the NC siRNA in ovine MDMs (p<0.05). In contrast, the 
knockdown of both NOD1 and NLRP3 results in significantly reduced IL-1β 
production by over 55% compared to the NC siRNA in bovine MDMs (p<0.05).  
There was no significant difference between the different control groups (p>0.05). 
 
Figure 5.5: IL-1β protein production from siRNA treated ovine (A) and bovine (B) 
MDMs that were infected with C. abortus (red bars) and non-infected control cells 
(blue bars). The presented data are means of results from 4 animals and the error bars 
represent standard error between the replicates. Significant reductions in IL-1β relative to the 



























* * * * * * 
 *  * 
 *  *  *  * 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 5: Identifying the role of NOD1 and NLRP3 in ruminant MDMs in response 
to C. abortus infection  151             
Preliminary investigation into the impact of NOD1 and NLRP3 knockdown on IL-1β 
mRNA revealed a similar pattern of IL-1β mRNA expression in ovine MDMs as 
observed with protein production (Figure 5.6). A decrease in IL-1β mRNA was 




Figure 5.6: IL-1β mRNA expression from siRNA treated ovine MDMs following C. 
abortus infection. The fold change of NLRP3 and NOD1 was calculated by comparing 
expression to the non-treated control cells (NTC). The presented data in A is representative 
of results from MDMs from 2 different animals and the data in B are means of results from 3 
different animals with error bars which represent standard error between the replicates. 
The RT-PCR primers and probes do not distinguish between pro and mature IL-1β 
and this information is critical for assessing IL-1β signalling pathways activated by 
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5.3.4 Assessing the production of pro and mature IL-1β by 
Western blot 
The production of IL-1β requires two processing steps: the transcription of a pro-
form of the cytokine and cleavage of the pro-form into mature IL-1β (as discussed in 
Chapter 1). There are no published protocols for the differentiation of ruminant pro 
and mature IL-1β, however previous studies in model organisms have successfully 
used Western blot to distinguish between the two (Kavathas et al., 2013). Western 
blotting separates proteins based on molecular weight and therefore can be used to 
distinguish the pro and mature form of IL-1β. The pro-form of IL-1β weighs 31 
kilodalton (kDa) and the mature form weighs 17kDa (Chen et al., 2013b; Soller et 
al., 2007). Therefore a Western blot using an anti-ovine IL-1β antibody (which cross-
reacts with bovine) was optimised to identify the different components of ruminant 
IL-1β. Transfected CHO cells stably expressing recombinant ovine IL-1β secreted 
mature cytokine into the supernatant and a single clear band was detected at 17kDa. 
The soluble lysate expressed a band at around 17kDa, but also a number of larger 
bands around 31kDa that may represent pro-IL-1β (Figure 5.7). 
Figure 5.7: The expression of pro- and mature IL-1β by CHO cells transfected to 
express ovine IL-1β. Supernatant and soluble lysate from CHO cells transfected with ovine 
IL-1β (TRA) and untransfected CHO cells (UTF) were analysed using Western blot and band 
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The same optimised Western blot was used to assess supernatants and cell lysates 
from ovine MDMs that were infected with C. abortus and compared to non-infected 
control MDMs. A single protein band of around 17kDa was present in both the 
supernatants and cell lysates of the infected MDMs. Larger bands around 31kDa 
were present in the supernatants but not the soluble lysates of infected MDMs. The 
Western blot detected an extra band in animal 2 which was larger than 31kDa. There 
were no bands detected in the non-infected control MDMs (Figure 5.8). 
 
 
Figure 5.8: Pro- and mature IL-1β expression by ovine MDMs from two sheep (1, 2). 
The supernatant and soluble lysate from non-infected (NI) and C. abortus-infected (I) MDMs 
were analysed using Western blot and band sizes attained compared to the molecular 
weight marker ladder (L). 
5.3.5 Caspase-1 activation by ruminant MDMs in response to 
C. abortus 
The cleavage of pro-IL-1β into mature IL-1β is mediated by caspase-1 (Franchi et 
al., 2012). Therefore, caspase-1 activation was measured using the FAM-FLICA
™
 
caspase-1 kit. The kit contains fluorescently labelled inhibitors of caspase-1 that bind 
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following the wash steps, unlike the cells that have not activated caspase-1. The kit is 
cross-reactive with cattle and has previously been used to measure caspase-1 
activation in bovine monocytes (Hussen et al., 2012). Caspase-1 activation was 
measured in ruminant MDMs at 6 and 24 hours post C. abortus infection. There was 
no caspase-1 activation detected at 6 hours post-infection, but a shift in fluorescence 
was detected at 24 hours post-infection, which was higher in bovine than ovine 
MDMs (Figure 5.9). However, the fluorescence measured in ruminant MDM 
infected with C. abortus was variable and the observed shift in fluorescence often not 
distinct. The aim was to use this method of measuring caspase-1 activation to assess 
the impact of NOD1 and NLRP3 knockdown.  However, preliminary data from 
siRNA treated ruminant MDMs was difficult to interpret and this caspase-1 detection 
method may not be sensitive enough to detect small but critical differences within 
MDMs following infection with C. abortus. 
 
Figure 5.9: Caspase-1 activation by bovine (A, B) and ovine (C, D) MDMs in response 
to C. abortus.  The histogram of the non-infected cells (blue) is shown compared to the C. 
             6 hours                                      24 hours                                
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abortus-infected cells (red). The histograms are from one animal but are representative of 
the profiles observed in three animals. 
5.3.6 Impact of NOD1 and NLRP3 knockdown on CXCL8 and 
TNF-α production 
The role of NOD1 and NLRP3 in the production of CXCL8 in response to C. abortus 
was also assessed. NOD1 knockdown significantly reduced CXCL8 production from 
ovine MDMs in response to C. abortus compared to the NC siRNA treated MDMs 
(p<0.05). NLRP3 knockdown had no effect on CXCL8 production from the ovine 
MDMs infected with C. abortus (p>0.05). The bovine MDMs did not produce 
significantly different levels of CXCL8 in response to C. abortus with NLRP3 or 
NOD1 knockdown compared to the NC siRNA (p>0.05) (Figure 5.10). 
 
 
Figure 5.10: CXCL8 protein production from siRNA treated ovine (A) and bovine (B) 
MDMs which were challenged with C. abortus (red bars) and non-infected control cells 
(blue bars). The presented data are means of results from 4 animals and the error bars 
represent standard error between the replicates. Significant reductions in CXCL8 relative to 
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The role of NOD1 and NLRP3 in the production of TNF-α protein was also assessed. 
The background production of TNF-α was high in the ovine MDMs and there was no 
difference in production between the cells infected with C. abortus and non-infected 
cells. NLRP3 and NOD1 knockdown had no significant effect on TNF-α production 
in ovine MDMs infected with C. abortus (p>0.05). The bovine MDMs had a lower 
level of TNF-α background production and significantly reduced (p<0.05) TNF-α 




Figure 5.11: TNF-α protein production from siRNA treated ovine (A) and bovine (B) 
MDMs which were challenged with C. abortus (red bars) and non-infected control cells 
(blue bars). The presented data are means of results from at least 3 different animals and 
the error bars represent standard error between the replicates. Significant reductions in TNF-
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5.4 Discussion 
The use of siRNA for gene knockdown is an effective method for studying gene 
function in various cell types. Recently, a siRNA protocol was optimised for the 
effective transfection of siRNA into bovine MDMs. The protocol has been 
successfully used to knockdown a number of different genes in bovine MDMs, 
including MEFV (Jensen et al., 2014) and TLR5 (Tahoun et al., 2015).  Similarly, we 
found that the protocol demonstrated high transfection efficiency and knockdown of 
the expression of NOD1, NLRP3 and GAPDH in both cattle and sheep MDMs. The 
knockdown of NLRP3 mRNA was lower than that of NOD1 and not found to be 
statistically significant in ovine MDMs. Ideally, the level of knockdown should be 
measured at both the mRNA and protein level (Mocellin and Provenzano, 2004), 
however commercial ruminant antibodies for the detection of NLRP3 or NOD1 
protein are not available. Recently, however, human NLRP3 antibodies have been 
demonstrated to recognise bovine NLRP3 using western blot (Jensen et al, 
unpublished) and may provide tools for further analysis.  
NOD1 knockdown significantly decreased IL-1β production in both ovine and 
bovine MDMs in response to C. abortus infection. The same result was obtained 
using two siRNA that target different parts of the gene, thereby increasing 
confidence in the result (Mocellin and Provenzano, 2004). Previous studies have 
identified that NOD1 is involved in the recognition of Chlamydia and production of 
pro-inflammatory cytokines, but most did not investigate the impact of NOD1 on IL-
1β production (Buchholz and Stephens, 2008; Opitz et al., 2005; Welter-Stahl et al., 
2006). A previous study demonstrated a role for NOD1 in C. trachomatis mediated 
IL-1β production from a human trophoblast cell line. The study identified that IL-1β 
protein produced in response to C. trachomatis was independent of TLR2, TLR4, 
NLRP3 and ASC, but NOD1 knockdown decreased production compared to the non-
target shRNA control (Kavathas et al., 2013). A role for NOD1 in IL-1β production 
has also been identified in response to other intracellular bacteria. Following lung 
infection with Legionella pneumophila, NOD1 KO mice had reduced IL-1β detected 
in lung homogenates at 4 hours post infection and also displayed delayed neutrophil 
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recruitment and impaired bacterial clearance compared to the wild-type mice 
(Berrington et al., 2010). Similarly, NOD1 KO mice intratracheally infected with C. 
pneumoniae displayed impaired bacterial clearance compared to wild-type mice, 
although the level of IL-1β production was not measured (Shimada et al., 2009). 
NOD1 recognises peptidoglycan expressed by Gram-negative bacteria (Opitz et al., 
2005), including Chlamydia in which expression has recently been identified. The 
development of a fluorescently labelled D-amino acid dipeptide probe, which is 
incorporated into peptidoglycan during synthesis, allowed the investigation of the 
expression of peptidoglycan by C. trachomatis. Peptidoglycan was detected from 8 
hours post-infection, which supports the current theory that peptidoglycan is 
synthesised during the conversion of EBs into RBs (Liechti et al., 2014). Therefore, 
the potential role for NOD1 in the detection of C. abortus and consequential 
activation of pro-inflammatory signalling pathways, may explain why the production 
of IL-1β protein in ruminant MDMs infected with C. abortus is observed within 24 
hours post infection (see Chapter 4).  
Upon recognition of peptidoglycan, NOD1 interacts with the adaptor molecule RIP2. 
RIP2 mediates a signalling cascade, which involves the activation of NF-κB and 
MAPK signalling pathways (Kaparakis-Liaskos, 2015). The production of pro-IL-1β 
is mediated by the activation of NF-κB (Latz et al., 2013) and therefore NOD1 may 
mediate pro-IL-1β production (Kersse et al., 2011). Preliminary investigation 
identified that the production of IL-1β mRNA mirrored the protein profile of ovine 
MDMs, which suggests that NOD1 may mediate the production of pro-IL-1β. NOD1 
also contains a CARD domain and therefore may activate caspase-1 for cleavage and 
production of mature IL-1β. A role for NOD1 and RIP2 in caspase-1 activation and 
induction of IL-1β secretion in response to LPS was identified using transfection 
assays in human cell lines (Yoo et al., 2002). The knockdown of NOD1 specifically 
decreased the quantity of mature IL-1β but not pro- IL-1β released into the 
supernatant by human trophoblasts following infection with C. trachomatis. This 
indicates that NOD1 is involved in the cleavage of pro-IL-1β; however, a limitation 
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of this study was that the level of intracellular pro-IL-1β was not measured (Kavathas 
et al., 2013). 
A role for NLRP3 in stimulating IL-1β production was also identified in bovine 
MDMs. Therefore, the relatively low level of knockdown achieved with these siRNA 
was sufficient to have a functional effect. Previous studies into the role of NLRP3 
have also confirmed the receptors involvement in stimulating IL-1β production with 
chlamydial infection. The knockdown of NLRP3 using shRNA in a human 
monocytic cell line decreased IL-1β production in response to both C. muridarum 
and C. trachomatis compared to cells transfected with the non-targeting shRNA 
(Abdul-Sater et al., 2010). The knockdown of NLRP3 using siRNA in a human 
monocytic cell line reduced the production of IL-1β with C. pneumoniae infection 
compared to cells treated with scrambled siRNA (Matsuo et al., 2015). BMDM from 
NLRP3 KO mice produced reduced IL-1β in response to C. pneumoniae compared to 
BMDM from wild-type mice (He et al., 2010; Itoh et al., 2014; Shimada et al., 2011). 
The knockdown of NLRP3 in human PBMC reduced IL-1β produced in response to 
C. pneumoniae compared to PBMC treated with non-silencing control siRNA (Eitel 
et al., 2012) 
In contrast, there was no impact of NLRP3 knockdown on IL-1β production from 
ovine MDMs infected with C. abortus. The lack of a role for NLRP3 may be 
reflective of the low levels of knockdown achieved with NLRP3 siRNA or indicative 
of species-specific difference in C. abortus recognition. Studies have previously 
identified a redundancy for NLRP3 in the induction of IL-1β secretion in response to 
chlamydial infection. NLRP3 knockdown did not reduce C. trachomatis induced IL-
1β production in a human trophoblast cell line (Kavathas et al., 2013). The 
production of IL-1β was not reduced in peritoneal macrophages, which were pre-
stimulated with E. coli LPS, derived from NLRP3 KO mice but was reduced in 
peritoneal macrophages derived from ASC KO mice following infection with C. 
muridarum (Nagarajan et al., 2012). Therefore, other inflammasome receptors may 
be involved in the detection of chlamydial infection and may be worth further 
investigation.  
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In order to fully understand the IL-1β production pathway, a Western blot that could 
detect the ruminant pro and mature form of IL-1β was optimised. The detection of a 
clean 17kDa band represents mature IL-1β and a number of bands were detected 
around 31kDa that may represent the pro-form of IL-1β. The multiple bands detected 
around 31kDa added complexity to the interpretation of the Western blot. The 
multiple bands may be indicative of the action of various proteases, which can cleave 
IL-1β at different cleavage sites (Afonina et al., 2015), or may be due to 
glycosylation (Livi et al., 1991; Opdenakker et al., 1995). Mature IL-1β was detected 
in the supernatant and lysate of C. abortus-infected ovine MDMs by Western blot, 
which confirms previous ELISA and RT-PCR results (see Chapter 4). Bands around 
the size of pro- IL-1β were also detected in the supernatant of C. abortus-infected 
ruminant MDMs. The secretion of pro- IL-1β may be indicative of necrotic cell death 
(Lopez-Castejon and Brough, 2011), but pro-IL-1β is also produced by mouse 
macrophages independent of cell death. Released pro- IL-1β can be cleaved by 
extracellular proteases, which can be secreted by neutrophils at the site of infection, 
into the more potent mature form (Pelegrin et al., 2008). Further analysis including 
N-terminal protein sequencing of the bands could be used to identify what the bands 
represent. Thereafter this technique could be used to assess the effect of 
NOD1/NLRP3 knockdown on pro-IL-1β production, which would inform on the 
type of signalling pathways activated by these receptors.  
Caspase-1 activation was detected in bovine MDMs at 24 hours post C. abortus 
infection using the FAM-FLICA™ assay. The early activation of caspase-1 in 
response to chlamydial infection is consistent with previous studies. Caspase-1 
activation was detected using an active caspase-1 antibody and fluorescently labelled 
secondary antibody for flow cytometric analysis of primary mouse mast cells at 24 
hours following infection with C. pneumoniae (Rodriguez et al., 2015). The 
activation of caspase-1 was detected in HeLa cells at 24 hours following C. 
trachomatis infection using flow cytometry. The shRNA mediated knockdown of 
NLRP3 decreased caspase-1 activation by around 50%, compared to cells treated 
with the non-target shRNA control, following C. trachomatis infection of HeLa cells 
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(Abdul-Sater et al., 2009). The use of a cell line rather than more variable primary 
cells may explain the clear up-regulation of caspase-1 and ability to measure 
differences with gene knockdown unlike in ruminant MDMs.  
Caspase-1 activation has been identified as an important component in IL-1β 
secretion in response to chlamydial infection. Peritoneal macrophages harvested 
from caspase-1 knockout mice expressed significantly less IL-1β in response to C. 
muridarum compared to macrophages from wild-type mice. Caspase-1 knockout 
macrophages could still respond through TNF-α and IL-6 production at a similar 
level to WT macrophages indicating the specificity of its action (Cheng et al., 2008). 
Caspase-1 is also involved in the production of IL-18 as demonstrated in HeLa cells, 
which expressed decreased IL-18 in response to C. trachomatis in the presence of a 
caspase-1 inhibitor. Peritoneal macrophages from caspase-1 knockout mice also 
expressed reduced IL-18 in response to C. trachomatis or C. muridarum compared to 
macrophages from wild-type mice (Lu et al., 2000). A role for caspase-1 in C. 
pneumoniae mediated IL-1β and IL-18 production was identified in a human 
monocyte/macrophage cell line using a caspase-1 inhibitor (Matsuo et al., 2015). 
Similarly, the addition of a caspase-1 inhibitor to murine BMDMs reduced the 
production of IL-1β production with C. pneumoniae infection (Itoh et al., 2014). 
Caspase-1 activation was not detected in ovine MDMs infected with C. abortus. 
Caspase-1 is not the only inflammatory caspase that has been implicated in IL-1β 
processing. Murine caspase-11 (orthologous to human caspase-4 and caspase-5) can 
activate the non-canonical inflammasome, which potentiates caspase-1 activation but 
can also function independently of caspase-1 (Kayagaki et al., 2011). The combined 
expression of caspase-1 and caspase-5 was required for optimal pro-IL-1β cleavage 
in a human monocyte cell line (Martinon et al., 2002). A combined caspase-1 and 
caspase-5 inhibitor had an increased effect on reducing the infectivity of C. 
trachomatis in HeLa cells compared to the caspase-1 inhibitor (Abdul-Sater et al., 
2009). Therefore, further analysis of the expression of other inflammatory caspases 
may more fully inform on the role of caspases in C. abortus mediated IL-1β 
production. The production of IL-1β may also be caspase-1 independent. Previous 
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studies in C. muridarum and Mycobacterium tuberculosis have identified that IL-1β 
production may be produced in vivo in a caspase-1 independent manner (Mayer-
Barber et al., 2010; Nagarajan et al., 2012). A potential caspase-1 independent 
mechanism of pro-IL-1β cleavage is mediated by serine proteases, which can be 
expressed by macrophages and neutrophils (Netea et al., 2010). A role for serine 
proteases in IL-1β production in response to chlamydial infection has previously 
been demonstrated. The production of IL-1β from LPS-primed murine peritoneal 
macrophages infected with C. muridarum was inhibited by treatment with a serine 
protease inhibitor (Prantner et al., 2009). 
NOD1 activates the NF-κB and MAPK signalling pathways that are involved in the 
production of other pro-inflammatory cytokines, including CXCL8 and TNF-α 
(Kaparakis-Liaskos, 2015; Sabio and Davis, 2014). The knockdown of NOD1 
decreased CXCL8 production from ovine MDMs following C. abortus infection, 
which is consistent with previous studies. The knockdown of NOD1 in HeLa cells 
using siRNA resulted in reduced CXCL8 expression induced by C. muridarum 
infection compared to the cells treated with non-target siRNA (Prantner et al., 2010). 
The knockdown of NOD1 decreased CXCL8 production by human trophoblast cell 
lines in response to C. trachomatis compared to the cells treated with non-target 
shRNA (Kavathas et al., 2013). The knockdown of NOD1 in human endothelial cells 
decreased CXCL8 produced in response to C. pneumoniae compared to cells treated 
with the non-silencing control siRNA. This study also identified that the over-
expression of NOD1 in human embryonic kidney cells increased NF-κB activation 
mediated by C. pneumoniae (Opitz et al., 2005). NOD1 also contributed to the 
activation of the NF-κB pathway in HeLa cells infected with C. muridarum (Welter-
Stahl et al., 2006). The knockdown of NOD1 in ovine MDMs had no effect on TNF-
α expression indicating differences in the activation of specific cytokine signalling 
pathways. Similarly, NOD1 knockdown in human endothelial cells resulted in 
decreased CXCL8 compared to the non-silencing control siRNA, but had no effect 
on TNF-α production in response to C. pneumoniae (Opitz et al., 2005). The 
knockdown of NOD1 decreased TNF-α but not CXCL8 expression in bovine MDMs, 
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indicating species-specific differences in the signalling pathways activated in 
ruminant MDMs in response to C. abortus infection.   
NLRP3 has primarily been associated with the assembly of the inflammasome 
complex and regulation of IL18 and IL-1β production (Kersse et al., 2011). The NF-
κB and MAPK signalling pathways can be activated independently of NLRP3 as 
shown by knockout experiments (Kanneganti et al., 2006). The knockdown of 
NLRP3 had no effect on CXCL8 or TNF-α production in either ovine or bovine 
ruminant MDMs. Similarly, BMDMs from NLRP3 KO mice produced similar levels 
of TNF-α in response to C. pneumoniae compared to BMDMs from the wild-type 
(Shimada et al., 2011). Therefore, NLRP3 does not appear to be involved in 
activating the signalling pathways necessary for CXCL8 or TNF-α production by 
ruminant MDMs in response to C. abortus infection. 
The role for NOD1, NLRP3 and caspase-1 in determining the outcome of chlamydial 
infection in vivo is controversial. RIP2 KO mice displayed inhibited C. pneumoniae 
clearance from the lung and increased inflammation, which resulted in increased 
mortality compared to the wild-type controls (Shimada et al., 2009). However, the 
production of inflammatory cytokines and chemokines, including IL-6, IL-1β and 
MIP-2, in the genital tract was unaffected in NOD1 deficient mice challenged with 
C. muridarum. There was also no difference in the clearance of infection in NOD1 
deficient mice compared to wild-type mice (Welter-Stahl et al., 2006). NLRP3 KO 
mice had reduced IL-1β in genital secretions at 2 days post C. muridarum infection, 
but levels were comparable to wild-type mice levels from 3 days post-infection 
onwards. In the same study, NLRP3 KO mice did not have a significantly different 
rate of chlamydial clearance or incidence of hydrosalpinx pathology compared to the 
wild type mice (Nagarajan et al., 2012).  In vivo caspase-1 KO mice infected with C. 
muridarum presented with significantly reduced signs of inflammatory pathology, 
but had a similar course of infection to the wild-type mice (Cheng et al., 2008). 
Caspase-1 KO mice exhibited delayed bacterial clearance and increased mortality in 
response to C. pneumoniae infection compared to wild type mice. The early addition 
of recombinant IL-1β rescued caspase-1 KO mice from increased mortality rates 
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(Shimada et al., 2011). Although in vitro the role for different PRRs can be clearly 
demonstrated, often in vivo there is no clear effect of knockdown of a single receptor. 
This highlights the redundancy of single PRRs and the potential of the immune 
system to compensate for missing PRRs (Darville et al., 2003; Welter-Stahl et al., 
2006). In addition, these studies have all been conducted in mouse models and care 
needs to be taken when extrapolating the data to other hosts and different chlamydial 
infections.      
The host cell response to an infection is likely to be controlled by multiple PRRs, 
which is why knockdown or KO studies rarely show complete ablation of cytokine 
production. Studies have identified that TLRs and NLRs often collaborate in order to 
produce cytokine/chemokines in response to stimuli (Oviedo-Boyso et al., 2014). A 
number of studies have identified that a single pathogen can be recognised by 
multiple PRRs (Kersse et al., 2011; Oviedo-Boyso et al., 2014). Therefore, future 
studies investigating the combinatory knockdown of NOD1, NLRP3, TLR2, TLR4 
and caspase-1 or other inflammasome components in ruminant MDMs may further 
illuminate the signalling pathways activated by C. abortus.  
In order to summarize the five chapter objectives were revisited. The first objective 
was to establish the siRNA procedure in ovine MDMs, which were successfully 
transfected with fluorescently labelled siRNA and target genes knocked down. 
Secondly, siRNA-mediated knockdown of NOD1 and NLRP3 in ruminant MDMs 
was investigated and were found to induce knockdown of both receptors. The 
knockdown of NLRP3 was low, but future experiments with pooled siRNA may 
increase knockdown level. The third objective was to investigate the role of NOD1 
and NLRP3 in C. abortus driven IL-1β production. In both ovine and bovine MDMs, 
NOD1 was found to be important for the production of IL-1β and this may be 
mediated through a number of different pathways. NLRP3 was important for IL-1β 
production in bovine but not ovine MDMs, which indicates potentially important 
species-specific differences in C. abortus recognition (Table 5.2). The impact of C. 
abortus infection on the different components of the IL-1β processing pathway was 
then assessed, and further optimisation of the techniques used to detect the 
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components of the ruminant IL-1β pathway will aid future studies. The final aim was 
to investigate the role of NOD1 and NLRP3 in the production of other pro-
inflammatory cytokines/chemokines. Species-specific differences were identified in 
the role of NOD1 in CXCL8 and TNF-α production, but NLRP3 knockdown did not 
affect CXCL8 or TNF- α production in either species (Table 5.2).   
Table 5.2: Summary table of the impact of NOD1/NLRP3 knockdown on cytokine 
production in ruminant MDMs following C. abortus infection. 
 IL-1β CXCL8 TNF-α 
Ovine NOD1         -* 
Ovine NLRP3     -      -       -* 
Bovine NOD1       -         ** 
Bovine NLRP3       -       - 
  Detectable down-regulation in production; -no change in production; *only tested one 
siRNA; **down-regulation identified with one siRNA and not the other. 
Therefore, NOD1 and NLRP3 are involved in recognising C. abortus and activating 
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Chapter 6:  RNA-seq analysis of ruminant MPS 
cells and MDMs infected with C. abortus 
6.1 Introduction 
The term ‘transcriptome’ describes the expression profile of mRNA, non-coding 
RNA and small RNA in an organism (Wang et al., 2009). Transcriptomic analysis 
can be used to investigate the unique gene expression profiles that characterize 
different cell types (Vu Manh et al., 2015b) and define the cellular response to 
different pathogenic stimuli (Hossain et al., 2006). The availability of annotated 
reference genomes for both sheep and cattle facilitates the study of the ruminant 
transcriptome. Major advances in transcriptomic analysis, including the development 
of microarrays, and more recently RNA-seq, have facilitated deeper understanding of 
gene expression and potential function in these species (Bai et al., 2012).  
Microarrays involve the hybridisation of probes to target sequences (Miller and 
Tang, 2009) and can be used to assess a large number of genes at a relatively low 
cost (Roy et al., 2011). Microarray technology continues to improve and several 
microarray platforms that use different methods of hybridization are commercially 
available (Kim et al., 2010). Microarray technology has been used to study cell 
differentiation and host cell responses to pathogens, including Chlamydia. The 
Immunological Genome Project (ImmGen) was established to assess the gene 
expression profile of all immune cell subsets in the mouse (Heng and Painter, 2008). 
Already, the data from ImmGen has led to the improved understanding of the genes 
contributing to cell function and the differential expression of genes between cell 
subsets (Chow et al., 2011; Kim and Lanier, 2013). The FANTOM consortium has 
developed novel technology to interrogate genomic data, which has contributed to 
the understanding of gene function and regulation in mice and humans (Hoon et al 
2015). Information from the FANTOM consortium has been used to set up 
macrophages.com, which is an online resource combining macrophage multi-omic 
data and bioinformatics tools to facilitate further analysis (Robert et al, 2011). 
Microarray data have also been used for the cross-species comparison (including 
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sheep and pigs) of the gene expression profiles of MPS cells (Vu Manh et al., 
2015b). The host gene expression profile of human cells in response to chlamydial 
infection has also been studied using microarrays (Coombes and Mahony, 2001; 
Hess et al., 2003; Natividad et al., 2010; Ren et al., 2003; Schrader et al., 2007). 
However, microarray technology has a number of limitations. The technology uses 
pre-designed probes to detect transcripts and is therefore dependant on prior 
knowledge of the genome sequence. The probes can also cross-hybridize to 
transcripts that have a similar sequence to the intended target, generating false results 
(Shendure, 2008; Wang et al., 2009). The quantified level of gene expression is 
dependent on the binding affinity of the probe, which is determined by technical 
factors such as probe length and design (Kim et al., 2010). These technical issues 
affect the dynamic range of detection and hinder the quantification of low or highly 
expressed transcripts (Roy et al., 2011; Wang et al., 2009). The comparison of results 
across different microarray studies is also often difficult due to the variability in 
results from diverse microarray platforms (Kim et al., 2010). 
Transcriptomic analysis can also be conducted using sequencing-based approaches. 
The first studies using high-throughput RNA-seq technology were published in 2008 
(Roy et al., 2011). In brief, this technology involves fragmentation of RNA 
transcripts and the preparation of a cDNA library from the fragmented RNA, which 
is then amplified using PCR. The library is sequenced and aligned to the relevant 
reference genome. Alternatively, de novo assembly can be used if no reference 
genome is available (McGettigan, 2013; Roy et al., 2011). The expression is 
quantified based on the number of sequences aligned to the gene (Wang et al., 2009). 
Although there are also limitations with RNA-seq (difficulties associated with 
analysing/storing large amounts of data and potentially subject to PCR artefacts) 
(Wang et al., 2009) the technology has a number of advantages over microarray, 
including that less starting material is required (McGettigan, 2013), knowledge of the 
genome sequence is not necessary and cross-hybridization is not an issue because 
RNA-seq does not use probes (Wang et al., 2009). RNA-seq technology can also 
lead to the discovery of novel non-coding RNAs, including miRNAs and siRNAs, 
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which can be associated with important cellular processes, whereas microarrays are 
restricted to the detection of known non-coding RNAs (Morozova et al., 2009).  The 
technique is also more sensitive than microarrays as measures the transcript 
abundance directly instead of being limited by the hybridization features of the probe 
(Morozova et al., 2009).   
RNA-seq has also been used to differentiate between cell types and define host-
pathogen interactions but is still a relatively new technology, hence there are fewer 
published studies compared to the vast number of microarray studies. A recent study 
used RNA-seq to characterize gene expression profiles of monocytes as they 
differentiated into macrophages. The data correlated well with previously published 
microarray data on the monocyte-to-macrophage differentiation process, with RNA-
seq detecting more lower- expressed genes, suggesting higher sensitivity (Dong et 
al., 2013). Microarray and RNA-seq have also been compared for the assessment of 
the gene expression profiles of polarized human macrophages. An increased number 
of significantly differentially expressed (DE) genes and two novel gene networks, of 
potential biological importance, were identified using RNA-seq compared to 
microarray analysis (Beyer et al., 2012). The gene expression profile of bovine 
MDMs infected with Mycobacterium avium subsp. paratuberculosis (MAP) was 
assessed using both RNA-seq and microarray technology. RNA-seq identified an 
increased number of DE genes compared to microarray analysis, which potentially 
have important roles in MAP disease pathogenesis (Casey et al., 2015). There is 
currently only one published RNA-seq study that has characterized the cellular host 
response to chlamydial infection. This study used a novel RNA-seq method that 
simultaneously profiled host cell and chlamydial gene expression at early time-points 
following infection. The identified DE genes included genes that had not previously 
been associated with chlamydial infection and may be involved in the pathogenesis 
of scarring (Humphrys et al., 2013).  
A major challenge in analysing the transcriptomic data from both microarrays and 
RNA-seq is in the interpretation of the large data set results into biologically relevant 
information (Shendure, 2008). Typically, the functional analysis of large-scale data 
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of this type involves the identification of significantly DE genes, which are 
associated with a particular sample condition (e.g. infection). The biological 
relevance of the DE genes can be implied through the identification of functional 
categories that are enriched with DE genes. The identification of enriched cellular 
signalling pathways can also be useful for the biological interpretation of the data. 
Computer programmes are available for this type of analysis, including Ingenuity 
Pathway Analysis (IPA) which uses knowledge collated from published scientific 
sources to interpret large data sets (Roy et al., 2011).  
Therefore, RNA-seq is an improved method for the in-depth analysis of the 
transcriptome. RNA-seq analysis has been used to differentiate cell types, but has not 
yet been used to differentiate cells of the ruminant MPS. RNA-seq can also be used 
to reveal the full gene expression profile of cells in response to a particular stimulus, 
such as C. abortus. The full profile of receptors and signalling pathways that 
stimulate the production of innate immune cytokines in ruminant MDMs in response 
to C. abortus infection (as described in Chapter 4) can be investigated using unbiased 
RNA-seq technology.  Transcriptomic analysis can also be used to further explore 
and analyse the pathways that may underlie the observed differential C. abortus 
pathogenesis between cattle and sheep.  The aims of this chapter were to: 
 Investigate the transcriptome of ruminant MPS cells (as described in 
Chapter 2) for identification of differentiation-specific 'signature' 
profiles. 
 
 Investigate the transcriptomic profile of C. abortus-infected ruminant 
MDMs. 
 
 Infer the biological function of DE genes and enriched cellular 
pathways in C. abortus-infected MDMs compared to non-infected 
MDMs. 
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 Compare the DE genes of cattle and sheep C. abortus-infected 
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6.2 Materials and methods 




 monocytes, MDDCs and MDMs were generated as described in 
section 2.2.  The CD16
++ 
cells were included as part of a different study and were 
isolated as described in Corripio-Miyar et al., 2015. Four biological replicates from 
each cell type were generated. 
6.2.2 Infection of ruminant MDMs for RNA-seq analysis 
Ruminant MDMs were infected with an MOI of 1 C. abortus (S26/3) for 24 hours 
before harvesting lysates with TRIzol. Four biological replicates from ovine and 
bovine C. abortus-infected MDMs were generated.  
6.2.3 TRIzol total RNA extraction 
TRIzol (Life Technologies) was added in 1 ml volumes to cells and the cells lysed 
with repeat pipetting before storage at -80°C. The RNA was extracted according to 
the manufacturer’s instructions. Briefly, the samples were defrosted at RT for 5 
minutes before 200µl chloroform was added. The tube was vigorously shaken for 15 
seconds and incubated for 2-3 minutes at RT. The sample was centrifuged at 12000g 
for 15 minutes at 4°C and the clear aqueous phase removed into a new tube. 500µl of 
100% isoproponol containing 45µg/ml glycoblue (Ambion, Life Technologies) was 
added to the aqueous phase and incubated at RT for 10 minutes. The sample was 
centrifuged at 12000g for 10 minutes at 4°C. The supernatant was removed before 
the RNA pellet was resuspended in 1ml of 75% ethanol. The sample was vortexed 
and then centrifuged at 7500g for 5 minutes at 4°C. The supernatant was removed 
and the pellet air-dried for 10 minutes at RT. The pellet was resuspended in 25µl 
RNase-free water and quantified using the nanodrop. The quality was assessed using 
the Agilent RNA 6000 nano kit on the Agilent 2100 Bioanalyzer (Agilent 
technologies, Cheshire, UK). RNA integrity numbers (RINs) >8.4 were obtained for 
all RNA samples before submission to ARK genomics. 
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6.2.4 RNA-seq library preparation and sequencing 
The NEBNext ultra directional RNA library prep kit for Illumina (New England 
Biolabs, Hitchin, UK) was used by ARK genomics to generate 36 sequencing 
libraries (4 of bovine CD16
++
 cells and 4 each of ovine and bovine CD14
+ 
monocytes, MDDCs, MDMs and C. abortus-infected MDMs). Briefly, NEBNext 
Oligo d(T)25  beads were used to bind poly A RNA from 1µg of total RNA. The 
bound RNA was then fragmented into 180-200 bp fragments and used as a template 
for cDNA library generation which involved first and second strand synthesis, blunt 
end repair, adaptor ligation and PCR amplification. The libraries were clustered and 
sequenced using the Illumina HiSeq 2500 for 125 bases paired end sequencing (see 
appendix 9.1 for further details provided by Mr Richard Talbot from ARK 
genomics).  
6.2.5 RNA-seq data analysis 
The raw reads data files were quality checked using FastQC software (version 
0.10.1). Cutadapt v1.3 was used to trim 3’illumina adaptor sequences-m 50 -q 30 -a 
AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC. Reads were aligned to 
the bovine genome (UMD3.1 annotation, Ensembl release 78) and the ovine genome 
(UMD3.1 annotation, Ensemble release 78) using TopHat v2.0.13 (Kim et al., 2013) 
with --b2-sensitive. Reads that mapped to multiple sites were discarded and counts of 
the uniquely mapped genes were then generated using HTSeq-count v 0.6.0. EdgeR 
was used to conduct differential expression analysis which involved normalisation 
using the trimmed mean of M values (TMM) method (Robinson and Oshlack, 2010). 
Multidimensional scaling (MDS) and principal component analysis (PCA) plots were 
generated, using EdgeR and DEseq2 respectively, to show sample relationships and 
quality check the data. The distances in the MDS plot are the leading log-fold-
changes between pairs of samples. The leading log-fold-change is the root-mean-
square average of the largest log2-fold changes. The PCA plots use the first two 
components of a PCA of normalized log transformed counts. Samples were analysed 
as paired and tag wise dispersion was calculated. A negative binomial generalized 
log-linear model was fitted to the read counts of each gene and the p-values adjusted 
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using an FDR approach (Benjamini and Hochberg, 1995). The gene names and 
descriptions of the DE genes were downloaded from BioMart. Dr Timothee Cezard 
of ARK genomics should be acknowledged for completing the RNA-seq data 
analysis. The full lists of DE genes are provided on CD as appendix 9.4. 
Significantly DE genes were identified using a cut-off of a fold change > 2 and FDR 
adjusted p-value < 0.01. In the RNA-seq literature, groups use different cut-offs to 
identify significantly DE genes and the selected cut-off in this study fall within 
previously published criteria (Dorr et al., 2015; O'Loughlin et al., 2012).  
6.2.6 Ingenuity pathway analysis of RNA-seq DE genes 
Ingenuity
®
 pathway analysis (Qiagen, Summer Release, June 2015) was used to 
interpret the biological relevance of the DE gene data sets.  The software uses 
information from a Knowledge Base that contains gene relationship information 
from peer-reviewed journals and public/private databases, and has also been 
manually reviewed by experts.   
The disease and biological functions that were enriched by DE genes of the datasets 
were assessed. The functional categories were determined using IPA knowledge base 
information and are defined using IPA terminology (Jimenez-Marin et al., 2009). 
The DE genes were also overlaid onto known canonical pathways in the IPA 
Knowledge Base to identify the enriched pathways. The right-tailed Fisher exact test 
was used to calculate p-values across all IPA analysis. The p-value is calculated 
using the number of genes in the data set that participate in a function/pathway and 
the total number of genes known to participate in the function/pathway based on 
Knowledge Base information. 
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6.3 Results 
6.3.1 Summary statistics and visualizing relationships 
between samples 
The total numbers of sequenced reads in the RNA-seq libraries were calculated 
before alignment to the bovine and ovine genomes (Table 6.1). The reads that map to 
multiple locations (outside the genes or in ambiguous areas) have been removed to 
generate the reads in the count file used for EdgeR analysis (Table 6.1).  
Table 6.1: Summary of read ranges from RNA-seq data. 
 Range of total number of 
sequenced reads 
Range of number of reads in 
the count file 
Ovine CD14
+
 monocytes 73,533,448 - 82,312,462 33,271,142 - 40,844,480 
Ovine MDDCs 77,320,150 - 85,132,224 44,193,284 - 49,487,826 
Ovine MDMs 71,688,766 - 83,476,284 42,097,928 - 48,541,272 
Ovine C. abortus-infected MDMs 72,115,484 – 74,073,730 42,840,714 - 43,589,304 
Bovine CD14
+
 monocytes 52,155,064 – 61,995,386 28,513,258 - 34,818,598 
Bovine CD16
++ 
monocytes 48,985,228 – 55,876,038 26,237,258 - 29,145,280 
Bovine MDDCs 76,871,814 - 84,104,194 49,117,040 - 54,126,388 
Bovine MDMs 70,292,452 – 75,422,960 49,148,386 - 54,090,828 
Bovine C abortus-infected MDMs 69,762,836 – 78,350,202 45,982,098 - 54,403,114 
The relationship between the replicates and groups samples was assessed using a 
multidimensional scaling (MDS) plot. The four replicates of each cell type/treatment 
cluster tightly together. There is clear separation of the different cell types whereas 
the C. abortus-infected and non-infected MDMs cluster together, which suggests that 
there is less difference in gene expression as a result of infection than the 
transcriptomic differences between the various cell subtypes (Figure 6.1). 
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Figure 6.1: Multidimensional scaling plot demonstrating the relationship between 
bovine (A) and ovine (B) samples. The graphs plot the samples according to the logarithm 
of fold change (logFC dimension) of genes that most distinguish between samples.  
PCA plots were also generated comparing the C. abortus-infected MDMs to the non-
infected MDMs. The plots demonstrate that there is a higher degree of variance 
between animals within species than between the non-infected and infected treatment 
groups (Figure 6.2). 
  
Figure 6.2: PCA plots showing the variance of ovine (A) and bovine (B) C. abortus-
infected and non-infected MDMs. The graphs plot the samples according to the first two 
components of a PCA of normalised log transformed counts. 
A B 
A B 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 6: RNA-seq analysis of ruminant mononuclear phagocyte system cells and 
monocyte-derived macrophages infected with C. abortus 177 
Lists of DE genes were prepared for the different comparisons between cell types 
and treatment groups. At this point the DE genes in the ruminant C. abortus-infected 
MDMs compared to the non-infected MDMs were further analysed but due to time 
limitations the ruminant MPS cell subset comparisons were not further analysed.  
25196 DE genes were identified in the ovine data set comparing infected MDMs 
with non-infected MDMs and 24615 DE genes identified in the bovine data set (full 
list of DE genes available in appendix 9.4) before significantly DE genes were 
identified. Significant DE genes were identified using a cut-off of a fold change > 2 
and FDR adjusted p-value < 0.01. This cut-off identified 647 ovine genes (540 up-
regulated and 107 down-regulated) and 1040 bovine genes (555 up-regulated and 
485 down-regulated). Of the significant DE genes 529 ovine genes and 920 bovine 
genes mapped to the IPA knowledge base.    
6.3.2 Comparative analysis of the significant DE gene 
expression in ovine and bovine MDMs 
The DE genes and the direction of expression in both ovine and bovine MDMs 
infected with C. abortus compared to non-infected MDMs were visualised using a 
Venn diagram. Similar numbers of genes were significantly up-regulated, but not 
necessarily shared, in both bovine and ovine MDMs with C. abortus infection. More 
genes were down-regulated in bovine versus ovine MDMs with C. abortus infection 
(Figure 6.3).  
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Figure 6.3: A Venn diagram showing the DE genes identified in ovine and bovine C. 
abortus-infected MDMs compared to non-infected MDMs. The Venn diagram was 
created using Venny 2.0 (Oliveros, 2015). 
 
The DE genes that were shared between the ovine and bovine DE gene datasets and 
the direction of expression are detailed in Table 6.2. Most of the shared genes are up-
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ABCG1 ADAMTS4 ADM ANKRD22 APOL6 ARG2 ARNTL2 ARRDC4 ATP10B B3GNT3 BACE2 BATF2 BATF3 BCL2A1 BIRC3 BTG3 CASP7 
CBLN3 CCBE1 CCL20 CCL5 CD274 CD40 CD80 CFB CHI3L2 CMPK2 CPNE6 CSF2 CSF3 CXCL8 DMXL2 EBI3 EDN1 FOXS1 FUNDC1 G0S2 
GBP5 GLT1D1 GPR84 GRAMD1C HERC6 HES4 HIVEP2 HSH2D IER3 IFIH1 IFIT2 IGSF3 IL15 IL17REL IL1A IL1B IL23R IL27 IL6 IL7R IRF1 IRF7 
IRG1 ISG15 ISG20 KIF5C KLF5 MCEMP1 MCOLN2 MEFV MOV10 MST1R MUC1 NEURL3 NFE2L3 NFKB2 NFKBIE NFKBIZ NLRC5 NLRP12 
NMI OLR1 PARP14 PDE4B PIM3 PML POU2F2 PSMB10 PSMB9 PSME2 RARRES2 RELB RGS16 RHOH RNF19B RNF213 RSAD2 RTP4 SDC4 
SERPINB10 SLAMF1 SLAMF8 SLC28A3 SLC2A6 SOCS3 SOD2 STX11 TAP1 TBC1D9 TBX18 TGM1 TIFA TNF TNFAIP3 TNFSF13B TNIP3 



















ALOX5 ATOH8 C19orf35 CPM F13A1 FOS HCRTR1 KCNC1 MAMDC2 MBP NECAB3 PHOSPHO1 PIK3IP1 SH2D6 SLC7A8 SMIM4 STAB1 
TPBGL ZNF704 
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6.3.3 Top 20 up-regulated and down-regulated ruminant MDM 
DE genes 
The top 20 significantly up-regulated ovine DE genes in C. abortus infected 
compared to non-infected MDMs included cytokines/chemokines and enzymes that 
had immune functions, such as type 1-interferon response genes (Table 6.3). 
Table 6.3: The top 20 up-regulated DE genes for ovine C. abortus-infected MDMs 
compared to non-infected MDMs.  




ENSOARG00000000895 - Uncharacterized protein   8.40 7.85E-19 
ENSOARG00000014648 RSAD2 
Radical S-adenosyl methionine 
domain containing 2  8.16 1.05E-41 
ENSOARG00000001815 - Uncharacterized protein   8.15 4.08E-94 
ENSOARG00000020576 CCL20 Chemokine (C-C motif) ligand 20  7.74 1.55E-31 
ENSOARG00000007233 ISG15 
Interferon stimulated gene 15 
(ISG15) 7.67 3.43E-109 
ENSOARG00000016213 APOBEC3Z1 
Apolipoprotein B mRNA editing 
enzyme, catalytic polypeptide 7.53 1.35E-52 
ENSOARG00000015177 IFIT1 
Interferon-induced protein with 
tetratricopeptide repeats 1 7.48 3.76E-60 
ENSOARG00000011222 CLEC4F 
C-type lectin domain family 4, 
member F 7.37 7.00E-15 
ENSOARG00000016668 CXCL11 
Chemokine (C-X-C motif) ligand 
11  7.19 1.18E-29 
ENSOARG00000010283 MX1 
Myxovirus (influenza virus) 
resistance 1 7.00 1.52E-92 
ENSOARG00000010964 ISG20 
interferon stimulated 
exonuclease gene 20kDa  6.89 2.79E-73 
ENSOARG00000016611 CXCL10 
Ovis aries chemokine (C-X-C 
motif) ligand 10 (CXCL10) 6.74 2.00E-88 
ENSOARG00000011372 BATF2 
Basic leucine zipper 
transcription factor 6.67 1.05E-61 
ENSOARG00000001757 FOXS1 Forkhead box S1  6.35 3.03E-50 
ENSOARG00000015072 - Uncharacterized protein   6.33 2.06E-66 
ENSOARG00000001535 - Uncharacterized protein   6.21 4.20E-29 
ENSOARG00000014800 IFIT3 
interferon-induced protein with 
tetratricopeptide repeats 3  6.10 2.59E-69 
ENSOARG00000020215 - Uncharacterized protein   6.08 3.49E-06 
ENSOARG00000009241 CCL8 Chemokine (C-C motif) ligand 8  5.89 4.79E-36 
ENSOARG00000016617 TRANK1 
Tetratricopeptide repeat and 
ankyrin repeat containing 1  5.74 1.35E-45 
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The top 20 down-regulated genes included a number of enzymes and transporters 
involved in a range of cellular processes including growth, differentiation, adhesion 
and apoptosis (Table 6.4). 
Table 6.4: The top 20 down-regulated DE genes for ovine C. abortus-infected MDMs 








ENSOARG00000020956 ST6GAL2 ST6 beta-galactosamide alpha-2 -11.93 4.48E-06 
ENSOARG00000014010 CX3CR1 Chemokine (C-X3-C motif) receptor 1  -8.13 1.56E-07 
ENSOARG00000012933 MAMDC2 MAM domain containing 2  -6.25 0.001319134 
ENSOARG00000011251 TPBGL Trophoblast glycoprotein-like  -5.76 6.74E-06 
ENSOARG00000003312 DIRAS2 DIRAS family -5.43 0.000830803 
ENSOARG00000015249 CDH26 Cadherin 26  -4.98 0.002003027 
ENSOARG00000014027 C19orf35 
Chromosome 19 open reading frame 
35  -4.81 1.05E-06 
ENSOARG00000011582 CYP26B1 Cytochrome P450 -4.75 3.92E-20 
ENSOARG00000012285 VPS37D 
Vacuolar protein sorting 37 homolog 
D (S. cerevisiae)  -4.73 0.003205787 
ENSOARG00000007858 RASAL1 
RAS protein activator like 1 (GAP1 
like)  -4.42 5.48E-05 
ENSOARG00000017394 NRG2 Neuregulin 2  -2.13 0.003215491 
ENSOARG00000001269 STAR 
Ovis aries steroidogenic acute 
regulatory protein (STAR) -2.10 0.001532902 
ENSOARG00000020255 SLC4A3 
Solute carrier family 4 (anion 
exchanger) -2.08 0.000130044 
ENSOARG00000015923 CHDH Choline dehydrogenase  -2.06 0.001950291 
ENSOARG00000006108 PALD1 
Phosphatase domain containing, 
paladin 1 -2.05 0.00016121 
ENSOARG00000019421 IGFBP5 
Insulin-like growth factor binding 
protein 5 (IGFBP5) -2.0 0.001265343 
ENSOARG00000013875 HUNK 
Hormonally up-regulated Neu-
associated kinase  -1.94 9.23E-06 
ENSOARG00000004332 DOC2A Double C2-like domains -1.93 0.000120304 
ENSOARG00000002088 GRK5 G protein-coupled receptor kinase 5  -1.89 0.000885939 
ENSOARG00000018445 F13A1 Coagulation factor XIII -1.85 1.38E-06 
The top 2 up-regulated bovine genes were micro-RNA precursors that were removed 
from the analysis as were only found to be present and up-regulated in one animal. 
Further investigation into the micro-RNA precursor genes identified that they 
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mapped to an intron and not fully to an exon suggesting that their identification was 
probably an anomaly. These micro-RNA precursors were also excluded from the 
Venn diagram (Figure 6.3) for the same reasons. The top 20 up-regulated bovine DE 
genes included immune related genes, such as pro-inflammatory 
cytokines/chemokines and enzymes involved in antimicrobial defence (Table 6.5). 
CCL20 is the only top 20 up-regulated gene shared between ovine and bovine C. 
abortus infected compared to non-infected MDMs. 
Table 6.5: The top 20 up-regulated DE genes for bovine C. abortus-infected MDMs 












Colony stimulating factor 3 
(granulocyte) (CSF3) 5.53 1.00E-05 
ENSBTAG00000015214 CA3 Carbonic anhydrase III 5.06 0.00259806 
ENSBTAG00000013675 IL37 Interleukin 37  4.86 5.50E-18 
ENSBTAG00000007423 TNFRSF11B 
Tumour necrosis factor receptor 
superfamily 4.70 1.17E-14 
ENSBTAG00000023431 - Uncharacterized protein   4.65 0.004124423 
ENSBTAG00000016886 MT3 Metallothionein 3 (MT3) 4.64 8.51E-31 
ENSBTAG00000004714 MCEMP1 
Mast cell-expressed membrane 
protein 1  4.43 8.15E-13 
ENSBTAG00000006894 NOS2 Nitric oxide synthase 2, inducible 4.35 1.49E-10 
ENSBTAG00000021326 CCL20 
Chemokine (C-C motif) ligand 20 
(CCL20) 4.18 9.55E-30 
ENSBTAG00000001321 IL1B Interleukin 1 beta 4.14 1.09E-14 
ENSBTAG00000020602 IDO1 Indoleamine 2,3-dioxygenase 1 4.14 1.83E-07 
ENSBTAG00000008096 EDN1 Endothelin 1 (EDN1) 4.09 1.78E-34 
ENSBTAG00000037800 APOBEC3A 
Apolipoprotein B mRNA editing 
enzyme 3.90 5.18E-11 
ENSBTAG00000004710 HNF1B HNF1 homeobox B  3.82 0.001599711 
ENSBTAG00000044676 U6 U6 spliceosomal RNA  3.82 4.15E-06 
ENSBTAG00000012529 IFNG Interferon gamma 3.74 1.25E-09 
ENSBTAG00000001870 CPNE6 Copine VI (neuronal)  3.68 3.93E-10 
ENSBTAG00000000597 TMPRSS15 
Transmembrane protease, serine 
15 3.64 4.16E-09 
ENSBTAG00000014921 IL6 Interleukin 6  3.64 0.000346062 
ENSBTAG00000046944 - Uncharacterized protein   3.63 2.67E-14 
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The top 20 down-regulated DE genes in bovine MDMs included enzymes and G-
protein coupled receptors with cellular functions in growth, chemotaxis, recruitment 
and binding (Table 6.6). 
Table 6.6: The top 20 down-regulated DE genes for bovine C. abortus-infected MDMs 













Novel gene with description: 




RUN and FYVE domain-
containing protein 4   
-4.42 1.05E-41 




bta-mir-2887-1 -4.3 1.25E-12 




domain 2  
-4.18 1.35E-52 
ENSBTAG00000047910 - Uncharacterized protein   -4.0 3.76E-60 
ENSBTAG00000020319 ALOX5 Arachidonate 5-lipoxygenase  -3.98 7.00E-15 
ENSBTAG00000038680 - Uncharacterized protein -3.88 2.50E-13 
ENSBTAG00000017043 GPR1 G protein-coupled receptor 1  -3.81 0.003118113 
ENSBTAG00000022039 CMKLR1 
Chemokine-like receptor 1 
(CMKLR1) -3.80 3.29E-07 
ENSBTAG00000021252 TMEM35 Transmembrane protein 35  -3.71 0.003896717 
ENSBTAG00000007268 F13A1 Coagulation factor XIII -3.65 8.90E-44 
ENSBTAG00000004950 BRN Brain ribonuclease  -3.61 2.28E-20 
ENSBTAG00000007642 ADORA3 Adenosine A3 receptor  -3.60 7.27E-45 
ENSBTAG00000022509 DNAH9 Dynein -3.55 8.88E-14 
ENSBTAG00000014782 STAB1 Stabilin 1  -3.54 1.80E-26 
ENSBTAG00000017369 MAMDC2 MAM domain containing 2  -3.54 3.73E-16 
ENSBTAG00000016997 - Uncharacterized protein   -3.53 1.06E-14 
ENSBTAG00000026181 UGT1A1 
UDP glucuronosyltransferase 
1 family -3.40 6.25E-05 
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6.3.4 Inferring function of ruminant MDM DE genes 
The IPA disease and function terms that were enriched by ovine DE genes included 
cellular function and maintenance, infectious disease and inflammatory response 
(Table 6.7).   
Table 6.7: The top 15 enriched disease and biological functions with DE genes from 
ovine C. abortus-infected compared to non-infected MDMs. The p-value range describes 
the p-values of the subcategories within the functional category and the # molecules 
describes the number of molecules from the ovine DE gene dataset associated with the 
functions in the category. 
 
Similarly, functional analysis of the bovine DE genes identified enriched roles in 




Functional category P-value range # Molecules 
Cellular Function and Maintenance 1.27E-37-1.93E-08 166 
Infectious diseases 1.30E-37-1.71E-08 174 
Immunological Disease 2.63E-33-1.83E-08 183 
Hematological System Development and Function 1.60E-29-1.94E-08 188 
Tissue Morphology 1.60E-29-1.94E-08 158 
Cellular Movement 8.37E-29-1.27E-08 159 
Immune Cell Trafficking 8.37E-29-1.83E-08 134 
Connective tissue disorders 1.04E-28-6.85E-10 114 
Inflammatory Disease 1.04E-28-1.71E-08 155 
Skeletal and muscular disorders 1.04E-28-6.85E-10 126 
Cell-to-cell signalling 1.27E-27-1.83E-08 163 
Cellular development 1.29E-26-1.46E-08 186 
Cellular growth and proliferation 1.29E-26-1.38E-08 232 
Cell death and survival 3.53E-26-1.91E-08 230 
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Table 6.8: The top 15 enriched disease and biological functions with the DE genes 
from bovine C. abortus-infected compared to non-infected MDMs. The p-value range 
describes the p-values of the subcategories within the functional category and the # 
molecules describes the number of molecules from the bovine DE gene dataset associated 
with the functions in the category. 
Functional Category p-value range # Molecules 
Cellular movement 7.88E-43-5.51E-09 279 
Immune cell trafficking 1.91E-42-5.50E-09 209 
Haematological System Development and 
Function 2.33E-41-5.50E-09 
316 
Tissue morphology 2.33E-41-2.84E-09 255 
Cellular Function and Maintenance 1.77E-37-3.54E-09 260 
Cell-To-Cell Signaling and Interaction 2.77E-33-5.50E-09 253 
Inflammatory Response 1.01E-32-5.50E-09 294 
Cancer 9.23E-28-5.07E-09 788 
Organismal injury and abnormalities 9.23E-28-5.46E-09 793 
Cellular growth and proliferation 4.29E-27-4.81E-09 377 
Infectious diseases 2.13E-25-4.31E-09 207 
Cell death and survival 8.17E-24-2.23E-09 347 
Cardiovascular system development 2.30E-22-3.51E-09 198 
Organismal development 2.30E-22-4.59E-09 276 
Metabolic disease 1.32E-21-4.06E-09 365 
IPA analysis identified 98 statistically significant (FDR adjusted p-value<0.05) 
canonical pathways enriched with DE genes from C. abortus-infected ovine MDMs 
compared to non-infected MDMs. All of the top 10 canonical pathways were 
associated with the immune response (Figure 6.4).  
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Figure 6.4: The top 10 canonical pathways enriched with DE genes from ovine C. 
abortus-infected compared to non-infected MDMs. The threshold was set at p=0.05. The 
blue bars represent the FDR adjusted p-value. The yellow line represents the ratio, which 
was determined using the DE genes in the ovine DE gene dataset compared to the total 
genes in the pathway according the IPA knowledge base. 
 IPA analysis identified 73 statistically significant (FDR adjusted p-value<0.05) 
canonical pathways enriched with DE genes from C. abortus-infected bovine MDMs 
compared to non-infected MDMs. The top 10 canonical pathways in bovine MDMs 
were all involved in the immune response (Figure 6.5).  
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Figure 6.5: The top 10 canonical pathways enriched with DE genes from bovine C. 
abortus-infected compared to non-infected MDMs. The threshold was set at p=0.05. The 
blue bars represent the FDR adjusted P-value. The yellow line represents the ratio, which 
was determined using the DE genes in the bovine DE gene dataset compared to the total 
genes in the pathway according the IPA knowledge base. 
The top ranked canonical pathways were overlaid with the DE genes from both 
bovine and ovine datasets. The most significant enriched canonical pathway in ovine 
MDMs was the ‘Activation of the interferon regulatory factors by cytosolic pattern 
recognition receptors’. The ovine DE genes that were up-regulated in the pathway 
included the intracellular receptors, retinoic acid inducible gene-1 (RIG1) and 
melanoma differentiation gene-5 (MDA5). The intracellular receptors bind to 
mitochondrial antiviral signalling protein (MAVS) signalsome that mediates the 
activation of interferon regulatory factor 3 (IRF3) and IRF7, which were also up-
regulated in the ovine DE dataset. IRF3 and IRF7 induce the expression of interferon 
and interferon-stimulated genes (ISGs) of which IFN- β and ISG15 were among the 
genes up-regulated in the ovine DE dataset (Figure 6.6).The top canonical pathway 
in cattle was the ‘Differential regulation of cytokine production in macrophages and 
T-helper cells by IL-17A and IL-17F’. The bovine DE genes which were up-
regulated in the pathway included the pro-inflammatory cytokines IL-17A and IL-
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17F, which can mediate the up-regulation of expression of cytokines/chemokines 
including IL-1β and TNF-α (also up-regulated in the bovine DE genes) (Figure 6.7). 
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Figure 6.6: The top-ranked canonical pathway enriched with DE genes from ovine C. abortus-infected compared to non-infected MDMs: 
Activation of Interferon regulatory factors (IRFs) by cytosolic pattern recognition receptors. The degree of red shading indicates the level of up-
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regulated expression in C. abortus-infected MDMs. Green shading would indicate down-regulated expression and no shading indicates no detected 
differential expression in dataset (see appendix 9.4 for enlargeable copy of diagram).  
  
Figure 6.7: The top-ranked canonical pathway enriched with DE genes from bovine C. abortus-infected compared to non-infected MDMs: 
Differential regulation of cytokine production in macrophages and T helper cells by IL-17A and IL-17F. The degree of red shading indicates the 
level of up-regulated expression in C. abortus-infected MDMs. Green shading would indicate down-regulated expression and no shading indicates no 
detected DE in dataset 
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6.4 Discussion 
The experimental samples clustered together on the MDS plot according to cell type, 
which indicates that the gene expression profiles differed between cell types to a 
greater degree than between animals. PCA analysis of the ruminant MDMs infected 
with C. abortus and the non-infected MDMs identified that there was more variation 
between animals of the same species than between treatment groups. This indicates 
animal specific differences within the MDMs and exemplifies the difficulty of 
working with an out-bred population. Time limitations meant that the differentiation 
specific ‘signature’ profiles of the different MPS cells were not analysed. Future 
work will involve the analysis of DE genes from the pair-wise comparison of the 
different cell types. Gene clustering based on co-expression can also be used to 
simplify the comparison of gene expression profiles across cell types and understand 
the functional relevance and relationships between genes (Mabbott et al., 2013). The 
significantly DE genes from the comparison of ovine and bovine C. abortus-infected 
MDMs to non-infected MDMs were selected for further analysis. 
Host cells can exhibit a gene expression profile that is commonly induced in 
response to various pathogenic challenges. Microarray technology has been used 
extensively to characterize the common gene expression profile (Jenner and Young, 
2005).  A study compared the responses of human PBMCs to various bacterial 
stimuli and identified that commonly up-regulated genes included pro-inflammatory 
cytokines/chemokines and genes involved in NF-κB signalling. Commonly down-
regulated genes included a subset of cytokine/chemokine receptors and also genes 
involved in antigen processing (Boldrick et al., 2002). Similarly, human MDMs 
responded to various bacterial stimuli with the up-regulation of pro-inflammatory 
cytokines/chemokines, cytokine/chemokine receptors, signalling pathway molecules 
and anti-apoptotic genes. Genes involved in the anti-inflammatory response, 
transcription and various enzymes were down-regulated in response to infection 
(Nau et al., 2002). The gene expression profiles from previously published studies 
using various host cells (including macrophages, T cells and epithelial cells) 
challenged with different pathogenic stimuli (bacterial, viral and parasitic) were 
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compared. Common host responses cluster into functional groups (Jenner and 
Young, 2005) and a number of genes identified in these groups are up-regulated in 
both ovine and bovine C. abortus infected compared to non-infected MDMs (Table 
6.9).  
Table 6.9: The ‘common’ host functional groups of genes (Jenner and Young, 2005) 
and the genes in these groups which were up-regulated in ruminant MDMs following 
C. abortus infection. 
Functional groups of common genes Common genes up-regulated in ruminant 
 MDMs in response to C. abortus 
Co-stimulators CD40, CD80 
Cytokine receptors IL7R 
Pro-inflammatory cytokines IL-1β, IL-6, TNF, IL1A 
Chemotactic cytokines  CCL20, CXCL8, CCL5 
Other cytokines CSF2, CSF3 
Transcription factors NFKBIE, IRF1, IRF7 
Interferon stimulated genes ISG20, PML 
Antigen processing TAP1, PSMB9, PSMB10 
Apoptosis CASP7, BIRC3, BCL2A1 
 
However, gene expression profiles that were specific to intracellular pathogens, cell-
types and individual pathogens have also been identified using microarrays.  Human 
MDDCs exhibited up-regulated expression of genes involved in NF-κB signalling, 
apoptosis and the TNF-α pathway in response to intracellular Toxoplasma gondii, 
Mycobacterium tuberculosis, Leishmania major, Leishmania donovani but not 
extracellular Brugia malayai (Chaussabel et al., 2003). The up-regulation of 
particular clusters of genes can also be associated with different cell types and their 
specific immunological function. A cluster of chemokines including CXCL9, 
CXCL10, CCL8 and CXCL11, which are involved in T cell recruitment, were more 
strongly up-regulated in DCs compared to macrophages, T cells, B cells or epithelial 
cells in response to pathogenic stimuli (Jenner and Young, 2005). Human MDDCs 
and MDMs displayed unique ISG expression profiles in response to different 
bacterial pathogens (Chaussabel et al., 2003). Specific gene expression profiles to 
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individual pathogens have also been identified. The expression of IL-12p40, IL-15 
and signal transducer and activator of transcription 2 (STAT2) was shown to be 
pathogen-specific in human MDMs following infection with M. tuberculosis, E. coli 
or Staphylococcus aureus (Nau et al., 2002).  The comparison of human PBMC gene 
expression profiles identified a number of genes including the chemokine receptor 
(CCR1) and monocytic chemotactic protein (MCP1) that were selectively down-
regulated in response to different heat-killed bacteria (Boldrick et al., 2002). A 
number of ISGs, including IFIT1 and ISG15, were shown to have pathogen-specific 
profiles when comparing the gene expression of human MDDCs and MDMs in 
response to different bacterial pathogens (Chaussabel et al., 2003). The 
transcriptomes of ovine and bovine MDMs in response to C. abortus were 
investigated to identify potentially novel chlamydial-specific gene expression 
profiles. 
A number of DE genes that were significantly up-regulated in response to C. abortus 
infection were shared by bovine and ovine MDMs. However, more genes were not 
shared and up-regulated in either cattle or sheep. Further, notably more genes were 
down-regulated in cattle than sheep but the relevance of this requires further analysis. 
The functional role of the significantly DE genes in ruminant MDMs was implied by 
identifying the top 20 up and down-regulated genes and using pathway analysis.  
Many of the top 20 up-regulated DE genes identified in C. abortus-infected ovine 
MDMs compared to non-infected MDMs were associated with the type 1 interferon 
response. Type 1 interferons are typical of the innate immune response to a viral 
infection. The type 1 interferons bind to the IFNα receptor (IFNAR) and induce the 
expression of interferon-inducible genes including MX1, ISG15, IFIT1, RSAD2 and 
APOBEC proteins (Sadler and Williams, 2008), which were all identified in the 
ovine MDM top 20 up-regulated DE genes.  The potential role for type 1 IFNs was 
supported by the finding that the top canonical pathway enriched with ovine MDM 
DE genes describes the activation of cytosolic PRRs inducing the expression of type 
1 interferons and ISGs. The type 1 interferons and ISGs can control viral infection 
through the inhibition of viral replication or release of virus from infected cells 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 6: RNA-seq analysis of ruminant mononuclear phagocyte system cells and 
monocyte-derived macrophages infected with C. abortus 194 
(Sadler and Williams, 2008).  Although the type 1 interferon response is best 
characterized in terms of antiviral immune defense, Chlamydia has also previously 
been shown to activate type 1 interferons and ISGs. The increased expression of the 
ISGs CCL5, CXCL10 and ISG56 was detected in murine fibroblasts infected with C. 
pneumoniae (Chiliveru et al., 2010).  Interferon inducible genes (including MX1 and 
ISG15) were also up-regulated in a human monocytic cell line following infection 
with C. trachomatis (Ren et al., 2003). 
The role for type 1 IFNs in bacterial infection is complex and unlike in viral infection 
not simply a host defense mechanism. Conflicting studies demonstrating both 
protective and adverse roles for type 1 IFNs with bacterial infection have been 
published (Decker et al., 2005). The role of type 1 IFNs in chlamydial pathogenesis 
has been the subject of a number of studies. Type 1 IFNs can activate IDO, 
restricting chlamydial growth through tryptophan depletion in human MDMs 
indicating a potentially protective role (Carlin et al., 1989). However, IFNAR KO 
mice had lower weight loss, bacterial burden and milder lung inflammation 
compared to wild-type mice following intranasal challenge with C. muridarum. The 
study identified that the increased macrophages in the lung of IFNAR KO mice 
compared to the wild-type mice following C. muridarum infection contributed to 
chlamydial clearance. The decrease in macrophages in the wild-type was attributed 
to type 1 IFN mediated apoptosis, which may mediate the pathogenic effect of type 1 
IFN in vivo with chlamydial infection (Qiu et al., 2008). Similarly, IFNAR KO mice 
infected vaginally with C. muridarum exhibit faster bacterial clearance and reduced 
incidence of hydrosalpinx compared to wild-type mice (Nagarajan et al., 2008). 
A number of pro-inflammatory genes were identified in the top 20 up-regulated DE 
genes in bovine MDMs, including IL-1β, G-CSF, IL-37 and IFN-γ. As described in 
Chapter 1, IFN-γ is thought to mediate defence against chlamydial infection through 
the induction of IDO. IDO1, the gene that encodes IDO, was also identified in the 
top 20 up-regulated genes in bovine MDMs indicating that a protective immune 
response is activated. Inducible nitric oxide synthase (NOS2) is another target gene 
of IFN-γ, which induces the production of anti-microbial nitric oxide (NO) (Zhang et 
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al., 2012). NOS2 is also in the top 20 up-regulated DE genes in bovine MDMs. The 
top two up-regulated canonical pathways in bovine MDMs involve the IL-17A and 
IL-17F driven production of pro-inflammatory cytokines. Although usually 
associated with Th17 cells, IL-17A and IL-17F production by macrophages has also 
been identified in a small number of studies (Reynolds et al., 2010). The addition of 
recombinant IL-17A to human MDMs induced a distinct inflammatory profile, which 
up-regulated the expression of pro-inflammatory IL-6, IL-1α and CCL20 (Erbel et al, 
2014). A recent RNA-seq study identified the up-regulation of IL-17A expression in 
bovine MDMs infected with M. bovis (Nalpas et al., 2013). IL-17A has been 
implicated in the mediation of protective immunity to C. muridarum lung infection 
(Bai et al., 2009).  A novel mode of action for IL-17A in the up-regulation of IFN-γ 
driven iNOS production, which inhibits chlamydial growth in C. muridarum infected 
murine epithelial and macrophage cells was recently identified (Zhang et al., 2012). 
How this relates to ruminants, and particularly the differential pathogenesis of C. 
abortus in infection in sheep and cattle remains to be investigated.   
Chemokine receptor 1 (CX3CR1) is strongly down-regulated in ovine C. abortus-
infected MDMs compared to non-infected MDMs. CX3CR1 is the receptor that 
recognises fractalkine, which mediates cellular adhesion and chemotaxis (Imai et al., 
1997). The expression of CX3CR1 was also strongly down-regulated on BMDM 
derived from mice infected with Listeria monocytogenes compared to BMDM 
derived from control mice (Drevets et al., 2010).  Cadherin 26 (CDH26) is also 
highly down-regulated in the ovine DE gene dataset, with similar roles in cellular 
adhesion and migration and is also down-regulated in bovine MDMs in response to 
M. bovis (Nalpas et al., 2013). Arachidonate 5-lipoxygenase (ALOX5) is strongly 
down-regulated in the bovine DE gene dataset and is also down-regulated in ovine 
DE gene dataset. ALOX5 is an enzyme that synthesizes the production of 
leukotrienes and lipoxins. Leukotrienes can induce chemotaxis and oedema 
formation, whereas lipoxins can have anti-inflammatory functions including 
increasing the production of anti-inflammatory cytokines. Studies investigating the 
role of ALOX5 against different pathogens have conflicting results over whether the 
enzyme is protective or pathogenic (Fahel et al., 2015). FBJ murine osteosarcoma 
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viral oncogene homolog (FOS) is also down-regulated in both bovine and ovine 
MDM DE gene datasets and is involved in differentiation, cell death and the immune 
response (Durchdewald et al., 2009). FOS was down-regulated in bovine MDM 
infected with M. bovis (Nalpas et al., 2013) and in epithelial cells at 1 hour post 
infection with C. trachomatis (Humphrys et al., 2013).  Further studies are necessary 
to identify why these genes are down-regulated in response to C. abortus infection.  
Many of the top 10 canonical pathways enriched with genes from both bovine and 
ovine MDM DE gene datasets are shared. These include the ‘role of cytokines in 
mediating communication between immune cells’ and ‘communication between 
innate and adaptive immune cells’, which describes the expression of pro-
inflammatory cytokines/chemokines. Similarly, ‘inflammatory response’ and 
‘inflammatory disease’ are functions in the top 15 of the enriched disease and 
biological functions from bovine and ovine data sets respectively. The induction of a 
pro-inflammatory response is a characteristic feature of chlamydial infection 
(Entrican et al., 2004). A number of pro-inflammatory cytokines/chemokines genes 
including IL-1β, TNF-α, IL-6 and CXCL8 were up-regulated in both ovine and 
bovine MDM DE gene datasets, which was supported by results from Chapter 4. One 
of the first studies to characterize the Chlamydia infected host cell transcriptomic 
profile used a human endothelial cell line infected with C. pneumoniae. C. 
pneumoniae infection up-regulated the expression of cytokines/chemokines and 
growth factors, including CXCL8 and IL-1β expression (Coombes and Mahony, 
2001). The gene expression of human monocytes infected with C. trachomatis 
identified the up-regulation of CXCL8, TNF-α, IL-6 and IL-1β (Schrader et al., 
2007). Microarray analysis of a human epithelial cell line infected with C. 
trachomatis and C. pneumoniae identified the up-regulation of pro-inflammatory 
cytokines, including CXCL8 and IL-6 (Hess et al., 2003). The C. trachomatis cryptic 
plasmid is thought to be an important virulence factor as deficient strains produce 
attenuated disease. The expression levels of a number of pro-inflammatory genes, 
including CXCL8 and IL-6, were significantly increased in cells challenged with 
plasmid-bearing C. trachomatis compared to the deficient strain (Porcella et al., 
2015).  
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A number of pro-inflammatory mediators that have not yet been investigated 
in response to C. abortus were also up-regulated in ruminant MDMs. Mediators 
included endothelin 1 (EDN1), CCL20 and CCL5. EDN1 has been described to 
function like a pro-inflammatory cytokine (Teder and Noble, 2000) and has 
previously been shown to be up-regulated in human MDDC and MDMs in response 
to intracellular pathogens, including M. tuberculosis and T. gondii (Chaussabel et al., 
2003). EDN1 was also up-regulated in human epithelial cells in response to the 
plasmid-bearing compared to the plasmid-deficient strains of C. trachomatis 
(Porcella et al., 2015). CCL20 was the highest up-regulated chemokine in both cattle 
and sheep MDMs in response to C. abortus. CCL20 and CCL5 both function in 
lymphocyte chemotaxis and are up-regulated by C. trachomatis in human epithelial 
cells (Porcella et al., 2015). CCL5 was also up-regulated in conjunctival swabs from 
individuals with detectable C. trachomatis infection and clinical signs of trachoma 
compared to the control group, which had no clinical signs or detectable C. 
trachomatis infection (Natividad et al., 2010). Therefore, transcriptomic analysis has 
provided more in-depth and novel information on the pro-inflammatory response 
profile to chlamydial infection.  
The DE gene analysis of C. abortus-infected ruminant MDMs identified the up-
regulation of other groups of genes, which may be involved in chlamydial 
pathogenesis. Apoptosis describes a type of programmed cell death that is regulated 
to prevent the induction of an inflammatory response and is mediated by caspases 
(Sharma and Rudel, 2009). The ‘cell death and survival’ function that includes 
apoptosis is highly enriched with genes from the DE ruminant datasets. Genes 
including Baculoviral IAP Repeat Containing 3 (BIRC3) and BCL2-related protein 
A1 (BCL2A1) are up-regulated in ruminant MDMs. BIRC3 is an inhibitor of 
apoptosis protein (IAP) that functions through the inhibition of caspases. BCL2A1 is 
a member of the BCL-2 family that inhibits the permeabilization of the 
mitochondrial membrane and therefore inhibits caspase activation. Studies have 
shown that Chlamydia can inhibit apoptosis to facilitate their survival within the host 
cell (Sharma and Rudel, 2009). Recently, C. trachomatis infection was shown to 
down-regulate p53 expression in human umbilical vein epithelial cells and human 
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fallopian primary cells. The down-regulation of p53 may be the main mechanism by 
which Chlamydia inhibits apoptosis and permits intracellular growth (Siegl et al., 
2014). Chlamydia studies have also previously identified the up-regulation of BIRC3 
and BCL2A1 in epithelial cell lines in response to C. trachomatis (Rajalingam et al., 
2006; Ren et al., 2003). Therefore, these anti-apoptotic genes could contribute to the 
mediation of C. abortus persistence within the host. 
Similar results have been identified in other RNA-seq studies investigating the 
transcriptomic profile of cells infected with intracellular bacteria. The same 
functional categories that were enriched in ruminant MDMs infected with C. abortus 
were also enriched with DE genes from M. bovis infected bovine MDMs including: 
‘haematological system development and function’, ‘tissue morphology’ and 
‘cellular movement’.  The top 3 canonical pathways activated in bovine MDMs at 24 
hours post infection with M. bovis (Nalpas et al., 2013) were also the top 3 activated 
in ovine MDMs infected with C. abortus, suggesting a common gene expression 
profile to the two intracellular pathogens. An RNA-seq study of cervine MDMs 
identified the up-regulation of type 1 IFN genes (including RSAD2, IFIT2 and 
ISG15) and chemokines (including CCL8 and CXCL10) with Mycobacterium avium 
subspecies paratuberculosis (MAP) infection. The up-regulation of these genes was 
higher in MDMs derived from deer susceptible to Johne’s disease compared to 
resistant animals, which the authors suggested may contribute to the inflammatory 
pathology (Marfell et al., 2013). An RNA-seq study identified that the enriched 
functions in epithelial cells infected with C. trachomatis included the inflammatory 
and immune response. The study also identified novel host DE genes involved in the 
remodelling of the extracellular matrix, including mucins, metalloproteinases and 
collagens (Humphrys et al., 2013). Genes included in these categories are up-
regulated in the ruminant MDMs infected with C. abortus (including mucin 1 (muc1) 
and A Disintegrin-Like And Metalloprotease (Reprolysin Type) With 
Thrombospondin Type 1 Motif, 4 (ADAMTS4)); however, the same extensive range 
of genes within these categories was not detected which may be due to differences in 
cell type/Chlamydia species.  
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Further experiments are necessary to confirm mRNA expression, assess protein 
expression and identify the biological function of DE genes using knockdown 
experiments (Chow et al., 2011). Specifically, these studies could investigate the role 
of ISGs and IL-17 in C. abortus mediated pathogenesis. Future analysis will also 
involve clustering DE genes to identify subset differences in gene expression 
patterns. The direct DE gene analyses of sheep and cattle C. abortus-infected MDMs 
may also reveal further important species-specific differences. The novel RNA-seq 
protocol for the simultaneous transcriptomic analysis of the host cell and pathogen 
could also be used with primary host cells to further elucidate host-Chlamydia 
interactions. An important caveat with RNA-seq data interpretation is that the 
transcriptomic profile of the sample that is generated is only as good as the genome 
annotation database (e.g. Ensembl, RefGene) selected. A recent study compared 
using Ensembl, RefGene and UCSC to analyse the same human RNA-seq data. The 
study identified that none of the genome annotations were perfect and differed in the 
definition of some genes, meaning that the annotations of certain genes may not be 
completely accurate and in some cases may be wrong (Zhao and Zhang, 2015).  
In summary, the first aim to assess the transcriptomic profile of ruminant MPS cells 
was completed using RNA-seq, which will provide the basis for future studies to 
identify differentiation-specific signature profiles. Secondly, the transcriptome of C. 
abortus-infected ruminant MDMs was investigated using RNA-seq. The RNA-seq 
data was analysed by identifying the DE genes expressed in C. abortus-infected 
compared to non-infected MDMs. The potential biological function of DE genes and 
their involvement in signalling pathways was investigated and implied fulfilling the 
third aim. The fourth aim to compare the DE genes from cattle and sheep C.abortus-
infected MDMs identified differences in gene expression profiles and enriched 
signalling pathways, which may have implications for the differential disease 
pathogenesis of C. abortus in sheep and cattle. 
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Chapter 7: General Discussion 
The differential outcome of C. abortus infection in sheep and cattle provides an 
opportunity to identify differences in the ruminant immune system that determine 
susceptibility to disease. Chlamydial genetics have identified various genes that may 
play important roles in determining their host specificity and pathogenesis. The 
genetic analysis of C. abortus strains isolated from sheep and cattle suggest that the 
differences observed with C. abortus are due to the host, not the pathogen 
(Longbottom et al, unpublished). However, as discussed in section 1.1.4.2 small 
differences in chlamydial isolates can have a large impact on pathology and therefore 
it is difficult to determine the impact of host or pathogen factors. The focus of this 
thesis was to investigate the innate immune response to chlamydial infection in sheep 
and cattle, which, until now, has been primarily characterized in humans and mice. 
The immune response to pathogens can vary across species (Entrican et al., 2009) 
and therefore it is important to study the immune response of the natural host. The 
role of the inflammasome complex and IL-1β production in response to chlamydial 
infection has been the topic of many human and mouse studies (Abdul-Sater et al., 
2010; Shimada et al., 2012), but prior to this study had not been investigated in 
ruminants. The improved understanding of the innate immune response to specific 
pathogens can be used for the design of improved vaccines as innate immune cells 
infected with Chlamydia can polarize the adaptive immune response (Flego et al., 
2013). Although commercially available vaccines are available for C. abortus, there 
is clearly room for improvement as it is still the most common infectious cause of 
ovine abortion in the UK (Animal and Plant Health Agency (APHA), 2014) 
The research conducted during this thesis addressed the hypothesis that ruminant 
hosts differ in their ability to innately sense C. abortus infection and activate the 
inflammasome. A number of aims were formulated in order to address this 
hypothesis, the outcomes of each and their potential collective impact will be 
discussed here.   
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The first aim was to analyse the expression of selected PRRs by ruminant innate 
immune cells. TLR2, TLR4, NOD1 and NLRP3 are commonly recognised to be 
involved in the detection of mouse and human chlamydial species (as described in 
Chapter 1). Turbinate cells, MDMs and MDDCs from both cattle and sheep were 
found to express all four receptors (Chapter 3 and Chapter 4). The expression of both 
intracellular and extracellular PRRs by both ovine and bovine cells indicates that 
they possess the capability to recognise chlamydial infection at different stages of the 
developmental cycle. The expression of the four receptors by all of the different cell 
types supports their role as important innate immune sentinels, which need to be 
primed to respond to a range of pathogens. The potential role of NOD1 and NLRP3 
in C. abortus detection was assessed in ruminant MDMs using siRNA, which will be 
discussed later. Future studies could assess the expression of the TLRs and NLRs 
that were not investigated in the duration of this thesis. Particularly, the receptors that 
have only recently been identified to recognise intracellular pathogens may be worth 
further investigation, including NLRP7 (Broz and Monack, 2013). Candidate gene 
approaches and genome wide association studies (GWAs) have been used to identify 
genetic variations in PRRs, which are associated with susceptibility to disease 
(Pothlichet and Quintana-Murci, 2013). For example, mutations have been identified 
in TLR1, 2 and 4 that have been associated with increased susceptibility to infection 
with Mycobacterium avium Subspecies paratuberculosis in cattle (Mucha et al., 
2009). Differences in TLR sequences have been identified between species, which 
may facilitate the detection of species-specific pathogens (Werling et al., 2009). 
Mutations do not necessarily affect the function of the protein and therefore it is 
important to identify whether mutations are present in functional regions and likely 
to change the function of the receptor (Smith et al., 2014). Therefore, further studies 
could identify the genetic variation between ovine and bovine PRRs and determine 
whether variation affects receptor function, impacting on susceptibility to disease 
caused by C. abortus.   
Assessing the inflammatory response of innate immune cells to C. abortus infection 
was the second aim. The first step was to assess whether the cells were susceptible to 
C. abortus infection. C. abortus formed large inclusions within the ruminant 
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turbinate cells, unlike in the MDMs and MDDCs where small fragmented inclusions 
were formed. The inclusion morphology may reflect the differential role of these 
cells in chlamydial disease pathogenesis. Previous studies have identified that 
chlamydial species replicate in epithelial cells but replication within mononuclear 
phagocytes is more limited, to the extent that the growth measured almost never 
exceeds the starting infectious dose (Beagley et al., 2009a). Studies have shown the 
Chlamydiae can establish a persistent infection within mononuclear phagocytes. 
Persistence involves the bacteria maintaining viability but not actively progressing 
through the developmental cycle to produce infectious EBs (Beagley et al., 2009a; 
Datta et al., 2014). However, the biological and functional relevance for persistence 
in vivo is not clear. Chlamydia has been detected in vivo in alveolar /peritoneal 
macrophages and PBMC following intranasal/intraperitoneal infection with C. 
pneumoniae. C. pneumoniae was also detected in the lymph nodes and spleen of 
mice following the adoptive transfer of alveolar/peritoneal macrophages from C. 
pneumoniae infected mice. Theoretically, the macrophages may be facilitating the 
carriage of the bacteria into the draining lymphatics and lymph nodes, entering the 
blood stream via the thoracic duct (Moazed et al., 1998). However, this theory of 
chlamydial dissemination has not yet been experimentally proven. The proposed 
theory is also complicated by the fact that monocyte-derived cells in the efferent 
lymph are rare; however, under inflammatory conditions where DC migration from 
the periphery is induced, increased DCs are detected in the efferent lymph (Randolph 
et al., 2005). Mononuclear phagocytes could be involved in the dissemination of C. 
abortus from the initial site of infection to the site of persistence and/or to the site of 
pathology (placenta). However, further studies are required to identify whether C. 
abortus remains viable and infectious, and if so for how long, in the different 
ruminant cell types.  
 UV-inactivated bacteria did not form inclusions within ruminant turbinate cells, 
MDMs or MDDCs, although visible fluorescent specks were present in the 
immunofluorescent images (Chapter 3 and Chapter 4). This indicates that they were 
unable to enter the multiplication phase but does not rule out invasion and/or cellular 
uptake. Confocal microscopy studies are required to determine whether the UV-
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inactivated bacteria are intracellular or attached to the cell surface. Identifying 
whether the UV-inactivated bacteria were intracellular is important for determining 
whether cytokine/chemokine production is likely due to intracellular or cell-surface 
PRR activation.  
The production of CXCL8, IL-6, TNF-α and IL-1β by ruminant turbinate cells, 
MDDCs and MDMs in response to C. abortus infection was then measured. The 
ruminant turbinate cells responded to infection late in the chlamydial developmental 
cycle with significantly increased production of CXCL8 only detected at 72 hours 
post C. abortus infection. There was no TNF-α or IL-1β production detected.  In 
contrast, the ruminant MDMs and MDDCs produced significantly increased CXCL8, 
TNF-α and IL-1β by 24 hours post C. abortus infection. The cytokine/chemokine 
production profiles of these cells suggest the activation of signalling pathways that 
are specific to the different cell types. The unique cytokine/chemokine profiles are 
likely to be reflective of the specialized roles of different cell types in chlamydial 
disease pathogenesis. Similarly, a previous study identified that the primary 
producers of IL-1β in the murine genital tract following C. muridarum infection were 
macrophages and neutrophils and not epithelial cells (Prantner et al., 2009).   
Late CXCL8 production has previously been identified as a feature of the epithelial 
cell response to chlamydial infection (Buchholz and Stephens, 2008; Rasmussen et 
al., 1997).  Epithelial cells have been shown to respond to other intracellular bacteria, 
such as Salmonella Dublin and Listeria monocytogenes, with the rapid production of 
CXCL8 (Eckmann et al., 1993). Therefore, the delayed CXCL8 production may be a 
unique feature of chlamydial infection of epithelial cells, which allows the bacterium 
to enter the cell and begin its developmental cycle before the immune system is 
alerted. CXCL8 has been implicated in the recruitment of neutrophils to the site of 
chlamydial infection (Molestina et al., 1999), which were shown to permit 
chlamydial survival and potentiate replication in macrophages (Rupp et al., 2009). 
Therefore, late CXCL8 production by ruminant turbinate cells could facilitate the 
dissemination of C. abortus from the oro-nasal mucosa by recruiting neutrophils at a 
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time when mature EBs are being released from the target cells of the primary 
infection.  
Generally, monocytes can be recruited into infected tissue and under certain 
conditions can differentiate into MDDC or MDMs (Shi and Pamer, 2011). 
Mononuclear cell (MHCII
+
) infiltration has been detected in the maternal placental 
membranes following C. abortus infection (Navarro et al., 2004). The contribution of 
these cells to the C. abortus induced inflammatory cascade in the placenta is not fully 
understood; however, mononuclear cells may contribute to TNF-α production in C. 
abortus-infected placentas (Buxton et al., 2002). Ruminant MDDCs and MDMs 
respond in vitro to C. abortus with the production of pro-inflammatory cytokines 
(Chapter 4) and therefore they may contribute to the inflammatory milieu in vivo 
leading to abortion.  
The ruminant turbinate cells did not produce CXCL8 in response to UV-inactivated 
C. abortus (Chapter 3), which contrasts with MDMs and MDDCs. The MDMs and 
MDDCs were capable of producing both CXCL8 and TNF-α in response to UV-
inactivated C. abortus (Chapter 4). This may be indicative of the phagocytic ability 
of monocyte-derived cells and/or the activation of different cell type specific 
signalling pathways. Viable C. abortus was required for IL-1β protein production in 
the ruminant MDMs and MDDCs, although mRNA encoding IL-1β was elevated at 
6 hours post infection in MDMs challenged with UV-inactivated C. abortus (but not 
protein). The IL-1β RT-PCR primers and probe do not distinguish between the pro 
and mature form of IL-1β, it is therefore possible that pro-IL-1β production is 
induced in response to UV-inactivated C. abortus but not subsequently cleaved into 
the mature form for extracellular secretion. The cleavage of pro-IL-1β therefore 
appears to be dependent on a viable chlamydial infection, which fits logically with 
the theory that cleavage may be mediated by intracellular stress pathways (Tschopp 
and Schroder, 2010). The production of IL-1β in murine macrophages was found to 
be dependent on viable C. muridarum infection but not on chlamydial growth, which 
led the authors to speculate that effector proteins secreted by viable C. muridarum 
were activating the pathway (Prantner et al., 2009). The differences in 
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cytokine/chemokine profiles with live and inactivated bacteria should be considered 
when designing novel vaccines as the live pathogen is uniquely interacting with the 
host cell to activate host genes that may influence protection/pathology. 
The innate immune cytokine profiles were similar in pattern between cattle and 
sheep cells in response to C. abortus infection. Differences in the quantity of 
production were identified between the two species; however, it was difficult to 
determine whether ELISA sensitivity issues accounted for these differences and that 
it wasn’t a technical effect rather than a biological effect. From this, it is unlikely that 
the production of CXCL8, IL-1β or TNF-α by the ruminant turbinate cells, MDDCs 
or MDMs contribute to the differential C. abortus disease pathogenesis between 
cattle and sheep. However, it is important to remember that the in vivo production 
has not been assessed and may be different.  
The third aim focussed on identifying the role of NOD1 and the NLRP3 
inflammasome in IL-1β and CXCL8 production by ruminant MDMs in response to 
C. abortus infection (Chapter 5). A role for NOD1 was identified in the production 
of IL-1β by both ovine and bovine MDMs as well as the production of CXCL8 by 
ovine MDMs in response to C. abortus infection using siRNA technology. 
Previously, C. pneumoniae and C. muridarum studies had identified a role for NOD1 
in the production of CXCL8, but most did not investigate IL-1β production (Opitz et 
al., 2005; Prantner et al., 2010). The level of target knockdown with NLRP3 siRNA 
was lower than that observed with NOD1 siRNA. One of the NLRP3 siRNA 
sequences significantly reduced IL-1β production in bovine but not ovine MDMs. 
Therefore, NLRP3 may be involved in the recognition of C. abortus and activation of 
IL-1β processing pathways in bovine but not ovine MDMs. Further development of 
the tools to investigate the components of the ruminant inflammasome and IL-1β 
production pathway is required for future studies. For example, specific ruminant 
antibodies that measure ruminant NLRP3, NOD1 and caspase-1 protein (pro-form 
and cleaved form) may facilitate further studies.   
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Targeting NOD1 or NLRP3 may be beneficial for the design of novel C. abortus 
vaccine delivery systems. A subunit vaccine is desirable from the perspectives of 
safety and for the potential to be used in conjunction with a DIVA (discrimination 
between vaccinated and infected animals) diagnostic test (Entrican et al., 2012). 
However, subunit vaccines generally lack immunogenicity and require the addition 
of an adjuvant to stimulate the immune response. Adjuvants that target PRRs and 
activate specific signalling pathways that can shape the protective adaptive immune 
response have been developed. For example, monophosphoryl lipid A extracted from 
Salmonella minnesota LPS is a TLR4 agonist, which is used in licensed human 
papilloma virus and hepatitis B vaccines (Maisonneuve et al., 2014). Further studies 
identifying the role of IL-1β and CXCL8 production in vivo with C. abortus infection 
will help identify whether stimulating these pathways will provide protection or 
cause pathology. 
The knockdown of NOD1 or NLRP3 did not completely ablate IL-1β production, 
which is a common finding in knockdown studies. The innate immune response to a 
single pathogen is co-ordinated by various different types of PRRs. This is because 
pathogens usually contain a number of PAMPs that are recognised by different PRRs 
and single PAMPs can be recognised by multiple types of PRR. The cross-talk 
between PRRs has been shown to be necessary for the induction of effective innate 
immune responses to various pathogens (Kawai and Akira, 2011). PRR cross-talk in 
the host recognition of chlamydial infection was exemplified in a study which 
identified that combined TLR2/TLR4 KO mice had increased morbidity and 
mortality to C. pneumoniae infection compared to single KO mice (Rodriguez et al., 
2006). Further studies that knockdown combinations of TLRs and NLRs may reveal 
the full complexity of the signalling pathways activated by C. abortus. 
The final aim was to use RNA-seq analysis to provide an unprecedented view of the 
RNA transcripts of ruminant MPS cells and C. abortus-infected MDMs (Chapter 6). 
Future studies will further analyse the RNA-seq data with a view to identifying 
specific ‘signature’ profiles for the ruminant MPS cells. This will not only inform on 
the experiments conducted within this thesis but will be a valuable resource for the 
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veterinary immunology field. The commonly up-regulated DE genes in C. abortus-
infected ruminant MDMs included IL-1β, CXCL8 and TNF-α, which were 
previously targeted in Chapter 5 as molecules of interest in chlamydial infections. 
The TLRs and NLRs which were identified to be up-regulated at 6 hours following 
C. abortus infection in ruminant MDMs by RT-PCR (Chapter 4) were not detected to 
be significantly DE by RNA-seq in both sheep and cattle MDMs at 24 hours 
following C. abortus infection (Chapter 6). The disparity in these results may be due 
to the different techniques used or the different time points assessed. However, it is 
important to note that no detectable up-regulated expression does not mean that the 
receptor in not involved in C. abortus recognition. Novel pathways and functional 
groups of genes involved in inflammatory signalling were enriched with DE genes 
from both ovine and bovine C. abortus infected compared to non-infected MDMs. 
However, differences in the type of signalling pathways and the top genes that were 
up-regulated identified potentially important species-specific differences.  
The highest up-regulated DE genes in ovine C. abortus-infected MDMs included 
many type 1 IFN related genes. The top enriched ovine canonical pathway described 
the activation of intracellular signalling PRRs (including RLRs) in the induction of 
type 1 IFN and ISG expression. The identification of the RLR signalling pathway 
with C. abortus infection highlights a novel PRR pathway worthy of investigation as 
RLRs are linked to inflammasome activation. For example, RIG-1 has been shown to 
interact with ASC independent of NLRP3 to mediate IL-1β production in murine 
BMDCs in response to the RIG-1agonist 5’-triphosphate RNA (Poeck et al., 2010). 
Type 1 IFN signalling has also been shown to contribute to the induction of IL-1β 
production in murine BMDMs in response to the intracellular bacteria Francisella 
tularensis (Henry et al., 2007). This reinforces the earlier discussion about the 
complexity of PRR signalling pathways and the role of cross-talk in coordinating the 
immune response to a single pathogen. The role of type I IFNs in chlamydial 
infection is still poorly understood. Previous in vivo mouse studies have identified a 
role for type 1 interferons in Chlamydia induced morbidity (Nagarajan et al., 2008; 
Qiu et al., 2008). Given the RNAseq data with the C. abortus-infected ovine MDMs, 
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further investigation into the role of type1 interferons in C. abortus infection is 
warranted.  
In contrast, the highest up-regulated bovine DE genes were not enriched with type 1 
IFN genes and instead contained a number of pro-inflammatory genes, including 
IFN-γ, IL-1β and G-CSF. NOS2 is a target gene of IFN-γ, which was also highly up-
regulated in bovine MDMs following C. abortus infection. NOS2 has been shown to 
inhibit chlamydial growth in vitro in murine cells and therefore may be an important 
host defence mechanism (Zhang et al., 2012). NOS2 was not significantly up-
regulated in ovine MDMs in response to C. abortus infection. This echoes previous 
results in ovine alveolar macrophages, which did not produce detectable NO when 
stimulated with recombinant ovine IFN-γ in combination with LPS or C. abortus 
(Brown, 1999). Therefore, NO may be involved in IFN-γ driven defence to C. 
abortus in cattle but not sheep, which may be an important species-specific 
difference that could impact on disease pathogenesis. The top enriched bovine 
canonical pathway suggested a potentially novel role for IL-17A and IL-17F in 
driving the production of inflammatory cytokines in bovine MDMs in response to C. 
abortus infection. This is interesting as the analyses were conducted on myeloid 
cells, not lymphoid cells. A potentially protective role for IL-17A with C. muridarum 
lung infection has been identified (Bai et al., 2009), which may be connected to the 
recently discovered role for the cytokine in the induction of IFN-γ mediated NOS2 
production (Zhang et al., 2012).  
A number of challenges associated with working in the veterinary immunology field 
were encountered in the course of this thesis. Although the veterinary reagents which 
are commercially available have increased, gaps in availability still exist (Entrican 
and Lunney, 2012). Ideally, commercially available ELISA kits containing standards 
for both cattle and sheep would be available for all cytokines/chemokines. However, 
in the case of CXCL8, IL-6, IL-1β and TNF-α commercially available reagents are 
limited to antibody pairs, which were designed for the detection of either the sheep or 
cattle cytokine. Cattle and sheep are closely related species and therefore reagents are 
likely to cross-react (Entrican and Lunney, 2012), however reagents can show a 
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difference in sensitivity (Chapter 3). The commercial IL-6 antibody pairs detected 
recombinant ovine and bovine IL-6, however the ELISA failed to detect any IL-6 in 
the supernatants of the cells assessed in this thesis. Previous studies have identified 
that epithelial cells, monocytes and macrophages produce IL-6 in response to 
chlamydial infection (Rusconi and Greub, 2011). The up-regulation of IL-6 mRNA 
was detected at 6 hours post C. abortus infection in ruminant MDMs (Chapter 4) and 
also up-regulated in RNA-seq data from C. abortus-infected ruminant MDMs 
(Chapter 6). Although originally shown to detect native IL-6 in the efferent lymph of 
sheep (McWaters et al., 2000), results suggest that the current batch of IL-6 
antibodies may no longer detect native IL-6. Reagent availability also affects cell 
phenotyping in veterinary species, as some of the antibodies for the detection of 
differentiation-specific markers are not yet available. An example is Flt3 (CD135) 
that has been identified as a specific classical DC marker (Miller et al., 2012) but 
ruminant Flt3 antibodies are not yet available. 
Another challenge in the veterinary immunology field is that protocols that are well 
established and optimised for human and mouse studies are not established in 
veterinary species. An example is the generation of ovine MDMs, which has not 
previously been published. The protocol for bovine MDMs has been published 
(Jensen et al., 2014), but unfortunately was not transferrable to ovine cells. Various 
optimisation steps were assessed before the requirement for autologous serum was 
identified (Chapter 4). Equally, a protocol for the Western blot detection of the pro 
and mature forms of ruminant IL-1β had not been published and required 
development (Chapter 5). 
Gene expression technology is helping to bridge the gap in ruminant reagent 
availability as it uses the annotated ovine and bovine genomes and does not require 
the development of species-specific reagents. The analysis of gene expression 
profiles has been used to identify MPS differentiation specific signatures across 
species (Vu Manh et al., 2015b). Gene expression profiling has also identified novel 
pathways activated in ruminant cells in response to infection (Nalpas et al., 2013). 
RNA-seq technology is particularly useful for cross-species comparisons as it 
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identifies the complete RNA profile of any species without the microarray 
requirement to design species-specific probes, which requires previously annotated 
transcripts (Liu et al., 2011). Further validation experiments using other experimental 
methods (such as RT-PCR) on different biological replicates (different from those 
used in the RNA-seq experiment) are required to validate RNA-seq results including 
the results in Chapter 6 (Fang and Cui, 2011).  
In some cases in vivo studies are necessary to understand disease, however, 
alternative methods should be used wherever possible (Entrican et al, 2015).  In vitro 
studies have provided vast insight into the function of different immune cell types in 
response to various stimuli. However, studies into human MDDCs and mouse 
BMDCs have shown that in vitro differentiated cells do not display all the functions 
of their proposed in vivo counterparts (Guilliams and Malissen, 2015; Helft et al., 
2015; Wimmers et al., 2014). Similarly, in vitro studies do not replicate the complex 
cellular interactions that take place in tissues in vivo. Ex vivo explant cultures provide 
an intermediary step between in vitro and in vivo studies, which allow the 
investigation of host-pathogen interactions within intact tissue architecture unlike 
single-cell assays. The recent publication of the protocol for the ex vivo culture of 
bovine endometrial explants (Borges et al., 2012) identified a novel method for the 
investigation of the maternal immune response to C. abortus infection. BKTN PhD 
top-up funding facilitated the investigation of the potential of ex vivo ruminant 
endometrial explants to investigate maternal immune pathways in response to C. 
abortus infection (see appendix 9. 2). The study identified that the bovine 
endometrial explants could be infected with C. abortus, but the production of 
cytokines/chemokines to infection was not significant due to high variation between 
animals. The same protocol also did not generate comparable ovine explants due to 
anatomical differences in the cattle and sheep uteri. Larger sample sizes and further 
optimisation of the protocol to facilitate the culture of ovine endometrial explants 
could form the basis of future work.  
Understanding the innate immune response of the natural host to infection will 
contribute to the design of safer vaccines that can selectively target the protective 
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adaptive immune response. The innate immune cytokine profiles of ruminant oro-
nasal turbinate cells and monocyte-derived cells to C. abortus infection may reflect 
the cell-type specific roles in disease pathogenesis.  The cytokine profiles were 
similar between sheep and cattle cells, indicating that more complex interactions may 
be influencing the differential outcome of infection. NOD1 contributed to IL-1β 
production in both sheep and cattle MDMs and further investigation will identify 
what stage of the signalling pathway the receptor is involved. Finally, novel genes 
and pathways have been identified in ruminant C. abortus-infected MDMs that may 
impact on disease pathogenesis and will be the topic of future studies. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  213 
Chapter 8: Reference List 
Abdelrahman, Y.M., Belland, R.J., 2005. The chlamydial developmental cycle. 
FEMS Microbiol Rev. 29, 949-959. 
Abderrazak, A., Syrovets, T., Couchie, D., El, H.K., Friguet, B., Simmet, T., Rouis, 
M., 2015. NLRP3 inflammasome: From a danger signal sensor to a regulatory node 
of oxidative stress and inflammatory diseases. Redox. Biol 4C, 296-307. 
Abdul-Sater, A.A., Koo, E., Hacker, G., Ojcius, D.M., 2009. Inflammasome-
dependent caspase-1 activation in cervical epithelial cells stimulates growth of the 
intracellular pathogen Chlamydia trachomatis. J Biol Chem. 284, 26789-26796. 
Abdul-Sater, A.A., Said-Sadier, N., Padilla, E.V., Ojcius, D.M., 2010. Chlamydial 
infection of monocytes stimulates IL-1beta secretion through activation of the 
NLRP3 inflammasome. Microbes Infect. 12, 652-661. 
Afonina, I.S., Muller, C., Martin, S.J., Beyaert, R., 2015. Proteolytic Processing of 
Interleukin-1 Family Cytokines: Variations on a Common Theme. Immunity. 42, 
991-1004. 
Agrawal, T., Vats, V., Salhan, S., Mittal, A., 2007. Local markers for prediction of 
women at higher risk of developing sequelae to Chlamydia trachomatis infection. 
Am. J Reprod. Immunol 57, 153-159. 
Airenne, S., Surcel, H.M., Alakarppa, H., Laitinen, K., Paavonen, J., Saikku, P., 
Laurila, A., 1999. Chlamydia pneumoniae infection in human monocytes. Infect. 
Immun. 67, 1445-1449. 
Akira, S., Takeda, K., 2004. Toll-like receptor signalling. Nat. Rev. Immunol 4, 499-
511. 
Altschul, S.F., Gish, W., Miller, W., Myers, E.W., Lipman, D.J., 1990. Basic local 
alignment search tool. J Mol. Biol 215, 403-410. 
Ambesajir, A., Kaushik, A., Kaushik, J.J., Petros, S.T., 2012. RNA interference: A 
futuristic tool and its therapeutic applications. Saudi. J Biol Sci 19, 395-403. 
Amin, J.D., Wilsmore, A.J., 1995. Studies on the early phase of the pathogenesis of 
ovine enzootic abortion in the non-pregnant ewe. Br. Vet J 151, 141-155. 
Ammon, C., Meyer, S.P., Schwarzfischer, L., Krause, S.W., Andreesen, R., Kreutz, 
M., 2000. Comparative analysis of integrin expression on monocyte-derived 
macrophages and monocyte-derived dendritic cells. Immunology 100, 364-369. 
Anderson, I.E., 1986. Comparison of the virulence in mice of some ovine isolates of 
Chlamydia psittaci. Vet Microbiol 12, 213-220. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  214 
Andrew, D.W., Cochrane, M., Schripsema, J.H., Ramsey, K.H., Dando, S.J., 
O'Meara, C.P., Timms, P., Beagley, K.W., 2013. The duration of Chlamydia 
muridarum genital tract infection and associated chronic pathological changes are 
reduced in IL-17 knockout mice but protection is not increased further by 
immunization. PLoS One 8, e76664. 
Animal and Plant Health Agency (APHA), 2014. Veterinary Investigation Diagnosis 
Analysis (VIDA) report, 2014. https://www.gov.uk/government/statistics/veterinary-
investigation-diagnosis-analysis-vida-report-2014. Last accessed 04/09/15. 
Appino, S., Pregel, P., Manuali, E., Vincenti, L., Rota, A., Carnieletto, P., Tiberi, C., 
Bollo, E., 2007. Infection of bovine oviduct cell cultures with Chlamydophila 
abortus. Anim Reprod. Sci 98, 350-356. 
Atik, B., Skwor, T.A., Kandel, R.P., Sharma, B., Adhikari, H.K., Steiner, L., Erlich, 
H., Dean, D., 2008. Identification of novel single nucleotide polymorphisms in 
inflammatory genes as risk factors associated with trachomatous trichiasis. PLoS 
One 3, e3600. 
Bachmann, N.L., Fraser, T.A., Bertelli, C., Jelocnik, M., Gillett, A., Funnell, O., 
Flanagan, C., Myers, G.S., Timms, P., Polkinghorne, A., 2014a. Comparative 
genomics of koala, cattle and sheep strains of Chlamydia pecorum. BMC Genomics 
15, 667. 
Bachmann, N.L., Polkinghorne, A., Timms, P., 2014b. Chlamydia genomics: 
providing novel insights into chlamydial biology. Trends Microbiol 22, 464-472. 
Bai, H., Cheng, J., Gao, X., Joyee, A.G., Fan, Y., Wang, S., Jiao, L., Yao, Z., Yang, 
X., 2009. IL-17/Th17 promotes type 1 T cell immunity against pulmonary 
intracellular bacterial infection through modulating dendritic cell function. J 
Immunol 183, 5886-5895. 
Bai, Y., Sartor, M., Cavalcoli, J., 2012. Current status and future perspectives for 
sequencing livestock genomes. J Anim Sci Biotechnol 3, 8. 
Bailey, R., Duong, T., Carpenter, R., Whittle, H., Mabey, D., 1999. The duration of 
human ocular Chlamydia trachomatis infection is age dependent. Epidemiol. Infect. 
123, 479-486. 
Barbe, F., Douglas, T., Saleh, M., 2014. Advances in Nod-like receptors (NLR) 
biology. Cytokine Growth Factor Rev. 25, 681-697. 
Batteiger, B.E., Xu, F., Johnson, R.E., Rekart, M.L., 2010. Protective immunity to 
Chlamydia trachomatis genital infection: evidence from human studies. J Infect. Dis 
201 Suppl 2, S178-S189. 
Bauernfeind, F.G., Horvath, G., Stutz, A., Alnemri, E.S., MacDonald, K., Speert, D., 
Fernandes-Alnemri, T., Wu, J., Monks, B.G., Fitzgerald, K.A., Hornung, V., Latz, 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  215 
E., 2009. Cutting edge: NF-kappaB activating pattern recognition and cytokine 
receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. 
J Immunol 183, 787-791. 
Bavoil, P.M., 2014. What's in a word: the use, misuse, and abuse of the word 
"persistence" in Chlamydia biology. Front Cell Infect. Microbiol 4, 27. 
Beagley, K.W., Huston, W.M., Hansbro, P.M., Timms, P., 2009a. Chlamydial 
infection of immune cells: altered function and implications for disease. Crit Rev. 
Immunol 29, 275-305. 
Beagley, K.W., Timms, P., Debatistta, J., Wilson, D.P., 2009b. Time to rethink the 
expectations for a chlamydial vaccine. Mucosal Immunol 2, 278. 
Beare, P.A., Sandoz, K.M., Omsland, A., Rockey, D.D., Heinzen, R.A., 2011. 
Advances in genetic manipulation of obligate intracellular bacterial pathogens. Front 
Microbiol 2, 97. 
Beasley, T.M., Erickson, S., Allison, D.B., 2009. Rank-based inverse normal 
transformations are increasingly used, but are they merited? Behav. Genet. 39, 580-
595. 
Beatty, P.R., Stephens, R.S., 1994. CD8+ T lymphocyte-mediated lysis of 
Chlamydia-infected L cells using an endogenous antigen pathway. J Immunol 153, 
4588-4595. 
Belland, R.J., Scidmore, M.A., Crane, D.D., Hogan, D.M., Whitmire, W., McClarty, 
G., Caldwell, H.D., 2001. Chlamydia trachomatis cytotoxicity associated with 
complete and partial cytotoxin genes. Proc. Natl. Acad. Sci. USA 98, 13984-13989. 
Benjamini, Y., Hochberg, Y., 1995. Controlling the false discovery rate: a practical 
and powerful approach to multiple testing. Journal of the Royal Statistical Society. 
Series B (Methodological) 57, 289-300. 
Berrington, W.R., Iyer, R., Wells, R.D., Smith, K.D., Skerrett, S.J., Hawn, T.R., 
2010. NOD1 and NOD2 regulation of pulmonary innate immunity to Legionella 
pneumophila. Eur. J Immunol 40, 3519-3527. 
Berthon, P., Hopkins, J., 1996. Ruminant cluster CD14. Vet Immunol Immunopathol 
52, 245-248. 
Beutler, B.A., 2009. TLRs and innate immunity. Blood 113, 1399-1407. 
Beyer, M., Mallmann, M.R., Xue, J., Staratschek-Jox, A., Vorholt, D., Krebs, W., 
Sommer, D., Sander, J., Mertens, C., Nino-Castro, A., Schmidt, S.V., Schultze, J.L., 
2012. High-resolution transcriptome of human macrophages. PLoS One 7, e45466. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  216 
Bogefors, J., Rydberg, C., Uddman, R., Fransson, M., Mansson, A., Benson, M., 
Adner, M., Cardell, L.O., 2010. Nod1, Nod2 and Nalp3 receptors, new potential 
targets in treatment of allergic rhinitis? Allergy 65, 1222-1226. 
Boldrick, J.C., Alizadeh, A.A., Diehn, M., Dudoit, S., Liu, C.L., Belcher, C.E., 
Botstein, D., Staudt, L.M., Brown, P.O., Relman, D.A., 2002. Stereotyped and 
specific gene expression programs in human innate immune responses to bacteria. 
Proc. Natl. Acad. Sci. USA 99, 972-977. 
Borges, A.M., Healey, G.D., Sheldon, I.M., 2012. Explants of intact endometrium to 
model bovine innate immunity and inflammation ex vivo. Am. J Reprod. Immunol 
67, 526-539. 
Bortoluci, K.R., Medzhitov, R., 2010. Control of infection by pyroptosis and 
autophagy: role of TLR and NLR. Cell Mol. Life Sci 67, 1643-1651. 
Bradley, J.R., 2008. TNF-mediated inflammatory disease. J Pathol 214, 149-160. 
Brown, J., 1999. Immune regulation of Chlamydia psittaci persistence in sheep. Ph.D 
thesis, University of Edinburgh. 
Broz, P., Monack, D.M., 2013. Newly described pattern recognition receptors team 
up against intracellular pathogens. Nat. Rev. Immunol 13, 551-565. 
Brunham, R.C., Rappuoli, R., 2013. Chlamydia trachomatis control requires a 
vaccine. Vaccine 31, 1892-1897.  
Brunham, R.C., Rey-Ladino, J., 2005. Immunology of Chlamydia infection: 
implications for a Chlamydia trachomatis vaccine. Nat. Rev. Immunol 5, 149-161. 
Buchholz, K.R., Stephens, R.S., 2006. Activation of the host cell proinflammatory 
interleukin-8 response by Chlamydia trachomatis. Cell Microbiol 8, 1768-1779. 
Buchholz, K.R., Stephens, R.S., 2008. The cytosolic pattern recognition receptor 
NOD1 induces inflammatory interleukin-8 during Chlamydia trachomatis infection. 
Infect. Immun. 76, 3150-3155. 
Buckner, L. R., Lewis, M. E., Greene, S. J., Foster, T. P. & Quayle, A. J., 2013. 
Chlamydia trachomatis infection results in a modest pro-inflammatory cytokine 
response and a decrease in T cell chemokine secretion in human polarized 
endocervical epithelial cells. Cytokine 63, 151-65. 
Budhia, S., Haring, L.F., McConnell, I., Blacklaws, B.A., 2006. Quantitation of 
ovine cytokine mRNA by real-time RT-PCR. J Immunol Methods 309, 160-172. 
Bulut, Y., Shimada, K., Wong, M.H., Chen, S., Gray, P., Alsabeh, R., Doherty, T.M., 
Crother, T.R., Arditi, M., 2009. Chlamydial heat shock protein 60 induces acute 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  217 
pulmonary inflammation in mice via the Toll-like receptor 4- and MyD88-dependent 
pathway. Infect. Immun. 77, 2683-2690. 
Burton, M.J., Rajak, S.N., Bauer, J., Weiss, H.A., Tolbert, S.B., Shoo, A., Habtamu, 
E., Manjurano, A., Emerson, P.M., Mabey, D.C., Holland, M.J., Bailey, R.L., 2011. 
Conjunctival transcriptome in scarring trachoma. Infect. Immun. 79, 499-511. 
Butler, M., Morel, A.S., Jordan, W.J., Eren, E., Hue, S., Shrimpton, R.E., Ritter, 
M.A., 2007. Altered expression and endocytic function of CD205 in human dendritic 
cells, and detection of a CD205-DCL-1 fusion protein upon dendritic cell maturation. 
Immunology 120, 362-371. 
Buxton, D., Anderson, I.E., Longbottom, D., Livingstone, M., Wattegedera, S., 
Entrican, G., 2002. Ovine chlamydial abortion: characterization of the inflammatory 
immune response in placental tissues. J Comp Pathol 127, 133-141. 
Buxton, D., Barlow, R.M., Finlayson, J., Anderson, I.E., Mackellar, A., 1990. 
Observations on the pathogenesis of Chlamydia psittaci infection of pregnant sheep. 
J Comp Pathol 102, 221-237. 
Buzoni-Gatel, D., Guilloteau, L., Bernard, F., Bernard, S., Chardes, T., Rocca, A., 
1992. Protection against Chlamydia psittaci in mice conferred by Lyt-2+ T cells. 
Immunology 77, 284-288. 
Byrne, G.I., 1976. Requirements for ingestion of Chlamydia psittaci by mouse 
fibroblasts (L cells). Infect. Immun. 14, 645-651. 
Byrne, G.I., Moulder, J.W., 1978. Parasite-specified phagocytosis of Chlamydia 
psittaci and Chlamydia trachomatis by L and HeLa cells. Infect. Immun. 19, 598-
606. 
Cain, T.K., Rank, R.G., 1995. Local Th1-like responses are induced by intravaginal 
infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. 
Infect. Immun. 63, 1784-1789. 
Carlin, J.M., Borden, E.C., Byrne, G.I., 1989. Interferon-induced indoleamine 2,3-
dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages. 
J Interferon Res 9, 329-337. 
Caro, M.R., Buendia, A.J., Del, R.L., Ortega, N., Gallego, M.C., Cuello, F., Navarro, 
J.A., Sanchez, J., Salinas, J., 2009. Chlamydophila abortus infection in the mouse: a 
useful model of the ovine disease. Vet Microbiol 135, 103-111. 
Carrasco, C.P., Rigden, R.C., Schaffner, R., Gerber, H., Neuhaus, V., Inumaru, S., 
Takamatsu, H., Bertoni, G., McCullough, K.C., Summerfield, A., 2001. Porcine 
dendritic cells generated in vitro: morphological, phenotypic and functional 
properties. Immunology 104, 175-184. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  218 
Casey, M.E., Meade, K.G., Nalpas, N.C., Taraktsoglou, M., Browne, J.A., Killick, 
K.E., Park, S.D., Gormley, E., Hokamp, K., Magee, D.A., MacHugh, D.E., 2015. 
Analysis of the Bovine Monocyte-Derived Macrophage Response to Mycobacterium 
avium Subspecies Paratuberculosis Infection Using RNA-seq. Front Immunol 6, 23. 
Caswell, J.L., Middleton, D.M., Sorden, S.D., Gordon, J.R., 1998. Expression of the 
neutrophil chemoattractant interleukin-8 in the lesions of bovine pneumonic 
pasteurellosis. Vet Pathol 35, 124-131. 
Chalmers, W.S., Simpson, J., Lee, S.J., Baxendale, W., 1997. Use of a live 
chlamydial vaccine to prevent ovine enzootic abortion. Vet Rec. 141, 63-67. 
Chan, S.S., McConnell, I., Blacklaws, B.A., 2002. Generation and characterization of 
ovine dendritic cells derived from peripheral blood monocytes. Immunology 107, 
366-372. 
Chaussabel, D., Semnani, R.T., McDowell, M.A., Sacks, D., Sher, A., Nutman, T.B., 
2003. Unique gene expression profiles of human macrophages and dendritic cells to 
phylogenetically distinct parasites. Blood 102, 672-681. 
Chen, J., Zhang, H., Zhou, Z., Yang, Z., Ding, Y., Zhou, Z., Zhong, E., 
Arulanandam, B., Baseman, J., Zhong, G., 2014. Chlamydial induction of 
hydrosalpinx in 11 strains of mice reveals multiple host mechanisms for preventing 
upper genital tract pathology. PLoS One 9, e95076. 
Chen, L., Lei, L., Chang, X., Li, Z., Lu, C., Zhang, X., Wu, Y., Yeh, I.T., Zhong, G., 
2010. Mice deficient in MyD88 Develop a Th2-dominant response and severe 
pathology in the upper genital tract following Chlamydia muridarum infection. J 
Immunol 184, 2602-2610. 
Chen, L., Lei, L., Zhou, Z., He, J., Xu, S., Lu, C., Chen, J., Yang, Z., Wu, G., Yeh, 
I.T., Zhong, G., Wu, Y., 2013a. Contribution of interleukin-12 p35 (IL-12p35) and 
IL-12p40 to protective immunity and pathology in mice infected with Chlamydia 
muridarum. Infect. Immun. 81, 2962-2971. 
Chen, X., Threlkeld, S.W., Cummings, E.E., Sadowska, G.B., Lim, Y.P., Padbury, 
J.F., Sharma, S., Stonestreet, B.S., 2013b. In-vitro validation of cytokine neutralizing 
antibodies by testing with ovine mononuclear splenocytes. J Comp Pathol 148, 252-
258. 
Cheng, W., Shivshankar, P., Li, Z., Chen, L., Yeh, I.T., Zhong, G., 2008. Caspase-1 
contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory 
pathologies without affecting the course of infection. Infect. Immun. 76, 515-522. 
Chiliveru, S., Birkelund, S., Paludan, S.R., 2010. Induction of interferon-stimulated 
genes by Chlamydia pneumoniae in fibroblasts is mediated by intracellular 
nucleotide-sensing receptors. PLoS One 5, e10005. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  219 
Chow, A., Brown, B.D., Merad, M., 2011. Studying the mononuclear phagocyte 
system in the molecular age. Nat. Rev. Immunol 11, 788-798. 
Clarke, I.N., 2011. Evolution of Chlamydia trachomatis. Ann. N. Y Acad. Sci 1230, 
E11-E18. 
Coers, J., Starnbach, M.N., Howard, J.C., 2009. Modeling infectious disease in mice: 
co-adaptation and the role of host-specific IFNgamma responses. PLoS Pathog. 5, 
e1000333. 
Cogswell, J.P., Godlevski, M.M., Wisely, G.B., Clay, W.C., Leesnitzer, L.M., Ways, 
J.P., Gray, J.G., 1994. NF-kappa B regulates IL-1 beta transcription through a 
consensus NF-kappa B binding site and a nonconsensus CRE-like site. J Immunol 
153, 712-723. 
Conway, D.J., Holland, M.J., Bailey, R.L., Campbell, A.E., Mahdi, O.S., Jennings, 
R., Mbena, E., Mabey, D.C., 1997. Scarring trachoma is associated with 
polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and 
with elevated TNF-alpha levels in tear fluid. Infect. Immun. 65, 1003-1006. 
Coombes, B.K., Mahony, J.B., 2001. cDNA array analysis of altered gene expression 
in human endothelial cells in response to Chlamydia pneumoniae infection. Infect. 
Immun. 69, 1420-1427. 
Corripio-Miyar, Y., Hope, J., McInnes, C.J., Wattegedera, S., Jensen, K., Pang, Y., 
Entrican, G., Glass, E.J., 2015. Phenotypic and functional analysis of monocyte 
populations in cattle peripheral blood identifies a subset with high endocytic and 
allogenic T-cell stimulatory capacity. Vet Res. In press. 
Cotter, T.W., Ramsey, K.H., Miranpuri, G.S., Poulsen, C.E., Byrne, G.I., 1997. 
Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma 
interferon gene knockout mice. Infect. Immun. 65, 2145-2152. 
Da Costa, C.U., Wantia, N., Kirschning, C.J., Busch, D.H., Rodriguez, N., Wagner, 
H., Miethke, T., 2004. Heat shock protein 60 from Chlamydia pneumoniae elicits an 
unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo. Eur. J 
Immunol 34, 2874-2884. 
Darville, T., Andrews, C.W., Jr., Rank, R.G., 2000. Does inhibition of tumor 
necrosis factor alpha affect chlamydial genital tract infection in mice and guinea 
pigs? Infect. Immun. 68, 5299-5305. 
Darville, T., Hiltke, T.J., 2010. Pathogenesis of genital tract disease due to 
Chlamydia trachomatis. J Infect. Dis 201 Suppl 2, S114-S125. 
Darville, T., O'Neill, J.M., Andrews, C.W., Jr., Nagarajan, U.M., Stahl, L., Ojcius, 
D.M., 2003. Toll-like receptor-2, but not Toll-like receptor-4, is essential for 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  220 
development of oviduct pathology in chlamydial genital tract infection. J Immunol 
171, 6187-6197. 
Datta, B., Njau, F., Thalmann, J., Haller, H., Wagner, A.D., 2014. Differential 
infection outcome of Chlamydia trachomatis in human blood monocytes and 
monocyte-derived dendritic cells. BMC Microbiol 14, 209. 
Dautry-Varsat, A., Subtil, A., Hackstadt, T., 2005. Recent insights into the 
mechanisms of Chlamydia entry. Cell Microbiol 7, 1714-1722. 
Decker, T., Muller, M., Stockinger, S., 2005. The yin and yang of type I interferon 
activity in bacterial infection. Nat. Rev. Immunol 5, 675-687. 
Den Hartog, J.E., Ouburg, S., Land, J.A., Lyons, J.M., Ito, J.I., Pena, A.S., Morre, 
S.A., 2006. Do host genetic traits in the bacterial sensing system play a role in the 
development of Chlamydia trachomatis-associated tubal pathology in subfertile 
women? BMC Infect. Dis 6, 122. 
Derbigny, W.A., Shobe, L.R., Kamran, J.C., Toomey, K.S., Ofner, S., 2012. 
Identifying a Role for Toll-Like Receptor 3 in the Innate Immune Response to 
Chlamydia muridarum Infection in Murine Oviduct Epithelial Cells. Infect. Immun. 
80, 254-265. 
Devaraj, S., Dasu, M.R., Rockwood, J., Winter, W., Griffen, S.C., Jialal, I., 2008. 
Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from 
patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin. 
Endocrinol. Metab 93, 578-583. 
Dong, C., Zhao, G., Zhong, M., Yue, Y., Wu, L., Xiong, S., 2013. RNA sequencing 
and transcriptomal analysis of human monocyte to macrophage differentiation. Gene 
519, 279-287. 
Dorr, C., Wu, B., Guan, W., Muthusamy, A., Sanghavi, K., Schladt, D.P., Maltzman, 
J.S., Scherer, S.E., Brott, M.J., Matas, A.J., Jacobson, P.A., Oetting, W.S., Israni, 
A.K., 2015. Differentially expressed gene transcripts using RNA sequencing from 
the blood of immunosuppressed kidney allograft recipients. PLoS One 10, e0125045. 
Doull, L., Wattegedera, S.R., Longbottom, D., Mwangi, D., Nath, M., Glass, E.J., 
Entrican, G., 2015. Late production of CXCL8 in ruminant oro-nasal turbinate cells 
in response to Chlamydia abortus infection. Vet Immunol Immunopathol. In press, 
corrected proof. doi:10.1016/j.vetimm.2015.08.011 
Drevets, D.A., Schawang, J.E., Mandava, V.K., Dillon, M.J., Leenen, P.J., 2010. 
Severe Listeria monocytogenes infection induces development of monocytes with 
distinct phenotypic and functional features. J Immunol 185, 2432-2441. 
Durchdewald, M., Angel, P., Hess, J., 2009. The transcription factor Fos: a Janus-
type regulator in health and disease. Histol. Histopathol. 24, 1451-1461. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  221 
Dykxhoorn, D.M., Lieberman, J., 2005. The silent revolution: RNA interference as 
basic biology, research tool, and therapeutic. Annu. Rev. Med 56, 401-423. 
Dykxhoorn, D.M., Palliser, D., Lieberman, J., 2006. The silent treatment: siRNAs as 
small molecule drugs. Gene Ther. 13, 541-552. 
Eckmann, L., Kagnoff, M.F., Fierer, J., 1993. Epithelial cells secrete the chemokine 
interleukin-8 in response to bacterial entry. Infect. Immun. 61, 4569-4574. 
Eddy, R.G., Martin, W.B., 1986. Pregnant women and Chlamydia infection. 
Veterinary Record 118, 519. 
Eissenberg, L.G., Wyrick, P.B., 1981. Inhibition of phagolysosome fusion is 
localized to Chlamydia psittaci-laden vacuoles. Infect. Immun. 32, 889-896. 
Eitel, J., Meixenberger, K., van, L.C., Orlovski, C., Hocke, A., Schmeck, B., 
Hippenstiel, S., N'Guessan, P.D., Suttorp, N., Opitz, B., 2012. Rac1 regulates the 
NLRP3 inflammasome which mediates IL-1beta production in Chlamydophila 
pneumoniae infected human mononuclear cells. PLoS One 7, e30379. 
Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., Tuschl, T., 2001. 
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian 
cells. Nature 411, 494-498. 
Elkord, E., Williams, P.E., Kynaston, H., Rowbottom, A.W., 2005. Human monocyte 
isolation methods influence cytokine production from in vitro generated dendritic 
cells. Immunology 114, 204-212. 
Ellis, J.A., Davis, W.C., MacHugh, N.D., Emery, D.L., Kaushal, A., Morrison, W.I., 
1988. Differentiation antigens on bovine mononuclear phagocytes identified by 
monoclonal antibodies. Vet Immunol Immunopathol 19, 325-340. 
Engstrom, P., Bergstrom, M., Alfaro, A.C., Syam, K.K., Bahnan, W., Almqvist, F., 
Bergstrom, S., 2015. Expansion of the Chlamydia trachomatis inclusion does not 
require bacterial replication. Int J Med Microbiol 305, 378-382. 
Entrican, G., Brown, J., Graham, S., 1998. Cytokines and the protective host immune 
response to Chlamydia psittaci. Comp Immunol Microbiol Infect. Dis 21, 15-26. 
Entrican, G., Buxton, D., Longbottom, D., 2001. Chlamydial infection in sheep: 
immune control versus fetal pathology. J R. Soc. Med 94, 273-277. 
Entrican, G., Lunney, J.K., 2012. Veterinary Immunology Committee Toolkit 
Workshop 2010: progress and plans. Vet Immunol Immunopathol 148, 197-201. 
Entrican, G., Lunney, J.K., Rutten, V.P., Baldwin, C.L., 2009. A current perspective 
on availability of tools, resources and networks for veterinary immunology. Vet 
Immunol Immunopathol 128, 24-29. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  222 
Entrican, G., Wattegedera, S., Rocchi, M., Fleming, D.C., Kelly, R.W., Wathne, G., 
Magdalenic, V., Howie, S.E., 2004. Induction of inflammatory host immune 
responses by organisms belonging to the genera Chlamydia/Chlamydophila. Vet 
Immunol Immunopathol 100, 179-186. 
Entrican, G., Wattegedera, S., Wheelhouse, N., Allan, A., Rocchi, M., 2010. 
Immunological paradigms and the pathogenesis of ovine chlamydial abortion. Am. J 
Reprod. Immunol 64, 287-294. 
Entrican, G., Wheelhouse, N., Wattegedera, S.R., Longbottom, D., 2012. New 
challenges for vaccination to prevent chlamydial abortion in sheep. Comp Immunol 
Microbiol Infect. Dis 35, 271-276. 
Entrican, G., Wilkie, R., McWaters, P., Scheerlinck, J., Wood, P.R., Brown, J., 1999. 
Cytokine release by ovine macrophages following infection with Chlamydia psittaci. 
Clin. Exp Immunol 117, 309-315. 
            Erbel, C., Akhavanpoor, M., Okuyucu, D., Wangler, S., Dietz, A., Zhao, L., Stellos, 
K., Little, K.M., Lasitschka, F., Doesch, A., Hakimi, M., Dengler, T.J., Giese, T., 
Blessing, E., Katus, H.A., Gleissner, C.A., 2014. IL-17A influences essential 
functions of the monocyte/macrophage lineage and is involved in advanced murine 
and human atherosclerosis. J Immunol 193, 4344-4355. 
Essig, A., Longbottom, D., 2015. Chlamydia abortus: New Aspects of Infectious 
Abortion in Sheep and Potential Risk for Pregnant Women. Current Clinical 
Microbiology Reports 2, 22-34. 
Everett, K.D., Bush, R.M., Andersen, A.A., 1999. Emended description of the order 
Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. 
nov., each containing one monotypic genus, revised taxonomy of the family 
Chlamydiaceae, including a new genus and five new species, and standards for the 
identification of organisms. Int J Syst Bacteriol. 49 Pt 2, 415-440. 
Fahel, J.S., de Souza, M.B., Gomes, M.T., Corsetti, P.P., Carvalho, N.B., Marinho, 
F.A., de Almeida, L.A., Caliari, M.V., Machado, F.S., Oliveira, S.C., 2015. 5-
Lipoxygenase negatively regulates Th1 response during Brucella abortus infection in 
mice. Infect. Immun. 83, 1210-1216. 
Fang, Z., Cui, X., 2011. Design and validation issues in RNA-seq experiments. Brief. 
Bioinform. 12, 280-287. 
Fehlner-Gardiner, C., Roshick, C., Carlson, J.H., Hughes, S., Belland, R.J., Caldwell, 
H.D., McClarty, G., 2002. Molecular basis defining human Chlamydia trachomatis 
tissue tropism. A possible role for tryptophan synthase. J Biol Chem. 277, 26893-
26903. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  223 
Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E., Mello, C.C., 1998. 
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis 
elegans. Nature 391, 806-811. 
Flego, D., Bianco, M., Quattrini, A., Mancini, F., Carollo, M., Schiavoni, I., Ciervo, 
A., Ausiello, C.M., Fedele, G., 2013. Chlamydia pneumoniae modulates human 
monocyte-derived dendritic cells functions driving the induction of a Type 1/Type 17 
inflammatory response. Microbes Infect. 15, 105-114. 
Forsbach-Birk, V., Foddis, C., Simnacher, U., Wilkat, M., Longbottom, D., Walder, 
G., Benesch, C., Ganter, M., Sachse, K., Essig, A., 2013. Profiling antibody 
responses to infections by Chlamydia abortus enables identification of potential 
virulence factors and candidates for serodiagnosis. PLoS One 8, e80310. 
Franchi, L., Munoz-Planillo, R., Nunez, G., 2012. Sensing and reacting to microbes 
through the inflammasomes. Nat. Immunol 13, 325-332. 
Frazer, L.C., O'Connell, C.M., Andrews, C.W., Jr., Zurenski, M.A., Darville, T., 
2011. Enhanced neutrophil longevity and recruitment contribute to the severity of 
oviduct pathology during Chlamydia muridarum infection. Infect. Immun. 79, 4029-
4041. 
Galvao, K.N., Felippe, M.J., Brittin, S.B., Sper, R., Fraga, M., Galvao, J.S., Caixeta, 
L., Guard, C.L., Ricci, A., Gilbert, R.O., 2012. Evaluation of cytokine expression by 
blood monocytes of lactating Holstein cows with or without postpartum uterine 
disease. Theriogenology 77, 356-372. 
Gaydos, C.A., Summersgill, J.T., Sahney, N.N., Ramirez, J.A., Quinn, T.C., 1996. 
Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial 
cells, and aortic artery smooth muscle cells. Infect. Immun. 64, 1614-1620. 
Geisler, W.M., Lensing, S.Y., Press, C.G., Hook, E.W., III, 2013. Spontaneous 
resolution of genital Chlamydia trachomatis infection in women and protection from 
reinfection. J Infect. Dis 207, 1850-1856. 
Geissmann, F., Gordon, S., Hume, D.A., Mowat, A.M., Randolph, G.J., 2010. 
Unravelling mononuclear phagocyte heterogeneity. Nat. Rev. Immunol 10, 453-460. 
Gerard, H.C., Mishra, M.K., Mao, G., Wang, S., Hali, M., Whittum-Hudson, J.A., 
Kannan, R.M., Hudson, A.P., 2013. Dendrimer-enabled DNA delivery and 
transformation of Chlamydia pneumoniae. Nanomedicine. 9, 996-1008. 
Gervassi, A., Alderson, M.R., Suchland, R., Maisonneuve, J.F., Grabstein, K.H., 
Probst, P., 2004. Differential regulation of inflammatory cytokine secretion by 
human dendritic cells upon Chlamydia trachomatis infection. Infect. Immun. 72, 
7231-7239. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  224 
Gieffers, J., van, Z.G., Rupp, J., Sayk, F., Kruger, S., Ehlers, S., Solbach, W., Maass, 
M., 2004. Phagocytes transmit Chlamydia pneumoniae from the lungs to the 
vasculature. Eur. Respir. J 23, 506-510. 
Ginhoux, F., Jung, S., 2014. Monocytes and macrophages: developmental pathways 
and tissue homeostasis. Nat. Rev. Immunol 14, 392-404. 
Giuliani, A., Tentori, L., Pepponi, R., Porcelli, S.A., Aquino, A., Orlando, L., Sugita, 
M., Brenner, M.B., Bonmassar, E., Graziani, G., 1997. Cytokine-induced expression 
of CD1b molecules by peripheral blood monocytes: influence of 3'-azido-3'-
deoxythymidine. Pharmacol. Res 35, 135-140. 
Gliddon, D.R., Hope, J.C., Brooke, G.P., Howard, C.J., 2004. DEC-205 expression 
on migrating dendritic cells in afferent lymph. Immunology 111, 262-272. 
Gondek, D.C., Olive, A.J., Stary, G., Starnbach, M.N., 2012. CD4+ T cells are 
necessary and sufficient to confer protection against Chlamydia trachomatis 
infection in the murine upper genital tract. J Immunol 189, 2441-2449. 
Graham, S.P., Jones, G.E., MacLean, M., Livingstone, M., Entrican, G., 1995. 
Recombinant ovine interferon gamma inhibits the multiplication of Chlamydia 
psittaci in ovine cells. J Comp Pathol 112, 185-195. 
Greub, G., 2010. International Committee on Systematics of Prokaryotes. 
Subcommittee on the taxonomy of the Chlamydiae: minutes of the closed meeting, 
21 June 2010, Hof bei Salzburg, Austria. Int J Syst Evol Microbiol 60, 2694. 
Guarda, G., Zenger, M., Yazdi, A.S., Schroder, K., Ferrero, I., Menu, P., Tardivel, 
A., Mattmann, C., Tschopp, J., 2011. Differential expression of NLRP3 among 
hematopoietic cells. J Immunol 186, 2529-2534. 
Guilliams, M., Ginhoux, F., Jakubzick, C., Naik, S.H., Onai, N., Schraml, B.U., 
Segura, E., Tussiwand, R., Yona, S., 2014. Dendritic cells, monocytes and 
macrophages: a unified nomenclature based on ontogeny. Nat. Rev. Immunol 14, 
571-578. 
Guilliams, M., Malissen, B., 2015. A Death Notice for In-Vitro-Generated GM-CSF 
Dendritic Cells? Immunity. 42, 988-990. 
Gupta, R.S., Griffiths, E., 2006. Chlamydiae-specific proteins and indels: novel tools 
for studies. Trends Microbiol 14, 527-535. 
Gutierrez, J., Williams, E.J., O'Donovan, J., Brady, C., Proctor, A.F., Marques, P.X., 
Worrall, S., Nally, J.E., McElroy, M., Bassett, H.F., Sammin, D.J., Markey, B.K., 
2011. Monitoring clinical outcomes, pathological changes and shedding of 
Chlamydophila abortus following experimental challenge of periparturient ewes 
utilizing the natural route of infection. Vet Microbiol 147, 119-126. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  225 
Hall, G.A., Sopp, P., Howard, C.J., 1993. An investigation of temporary workshop 
clusters reacting with cells of the mononuclear phagocytic system. Vet Immunol 
Immunopathol 39, 225-236. 
Haniffa, M., Bigley, V., Collin, M., 2015. Human mononuclear phagocyte system 
reunited. Semin. Cell Dev. Biol. 41, 59-69. 
Haniffa, M., Shin, A., Bigley, V., McGovern, N., Teo, P., See, P., Wasan, P.S., 
Wang, X.N., Malinarich, F., Malleret, B., Larbi, A., Tan, P., Zhao, H., Poidinger, M., 
Pagan, S., Cookson, S., Dickinson, R., Dimmick, I., Jarrett, R.F., Renia, L., Tam, J., 
Song, C., Connolly, J., Chan, J.K., Gehring, A., Bertoletti, A., Collin, M., Ginhoux, 
F., 2012. Human tissues contain CD141hi cross-presenting dendritic cells with 
functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity. 37, 
60-73. 
He, X., Mekasha, S., Mavrogiorgos, N., Fitzgerald, K.A., Lien, E., Ingalls, R.R., 
2010. Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated 
by IL-1 and the NLRP3/ASC inflammasome. J Immunol 184, 5743-5754. 
Hedges, S.B., Dudley, J., Kumar, S., 2006. TimeTree: a public knowledge-base of 
divergence times among organisms. Bioinformatics. 22, 2971-2972. 
Helft, J., Bottcher, J., Chakravarty, P., Zelenay, S., Huotari, J., Schraml, B.U., 
Goubau, D., Reis E Sousa, 2015. GM-CSF Mouse Bone Marrow Cultures Comprise 
a Heterogeneous Population of CD11c(+)MHCII(+) Macrophages and Dendritic 
Cells. Immunity. 42, 1197-1211. 
Heng, T.S., Painter, M.W., 2008. The Immunological Genome Project: networks of 
gene expression in immune cells. Nat. Immunol 9, 1091-1094. 
Henry, T., Brotcke, A., Weiss, D.S., Thompson, L.J., Monack, D.M., 2007. Type I 
interferon signaling is required for activation of the inflammasome during 
Francisella infection. J Exp Med 204, 987-994. 
Hess, S., Peters, J., Bartling, G., Rheinheimer, C., Hegde, P., Magid-Slav, M., Tal-
Singer, R., Klos, A., 2003. More than just innate immunity: comparative analysis of 
Chlamydophila pneumoniae and Chlamydia trachomatis effects on host-cell gene 
regulation. Cell Microbiol 5, 785-795. 
Holland, M. J., Faal, N., Sarr, I., Joof, H., Laye M, Cameron E, Pemberton-Pigott F, 
Dockrell, H.M., Bailey RL, Mabey, D.C., 2006 .The frequency of Chlamydia 
trachomatis major outer membrane protein-specific CD8+ T lymphocytes in active 
trachoma is associated with current ocular infection. Infect. Immun. 74,1565-72. 
Hook, C.E., Telyatnikova, N., Goodall, J.C., Braud, V.M., Carmichael, A.J., Wills, 
M.R., Gaston, J.S., 2004. Effects of Chlamydia trachomatis infection on the 
expression of natural killer (NK) cell ligands and susceptibility to NK cell lysis. Clin. 
Exp Immunol 138, 54-60. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  226 
Horn, M., 2008. Chlamydiae as symbionts in eukaryotes. Annu. Rev. Microbiol 62, 
113-131. 
Hossain, H., Tchatalbachev, S., Chakraborty, T., 2006. Host gene expression 
profiling in pathogen-host interactions. Curr Opin. Immunol 18, 422-429. 
Hotzel, H., Berndt, A., Melzer, F., Sachse, K., 2004. Occurrence of Chlamydiaceae 
spp. in a wild boar (Sus scrofa L.) population in Thuringia (Germany). Vet Microbiol 
103, 121-126. 
Howard, C.J., Naessens, J., 1993. Summary of workshop findings for cattle (tables 1 
and 2). Vet Immunol Immunopathol 39, 25-47. 
Humphrys, M.S., Creasy, T., Sun, Y., Shetty, A.C., Chibucos, M.C., Drabek, E.F., 
Fraser, C.M., Farooq, U., Sengamalay, N., Ott, S., Shou, H., Bavoil, P.M., Mahurkar, 
A., Myers, G.S., 2013. Simultaneous transcriptional profiling of bacteria and their 
host cells. PLoS One 8, e80597. 
Hussen, J., Duvel, A., Koy, M., Schuberth, H.J., 2012. Inflammasome activation in 
bovine monocytes by extracellular ATP does not require the purinergic receptor 
P2X7. Dev. Comp Immunol 38, 312-320. 
Hybiske, K., Stephens, R.S., 2007. Mechanisms of host cell exit by the intracellular 
bacterium Chlamydia. Proc. Natl. Acad. Sci U. S A 104, 11430–11435. 
Igietseme, J. U., Portis, J. L. & Perry, L. L., 2001. Inflammation and clearance of 
Chlamydia trachomatis in enteric and nonenteric mucosae. Infect.Immun. 69, 1832-
1840. 
Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, 
M., Takagi, S., Nomiyama, H., Schall, T.J., Yoshie, O., 1997. Identification and 
molecular characterization of fractalkine receptor CX3CR1, which mediates both 
leukocyte migration and adhesion. Cell 91, 521-530. 
Innes, E.A., Mattsson, J.G., 2007. Neospora caninum emerges from the shadow of 
Toxoplasma gondii. Trends Parasitol 23, 43-44. 
Itoh, R., Murakami, I., Chou, B., Ishii, K., Soejima, T., Suzuki, T., Hiromatsu, K., 
2014. Chlamydia pneumoniae harness host NLRP3 inflammasome-mediated 
caspase-1 activation for optimal intracellular growth in murine macrophages. 
Biochem. Biophys. Res Commun. 452, 689-694. 
Jacquier, N., Frandi, A., Pillonel, T., Viollier, P.H., Greub, G., 2014. Cell wall 
precursors are required to organize the chlamydial division septum. Nat. Commun. 5, 
3578. 
Janeway, C.A., Jr., 1989. Approaching the asymptote? Evolution and revolution in 
immunology. Cold Spring Harb. Symp. Quant. Biol 54 Pt 1, 1-13. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  227 
Jeffrey, B.M., Suchland, R.J., Quinn, K.L., Davidson, J.R., Stamm, W.E., Rockey, 
D.D., 2010. Genome sequencing of recent clinical Chlamydia trachomatis strains 
identifies loci associated with tissue tropism and regions of apparent recombination. 
Infect. Immun. 78, 2544-2553. 
Jendro, M.C., Deutsch, T., Korber, B., Kohler, L., Kuipers, J.G., Krausse-Opatz, B., 
Westermann, J., Raum, E., Zeidler, H., 2000. Infection of human monocyte-derived 
macrophages with Chlamydia trachomatis induces apoptosis of T cells: a potential 
mechanism for persistent infection. Infect. Immun. 68, 6704-6711. 
Jenner, R.G., Young, R.A., 2005. Insights into host responses against pathogens from 
transcriptional profiling. Nat. Rev. Microbiol 3, 281-294. 
Jensen, K., Anderson, J.A., Glass, E.J., 2014. Comparison of small interfering RNA 
(siRNA) delivery into bovine monocyte-derived macrophages by transfection and 
electroporation. Vet Immunol Immunopathol 158, 224-232. 
Jiao, L., Gao, X., Joyee, A.G., Zhao, L., Qiu, H., Yang, M., Fan, Y., Wang, S., Yang, 
X., 2011. NK cells promote type 1 T cell immunity through modulating the function 
of dendritic cells during intracellular bacterial infection. J Immunol 187, 401-411. 
Jimenez-Marin, A., Collado-Romero, M., Ramirez-Boo, M., Arce, C., Garrido, J.J., 
2009. Biological pathway analysis by ArrayUnlock and Ingenuity Pathway Analysis. 
BMC Proc 3, S6. 
Jin, W., Dong, C., 2013. IL-17 cytokines in immunity and inflammation. Emerg 
Microbes Infect 2, e60. 
Johansson, M., Schon, K., Ward, M., Lycke, N., 1997a. Genital tract infection with 
Chlamydia trachomatis fails to induce protective immunity in gamma interferon 
receptor-deficient mice despite a strong local immunoglobulin A response. Infect. 
Immun. 65, 1032-1044. 
Johansson, M., Schon, K., Ward, M., Lycke, N., 1997b. Studies in knockout mice 
reveal that anti-chlamydial protection requires TH1 cells producing IFN-gamma: is 
this true for humans? Scand. J Immunol 46, 546-552. 
Johnson, F.W., Matheson, B.A., Williams, H., Laing, A.G., Jandial, V., Davidson-
Lamb, R., Halliday, G.J., Hobson, D., Wong, S.Y., Hadley, K.M., ., 1985. Abortion 
due to infection with Chlamydia psittaci in a sheep farmer's wife. Br. Med J (Clin. 
Res Ed) 290, 592-594. 
Jones, G.E., Anderson, I.E., 1988. Chlamydia psittaci: is tonsillar tissue the portal of 
entry in ovine enzootic abortion? Res Vet Sci 44, 260-261. 
Joseph, S.J., Didelot, X., Rothschild, J., de Vries, H.J., Morre, S.A., Read, T.D., 
Dean, D., 2012. Population genomics of Chlamydia trachomatis: insights on drift, 
selection, recombination, and population structure. Mol. Biol Evol 29, 3933-3946. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  228 
Juarez, E., Carranza, C., Hernandez-Sanchez, F., Loyola, E., Escobedo, D., Leon-
Contreras, J.C., Hernandez-Pando, R., Torres, M., Sada, E., 2014. Nucleotide-
oligomerizing domain-1 (NOD1) receptor activation induces pro-inflammatory 
responses and autophagy in human alveolar macrophages. BMC Pulm. Med 14, 152. 
Kalayoglu, M.V., Byrne, G.I., 1998. Induction of macrophage foam cell formation 
by Chlamydia pneumoniae. J Infect. Dis 177, 725-729. 
Kaltenboeck, B., Hehnen, H.R., Vaglenov, A., 2005. Bovine Chlamydophila spp. 
infection: do we underestimate the impact on fertility? Vet Res Commun. 29 Suppl 1, 
1-15. 
Kamalakaran, S., Chaganty, B.K., Gupta, R., Guentzel, M.N., Chambers, J.P., 
Murthy, A.K., Arulanandam, B.P., 2013. Vaginal chlamydial clearance following 
primary or secondary infection in mice occurs independently of TNF-alpha. Front 
Cell Infect. Microbiol 3, 11. 
Kannan, R.M., Gerard, H.C., Mishra, M.K., Mao, G., Wang, S., Hali, M., Whittum-
Hudson, J.A., Hudson, A.P., 2013. Dendrimer-enabled transformation of Chlamydia 
trachomatis. Microb. Pathog. 65, 29-35. 
Kanneganti, T.D., Ozoren, N., Body-Malapel, M., Amer, A., Park, J.H., Franchi, L., 
Whitfield, J., Barchet, W., Colonna, M., Vandenabeele, P., Bertin, J., Coyle, A., 
Grant, E.P., Akira, S., Nunez, G., 2006. Bacterial RNA and small antiviral 
compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440, 233-236. 
Kaparakis-Liaskos, M., 2015. The intracellular location, mechanisms and outcomes 
of NOD1 signaling. Cytokine 74, 207-212. 
Kari, L., Whitmire, W.M., Olivares-Zavaleta, N., Goheen, M.M., Taylor, L.D., 
Carlson, J.H., Sturdevant, G.L., Lu, C., Bakios, L.E., Randall, L.B., Parnell, M.J., 
Zhong, G., Caldwell, H.D., 2011. A live-attenuated chlamydial vaccine protects 
against trachoma in nonhuman primates. J Exp Med 208, 2217-2223. 
Kari, L., Goheen , M. M., Randall, L. B., Taylor, L. D., Carlson, J. H., Whitmire, W. 
M., Virok, D., Rajaram, K., Endresz, V., Mcclarty, G., Nelson, D. E. & Caldwell, H. 
D. 2011. Generation of targeted Chlamydia trachomatis null mutants. Proc. Natl. 
Acad. Sci U. S A 108, 7189-7193. 
Kato, A., Schleimer, R.P., 2007. Beyond inflammation: airway epithelial cells are at 
the interface of innate and adaptive immunity. Curr Opin. Immunol 19, 711-720. 
Kato, M., McDonald, K.J., Khan, S., Ross, I.L., Vuckovic, S., Chen, K., Munster, D., 
MacDonald, K.P., Hart, D.N., 2006. Expression of human DEC-205 (CD205) 
multilectin receptor on leukocytes. Int Immunol 18, 857-869. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  229 
Kavathas, P.B., Boeras, C.M., Mulla, M.J., Abrahams, V.M., 2013. Nod1, but not the 
ASC inflammasome, contributes to induction of IL-1beta secretion in human 
trophoblasts after sensing of Chlamydia trachomatis. Mucosal. Immunol 6, 235-243. 
Kawai, T., Akira, S., 2011. Toll-like receptors and their crosstalk with other innate 
receptors in infection and immunity. Immunity. 34, 637-650. 
Kayagaki, N., Warming, S., Lamkanfi, M., Vandewalle, L., Louie, S., Dong, J., 
Newton, K., Qu, Y., Liu, J., Heldens, S., Zhang, J., Lee, W.P., Roose-Girma, M., 
Dixit, V, M., 2011. Non-canonical inflammasome activation targets caspase-11. 
Nature. 479, 117-121. 
Kerr, K., Entrican, G., McKeever, D., Longbottom, D., 2005. Immunopathology of 
Chlamydophila abortus infection in sheep and mice. Res Vet Sci 78, 1-7. 
Kersse, K., Bertrand, M.J., Lamkanfi, M., Vandenabeele, P., 2011. NOD-like 
receptors and the innate immune system: coping with danger, damage and death. 
Cytokine Growth Factor Rev. 22, 257-276. 
Kim, C.C., Lanier, L.L., 2013. Beyond the transcriptome: completion of act one of 
the Immunological Genome Project. Curr Opin. Immunol 25, 593-597. 
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., Salzberg, S.L., 2013. 
TopHat2: accurate alignment of transcriptomes in the presence of insertions, 
deletions and gene fusions. Genome Biol 14, R36. 
Kim, K., Zakharkin, S.O., Allison, D.B., 2010. Expectations, validity, and reality in 
gene expression profiling. J Clin. Epidemiol. 63, 950-959. 
Knittler, M.R., Berndt, A., Bocker, S., Dutow, P., Hanel, F., Heuer, D., Kagebein, D., 
Klos, A., Koch, S., Liebler-Tenorio, E., Ostermann, C., Reinhold, P., Saluz, H.P., 
Schofl, G., Sehnert, P., Sachse, K., 2014. Chlamydia psittaci: New insights into 
genomic diversity, clinical pathology, host-pathogen interaction and anti-bacterial 
immunity. Int J Med Microbiol 304, 877-893. 
Kumar, H., Kawai, T., Akira, S., 2011. Pathogen recognition by the innate immune 
system. Int Rev. Immunol 30, 16-34. 
Kweon, M.N., 2014. Recent progress in mucosal immunology and vaccine 
development. Exp Mol. Med 46, e86. 
Laroucau, K., Vorimore, F., Sachse, K., Vretou, E., Siarkou, V.I., Willems, H., 
Magnino, S., Rodolakis, A., Bavoil, P.M., 2010. Differential identification of 
Chlamydophila abortus live vaccine strain 1B and C. abortus field isolates by PCR-
RFLP. Vaccine 28, 5653-5656. 
Latz, E., Xiao, T.S., Stutz, A., 2013. Activation and regulation of the 
inflammasomes. Nat. Rev. Immunol 13, 397-411. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  230 
Lauener, R.P., Goyert, S.M., Geha, R.S., Vercelli, D., 1990. Interleukin 4 down-
regulates the expression of CD14 in normal human monocytes. Eur. J Immunol 20, 
2375-2381. 
Le, H.T., Harton, J.A., 2013. Pyrin- and CARD-only Proteins as Regulators of NLR 
Functions. Front Immunol 4, 275. 
Leutenegger, C.M., Alluwaimi, A.M., Smith, W.L., Perani, L., Cullor, J.S., 2000. 
Quantitation of bovine cytokine mRNA in milk cells of healthy cattle by real-time 
TaqMan polymerase chain reaction. Vet Immunol Immunopathol 77, 275-287. 
Li, W., Murthy, A.K., Guentzel, M.N., Seshu, J., Forsthuber, T.G., Zhong, G., 
Arulanandam, B.P., 2008. Antigen-specific CD4+ T cells produce sufficient IFN-
gamma to mediate robust protective immunity against genital Chlamydia muridarum 
infection. J Immunol 180, 3375-3382. 
Liechti, G.W., Kuru, E., Hall, E., Kalinda, A., Brun, Y.V., VanNieuwenhze, M., 
Maurelli, A.T., 2014. A new metabolic cell-wall labelling method reveals 
peptidoglycan in Chlamydia trachomatis. Nature 506, 507-510. 
Littlejohn, A.I., 1950. Enzootic abortion in ewes; an investigation into the naturally 
occurring disease. Vet Rec. 62, 571-577. 
Liu, S., Lin, L., Jiang, P., Wang, D., Xing, Y., 2011. A comparison of RNA-Seq and 
high-density exon array for detecting differential gene expression between closely 
related species. Nucleic Acids Res 39, 578-588. 
Livi, G.P., Lillquist, J.S., Miles, L.M., Ferrara, A., Sathe, G.M., Simon, P.L., 
Meyers, C.A., Gorman, J.A., Young, P.R., 1991. Secretion of N-glycosylated 
interleukin-1 beta in Saccharomyces cerevisiae using a leader peptide from Candida 
albicans. Effect of N-linked glycosylation on biological activity. J Biol Chem. 266, 
15348-15355. 
Livingstone, M., Aitchison, K., Longbottom, D., 2014. Abortion in flocks vaccinated 
against enzootic abortion. Vet Rec. 174, 613-614. 
Livingstone, M., Entrican, G., Wattegedera, S., Buxton, D., McKendrick, I.J., 
Longbottom, D., 2005. Antibody responses to recombinant protein fragments of the 
major outer membrane protein and polymorphic outer membrane protein POMP90 in 
Chlamydophila abortus-infected pregnant sheep. Clin. Diagn. Lab Immunol 12, 770-
777. 
Livingstone, M., Wheelhouse, N., Maley, S.W., Longbottom, D., 2009. Molecular 
detection of Chlamydophila abortus in post-abortion sheep at oestrus and subsequent 
lambing. Vet Microbiol 135, 134-141. 
Longbottom, D., 2003. Chlamydial vaccine development. J Med Microbiol 52, 537-
540. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  231 
Longbottom, D., Coulter, L.J., 2003. Animal chlamydioses and zoonotic 
implications. J Comp Pathol 128, 217-244. 
Longbottom, D., Entrican, G., Wheelhouse, N., Brough, H., Milne, C., 2013a. 
Evaluation of the impact and control of enzootic abortion of ewes. Vet J 195, 257-
259. 
Longbottom, D., Livingstone, M., 2006. Vaccination against chlamydial infections of 
man and animals. Vet J 171, 263-275. 
Longbottom, D., Livingstone, M., Maley, S., van der Zon, A., Rocchi, M., Wilson, 
K., Wheelhouse, N., Dagleish, M., Aitchison, K., Wattegedera, S., Nath, M., 
Entrican, G., Buxton, D., 2013b. Intranasal infection with Chlamydia abortus 
induces dose-dependent latency and abortion in sheep. PLoS One 8, e57950. 
Longbottom, D., Russell, M., Dunbar, S.M., Jones, G.E., Herring, A.J., 1998. 
Molecular cloning and characterization of the genes coding for the highly 
immunogenic cluster of 90-kilodalton envelope proteins from the Chlamydia psittaci 
subtype that causes abortion in sheep. Infect. Immun. 66, 1317-1324. 
Lopez-Castejon, G., Brough, D., 2011. Understanding the mechanism of IL-1beta 
secretion. Cytokine Growth Factor Rev. 22, 189-195. 
Lu, H., Shen, C., Brunham, R.C., 2000. Chlamydia trachomatis infection of 
epithelial cells induces the activation of caspase-1 and release of mature IL-18. J 
Immunol 165, 1463-1469. 
Mabbott, N.A., Baillie, J.K., Brown, H., Freeman, T.C., Hume, D.A., 2013. An 
expression atlas of human primary cells: inference of gene function from 
coexpression networks. BMC Genomics 14, 632. 
Magee, D.M., Williams, D.M., Smith, J.G., Bleicker, C.A., Grubbs, B.G., Schachter, 
J., Rank, R.G., 1995. Role of CD8 T cells in primary Chlamydia infection. Infect. 
Immun. 63, 516-521. 
Maisonneuve, C., Bertholet, S., Philpott, D.J., De, G.E., 2014. Unleashing the 
potential of NOD- and Toll-like agonists as vaccine adjuvants. Proc. Natl. Acad. Sci 
U. S A 111, 12294-12299. 
Manor, E., Sarov, I., 1986. Fate of Chlamydia trachomatis in human monocytes and 
monocyte-derived macrophages. Infect. Immun. 54, 90-95. 
Mao, C.P., Lin, Y.Y., Hung, C.F., Wu, T.C., 2007. Immunological research using 
RNA interference technology. Immunology 121, 295-307. 
Marfell, B.J., O'Brien, R., Griffin, J.F., 2013. Global gene expression profiling of 
monocyte-derived macrophages from red deer (Cervus elaphus) genotypically 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  232 
resistant or susceptible to Mycobacterium avium subspecies paratuberculosis 
infection. Dev. Comp Immunol 40, 210-217. 
Martinon, F., Burns, K., Tschopp, J., 2002. The inflammasome: a molecular platform 
triggering activation of inflammatory caspases and processing of proIL-beta. Mol. 
Cell 10, 417-426. 
Mascellino, M.T., Boccia, P., Oliva, A., 2011. Immunopathogenesis in Chlamydia 
trachomatis Infected Women. ISRN. Obstet. Gynecol. 2011, 436936. 
Matsuo, J., Nakamura, S., Takeda, S., Ishida, K., Yamazaki, T., Yoshida, M., Chiba, 
H., Hui, S.P., Yamaguchi, H., 2015. Synergistic Costimulatory Effect of Chlamydia 
pneumoniae with Carbon Nanoparticles on NLRP3 Inflammasome-Mediated 
Interleukin-1beta Secretion in Macrophages. Infect. Immun. 83, 2917-2925. 
Matthews, J.N., Altman, D.G., Campbell, M.J., Royston, P., 1990. Analysis of serial 
measurements in medical research. BMJ 300, 230-235. 
Matzinger, P., 2002. The danger model: a renewed sense of self. Science 296, 301-
305. 
Mauel, S., Steinbach, F., Ludwig, H., 2006. Monocyte-derived dendritic cells from 
horses differ from dendritic cells of humans and mice. Immunology 117, 463-473. 
Mayer-Barber, K.D., Barber, D.L., Shenderov, K., White, S.D., Wilson, M.S., 
Cheever, A., Kugler, D., Hieny, S., Caspar, P., Nunez, G., Schlueter, D., Flavell, 
R.A., Sutterwala, F.S., Sher, A., 2010. Caspase-1 independent IL-1beta production is 
critical for host resistance to Mycobacterium tuberculosis and does not require TLR 
signaling in vivo. J Immunol 184, 3326-3330. 
McClure, R., Massari, P., 2014. TLR-Dependent Human Mucosal Epithelial Cell 
Responses to Microbial Pathogens. Front Immunol 5, 386. 
McClurkin, A.W., Pirtle, E.C., Coria, M.F., Smith, R.L., 1974. Comparison of low- 
and high-passage bovine turbinate cells for assay of bovine viral diarrhea virus. Arch 
Gesamte Virusforsch. 45, 285-289. 
McEwen, A.D., STAMP, J.T., Littlejohn, A.I., 1951. Enzootic abortion in ewes. II. 
Immunization and infection experiments. Vet Rec. 63, 197-201. 
McGettigan, P.A., 2013. Transcriptomics in the RNA-seq era. Curr Opin. Chem. Biol 
17, 4-11. 
McGovern, N., Schlitzer, A., Gunawan, M., Jardine, L., Shin, A., Poyner, E., Green, 
K., Dickinson, R., Wang, X.N., Low, D., Best, K., Covins, S., Milne, P., Pagan, S., 
Aljefri, K., Windebank, M., Miranda-Saavedra, D., Larbi, A., Wasan, P.S., Duan, K., 
Poidinger, M., Bigley, V., Ginhoux, F., Collin, M., Haniffa, M., 2014. Human 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  233 
dermal CD14(+) cells are a transient population of monocyte-derived macrophages. 
Immunity. 41, 465-477. 
McKeever, D.J., MacHugh, N.D., Goddeeris, B.M., Awino, E., Morrison, W.I., 
1991. Bovine afferent lymph veiled cells differ from blood monocytes in phenotype 
and accessory function. J Immunol 147, 3703-3709. 
McWaters, P., Hurst, L., Chaplin, P.J., Collins, R.A., Wood, P.R., Scheerlinck, J.P., 
2000. Characterisation of monoclonal antibodies to ovine interleukin-6 and the 
development of a sensitive capture ELISA. Vet Immunol Immunopathol 73, 155-
165. 
Meeusen, E.N., Scheerlinck, J.P., Wattegedera, S., Entrican, G., 2004. Advances in 
mucosal vaccination. Anim Health Res Rev. 5, 209-217. 
Miao, E.A., Rajan, J.V., Aderem, A., 2011. Caspase-1-induced pyroptotic cell death. 
Immunol Rev. 243, 206-214. 
Miller, J.C., Brown, B.D., Shay, T., Gautier, E.L., Jojic, V., Cohain, A., Pandey, G., 
Leboeuf, M., Elpek, K.G., Helft, J., Hashimoto, D., Chow, A., Price, J., Greter, M., 
Bogunovic, M., Bellemare-Pelletier, A., Frenette, P.S., Randolph, G.J., Turley, S.J., 
Merad, M., 2012. Deciphering the transcriptional network of the dendritic cell 
lineage. Nat. Immunol 13, 888-899. 
Miller, M.B., Tang, Y.W., 2009. Basic concepts of microarrays and potential 
applications in clinical microbiology. Clin. Microbiol Rev. 22, 611-633. 
Miller, V.J., McKinnon, C.M., Mellor, H., Stephens, D.J., 2013. RNA interference 
approaches to examine Golgi function in animal cell culture. Methods Cell Biol 118, 
15-34. 
Milne, C.E., Gunn, G.J., Entrican, G., Longbottom, D., 2009. Epidemiological 
modelling of chlamydial abortion in sheep flocks. Vet Microbiol 135, 128-133. 
Mishra, M.K., Gerard, H.C., Whittum-Hudson, J.A., Hudson, A.P., Kannan, R.M., 
2012. Dendrimer-enabled modulation of gene expression in Chlamydia trachomatis. 
Mol. Pharm. 9, 413-421. 
Mitchell, C.M., Hovis, K.M., Bavoil, P.M., Myers, G.S., Carrasco, J.A., Timms, P., 
2010. Comparison of koala LPCoLN and human strains of Chlamydia pneumoniae 
highlights extended genetic diversity in the species. BMC Genomics 11, 442. 
Miyairi, I., Ramsey, K.H., Patton, D.L., 2010. Duration of untreated chlamydial 
genital infection and factors associated with clearance: review of animal studies. J 
Infect. Dis 201 Suppl 2, S96-103. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  234 
Miyari, I., Laxton, J. D., Wang, X., Obert, C. A., Arva Tatireddigari, V. R., Van 
Rooijen, N., Hatch, T. P. & Byrne, G. I. 2011. Chlamydia psittaci genetic variants 
differ in virulence by modulation of host immunity. J Infect Dis 204, 654-63. 
Moazed, T.C., Kuo, C.C., Grayston, J.T., Campbell, L.A., 1998. Evidence of 
systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J 
Infect. Dis 177, 1322-1325. 
Mocellin, S., Provenzano, M., 2004. RNA interference: learning gene knock-down 
from cell physiology. J Transl. Med 2, 39. 
Mock, D.M., Quirk, J.G., and Mock, N.I. 2002. Marginal biotin deficiency during 
normal pregnancy. Am. J. Clin. Nutr. 75, 295–299. 
Molestina, R.E., Miller, R.D., Ramirez, J.A., Summersgill, J.T., 1999. Infection of 
human endothelial cells with Chlamydia pneumoniae stimulates transendothelial 
migration of neutrophils and monocytes. Infect. Immun. 67, 1323-1330. 
Moore, E.R., Ouellette, S.P., 2014. Reconceptualizing the chlamydial inclusion as a 
pathogen-specified parasitic organelle: an expanded role for Inc proteins. Front Cell 
Infect. Microbiol 4, 157. 
Morozova, O., Hirst, M., Marra, M.A., 2009. Applications of new sequencing 
technologies for transcriptome analysis. Annu. Rev. Genomics Hum. Genet. 10, 135-
151. 
Morrison, S.G., Morrison, R.P., 2001. Resolution of secondary Chlamydia 
trachomatis genital tract infection in immune mice with depletion of both CD4+ and 
CD8+ T cells. Infect. Immun. 69, 2643-2649. 
Morrison, S.G., Morrison, R.P., 2005. A predominant role for antibody in acquired 
immunity to chlamydial genital tract reinfection. J Immunol 175, 7536-7542. 
Morrison, S.G., Su, H., Caldwell, H.D., Morrison, R.P., 2000. Immunity to murine 
Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells 
but not CD8(+) T cells. Infect. Immun. 68, 6979-6987. 
Mozzato-Chamay, N., Corbett, E.L., Bailey, R.L., Mabey, D.C., Raynes, J., Conway, 
D.J., 2001. Polymorphisms in the IkappaB alpha promoter region and risk of diseases 
involving inflammation and fibrosis. Genes. Immun.  2, 153-155. 
Mucha, R., Bhide, M.R., Chakurkar, E.B., Novak, M., Mikula, I., Sr., 2009. Toll-like 
receptors TLR1, TLR2 and TLR4 gene mutations and natural resistance to 
Mycobacterium avium subsp. paratuberculosis infection in cattle. Vet Immunol 
Immunopathol 128, 381-388. 
Mueller, M., Postius, S., Thimm, J.G., Gueinzius, K., Muehldorfer, I., Hermann, C., 
2004. Toll-like receptors 2 and 4 do not contribute to clearance of Chlamydophila 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  235 
pneumoniae in mice, but are necessary for the release of monokines. Immunobiology 
209, 599-608. 
Murray, P.J., Wynn, T.A., 2011. Protective and pathogenic functions of macrophage 
subsets. Nat. Rev. Immunol 11, 723-737. 
Murthy, A.K., Li, W., Chaganty, B.K., Kamalakaran, S., Guentzel, M.N., Seshu, J., 
Forsthuber, T.G., Zhong, G., Arulanandam, B.P., 2011. Tumor necrosis factor alpha 
production from CD8+ T cells mediates oviduct pathological sequelae following 
primary genital Chlamydia muridarum infection. Infect. Immun. 79, 2928-2935. 
Muzio, M., Bosisio, D., Polentarutti, N., D'amico, G., Stoppacciaro, A., Mancinelli, 
R., van't Veer, C., Penton-Rol, G., Ruco, L.P., Allavena, P., Mantovani, A., 2000. 
Differential expression and regulation of toll-like receptors (TLR) in human 
leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 164, 5998-
6004. 
Nagarajan, U.M., Prantner, D., Sikes, J.D., Andrews, C.W., Jr., Goodwin, A.M., 
Nagarajan, S., Darville, T., 2008. Type I interferon signaling exacerbates Chlamydia 
muridarum genital infection in a murine model. Infect. Immun. 76, 4642-4648. 
Nagarajan, U.M., Sikes, J.D., Yeruva, L., Prantner, D., 2012. Significant Role of IL-
1 Signaling, but Limited Role of Inflammasome Activation, in Oviduct Pathology 
during Chlamydia muridarum Genital Infection. J Immunol 188, 2866-2875. 
Naiki, Y., Michelsen, K.S., Schroder, N.W., Alsabeh, R., Slepenkin, A., Zhang, W., 
Chen, S., Wei, B., Bulut, Y., Wong, M.H., Peterson, E.M., Arditi, M., 2005. MyD88 
is pivotal for the early inflammatory response and subsequent bacterial clearance and 
survival in a mouse model of Chlamydia pneumoniae pneumonia. J Biol Chem. 280, 
29242-29249. 
Nalpas, N.C., Park, S.D., Magee, D.A., Taraktsoglou, M., Browne, J.A., Conlon, 
K.M., Rue-Albrecht, K., Killick, K.E., Hokamp, K., Lohan, A.J., Loftus, B.J., 
Gormley, E., Gordon, S.V., MacHugh, D.E., 2013. Whole-transcriptome, high-
throughput RNA sequence analysis of the bovine macrophage response to 
Mycobacterium bovis infection in vitro. BMC Genomics 14, 230. 
Natividad, A., Freeman, T.C., Jeffries, D., Burton, M.J., Mabey, D.C., Bailey, R.L., 
Holland, M.J., 2010. Human conjunctival transcriptome analysis reveals the 
prominence of innate defense in Chlamydia trachomatis infection. Infect. Immun. 
78, 4895-4911. 
Natividad., A, Hanchard, N., Holland, M.J., Mahdi, O.S., Diakite. M., Rockett, 
K., Jallow, O., Joof, H.M., Kwiatkowski, D.P., Mabey, D.C., Bailey, R.L., 2007. 
Genetic variation at the TNF locus and the risk of severe sequeleae of ocular 
Chlamydia trachomatis infection in Gambians. Genes Immun 8, 288-295. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  236 
Nau, G.J., Richmond, J.F., Schlesinger, A., Jennings, E.G., Lander, E.S., Young, 
R.A., 2002. Human macrophage activation programs induced by bacterial pathogens. 
Proc. Natl. Acad. Sci U. S A 99, 1503-1508. 
Navarro, J.A., Garcia de la Fuente JN, Sanchez, J., Martinez, C.M., Buendia, A.J., 
Gutierrez-Martin, C.B., Rodriguez-Ferri, E.F., Ortega, N., Salinas, J., 2004. Kinetics 
of infection and effects on the placenta of Chlamydophila abortus in experimentally 
infected pregnant ewes. Vet Pathol 41, 498-505. 
Nelson, D.E., Virok, D.P., Wood, H., Roshick, C., Johnson, R.M., Whitmire, W.M., 
Crane, D.D., Steele-Mortimer, O., Kari, L., McClarty, G., Caldwell, H.D., 2005. 
Chlamydial IFN-gamma immune evasion is linked to host infection tropism. Proc. 
Natl. Acad. Sci U. S A 102, 10658-10663. 
Netea, M.G., Kullberg, B.J., Galama, J.M., Stalenhoef, A.F., Dinarello, C.A., Van 
der Meer, J.W., 2002. Non-LPS components of Chlamydia pneumoniae stimulate 
cytokine production through Toll-like receptor 2-dependent pathways. Eur. J 
Immunol 32, 1188-1195. 
Netea, M.G., Simon, A., van, d., V, Kullberg, B.J., Van der Meer, J.W., Joosten, 
L.A., 2010. IL-1beta processing in host defense: beyond the inflammasomes. PLoS 
Pathog. 6, e1000661. 
Nogueira, C.V., Zhang, X., Giovannone, N., Sennott, E.L., Starnbach, M.N., 2015. 
Protective Immunity against Chlamydia trachomatis Can Engage Both CD4+ and 
CD8+ T Cells and Bridge the Respiratory and Genital Mucosae. J Immunol 194, 
2319-2329. 
Nunes, A., Borrego, M.J., Gomes, J.P., 2013. Genomic features beyond Chlamydia 
trachomatis phenotypes: what do we think we know? Infect. Genet. Evol 16, 392-
400. 
Nunes, A., Gomes, J.P., 2014. Evolution, phylogeny, and molecular epidemiology of 
Chlamydia. Infect. Genet. Evol 23, 49-64. 
O'Connell, C.M., Abdelrahman, Y.M., Green, E., Darville, H.K., Saira, K., Smith, 
B., Darville, T., Scurlock, A.M., Meyer, C.R., Belland, R.J., 2011. Toll-like receptor 
2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-
responsive chromosomal loci are coordinately regulated in response to glucose 
limitation by C. trachomatis but not by C. muridarum. Infect. Immun. 79, 1044-
1056. 
O'Connell, C.M., Ingalls, R.R., Andrews, C.W., Jr., Scurlock, A.M., Darville, T., 
2007. Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and 
protect against oviduct disease. J Immunol 179, 4027-4034. 
O'Connell, C.M., Ionova, I.A., Quayle, A.J., Visintin, A., Ingalls, R.R., 2006. 
Localization of TLR2 and MyD88 to Chlamydia trachomatis inclusions. Evidence 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  237 
for signaling by intracellular TLR2 during infection with an obligate intracellular 
pathogen. J Biol Chem. 281, 1652-1659. 
O'Loughlin, A., Lynn, D.J., McGee, M., Doyle, S., McCabe, M., Earley, B., 2012. 
Transcriptomic analysis of the stress response to weaning at housing in bovine 
leukocytes using RNA-seq technology. BMC Genomics 13, 250. 
O'Mahony, D.S., Pham, U., Iyer, R., Hawn, T.R., Liles, W.C., 2008. Differential 
constitutive and cytokine-modulated expression of human Toll-like receptors in 
primary neutrophils, monocytes, and macrophages. Int J Med Sci 5, 1-8. 
Ojcius, D.M., Bravo de, A.Y., Kanellopoulos, J.M., Hawkins, R.A., Kelly, K.A., 
Rank, R.G., Dautry-Varsat, A., 1998. Internalization of Chlamydia by dendritic cells 
and stimulation of Chlamydia-specific T cells. J Immunol 160, 1297-1303. 
Olivares-Zavaleta, N., Whitmire, W. M., Kari, L., Sturdevant, G. L. & Caldwell, H. D. 
2014. CD8+ T cells define an unexpected role in live-attenuated vaccine protective 
immunity against Chlamydia trachomatis infection in macaques. J Immunol 192, 
4648-54. 
Oliveros, J.C., 2015. Venny. An interactive tool for comparing lists with Venn's 
diagrams. http://bioinfogp.cnb.csic.es/tools/venny/index.html 
Opdenakker, G., Rudd, P.M., Wormald, M., Dwek, R.A., Van, D.J., 1995. Cells 
regulate the activities of cytokines by glycosylation. FASEB J 9, 453-457. 
Opitz, B., Forster, S., Hocke, A.C., Maass, M., Schmeck, B., Hippenstiel, S., Suttorp, 
N., Krull, M., 2005. Nod1-mediated endothelial cell activation by Chlamydophila 
pneumoniae. Circ. Res 96, 319-326. 
Ou, C., Tian, D., Ling, Y., Pan, Q., He, Q., Eko, F.O., He, C., 2013. Evaluation of an 
ompA-based phage-mediated DNA vaccine against Chlamydia abortus in piglets. Int 
Immunopharmacol. 16, 505-510. 
Oviedo-Boyso, J., Bravo-Patino, A., Baizabal-Aguirre, V.M., 2014. Collaborative 
action of Toll-like and NOD-like receptors as modulators of the inflammatory 
response to pathogenic bacteria. Mediators. Inflamm. 2014, 432785. 
Pan, Q., Pais, R., Ohandjo, A., He, C., He, Q., Omosun, Y., Igietseme, J.U., Eko, 
F.O., 2015. Comparative evaluation of the protective efficacy of two formulations of 
a recombinant Chlamydia abortus subunit candidate vaccine in a mouse model. 
Vaccine 33, 1865-1872. 
Peek, A.S., Behlke, M.A., 2007. Design of active small interfering RNAs. Curr Opin. 
Mol. Ther. 9, 110-118. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  238 
Pelegrin, P., Barroso-Gutierrez, C., Surprenant, A., 2008. P2X7 receptor 
differentially couples to distinct release pathways for IL-1beta in mouse macrophage. 
J Immunol 180, 7147-7157. 
Penttila, J.M., Anttila, M., Varkila, K., Puolakkainen, M., Sarvas, M., Makela, P.H., 
Rautonen, N., 1999. Depletion of CD8+ cells abolishes memory in acquired 
immunity against Chlamydia pneumoniae in BALB/c mice. Immunology 97, 490-
496. 
Perry, L.L., Feilzer, K., Caldwell, H.D., 1997. Immunity to Chlamydia trachomatis is 
mediated by T helper 1 cells through IFN-gamma-dependent and -independent 
pathways. J Immunol 158, 3344-3352. 
Peters, J.H., Gieseler, R., Thiele, B., Steinbach, F., 1996. Dendritic cells: from 
ontogenetic orphans to myelomonocytic descendants. Immunol Today 17, 273-278. 
Philpott, D.J., Girardin, S.E., 2004. The role of Toll-like receptors and Nod proteins 
in bacterial infection. Mol. Immunol 41, 1099-1108. 
Poeck, H., Bscheider, M., Gross, O., Finger, K., Roth, S., Rebsamen, M., 
Hannesschlager, N., Schlee, M., Rothenfusser, S., Barchet, W., Kato, H., Akira, S., 
Inoue, S., Endres, S., Peschel, C., Hartmann, G., Hornung, V., Ruland, J., 2010. 
Recognition of RNA virus by RIG-I results in activation of CARD9 and 
inflammasome signaling for interleukin 1 beta production. Nat. Immunol 11, 63-69. 
Ponthan, F., Yusoff, N.M., Soria, N.M., Heidenreich, O., Coffey, K., 2015. Gene 
Silencing by RNAi in Mammalian Cells. Curr Protoc. Mol. Biol 111, 26. 
Porcella, S.F., Carlson, J.H., Sturdevant, D.E., Sturdevant, G.L., Kanakabandi, K., 
Virtaneva, K., Wilder, H., Whitmire, W.M., Song, L., Caldwell, H.D., 2015. 
Transcriptional profiling of human epithelial cells infected with plasmid-bearing and 
plasmid-deficient Chlamydia trachomatis. Infect. Immun. 83, 534-543. 
Pothlichet, J., Quintana-Murci, L., 2013. The genetics of innate immunity sensors 
and human disease. Int Rev. Immunol 32, 157-208. 
Prantner, D., Darville, T., Nagarajan, U.M., 2010. Stimulator of IFN gene is critical 
for induction of IFN-beta during Chlamydia muridarum infection. J Immunol 184, 
2551-2560. 
Prantner, D., Darville, T., Sikes, J.D., Andrews, C.W., Jr., Brade, H., Rank, R.G., 
Nagarajan, U.M., 2009. Critical role for interleukin-1beta (IL-1beta) during 
Chlamydia muridarum genital infection and bacterial replication-independent 
secretion of IL-1beta in mouse macrophages. Infect. Immun. 77, 5334-5346. 
Prebeck, S., Kirschning, C., Durr, S., da, C.C., Donath, B., Brand, K., Redecke, V., 
Wagner, H., Miethke, T., 2001. Predominant role of toll-like receptor 2 versus 4 in 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  239 
Chlamydia pneumoniae-induced activation of dendritic cells. J Immunol 167, 3316-
3323. 
Premium sheep and goat health scheme, 2008. Enzootic abortion of ewes (EAE) 
accreditation: rules and conditions. 
www.sruc.ac.uk/download/downloads/id/684/eae_rules_and_conditions. Last 
accessed 16/05/15. 
Preston, P.M., Brown, C.G., Entrican, G., Richardson, W., Boid, R., 1993. Synthesis 
of tumour necrosis factor-alpha and interferons by mononuclear cells from Theileria 
annulata-infected cattle. Parasite Immunol 15, 525-534. 
Qin, M., Pirouz, A., Kim, M.H., Krutzik, S.R., Garban, H.J., Kim, J., 2014. 
Propionibacterium acnes Induces IL-1beta secretion via the NLRP3 inflammasome 
in human monocytes. J Invest Dermatol. 134, 381-388. 
Qiu, H., Fan, Y., Joyee, A.G., Wang, S., Han, X., Bai, H., Jiao, L., Van, R.N., Yang, 
X., 2008. Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection 
by enhancing apoptosis of local macrophages. J Immunol 181, 2092-2102. 
Rajalingam, K., Sharma, M., Paland, N., Hurwitz, R., Thieck, O., Oswald, M., 
Machuy, N., Rudel, T., 2006. IAP-IAP complexes required for apoptosis resistance 
of C. trachomatis-infected cells. PLoS Pathog. 2, e114. 
Ramsey, K.H., Rank, R.G., 1991. Resolution of chlamydial genital infection with 
antigen-specific T-lymphocyte lines. Infect. Immun. 59, 925-931. 
Randolph, G.J., Angeli, V., Swartz, M.A., 2005. Dendritic-cell trafficking to lymph 
nodes through lymphatic vessels. Nat. Rev. Immunol 5, 617-628. 
Rank, R.G., Ramsey, K.H., Pack, E.A., Williams, D.M., 1992. Effect of gamma 
interferon on resolution of murine chlamydial genital infection. Infect. Immun. 60, 
4427-4429. 
Rank, R.G., Soderberg, L.S., Barron, A.L., 1985. Chronic chlamydial genital 
infection in congenitally athymic nude mice. Infect. Immun. 48, 847-849. 
Rank, R.G., Whittum-Hudson, J.A., 2010. Protective immunity to chlamydial genital 
infection: evidence from animal studies. J Infect. Dis 201 Suppl 2, S168-S177. 
Rasmussen, S.J., Eckmann, L., Quayle, A.J., Shen, L., Zhang, Y.X., Anderson, D.J., 
Fierer, J., Stephens, R.S., Kagnoff, M.F., 1997. Secretion of proinflammatory 
cytokines by epithelial cells in response to Chlamydia infection suggests a central 
role for epithelial cells in chlamydial pathogenesis. J Clin. Invest 99, 77-87. 
Read, T.D., Joseph, S.J., Didelot, X., Liang, B., Patel, L., Dean, D., 2013. 
Comparative analysis of Chlamydia psittaci genomes reveals the recent emergence 
of a pathogenic lineage with a broad host range. MBio. 4, e00604-e00612. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  240 
Register, K.B., Morgan, P.A., Wyrick, P.B., 1986. Interaction between Chlamydia 
spp. and human polymorphonuclear leukocytes in vitro. Infect. Immun. 52, 664-670. 
Reinhold, P., Sachse, K., Kaltenboeck, B., 2011. Chlamydiaceae in cattle: 
commensals, trigger organisms, or pathogens? Vet J 189, 257-267. 
Ren, Q., Robertson, S.J., Howe, D., Barrows, L.F., Heinzen, R.A., 2003. 
Comparative DNA microarray analysis of host cell transcriptional responses to 
infection by Coxiella burnetii or Chlamydia trachomatis. Ann. N. Y Acad. Sci 990, 
701-713. 
Rey-Ladino, J., Jiang, X., Gabel, B.R., Shen, C., Brunham, R.C., 2007. Survival of 
Chlamydia muridarum within dendritic cells. Infect. Immun. 75, 3707-3714. 
Rey-Ladino, J., Koochesfahani, K.M., Zaharik, M.L., Shen, C., Brunham, R.C., 
2005. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain 
induces the maturation of dendritic cells that are phenotypically and 
immunologically distinct. Infect. Immun. 73, 1568-1577. 
Reynolds, J.M., Angkasekwinai, P., Dong, C., 2010. IL-17 family member cytokines: 
regulation and function in innate immunity. Cytokine Growth Factor Rev. 21, 413-
423. 
Roan, N.R., Starnbach, M.N., 2008. Immune-mediated control of Chlamydia 
infection. Cell Microbiol 10, 9-19. 
Robinson, M.D., Oshlack, A., 2010. A scaling normalization method for differential 
expression analysis of RNA-seq data. Genome Biol 11, R25. 
Rocchi, M.S., Wattegedera, S., Meridiani, I., Entrican, G., 2009. Protective adaptive 
immunity to Chlamydophila abortus infection and control of ovine enzootic abortion 
(OEA). Vet Microbiol 135, 112-121. 
Rockey, D.D., 2011. Unraveling the basic biology and clinical significance of the 
chlamydial plasmid. J Exp Med 208, 2159-2162. 
Rodriguez, A.R., Plascencia-Villa, G., Witt, C.M., Yu, J.J., Jose-Yacaman, M., 
Chambers, J.P., Perry, G., Guentzel, M.N., Arulanandam, B.P., 2015. Chlamydia 
pneumoniae promotes dysfunction of pancreatic beta cells. Cell Immunol 295, 83-91. 
Rodriguez, N., Fend, F., Jennen, L., Schiemann, M., Wantia, N., Prazeres da Costa, 
C.U., Durr, S., Heinzmann, U., Wagner, H., Miethke, T., 2005. Polymorphonuclear 
neutrophils improve replication of Chlamydia pneumoniae in vivo upon MyD88-
dependent attraction. J Immunol 174, 4836-4844. 
Rodriguez, N., Wantia, N., Fend, F., Durr, S., Wagner, H., Miethke, T., 2006. 
Differential involvement of TLR2 and TLR4 in host survival during pulmonary 
infection with Chlamydia pneumoniae. Eur. J Immunol 36, 1145-1155. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  241 
Romero, R., Mazor, M., Brandt, F., Sepulveda, W., Avila, C., Cotton, D.B., 
Dinarello, C.A., 1992. Interleukin-1 alpha and interleukin-1 beta in preterm and term 
human parturition. Am. J Reprod. Immunol 27, 117-123. 
Rothel, J.S., Hurst, L., Seow, H.F., Pepin, M., Berthon, P., Corner, L.A., Wood, P.R., 
1997. Analysis of ovine IL-1 beta production in vivo and in vitro by enzyme 
immunoassay and immunohistochemistry. Vet Immunol Immunopathol 57, 267-278. 
Rothermel, C.D., Byrne, G.I., Havell, E.A., 1983. Effect of interferon on the growth 
of Chlamydia trachomatis in mouse fibroblasts (L cells). Infect. Immun. 39, 362-
370. 
Roy, N.C., Altermann, E., Park, Z.A., McNabb, W.C., 2011. A comparison of analog 
and Next-Generation transcriptomic tools for mammalian studies. Brief Funct. 
Genomics 10, 135-150. 
Rozen, S., Skaletsky, H., 2000. Primer3 on the WWW for general users and for 
biologist programmers. Methods Mol. Biol 132, 365-386. 
Rupp, J., Pfleiderer, L., Jugert, C., Moeller, S., Klinger, M., Dalhoff, K., Solbach, 
W., Stenger, S., Laskay, T., van, Z.G., 2009. Chlamydia pneumoniae hides inside 
apoptotic neutrophils to silently infect and propagate in macrophages. PLoS One 4, 
e6020. 
Rusconi, B., Greub, G., 2011. Chlamydiales and the innate immune response: friend 
or foe? FEMS Immunol Med Microbiol 61, 231-244. 
Russo, R.C., Garcia, C.C., Teixeira, M.M., Amaral, F.A., 2014. The CXCL8/IL-8 
chemokine family and its receptors in inflammatory diseases. Expert Rev. Clin. 
Immunol 10, 593-619. 
Sabio, G., Davis, R.J., 2014. TNF and MAP kinase signalling pathways. Semin. 
Immunol 26, 237-245. 
Sachse, K., Bavoil, P.M., Kaltenboeck, B., Stephens, R.S., Kuo, C.C., Rossello-
Mora, R., Horn, M., 2015. Emendation of the family Chlamydiaceae: Proposal of a 
single genus, Chlamydia, to include all currently recognized species. Syst Appl. 
Microbiol 38, 99-103. 
Sachse, K., Laroucau, K., Riege, K., Wehner, S., Dilcher, M., Creasy, H.H., 
Weidmann, M., Myers, G., Vorimore, F., Vicari, N., Magnino, S., Liebler-Tenorio, 
E., Ruettger, A., Bavoil, P.M., Hufert, F.T., Rossello-Mora, R., Marz, M., 2014. 
Evidence for the existence of two new members of the family Chlamydiaceae and 
proposal of Chlamydia avium sp. nov. and Chlamydia gallinacea sp. nov. Syst Appl. 
Microbiol 37, 79-88. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  242 
Sachse, K., Vretou, E., Livingstone, M., Borel, N., Pospischil, A., Longbottom, D., 
2009. Recent developments in the laboratory diagnosis of chlamydial infections. Vet 
Microbiol 135, 2-21. 
Sadler, A.J., Williams, B.R., 2008. Interferon-inducible antiviral effectors. Nat. Rev. 
Immunol 8, 559-568. 
Sait, M., Livingstone, M., Clark, E.M., Wheelhouse, N., Spalding, L., Markey, B., 
Magnino, S., Lainson, F.A., Myers, G.S., Longbottom, D., 2014. Genome 
sequencing and comparative analysis of three Chlamydia pecorum strains associated 
with different pathogenic outcomes. BMC Genomics 15, 23. 
Salinas, J., Caro, M.R., Vicente, J., Cuello, F., Reyes-Garcia, A.R., Buendia, A.J., 
Rodolakis, A., Gortazar, C., 2009. High prevalence of antibodies against 
Chlamydiaceae and Chlamydophila abortus in wild ungulates using two "in house" 
blocking-ELISA tests. Vet Microbiol 135, 46-53. 
Santin, A.D., Hermonat, P.L., Ravaggi, A., Chiriva-Internati, M., Cannon, M.J., 
Hiserodt, J.C., Pecorelli, S., Parham, G.P., 1999. Expression of surface antigens 
during the differentiation of human dendritic cells vs macrophages from blood 
monocytes in vitro. Immunobiology 200, 187-204. 
Sargison, N.D., Truyers, I.G., Howie, F.E., Thomson, J.R., Cox, A.L., Livingstone, 
M., Longbottom, D., 2015. Identification of the 1B vaccine strain of Chlamydia 
abortus in aborted placentas during the investigation of toxaemic and systemic 
disease in sheep. N. Z. Vet J, 1-11. 
Schachter, J., Stephens, R.S., Timms, P., Kuo, C., Bavoil, P.M., Birkelund, S., 
Boman, J., Caldwell, H., Campbell, L.A., Chernesky, M., Christiansen, G., Clarke, 
I.N., Gaydos, C., Grayston, J.T., Hackstadt, T., Hsia, R., Kaltenboeck, B., 
Leinonnen, M., Ojcius, D., McClarty, G., Orfila, J., Peeling, R., Puolakkainen, M., 
Quinn, T.C., Rank, R.G., Raulston, J., Ridgeway, G.L., Saikku, P., Stamm, W.E., 
Taylor-Robinson, D.T., Wang, S.P., Wyrick, P.B., 2001. Radical changes to 
chlamydial taxonomy are not necessary just yet. Int J Syst Evol Microbiol 51, 249-3. 
Schautteet, K., De, C.E., Vanrompay, D., 2011. Chlamydia trachomatis vaccine 
research through the years. Infect. Dis Obstet. Gynecol. 2011, 963513. 
Schoborg, R.V., 2011. Chlamydia persistence -- a tool to dissect chlamydia--host 
interactions. Microbes Infect. 13, 649-662. 
Schrader, S., Klos, A., Hess, S., Zeidler, H., Kuipers, J.G., Rihl, M., 2007. 
Expression of inflammatory host genes in Chlamydia trachomatis-infected human 
monocytes. Arthritis Res Ther. 9, R54. 
Scurlock, A.M., Frazer, L.C., Andrews, C.W., Jr., O'Connell, C.M., Foote, I.P., 
Bailey, S.L., Chandra-Kuntal, K., Kolls, J.K., Darville, T., 2011. Interleukin-17 
contributes to generation of Th1 immunity and neutrophil recruitment during 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  243 
Chlamydia muridarum genital tract infection but is not required for macrophage 
influx or normal resolution of infection. Infect. Immun. 79, 1349-1362. 
Seong, S.Y., Matzinger, P., 2004. Hydrophobicity: an ancient damage-associated 
molecular pattern that initiates innate immune responses. Nat. Rev. Immunol 4, 469-
478. 
Seow, H.F., Rothel, J.S., Wood, P.R., 1994a. Expression and purification of 
recombinant ovine interleukin-1 beta from Escherichia coli. Vet Immunol 
Immunopathol 41, 229-239. 
Seow, H.F., Yoshimura, T., Wood, P.R., Colditz, I.G., 1994b. Cloning, sequencing, 
expression and inflammatory activity in skin of ovine interleukin-8. Immunol Cell 
Biol 72, 398-405. 
Shan, G., 2010. RNA interference as a gene knockdown technique. Int J Biochem. 
Cell Biol 42, 1243-1251. 
Sharma, M., Rudel, T., 2009. Apoptosis resistance in Chlamydia-infected cells: a fate 
worse than death? FEMS Immunol Med Microbiol 55, 154-161. 
Shaw, J.L., Wills, G.S., Lee, K.F., Horner, P.J., McClure, M.O., Abrahams, V.M., 
Wheelhouse, N., Jabbour, H.N., Critchley, H.O., Entrican, G., Horne, A.W., 2011. 
Chlamydia trachomatis infection increases fallopian tube PROKR2 via TLR2 and 
NFkappaB activation resulting in a microenvironment predisposed to ectopic 
pregnancy. Am. J Pathol 178, 253-260. 
Shendure, J., 2008. The beginning of the end for microarrays? Nat. Methods 5, 585-
587. 
Shi, C., Pamer, E.G., 2011. Monocyte recruitment during infection and 
inflammation. Nat. Rev. Immunol 11, 762-774. 
Shimada, K., Chen, S., Dempsey, P.W., Sorrentino, R., Alsabeh, R., Slepenkin, A.V., 
Peterson, E., Doherty, T.M., Underhill, D., Crother, T.R., Arditi, M., 2009. The 
NOD/RIP2 pathway is essential for host defenses against Chlamydophila 
pneumoniae lung infection. PLoS Pathog. 5, e1000379. 
Shimada, K., Crother, T.R., Arditi, M., 2012. Innate immune responses to Chlamydia 
pneumoniae infection: role of TLRs, NLRs, and the inflammasome. Microbes Infect. 
14, 1301-1307. 
Shimada, K., Crother, T.R., Karlin, J., Chen, S., Chiba, N., Ramanujan, V.K., 
Vergnes, L., Ojcius, D.M., Arditi, M., 2011. Caspase-1 dependent IL-1beta secretion 
is critical for host defense in a mouse model of Chlamydia pneumoniae lung 
infection. PLoS One 6, e21477. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  244 
Siegl, C., Prusty, B. K., Karunakaran, K., Wischhusen, J. & Rudel, T. 2014. Tumor 
Suppressor p53 Alters Host Cell Metabolism to Limit Chlamydia trachomatis 
Infection. Cell Rep. 9, 918-29. 
Sironi, M., Cagliani, R., Forni, D., Clerici, M., 2015. Evolutionary insights into host-
pathogen interactions from mammalian sequence data. Nat. Rev. Genet. 16, 224-236. 
Smith, S.A., Haig, D., Emes, R.D., 2014. Novel ovine polymorphisms and adaptive 
evolution in mammalian TLR2 suggest existence of multiple pathogen binding 
regions. Gene 540, 217-225. 
Soller, J.T., Murua-Escobar, H., Willenbrock, S., Janssen, M., Eberle, N., Bullerdiek, 
J., Nolte, I., 2007. Comparison of the human and canine cytokines IL-1(alpha/beta) 
and TNF-alpha to orthologous other mammalians. J Hered. 98, 485-490. 
Song, L., Carlson, J. H., Whitmire, W. M., Kari, L., Virtaneva, K., Sturdevant, D. E., 
Watkins, H., Zhou, B., Sturdevant, G. L., Porcella, S. F., Mcclarty, G. & Caldwell, 
H. D. 2013. Chlamydia trachomatis plasmid-encoded Pgp4 is a transcriptional 
regulator of virulence-associated genes. Infect. Immun. 81, 636-44. 
Steinman, R.M., Cohn, Z.A., 1973. Identification of a novel cell type in peripheral 
lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 
137, 1142-1162. 
Stephens, R.S., 2003. The cellular paradigm of chlamydial pathogenesis. Trends 
Microbiol 11, 44-51. 
Stephens, R.S., Myers, G., Eppinger, M., Bavoil, P.M., 2009. Divergence without 
difference: phylogenetics and taxonomy of Chlamydia resolved. FEMS Immunol 
Med Microbiol 55, 115-119. 
Stothard, D.R., Toth, G.A., Batteiger, B.E., 2003. Polymorphic membrane protein H 
has evolved in parallel with the three disease-causing groups of Chlamydia 
trachomatis. Infect. Immun. 71, 1200-1208. 
Su, H., Feilzer, K., Caldwell, H.D., Morrison, R.P., 1997. Chlamydia trachomatis 
genital tract infection of antibody-deficient gene knockout mice. Infect. Immun. 65, 
1993-1999. 
Su, H., Messer, R., Whitmire, W., Fischer, E., Portis, J.C., Caldwell, H.D., 1998. 
Vaccination against chlamydial genital tract infection after immunization with 
dendritic cells pulsed ex vivo with nonviable Chlamydiae. J Exp Med 188, 809-818. 
Szebeni, B., Veres, G., Dezsofi, A., Rusai, K., Vannay, A., Mraz, M., Majorova, E., 
Arato, A., 2008. Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the 
colonic mucosa of children with inflammatory bowel disease. Clin. Exp Immunol 
151, 34-41. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  245 
Tada, H., Aiba, S., Shibata, K., Ohteki, T., Takada, H., 2005. Synergistic effect of 
Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to 
generate interleukin-12 and T helper type 1 cells. Infect. Immun. 73, 7967-7976. 
Tahoun, A., Jensen, K., Corripio-Miyar, Y., McAteer, S.P., Corbishley, A., Mahajan, 
A., Brown, H., Frew, D., Aumeunier, A., Smith, D.G., McNeilly, T.N., Glass, E.J., 
Gally, D.L., 2015. Functional analysis of bovine TLR5 and association with IgA 
responses of cattle following systemic immunisation with H7 flagella. Vet Res 46, 9. 
Tam, J.E., Davis, C.H., Wyrick, P.B., 1994. Expression of recombinant DNA 
introduced into Chlamydia trachomatis by electroporation. Can. J Microbiol 40, 583-
591. 
Teder, P., Noble, P.W., 2000. A cytokine reborn? Endothelin-1 in pulmonary 
inflammation and fibrosis. Am. J Respir. Cell Mol. Biol 23, 7-10. 
Thompson, J.D., Higgins, D.G., Gibson, T.J., 1994. CLUSTAL W: improving the 
sensitivity of progressive multiple sequence alignment through sequence weighting, 
position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 
4673-4680. 
Thomson, N.R., Holden, M.T., Carder, C., Lennard, N., Lockey, S.J., Marsh, P., 
Skipp, P., O'Connor, C.D., Goodhead, I., Norbertzcak, H., Harris, B., Ormond, D., 
Rance, R., Quail, M.A., Parkhill, J., Stephens, R.S., Clarke, I.N., 2008. Chlamydia 
trachomatis: genome sequence analysis of lymphogranuloma venereum isolates. 
Genome Res 18, 161-171. 
Thomson, N.R., Yeats, C., Bell, K., Holden, M.T., Bentley, S.D., Livingstone, M., 
Cerdeno-Tarraga, A.M., Harris, B., Doggett, J., Ormond, D., Mungall, K., Clarke, 
K., Feltwell, T., Hance, Z., Sanders, M., Quail, M.A., Price, C., Barrell, B.G., 
Parkhill, J., Longbottom, D., 2005. The Chlamydophila abortus genome sequence 
reveals an array of variable proteins that contribute to interspecies variation. Genome 
Res 15, 629-640. 
Thonur, L., Haig, D.M., Thomson, J., Russell, G.C., 2012. Toll-like receptor gene 
expression in fresh and archived ovine pseudoafferent lymph DEC205+ dendritic 
cells. J Comp Pathol 147, 296-304. 
Tschopp, J., Schroder, K., 2010. NLRP3 inflammasome activation: The convergence 
of multiple signalling pathways on ROS production? Nat. Rev. Immunol 10, 210-
215. 
Tseng, C.T., Rank, R.G., 1998. Role of NK cells in early host response to chlamydial 
genital infection. Infect. Immun. 66, 5867-5875. 
Van Voorhis, W.C., Barrett, L.K., Sweeney, Y.T., Kuo, C.C., Patton, D.L., 1996. 
Analysis of lymphocyte phenotype and cytokine activity in the inflammatory 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  246 
infiltrates of the upper genital tract of female macaques infected with Chlamydia 
trachomatis. J Infect. Dis 174, 647-650. 
Vandermeer, J., Sha, Q., Lane, A.P., Schleimer, R.P., 2004. Innate immunity of the 
sinonasal cavity: expression of messenger RNA for complement cascade components 
and toll-like receptors. Arch Otolaryngol. Head Neck Surg. 130, 1374-1380. 
Voigt, A., Schofl, G., Saluz, H.P., 2012. The Chlamydia psittaci genome: a 
comparative analysis of intracellular pathogens. PLoS One 7, e35097. 
Vorimore, F., Hsia, R.C., Huot-Creasy, H., Bastian, S., Deruyter, L., Passet, A., 
Sachse, K., Bavoil, P., Myers, G., Laroucau, K., 2013. Isolation of a New Chlamydia 
species from the Feral Sacred Ibis (Threskiornis aethiopicus): Chlamydia ibidis. 
PLoS One 8, e74823. 
Vu Manh, T.P., Bertho, N., Hosmalin, A., Schwartz-Cornil, I., Dalod, M., 2015a. 
Investigating Evolutionary Conservation of Dendritic Cell Subset Identity and 
Functions. Front Immunol 6, 260. 
Vu Manh, T.P., Elhmouzi-Younes, J., Urien, C., Ruscanu, S., Jouneau, L., Bourge, 
M., Moroldo, M., Foucras, G., Salmon, H., Marty, H., Quere, P., Bertho, N., 
Boudinot, P., Dalod, M., Schwartz-Cornil, I., 2015b. Defining Mononuclear 
Phagocyte Subset Homology Across Several Distant Warm-Blooded Vertebrates 
Through Comparative Transcriptomics. Front Immunol 6, 299. 
Wang, Y., Kahane, S., Cutcliffe, L.T., Skilton, R.J., Lambden, P.R., Clarke, I.N., 
2011. Development of a transformation system for Chlamydia trachomatis: 
restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS 
Pathog. 7, e1002258. 
Wang, Z., Gerstein, M., Snyder, M., 2009. RNA-Seq: a revolutionary tool for 
transcriptomics. Nat. Rev. Genet. 10, 57-63. 
Wattegedera, S., Rocchi, M., Sales, J., Howard, C.J., Hope, J.C., Entrican, G., 2008. 
Antigen-specific peripheral immune responses are unaltered during normal 
pregnancy in sheep. J Reprod. Immunol 77, 171-178. 
Wattegedera, S., Sills, K., Howard, C.J., Hope, J.C., McInnes, C.J., Entrican, G., 
2004. Variability in cytokine production and cell proliferation by mitogen-activated 
ovine peripheral blood mononuclear cells: modulation by interleukin (IL)-10 and IL-
12. Vet Immunol Immunopathol 102, 67-76. 
Wattegedera, S.R., Watson, D.M., Hope, J.C., Kaiser, P., Sales, J., McInnes, C.J., 
Entrican, G., 2010. Relative quantitative kinetics of interferon-gamma and 
interleukin-10 mRNA and protein production by activated ovine peripheral blood 
mononuclear cells. Vet Immunol Immunopathol 136, 34-42. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  247 
Welter-Stahl, L., Ojcius, D.M., Viala, J., Girardin, S., Liu, W., Delarbre, C., Philpott, 
D., Kelly, K.A., Darville, T., 2006. Stimulation of the cytosolic receptor for 
peptidoglycan, Nod1, by infection with Chlamydia trachomatis or Chlamydia 
muridarum. Cell Microbiol 8, 1047-1057. 
Werling, D., Hope, J.C., Howard, C.J., Jungi, T.W., 2004. Differential production of 
cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells 
stimulated with Toll-like receptor agonists. Immunology 111, 41-52. 
Werling, D., Jann, O.C., Offord, V., Glass, E.J., Coffey, T.J., 2009. Variation 
matters: TLR structure and species-specific pathogen recognition. Trends Immunol 
30, 124-130. 
Wheelhouse, N., Aitchison, K., Laroucau, K., Thomson, J., Longbottom, D., 2010. 
Evidence of Chlamydophila abortus vaccine strain 1B as a possible cause of ovine 
enzootic abortion. Vaccine 28, 5657-5663. 
Wheelhouse, N., Wattegedera, S., Stanton, J., Maley, S., Watson, D., Jepson, C., 
Deane, D., Buxton, D., Longbottom, D., Baszler, T., Entrican, G., 2009. Ovine 
trophoblast is a primary source of TNFalpha during Chlamydophila abortus 
infection. J Reprod. Immunol 80, 49-56. 
Willcox, M. D. P., 2013. Charaterization of the normal microbiota of the ocular 
surface." Exp Eye Res 117, 1-7. 
Williams, D.M., Grubbs, B.G., Darville, T., Kelly, K., Rank, R.G., 1998. A role for 
interleukin-6 in host defense against murine Chlamydia trachomatis infection. Infect. 
Immun. 66, 4564-4567. 
Williams, D.M., Magee, D.M., Bonewald, L.F., Smith, J.G., Bleicker, C.A., Byrne, 
G.I., Schachter, J., 1990. A role in vivo for tumor necrosis factor alpha in host 
defense against Chlamydia trachomatis. Infect. Immun. 58, 1572-1576. 
Wilson, R.C., Doudna, J.A., 2013. Molecular mechanisms of RNA interference. 
Annu. Rev. Biophys. 42, 217-239. 
Wimmers, F., Schreibelt, G., Skold, A.E., Figdor, C.G., De Vries, I.J., 2014. 
Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated 
Monocyte-Derived DCs to Naturally Circulating DC Subsets. Front Immunol 5, 165. 
Wizel, B., Nystrom-Asklin, J., Cortes, C., Tvinnereim, A., 2008. Role of CD8(+)T 
cells in the host response to Chlamydia. Microbes Infect. 10, 1420-1430. 
Wyrick, P.B., Brownridge, E.A., 1978. Growth of Chlamydia psittaci in 
macrophages. Infect. Immun. 19, 1054-1060. 
Wyrick, P.B., Brownridge, E.A., Ivins, B.E., 1978. Interaction of Chlamydia psittaci 
with mouse peritoneal macrophages. Infect. Immun. 19, 1061-1067. 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 8: Reference List  248 
Yoo, N.J., Park, W.S., Kim, S.Y., Reed, J.C., Son, S.G., Lee, J.Y., Lee, S.H., 2002. 
Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the 
interaction with pro-caspase-1. Biochem. Biophys. Res Commun. 299, 652-658. 
Zaharik, M.L., Nayar, T., White, R., Ma, C., Vallance, B.A., Straka, N., Jiang, X., 
Rey-Ladino, J., Shen, C., Brunham, R.C., 2007. Genetic profiling of dendritic cells 
exposed to live- or ultraviolet-irradiated Chlamydia muridarum reveals marked 
differences in CXC chemokine profiles. Immunology 120, 160-172. 
Zandbergen, V.G., Gieffers, J., Kothe, H., Rupp, J., Bollinger, A., Aga, E., Klinger, 
M., Brade, H., Dalhoff, K., Maass, M., Solbach, W., Laskay, T., 2004. Chlamydia 
pneumoniae multiply in neutrophil granulocytes and delay their spontaneous 
apoptosis. J Immunol 172, 1768-1776. 
Zarember, K.A., Godowski, P.J., 2002. Tissue expression of human Toll-like 
receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in 
response to microbes, their products, and cytokines. J Immunol 168, 554-561. 
Zhang, X., Edwards, J.P., Mosser, D.M., 2009a. The expression of exogenous genes 
in macrophages: obstacles and opportunities. Methods Mol. Biol 531, 123-143. 
Zhang, X., Gao, L., Lei, L., Zhong, Y., Dube, P., Berton, M.T., Arulanandam, B., 
Zhang, J., Zhong, G., 2009b. A MyD88-dependent early IL-17 production protects 
mice against airway infection with the obligate intracellular pathogen Chlamydia 
muridarum. J Immunol 183, 1291-1300. 
Zhang, Y., Wang, H., Ren, J., Tang, X., Jing, Y., Xing, D., Zhao, G., Yao, Z., Yang, 
X., Bai, H., 2012. IL-17A synergizes with IFN-gamma to upregulate iNOS and NO 
production and inhibit chlamydial growth. PLoS One 7, e39214. 
Zhao, S., Zhang, B., 2015. A comprehensive evaluation of ensembl, RefSeq, and 
UCSC annotations in the context of RNA-seq read mapping and gene quantification. 
BMC Genomics 16, 97. 
Ziegler-Heitbrock, H.W., Ulevitch, R.J., 1993. CD14: cell surface receptor and 
differentiation marker. Immunol Today 14, 121-125. 
Zilbauer, M., Dorrell, N., Elmi, A., Lindley, K.J., Schuller, S., Jones, H.E., Klein, 
N.J., Nunez, G., Wren, B.W., Bajaj-Elliott, M., 2007. A major role for intestinal 
epithelial nucleotide oligomerization domain 1 (NOD1) in eliciting host bactericidal 
immune responses to Campylobacter jejuni. Cell Microbiol 9, 2404-2416. 
 
Inflammasome activation in ruminant cells infected with Chlamydia abortus 
Chapter 9: Appendix  249 
Chapter 9: Appendix 
9.1 RNA seq library preparation  
The total RNA was assessed for quality and quantity using the Agilent RNA 
ScreenTape and Life Technologies Qubit RNA BR assay kits.  RNA with a RNA 
integrity score (RINe) >6.8 was considered suitable for analysis (range 6.8 – 9.2 
when measured by ARK genomics).  The Sequencing library was prepared using the 
NEB Next Ultra directional RNA Library Prep Kit for Illumina according to the 
manufacturer’s protocol. Briefly the  poly A RNA was captured from 1microgram of 
total RNA using oligo d(T) beads in two rounds of capture to eliminate as much of 
the non poly adenylated RNA as possible. The poly A RNA was eluted from the 
oligo d(T) beads using the provided elution and fragmentation solution. This stage 
was carefully controlled for temperature at 94
o
C and a time of 8 minutes. The RNA 
is fragmented into an average insert size of 180-200 bases. The fragmented RNA was 
used as a template for first strand DNA synthesis with random hexamer oligo 
primers. The first strand cDNA is used as a template for the second strand synthesis 
which incorporates dUTP in place of dTTP to generate ds cDNA. The incorporation 
of dUTP quenches the second strand during amplification, because the polymerase 
does not incorporate past this nucleotide. The resulting ds cDNA is then blunt ended 
before incorporation of a single A base the 3’ end of each strand. The addition of an 
A nucleotide tail prevents the formation of concatamers during the next ligation step.  
The sequencing adapters to create the library are ligated to the A tailed ds cDNA. 
Each of the ligated adapters are different for each sample as each contains a 6 base 
barcode sequence which will allow identification of sequences for each sample in the 
analysis. The dsDNA with the ligated adapters form the sequencing library with each 
sample having its own barcoded adapter. This final product is amplified using PCR 
with only 10 cycle of PCR to amplify the resulting library. The amplified library was 
assessed for quality and quantity using the Agilent DNA 1000 ScreenTape and Life 
Technologies Qubit DNA BR assay kits. The Qubit quantification was used to guide 
the dilution of the library for accurate quantification using qPCR. The nano molar 
concentration of the library was determined by qPCR using the KAPA Library 
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Quantification Kits for Illumina on an ABI 7500 qPCR machine. The quantified 
libraries were diluted to a concentration of 5nM and stored until sequencing. 
The normalised sequencing libraries were pooled at equal concentrations to form two 
independent pools of libraries which were sequenced over 3 lanes for each pool. The 
sequencing was performed Illumina HiSeq 2500 for 125 bases paired end sequencing 
using SBS v4 chemistry.  
Briefly the libraries were denatured using NaOH at a final concentration of 0.1N of 
NaOH and 2nM of library pool in a 20 micro litre reaction volume for a period of 5 
minutes at room temperature. After denaturation the libraries were diluted to 14pM 
by adding 7 micro litres of denatured 2nM library to 986 micro litres of Illumina 
buffer HT 1. The libraries were loaded and clustered onto the Illumina reaction flow 
cell using the Illumina cBot instrument using the TruSeq PE Cluster Kit v4-cBot-HS. 
The clustered flow cell was placed on the Illumina HiSeq 2500 instrument and the 
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9.2 Investigation of innate immunity and uterine 
inflammation caused by C. abortus infection using 
endometrial explant cultures 
9.2.1 Introduction 
Chlamydia abortus is the most common known infectious cause of ovine abortion 
worldwide (excluding New Zealand and Australia). Interestingly, the bacterium can 
also infect cattle but is not a causal factor of abortion. C. abortus can infect ewes at 
any time via the oro-nasal route and establish a latent sub-clinical infection. During 
pregnancy the bacteria colonize the placenta, inducing a powerful innate pro-
inflammatory response which can result in pathology (Rocchi et al., 2009). It is not 
known how this innate pro-inflammatory response is initiated. We hypothesize that 
sheep and cattle differ in their ability to innately sense and respond to C. abortus and 
that this may explain the differences in pathogenesis observed in ruminants.  
The primary focus of the PhD project has been the investigation of in vitro responses 
of various cell types to C. abortus infection, including oro-nasal turbinate cells 
(potentially the primary targets for the bacteria) macrophages and dendritic cells. 
Interestingly, both macrophages and dendritic cells were found to produce IL-1β in 
response to C. abortus infection whereas turbinate cells did not. Studies investigating 
the role of IL-1β in other chlamydial species suggest that this cytokine has an 
important role in bacterial clearance but is also involved in pathology. As IL-1β has 
been linked with infection associated pre-term birth in animal models it may have a 
critical role in pathology, hence our interest in investigating the expression of this 
cytokine in the uterine tissues of sheep and cattle.  
9.2.2 Aims  
Ex-vivo uterine explants provide an opportunity to study host-pathogen interactions 
within intact tissue architecture unlike single-cell in vitro assays. As a precedent, ex-
vivo fallopian tube explants up-regulate prokineticin receptor expression in response 
to C. trachomatis infection, which may be linked to ectopic pregnancy (Shaw et al., 
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2011). At the start of this PhD project there were no validated ex-vivo models that 
detect cytokine production in the ruminant uterus following infection. However, a  
bovine endometrial explant model has recently been developed and the protocol 
published (Borges et al., 2012).  The aims of this project were to: (A) learn how to 
isolate bovine endometrial explants from the group at Swansea University, led by 
Prof Martin Sheldon, who developed the technology; and (B) transfer the method 
back to the MRI where the effects of C. abortus infection on uterine cytokine 
production could be investigated and compared between cattle and sheep.  
9.2.3 Methodology 
A visit to the laboratory in Swansea was arranged for July 2013. Uteri were collected 
from the local abattoir in Swansea and transported back to the laboratory where the 
uterine horns were cut open to expose the endometrium. Biopsy punch explants were 
collected from intercaruncular areas of the endometrium and cultured in 6 well plates 
for up to 96 hours. This protocol was repeated at the MRI with both cattle and sheep 
uteri and explants were cultured overnight and then infected with C. abortus. 
Explants were also collected into neutral buffered formalin and snap-frozen for 
immunohistochemical analysis of infection and inflammation. Culture supernatants 
were collected at various time points for analysis by cytokine ELISA and cell lysates 
collected for RNA analysis. 
9.2.4 Results 
Immediately apparent was the distinct anatomical differences between bovine and 
ovine uteri. The uteri walls were much thinner in the sheep and the whole of the 
endometrium was covered in caruncles compared to cattle (Figure 9.1).  
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Figure 9.1: Bovine (A) and ovine (B) uteri collected from the abattoir. 
Due to these anatomical differences it was not possible to collect the single 
endometrial layer from the ovine uteri. Therefore biopsy punches through the uterine 
wall, including both the endometrial layer and stroma were taken and cultured using 
the bovine explant protocol.  
Ovine and bovine explants were found to express mRNA encoding TLR2, TLR4, 
NOD1 and NLRP3 which are important PRRs for sensing bacterial pathogens. 
Immunohistochemical analysis identified C. abortus within the bovine explants but 
not the ovine explants. This suggests that the bovine explants were susceptible to C. 
abortus infection but further optimisation is required to establish an active infection 
in the ovine explants (Figure 9.2).  
 
Figure 9.2: Immunohistochemistry with C. abortus challenged endometrial explants. 
Positive brown staining was present in the bovine endometrial explants (A) which specifically 
labelled infected cells (B). No positive immunohistochemical staining was observed in ovine 
explants (C). 
The explants produced the innate immune chemokines/cytokines CXCL8, TNF-α, 
IL-6 and IL-1β. However, these were highly variable between animals. Moreover, 
there was no significant effect of C. abortus infection on cytokine/chemokine 
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production (Figure 9.3), which is different to the effects that have been observed with 
single-cell ruminant cultures. 
 
Figure 9.3: IL-1β production by bovine (A) and ovine (B) endometrial explants in 
response to C. abortus infection. 
9.2.5 Conclusions and summary 
The development of a protocol for the generation of bovine endometrial explants 
provided a valuable opportunity to assess uterine immune responses to C.abortus. 
Due to the anatomical differences between cattle and sheep uteri it became clear that 
direct comparisons could not be drawn between the species as described in the aims. 
Furthermore, the inherent variation between animals made it difficult to establish any 
clear effect of C. abortus infection on cytokine production.  It is possible that further 
studies on a larger number of uteri would reveal trends. Although the results were 
overall inconclusive with regards to cytokine production, the project has confirmed 
the expression of PRRs in both cattle and sheep uteri. The project has added another 
layer to the PhD ensuring that more than in vitro immunology data is considered and 
has allowed new skill sets to be developed in anatomy and tissue handling. Close 
collaboration between Swansea University and Moredun Research Institute has 
allowed the successful transfer of endometrial explant technology which has great 
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a  b  s  t  r  a  c  t
Chlamydia  abortus  is  an  obligate  intracellular  bacterium  that  is  an  important  cause  of  ovine  abortion
worldwide.  There  are  reports  of  abortions  in cattle,  but these  are  very  rare compared  to  the  reported  inci-
dence in  sheep.  The  bacterium  is  transmitted  oro-nasally  and  can establish  a sub-clinical  infection  until
pregnancy,  when  it can  invade  the placenta  and  induce  an  inflammatory  cascade  leading  to  placentitis
and  abortion.  Early  host–pathogen  interactions  could  explain  differential  pathogenesis  and  subsequent
disease  outcome  in ruminant  species.  In  this  study,  we  assessed  the  ability  of sheep  and  cattle  oro-nasal
turbinate  cells  to sense  and  respond  to C. abortus  infection.  The  cells  expressed  toll  like  receptor  (TLR)
2, TLR4,  nucleotide  oligomerization  domain  (NOD)  1 and  NOD-like  receptor  pyrin  domain  containing  3nflammation
uminant
(NLRP3)  mRNA.  In response  to  C.  abortus  infection,  both  ovine  and bovine  turbinate  cells  produce  CXCL8
mRNA  and  protein  late  in  the  bacterial  developmental  cycle,  but do not  produce  IL-1  or  TNF-.  The  UV-
inactivated  bacteria  did  not  elicit  a CXCL8  response,  suggesting  that intracellular  multiplication  of  the
bacteria  is important  for activating  the  signalling  pathways.  The  production  of  innate  immune  cytokines
from  cattle  and  sheep  turbinate  cells  in  response  to  C.  abortus  infection  was  found  to  be largely  similar.
© 2015  Elsevier  B.V.  All  rights  reserved.. Introduction
Chlamydia abortus is a major infectious cause of ovine abortion
orldwide (excluding Australia and New Zealand). The bacteria
an also cause abortion in goats, but interestingly, is rarely linked
o abortion in cattle even though cattle are susceptible to infec-
ion (Animal and Plant Health Agency (APHA), 2014; Longbottom
nd Coulter, 2003). C. abortus is transmitted oro-nasally and can
nfect the ewe at any time, persisting sub-clinically (site unknown)
ntil late stage gestation when abortion facilitates the shedding of
he bacteria for propagation of the infection cycle. Once a ewe has
borted due to C. abortus it does not abort again with re-infectionPlease cite this article in press as: Doull, L., et al., Late production of CXC
abortus infection. Vet. Immunol. Immunopathol. (2015), http://dx.doi
ndicative of the development of protective immunity (Rocchi et al.,
009).
∗ Corresponding author at: Moredun Research Institute, Pentlands Science
ark, Bush Loan, Edinburgh EH26 0PZ, Scotland, UK. Tel.: +44 131 445 5111;
ax:  +44 131 445 6235.
E-mail address: gary.entrican@moredun.ac.uk (G. Entrican).
ttp://dx.doi.org/10.1016/j.vetimm.2015.08.011
165-2427/© 2015 Elsevier B.V. All rights reserved.During late-stage gestation, C. abortus recrudesces from its per-
sistent state and invades the placenta inducing an inflammatory
cascade typified by the infiltration of immune cells and production
of TNF- and CXCL8 (Kerr et al., 2005; Wheelhouse et al., 2009).
To date, the strongest known single immunological correlate of
protection to C. abortus is the production of IFN-; however the
ovine cellular source of IFN- and the innate immune mediators
involved have yet to be elucidated (Entrican et al., 2010). Gener-
ally, the current understanding of innate and adaptive immune
responses in small ruminants is relatively poor due to lack of spe-
cific immunological tools (Entrican and Lunney, 2012). The study
of C. abortus in both small and large ruminants should there-
fore inform on pathogen-host co-evolution, thereby highlighting
potentially important differences in immune recognition which
contribute to pathological outcomes.
The genus Chlamydia currently comprises 12 species (Sachse
et al., 2014; Vorimore et al., 2013) that share a characteris-L8 in ruminant oro-nasal turbinate cells in response to Chlamydia
.org/10.1016/j.vetimm.2015.08.011
tic biphasic developmental cycle, which involves extracellular
and intracellular forms. The infectious elementary body (EB)
is internalized by the host cell and induces the formation of
an intracellular vacuole that allows transformation into the
 ING ModelV
























































ARTICLEETIMM-9393; No. of Pages 6
 L. Doull et al. / Veterinary Immunology
etabolically active reticulate bodies (RB), which multiply by
inary fission (Abdelrahman and Belland, 2005). Consequently,
oth intracellular and extracellular pathogen recognition receptors
PRRs) are likely to be important for the detection of the bacteria
y the host cell. A number of studies in mice and humans have
ighlighted the importance of TLR2 and TLR4 found on the host
ell surface and intracellular NLRP3 and NOD1 for the activation of
ignalling pathways and release of pro-inflammatory chemokines
nd cytokines in response to chlamydial infection (Rusconi and
reub, 2011; Shimada et al., 2012). In particular, CXCL8, TNF- and
L-1 have been identified as important innate immune cytokines
roduced in response to chlamydial infection (Rusconi and Greub,
011).
Turbinate cells are components of the oral-nasal mucosa, which
orms one of the first barriers of immune defence to pathogens.
herefore, the role of cattle and sheep turbinate cells to detect
nd activate the innate immune response to C. abortus infection
as investigated. The expression profiles of pathogen recognition
eceptors (PRRs) by ovine and bovine turbinate cells and their pro-
uction of innate immune chemokines and cytokines in response
o C. abortus infection was  assessed.
. Materials and methods
.1. Propagation of C. abortus stocks
C. abortus strain S26/3 was isolated at the Moredun Research
nstitute (MRI) and grown and titrated in HeLa cells, as previously
escribed (Graham et al., 1995). Harvested bacteria were re-
uspended in sucrose–phosphate–glutamate (SPG) (sucrose based
edium containing FBS, antibiotics and fungicides) for storage at
80 ◦C.
.2. Cell culture and infection
Ruminant turbinate cells were generated at post-mortem by
arvesting foetal turbinate tissues, which were then trypsinised to
ake a single cell suspension and cultured as previously reported
McClurkin et al., 1974) in order to create frozen cell banks. The
rimary cell lines used in this study represent different passages
f cattle and sheep turbinate cells that were initially derived from
he same fetal bovine or fetal ovine sources, respectively. These
ells were screened and shown to be negative for pestivirus. After
esuscitation, cells were adjusted to 1 × 105/ml  and grown to sub-
onfluence by adding 1 ml/well in 24 well plates (Corning Costar,
igh Wycombe, UK) or 500 l/well in 8-well chamber slides (Nunc,
oskilde, Denmark). The culture medium consisted of Iscove’s Mod-
fied Dulbecco’s Medium (IMDM, Life Technologies, Paisley, UK)
upplemented with 10% heat inactivated fetal calf serum (PAA, Han-
iger, Austria). As for the cell lines, the fetal calf serum was  tested
or live pestivirus and shown to be negative. The cells were then
hallenged with live C. abortus at a multiplicity of infection (MOI)
f 10, with UV inactivated C. abortus (equivalent to MOI  10) and
edium only. UV treatment was shown to be effective at killing
he bacteria as UV-inactivated C. abortus failed to form inclusions
n HeLa cells (data not shown). Supernatants and lysates were har-
ested at 24, 48 and 72 h from separate wells. The experiments
ere repeated on three separate occasions.
.3. Immunofluorescence
Slides were fixed in cold 90% acetone 10% methanol and storedPlease cite this article in press as: Doull, L., et al., Late production of CXC
abortus infection. Vet. Immunol. Immunopathol. (2015), http://dx.doi
t −20 ◦C. Slides were rehydrated in PBS prior to the addition of
mage-iT® FX signal enhancer (Life Technologies) for 30 min  in a
umidity chamber protected from light. The slides were washed
nd then incubated with 1:1000 anti-C. abortus MOMP  mouse PRESS
mmunopathology xxx (2015) xxx–xxx
monoclonal antibody (mAb) (4/11) (Santa Cruz Biotechnology, Hei-
delberg, Germany) for 30 min. After washing the slides three times,
the Alexafluor 488 goat anti-mouse IgG (H + L) secondary polyclonal
antibody (pAb) (Life Technologies) was  added at 1:2000 for 30 min.
The slides were washed three more times before mounting with
ProLong Gold anti-fade reagent containing DAPI (Life Technolo-
gies).
2.4. Total RNA extraction and cDNA preparation
Cell lysates were harvested and stored in RLT lysis buffer at
−80 ◦C before total RNA was extracted using the RNAeasy plus mini
kit (Qiagen, Crawley, UK), following the manufacturer’s instruc-
tions. The concentration of RNA was determined using a Nanodrop
spectrophotometer (Thermofisher Scientific, Rochester, NY, USA)
and 1 g reverse transcribed into cDNA using Taqman® Reverse
Transcription Reagents (Life Technologies). Reverse transcriptase
was omitted from the process for the production of negative con-
trols. Peripheral blood mononuclear cells (PBMC) were stimulated
with Concanavalin A (Con A; ICN Biochemical, Cleveland, OH,
USA) at 5 g/ml for 24 h to generate cDNA to be used as positive
controls.
2.5. Standard PCR
Primers were designed using primer 3 (http://primer3.
sourceforge.net/) and details are shown in Table 1.
PCR cycling conditions were 95 ◦C for 5 min, followed by 40
cycles of 95 ◦C for 30 s, the appropriate annealing temperature for
30 s and 72 ◦C for 1 min  and then a final extension of 72 ◦C for 5 min.
The cycle was  finished with 5 min  at 72 ◦C. PCR products were run
along with a 100 bp ladder (New England Biolabs, Hitchin, UK) on
a 1% agarose gel containing Gel RedTM (Biotum, Hayward, CA, USA)
and visualized using UV light.
2.6. Taqman RT-PCR
Taqman RT-PCR was  run using custom designed primers
and probes for CXCL8. The commercially available eukaryotic
18s rRNA endogenous control (VIC/TAMRATM, Life Technolo-
gies), identified as the most stably expressed compared with
GAPDH and -actin, was used as the reference gene. The bovine
CXCL8, TNF- and IL-1 primers and FAM/TAMRA probes used
were previously designed (Galvao et al., 2012; Leutenegger
et al., 2000), as were the ovine IL-1 and TNF- primers and
FAM/TAMRA probes (Budhia et al., 2006). The ovine CXCL8 for-
ward primer (5′-CACTGCGAAAATTCAGAAATCATTGTTA-3′), reverse
primer (5′-CTTCAAAAATGCCTGCACAACCTTC-3′) and probe (FAM-
CCAACGGAAAAGAGGTGTGCTTAGACCCC-TAMRA) were designed as
part of this study using Primer Express (Life Technologies). Samples
were analyzed in triplicate on an ABI prism 7000 machine (Applied
Biosystems, Foster City, CA, USA) using the following cycling con-
ditions; 50 ◦C for 2 min, 95 ◦C for 10 min  and 40 cycles at 95 ◦C for
15 s followed by 60 ◦C for 1 min. Gene expression was quantified
using the comparative 2−CT method. Cells cultured without any
exogenous stimulation in medium alone were harvested at each
time point and used as a calibrator for all analyses of the treatment
groups at that time point.
2.7. Cytokine ELISAs
Cytokine sandwich ELISAs using commercial pairs of mouseL8 in ruminant oro-nasal turbinate cells in response to Chlamydia
.org/10.1016/j.vetimm.2015.08.011
anti-sheep mAbs and rabbit anti-sheep pAbs to CXCL8 and IL-1
(Bio-Rad AbD Serotec, Kidlington, UK), or rabbit anti-bovine pAb
and biotin conjugated pAb to TNF- (Thermoscientific, Cramling-
ton, UK) were run as previously described (Rothel et al., 1998).
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L. Doull et al. / Veterinary Immunology and Immunopathology xxx (2015) xxx–xxx 3
Table  1
Standard PCR primer sequences for the detection of PRRs in ruminant turbinate cells.




Ovine NOD1 XM 004007930.1 CCA TCT TTG AAG TCG GGA TG CGG GCT TTA TCA AGT TTC CA 378 50
Ovine  NLRP3 XM 004008740.1 AAT CCC TTT CCC TGA GGT TG GGG AAT GGT TGG TGC TTA GA 531 52
Ovine TLR2 NM 001048231.1 GCT CCT GTG ACT TCC TGT CC AGT GGG AGA AGT CCA GCT CA 555 52
Ovine TLR4 NM 001135930.1 GGA CAA CCA ACC TGA AGC AT TGA GGT TCC TTG GCA AAT TC 525 50
Bovine NOD1 NM 001256563.1 GCC TTC TTT GCT GCC CTT TTT C CCC CAC CTT TTC ACT CTG TGT C 395 52
Bovine NLRP3 NM 001102219.1 TCA AGC TGT CCA CCA GAA TG CAG AAT TCA CCA ACC CCA GT 711 52
Bovine TLR2 NM 174197.2 GGG GAT GAC AGA GGA TGA GA GGC AGA AAG CTG ATG GAA AG 404 52
Bovine TLR4 NM 174198.6 GAC CCT TGC GTA CAG GTT GT GGT TGA GTA GGG GCA TTT GA 538 52
Fig. 1. Immunofluorescent images of bovine (A–C) and ovine (D–F) turbinate cells demonstrating susceptibility to C. abortus infection. C. abortus was labelled green with
anti-C.  abortus MOMP  mouse monoclonal antibody 4/11 and visualized using Alexafluor 488 goat anti-mouse IgG secondary antibody and host cell nuclei were stained blue
with  DAPI. Turbinate cells challenged with MOI  10 live C. abortus (A, D), UV inactivated C. abortus (MOI 10 equivalent) (B, E) and medium only (C, F) for 72 h. The scale bars
correspond to 20 m.



















BMC,  which was  then reverse transcribed and PRRs amplified with specific primer
nd  12: no reverse transcriptase control. Lanes 1–3: NLRP3; Lanes 4–6: NOD1; Lane
olecular weight.
ecombinant ovine CXCL8 expressed in Chinese Hamster Ovary
ells by a standard protocol (Wattegedera et al., 2004), recombinant
ovine IL-1 (Bio-Rad AbD Serotec) and recombinant bovine TNF-
 (Bio-Rad AbD Serotec) were used to generate standard curves.
he ELISAs were cross-reactive between cattle and sheep (Caswell
t al., 1998; Tahoun et al., 2015; Wheelhouse et al., 2009) and had
he following sensitivities: CXCL8 15 pg/ml; TNF- 1.95 ng/ml and
L-1 60 pg/ml.
.8. Statistical analysis
Data included the expression profiles of CXCL8 mRNA and pro-
ein, and comprised three different passages of cell lines for each
pecies (bovine and ovine) to which each level of treatment groupPlease cite this article in press as: Doull, L., et al., Late production of CXC
abortus infection. Vet. Immunol. Immunopathol. (2015), http://dx.doi
3 levels: live C. abortus, UV inactivated C. abortus and medium
nly) was applied and measured at three time points (24, 48 and
2 h). The data on mRNA were obtained by comparative 2−CT
ethod by calibrating the expression for medium control fromle 1). Lanes 1, 4, 7 and 10: turbinate cells; Lanes 2, 5, 8 and 11: PBMC; Lanes 3, 6, 9
 TLR2; Lanes 10–12: TLR4. L: 100 bp ladder. Products obtained were of the expected
each treatment group for each time point. Both mRNA and protein
data showed increased variability with increased mean; hence the
data on mRNA and protein were transformed by the logarithmic
(after adding a constant value of 1) and square root transforma-
tion, respectively. The main effect of species, treatment group and
time as well as possible two and three-way interaction effects
were tested by univariate analysis of variance separately for the
expression data of CXCL8 mRNA and protein. The blocking structure
included the following categorical variables: cell line and inter-
actions of cell line by treatment group and cell line by time. The
overall statistical significance of the interaction effect was  assessed
using the F-statistic. If the overall test was statistically significant
(P < 0.05), we obtained two-sided probabilities of comparisons of
means of treatment groups at each time point. Finally, these prob-L8 in ruminant oro-nasal turbinate cells in response to Chlamydia
.org/10.1016/j.vetimm.2015.08.011
abilities were adjusted using a False Discovery Rate (FDR) approach
(Benjamini and Hochberg, 1995) to take into account the multiple
comparisons of means so that the expected proportion of false posi-
tives among all positives (i.e. rejecting the null hypothesis) was less
Please cite this article in press as: Doull, L., et al., Late production of CXCL8 in ruminant oro-nasal turbinate cells in response to Chlamydia
abortus infection. Vet. Immunol. Immunopathol. (2015), http://dx.doi.org/10.1016/j.vetimm.2015.08.011
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Fig. 3. CXCL8 mRNA and protein production by ruminant turbinate cells in response to C. abortus. The expression of (A) CXCL8 mRNA (on the logarithmic scale after adding
a  constant of one), measured in two treatment groups (response to UV-inactivated C. abortus and live C. abortus) relative to medium alone and (B) protein (on the square
root  scale) measured in three treatment groups (response to medium alone, UV-inactivated C. abortus and live C. abortus) at three different time points (24, 48 and 72 h)
in  two  ruminant (bovine and ovine) turbinate cells. The plots show the mean expression (solid square) of mRNA and protein along with corresponding 95% confidence
intervals (error bar). The plots also present the observed mRNA or protein data on each treatment group; with shapes (circle, triangle and diamond) representing each of the
three  treatment groups. The data on the expression profiles of mRNA and protein were separately analyzed using an analysis of variance approach incorporating main and
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han 5% and we denoted the adjusted probabilities as Pf. Statistical
nalyses were performed using GenStat (GenStat version 16.2) and
 (R Core Team, version 3.1).
. Results and discussion
Previous in vivo studies in sheep have demonstrated that C.
bortus can induce abortion if inoculated over the tonsillar crypts
Jones and Anderson, 1988) and mucosal nasopharyngeal lymphoid
issues prior to a subsequent pregnancy (Longbottom et al., 2013).
his suggests that turbinate cells are an appropriate in vitro model
or studying initial infection. Initially, the ability of ovine and bovine
urbinate cells to sustain an active C. abortus infection was  assessed.
hallenge with live C. abortus resulted in the formation of large
ntracellular inclusions (Fig. 1A, D) at 72 h post-infection. Inclusions
ere not visible after exposure to UV-inactivated C. abortus how-
ver, visible fluorescent specks, an indication of dead bacteria, were
resent (Fig. 1B, E) which were not detected in the non-exposed
ontrols (Fig. 1C, F).
As turbinate cells are a component of the oro-nasal mucosa,
hey are likely to be important sentinels of the immune system.
e observed that ruminant turbinate cells express NLRP3, NOD1,
LR2 and TLR4 (Fig. 2); thus ruminant turbinate cells fit the sen-
inel role as a varied complement of PRRs would be beneficial in
he detection of pathogens. The human nasal mucosa expresses
LR2, TLR4 (Vandermeer et al., 2004), NOD1 and NLRP3 (Bogefors
t al., 2010), and this is the first study to demonstrate that ruminant
urbinate cells also express these receptors. As these cells express
 range of PRRs, they have the potential to respond to both intra-
ellular and extracellular stages of C. abortus infection and activate
ignalling pathways leading to the transcription of cytokines and
hemokines.
The expression profiles of CXCL8, TNF- and IL-1 mRNA and
rotein in three treatment groups (live C. abortus, UV-inactivated C.
bortus and medium only) were assessed at three time points (24,
8 and 72 h). There was no IL-1 mRNA or protein detected at any
ime points nor any TNF- protein. Although low mRNA signal was
etected in the TNF- RT-PCR, it was around the threshold limit
f detection for the assay. The absence of IL-1 and TNF- mRNA
xpression or protein production from ruminant turbinate cells is
erhaps not too surprising as these cytokines are more commonly
but not exclusively) produced by myeloid cells, as has been shown
or C. trachomatis and C. pneumoniae infections (Rusconi and Greub,
011).
For the expression profile of CXCL8 mRNA, the interaction effect
f treatment group and time was statistically significant (P = 0.006).
he mean CXCL8 mRNA expression, relative to the medium only
roup, in ovine and bovine turbinate cells for the live C. abortus
roup was significantly higher compared with the UV-inactivated
. abortus group at 72 h post infection (Pf < 0.001) (Fig. 3A). The
XCL8 protein production mirrored the CXCL8 mRNA profiles: the
nteraction effect of treatment group and time was statistically sig-
ificant (P < 0.001). The live C. abortus treatment group produced
ignificantly higher mean CXCL8 protein compared with the UV-
nactivated C. abortus treatment group at 72 h post infection in both
vine (Pf < 0.001) and bovine (Pf = 0.028) turbinate cells (Fig. 3B).
he live C. abortus group also showed higher mean CXCL8 protein
roduction compared with the medium only group at 72 h post
nfection in both ovine (Pf < 0.001) and bovine (Pf = 0.022) turbinate
ells.
CXCL8 is a pro-inflammatory chemokine which functions as a
hemotactic factor driving the recruitment of immune cells includ-Please cite this article in press as: Doull, L., et al., Late production of CXC
abortus infection. Vet. Immunol. Immunopathol. (2015), http://dx.doi
ng neutrophils. Neutrophils have been identified as potential
arriers of C. pneumoniae, which may  perpetuate the survival and
issemination of the bacteria (Rupp et al., 2009; Zandbergen et al.,
004). Therefore, the production of CXCL8 by ruminant turbinate PRESS
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cells may  aid in the dissemination of C. abortus from the site
of infection. The increased CXCL8 production, however, occurred
only at 72 h, which is late in the chlamydial developmental cycle
(Longbottom and Coulter, 2003). Earlier studies identified that the
late production of CXCL8 is a feature of C. trachomatis infection of
epithelial cells (Buchholz and Stephens, 2006; Rasmussen et al.,
1997). Potential explanations on CXCL8 production at a later stage
include: inhibition of production by C. abortus, the pathogen asso-
ciated molecular pattern (PAMP) threshold is not reached until the
bacteria has multiplied or cell lysis is necessary for its production
(Buchholz and Stephens, 2008; O’Connell et al., 2006).
We did not find any statistical evidence of interaction effects
between species and treatment group, and between species and
time for the expression of mRNA (P > 0.12) and protein (P > 0.77).
These observations suggest that the production of CXCL8 from
bovine and ovine turbinate cells on average had similar trends
across treatment groups and time points. We  also did not observe
any evidence (Pf > 0.46) that the mean CXCL8 protein production
differed between the medium only group and UV-inactivated C.
abortus challenged group at any time point in either species (Fig. 3).
This implies that intracellular detection of the active infection
is necessary for the stimulation of CXCL8 mRNA expression. A
previous study has also shown that CXCL8 production in ovine
trophoblasts depends on challenge with live C. abortus compared
to UV-inactivated C. abortus (Wheelhouse et al., 2009). Gener-
ally, pathogens are recognized by a range of PRRs which initiate
a signal transduction cascade inducing activation of NF-B and
MAPK kinases and production of pro-inflammatory chemokines
and cytokines, including CXCL8 (Arthur and Ley, 2013). Previ-
ous studies have identified that the MAPK and NF-B signalling
pathways regulated the induction of CXCL8 production following
chlamydial infection (Buchholz and Stephens, 2006; Buchholz and
Stephens, 2008; Rasmussen et al., 1997; Welter-Stahl et al., 2006).
TLR2, which co-localises intracellularly with the inclusion, acti-
vates CXCL8 production from epithelial cells challenged with C.
trachomatis (O’Connell et al., 2006). Intracellular NOD 1 mediates
production of CXCL8 in an epithelial cell line challenged with C.
trachomatis (Buchholz and Stephens, 2008). Our  results showed
that ruminant turbinate cells express TLR2, TLR4 and NOD1 (Fig. 2),
which indicates that C. abortus may activate similar signalling path-
ways for the production of CXCL8 within turbinate cells.
Understanding how the early innate immune response activates
a protective adaptive immune response is critical for understanding
disease pathogenesis and for the delivery of new vaccines. In this
study, we observed that C. abortus is capable of infecting oro-nasal
turbinate cells from cattle and sheep. Both ovine and bovine cells
responded similarly to C. abortus infection by production of CXCL8
late in the chlamydial developmental cycle with undetectable lev-
els of IL-1 and TNF-. This suggests that innate cytokine and
chemokine production by turbinate cells is not a discriminating
factor for disease pathogenesis between cattle and sheep.
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